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Abstract 
Sonic hedgehog (Shh) is a secreted morphogen involved in patterning a wide range of 
structures in the developing embryo. When cells receive the Shh signal a cascade of effects 
begin which in turn regulate downstream target genes. The genes controlled by Sonic 
hedgehog provide messages instructing cells how to differentiate or when to divide. 
Disruption of the hedgehog signalling cascade leads to a number of developmental disorders 
and plays a key role in the formation of a range of human cancers. Patched, the receptor for 
Shh, acts as a tumour suppressor and is mutated in naevoid basal cell carcinoma syndrome 
(NBCCS). NBCCS patients display a susceptibility to tumour formation, particularly for basal 
cell carcinoma (BCC). The discovery of Patched mutations in sporadic BCCs and other 
tumour types further highlights the importance of this pathway to human cancer. 
The identification of genes regulated by hedgehog is crucial for understanding how disruption 
of this pathway leads to neoplastic transformation. It is assumed that the abnormal expression 
of such genes plays a large role in directing cells to divide at inappropriate times. Only a 
small number of genes controlled by Shh have been described in vertebrate tissues. 
In the work presented in this thesis a Sonic hedgehog responsive embryonic mouse cell line, 
C3H/10T1/2, was used as a model system for hedgehog target gene discovery. Known 
downstream target genes were profiled to determine their induction kinetics, building up a 
body of knowledge on the response to Shh for this cell type. During this work, it was 
discovered that C3H/10T1/2 cells do not become fully competent to respond to Shh 
stimulation until the cells reach a critical density, a factor that had to be taken into accoimt 
when determining timepoints of interest for further investigation. Several techniques were 
employed to identify genes that show expression changes between Shh stimulated and control 
cells. 
In one of these techniques, RNA from cell cultures activated with Shh was used to interrogate 
cDNA microarrays, and this provided many insights into the downstream transcriptional 
consequences of hedgehog stimulation. Microarrays consist of thousands of spots of DNA of 
known sequence gridded onto glass slides. Experiments using this technology allow the 
expression level of thousands of genes to be measured simuhaneously. Independent 
stimulation methods combined with northern blotting were used to investigate individual 
viii Abstract 
genes of interest, allowing genuine targets to be confirmed and false positives eliminated. 
This resulted in the identification of eleven target genes. Seven of these are induced by Sonic 
hedgehog {Thrombomodulin (Thbd), Glucocorticoid induced leucine zipper {GHz), Brain 
factor 2 {Bf2), Nuclear receptor subfamily 4, group A, member 1 {Nr4al), Insulin-like growth 
factor 2 {Igf2), Peripheral myelin protein 22 {Pmp22), Lim and SH3 Protein 1 {Laspl)), and 
four are repressed {Secreted frizzled related proteins 1 and 2 {Sfrpl and Sfrp2), Macrophage 
inflammatory protein-1 gamma {Mip-ly), and Anti-mullerian hormone {Amh)). The majority 
of these represent novel downstream genes not previously reported as targets of Shh. The new 
target genes have a diverse range of functions, and include transcriptional regulators and 
molecules known to be involved in regulating cell growth or apoptosis. 
The corroboration of genes previously implicated in hedgehog signalling, along with the 
finding of novel targets, demonstrates both the validity and power of the C3H/10T1/2 system 
for Shh target gene discovery. The identification of novel Sonic hedgehog responsive genes 
provides candidates whose abnormal expression may be decisive in initiating tumour 
formation and future studies will investigate their role in development and disease. It is 
expected that such findings will provide vital clues to the aetiology of various human cancers, 
and that an understanding of their roles may ultimately provide greater opportunities in the 
future design of anti-tumour therapies. 
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Chapter 1: General Introduction and 
Literature Review 
1.1 Introduction 
Understanding the molecular nature of human diseases with a genetic component offers not 
only new opportunities for the prevention and treatment of disorders, but also leads to a 
greater understanding of the fundamental workings of key biological processes. In the latter 
decades of last century the molecular origins of a number of genetic diseases were identified. 
The finding in 1996 of the gene mutated in one such disorder, naevoid basal cell carcinoma 
syndrome (NBCCS), has shed light on a particular pathway pivotal to regulation of normal 
growth and development. The disruption of this pathway, which is involved in receiving and 
interpreting the developmental signals from a secreted protein called Hedgehog, is now 
known to be associated with a number of human health problems. 
Studies of hedgehog signalling offer potential insight into important mechanisms of tumour 
formation, as the pathway is frequently disrupted in a number of cancer types. These range 
from the relatively benign basal cell carcinoma to meduUoblastoma and other often-fatal 
human neoplasms. In the six years since Patched (which acts as the receptor for Hedgehog) 
was identified as the gene responsible for NBCCS a number of research groups around the 
world have uncovered further components of this signalling pathway. Much progress has been 
made toward understanding the molecular mechanism of hedgehog signalling but despite this 
a number of questions remain unanswered. 
In many ways the hedgehog pathway acts as a master switch for the control of other genes 
needed at specific times. In the developing embryo, cells that sense the presence of hedgehog 
molecules respond by activating suites of genes that control differentiation or proliferation. 
The exact response depends on temporal and positional information and the type of receiving 
cell. In this way hedgehog is able to direct a diverse range of developmental processes in a 
large number of tissue types using the same underlying mechanism. 
An unanswered question of critical importance is what genes does hedgehog control. At 
present few of these downstream target genes are known in mammals. Understanding how 
defects in hedgehog signalling are involved in tumourigenesis will be aided by the 
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identification of these targets. Genes that control cell growth, when expressed at an 
inappropriate time or in an inappropriate place, can instigate neoplastic transformation. By 
finding such genes and investigating both their normal role and consequences of miss-
expression, we stand to learn more about the fiindamental molecular events leading to human 
cancer. This thesis details studies undertaken with the aim of discovering new downstream 
target genes regulated by the hedgehog pathway. 
This project was begun at a time when techniques using a genomic approach were becoming 
widely available, enabling biological investigations to be undertaken on a scale not previously 
possible. With the advent of microarray technology the expression of many thousands of 
genes can now be investigated simultaneously. This thesis describes the successfiil use of this 
technique for the discovery of novel target genes of the hedgehog pathway. Alternative 
methodologies were used in the early stages of this work before necessary resources became 
available for the microarray studies and are also included in this work. Two issues critical for 
meaningful biological outcomes from studies of comparative gene expression are: 
1. the development of a robust and biologically relevant model system 
2. the employment of rigorous control strategies 
Investigations used to establish such conditions and compare potential strategies for deliberate 
activation of the hedgehog signalling cascade are detailed in the early thesis chapters and are 
followed by sections describing investigations of differential gene expression. The latter 
chapters of this thesis describe the procedures used to validate genuine hedgehog target genes 
and the results of investigations into the transcriptional responses of these genes to hedgehog 
stimulation. The final chapter discusses the implication of the new findings in a biological 
context. 
1.2 The mechanism of hedgehog signalling 
Hedgehog is a secreted protein that acts as a morphogen to direct the patterning of many 
tissues and organs in the developing embryo. Much of what is known about this important 
molecule and the signalling pathway it is involved in came from studies in the firiit fly, 
Drosophila melanogaster. Hedgehog is the initial molecule in a complex signalling cascade 
that is highly conserved among invertebrate and vertebrate species. This chapter provides a 
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review of the literature outiining the components of the hedgehog signalling pathway, how 
these components are thought to act together to transmit the hedgehog signal and their 
importance in human disease. The final section of the chapter outlines the aims addressed by 
this thesis in respect to the current state of knowledge on the hedgehog pathway. 
1.2.1 Early studies and key pathway components in Drosophila 
Genes for both hedgehog {hh) and its receptor patched {ptc; originally referred to as patch 
{pat) in early studies) were initially identified during screening for mutations affecting 
Drosophila segmental polarity (Nusslein-Volhard and Wieschaus, 1980). Cloning of 
Drosophila ptc was achieved in 1989 (Hooper and Scott, 1989; Nakano et al, 1989), and 
followed three years later by the isolation of hh and its molecular characterisation by four 
independent laboratories (Lee, J. J. et al, 1992a; Mohler and Vani, 1992; Tabata et al, 1992; 
Tashiro et al, 1993). Both hh and ptc were named from the phenotypes of their mutants, 
which show disruption of normal segment formation in larvae and alterations to the wild-type 
pattern of hairs and bristles of the cuticle. 
Drosophila Hh is initially expressed as a 46 kDa protein, that is subsequently cleaved into two 
forms: a 19 kDa amino-terminal (Hh-N) and a 26 kDa carboxyl-terminal (Hh-C) fragment 
(Lee, J. J. et al, 1994). The cleavage is catalysed by the C-terminal region of Hh itself and 
involves cholesterol, which becomes bound to Hh-N during processing. The autocatalysis 
involves two steps. Firstly, a nucleophilic attack occurs which results in the formation of an 
internal thioester linkage between Glycine-257 and Cysteine-258. Addition of cholesterol to 
Gly-257 is then facilitated by Hh-C, resulting in splitting of the Hh molecule and release of 
the two fragments (Lee, J. J. et al, 1994; Bumcrot et al, 1995; Porter et al, 1995; Porter et 
al, 1996a; Porter et al, 1996b). While Hh-C is readily secreted, Hh-N and its attached 
cholesterol molecule tends to stay associated with the cell surface (Lee, J. J. et al, 1994; 
Bumcrot et al, 1995; Porter et al, 1995). Initially it was hypothesised that the two forms of 
Hh might represent a mechanism for long and short range signalling, however, all known 
signalling activities, both local and to more distant regions, can be attiibuted to Hh-N (Fan, C. 
M. et al, 1995; Roelink et al, 1995). 
In Drosophila and vertebrates Patched encodes a large twelve pass transmembrane protein 
with two large exfracellular loops and several sites of post-franslational glycosylation (Hooper 
and Scott, 1989; Nakano et al, 1989; Goodrich et al, 1996; Hahn, H. et al, 1996a; Johnson 
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et al, 1996). It has structural similarity to transporters of ions and small molecules, though 
biochemical studies have failed to find evidence of any channel fimction (Marigo et al, 
1996a). Two motifs of note are present by sequence homology: a small region related to 
growth hormone (Hooper and Scott, 1989) and a sterol sensing domain (Martin, V. et al, 
2001), the relevance of which is discussed in Section 1.2.7. As a receptor, Patched is unusual 
in that it does not appear to have direct signalling capability, and paradoxically activates the 
pathway rather than repressing it when its fimction is knocked out. This is exemplified by the 
phenotypes of Drosophila mutants, where loss of fimction of patched has opposite effects to 
loss of hedgehog activity (Ingham and Hidalgo, 1993). 
Strong evidence for Patched as a receptor for Hedgehog came from the work of Stone et al, 
(1996), who transfected mammalian cell lines with a Patched cDNA, and Marigo et al, 
(1996) who used Xenopus oocytes to produce Patched from injected messenger RNA. In both 
cases the Patched-expressing cells bound a vertebrate Hedgehog protein with high affinity and 
coimmunoprecipitation of Hh and Patched was demonsfrated. Importantly, binding occurs at 
similar levels to that at which Hedgehog is expected to fimction biologically (Fan, C. M. et 
al, 1995; Roelink et al, 1995). These studies confirmed the hypothesis of Ingham et al, 
(1991), who proposed Patched would act as the Hedgehog receptor by the unusual mechanism 
of ligand-dependent receptor inactivation. Patched can limit the range of Hh activity, 
suggesting that it has a dual fimction as both a receptor and a sink for Hh, limiting how far the 
Hh signal can travel as well as responding to it. As patched itself is up regulated in response 
to Hh, this provides a novel "self limiting" mechanism whereby Hh effectively confrols its 
own range of action (Chen, Y. and Struhl, 1996). 
A second gene encoding part of the hedgehog receptor-transducer complex, smoothened {smo, 
also referred to as smooth in initial studies) was also uncovered by the pioneering work of 
Nusslein-Volhard and Wieschaus (Nusslein-Volhard et al, 1984). In conti-ast to ptc, smo 
mutants in Drosophila do display a phenotype similar to that for hh mutants (Quirk et al, 
1997). Smo encodes a seven-pass fransmembrane protein with homology to members of the 
frizzled ifz) family of serpentine proteins (Alcedo et al, 1996; van den Heuvel and Ingham, 
1996). In addition, Smo also contains a long carboxy-terminal extension which contains 
consensus target sites for protein kinase A and G-protein-coupled receptor kinases (van den 
Heuvel and Ingham, 1996). Smo is analogous to molecules that regulate G-protein gated ion 
channels, initially suggesting that Smo might control a proposed channel fimction in Patched 
(van den Heuvel and Ingham, 1996). The observed biology showed an opposite scenario, 
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firstly because epistasis analysis of Drosophila mutants places ;?/c upstream of the effects of 
smo, and secondly because a range of biochemical studies have established that Patched 
signals through Smoothened, rather than the other way around. Though the protein encoded 
by smo looks like a classical receptor, it is Ptc and not Smo that binds Hh in biochemical 
studies (Stone et al, 1996). Although evidence for patched being the receptor for Hh is 
strong, this does not preclude Smo having an as yet unidentified ligand, especially given that 
it contains a region with homology to proteins implicated as Wnt receptors (Bhanot et al, 
1996). 
Steps in Hedgehog signal transmission are illustrated in Figure 1.1. In the absence of Hh, Ptc 
acts to inhibit the signalling activity of Smo. When Hh is present it is bound by Ptc, which 
then releases its inhibition and allows Smo to transmit the signal fiirther downstream 
(reviewed by Ingham, 1998). The exact mechanism by which this occurs is yet to be fiilly 
elucidated. Initially it was thought that Patched and Smoothened form a heteromeric 
signalling complex, such that release of inhibition could occur by a conformational change in 
Ptc upon Hh binding. Evidence for this theory came from studies showing patched and Smo 
can be immunoprecipitated as a complex both in the presence and absence of Hh (Stone et al, 
1996). This theory has been challenged by studies suggesting that active Smo does not remain 
associated with Ptc, and that Ptc may not interact stoichiometrically with Smo, but rather 
inhibits its activity by a catalytic mechanism (reviewed by Kalderon, 2000). Recent studies 
provide strong support for the latter hypothesis (Taipale et al, 2002). 
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Figure 1.1 Overview of key components of the hedgehog pathway and their interactions.
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The presence of Patched is not essential for signalling, and its removal results in constitutive 
signalling by Smoothened (Alcedo et al, 1996; Quirk et al, 1997). This unrestrained 
signalling through reduced or absent Patched function is thought to be responsible for the 
abnormalities observed in the human disease naevoid basal carcinoma syndrome, discussed in 
Section 1.6. 
In summary. Hedgehog inhibits Patched, which inhibits Smoothened signalling. This series of 
inhibitions that are functionally relieved on ligand binding is highly unusual for a receptor 
complex. Further transmission of the hedgehog signal through to the transcriptional control of 
Hh downstream target genes is discussed in the following section. 
1.2.2 Signal transmission after Hedgeliog reception 
The immediate action of Smo in transmitting the Hh signal is unknown, although a number of 
molecules involved in subsequent steps apparent from studies in Drosophila have been cloned 
and described. On the basis of epistatic relationships of various mutants with ptc, the genes 
fused, costal2 {cos2) and cubitus interruptus {ci), have been established as encoding 
components involved in transmitting the hedgehog signal (Forbes et al, 1993; Hooper, 1994). 
Cubitus interruptus was cloned in 1990 and found to encode a zinc finger transcription factor 
(Eaton and Komberg, 1990; Orenic et al, 1990). Ci acts to enhance transcription of several 
key hedgehog target genes including wingless {wg), decapentaplegic {dpp) and ptc itself 
(Alexandre et al, 1996; Dominguez et al, 1996; Hepker et al, 1997), and is considered to be 
the main, and possibly exclusive, mediator of hedgehog signalling in Drosophila. 
Ci activity is regulated post-transcriptionally by hedgehog signalling. In the absence of Hh, 
the full length 155 kDa protein (Ci^ ^ )^ is cleaved to yield a 75 kDa repressor molecule (Ci^ )^ 
that enters the nucleus and binds DNA to inhibit transcription of Hh target genes (Aza-Blanc 
et al, 1997). The presence of Hh inhibits Ci'^ ^ cleavage, thereby increasing the expression of 
Hh targets. Ci^ ^^  can also mediate positive effects of Hh signalling, as its ectopic expression in 
Drosophila causes an increase in the level of several known target genes (reviewed by Ruiz i 
Altaba, 1997, and Aza-Blanc and Komberg, 1999). 
Evidence for positive effects of Ci'^ ^ has led to a model where Ci has dual effects on Hh target 
genes, regulating genes both by repression and by activation. Support for this comes fi-om the 
analysis of null ci mutants in Drosophila that show a gain-of-fUnction phenotype when 
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compared to hh mutants. In the unstimulated state Ci acts as a repressor, therefore removing it 
from the system produces some effects that are normally only unmasked by hh stimulation in 
a wild-type animal (Methot and Easier, 2001). Interestingly, Ci'^^ has a cytoplasmic 
localisation and this has previously caused debate over whether or not a very small amount of 
Ci'^ ^ reaching the nucleus would be enough to trigger positive responses, or whether further 
processing or control is needed to produce an "activator" molecule. Evidence of a distinct 
activated form of Ci came from an elegant study by Methot and Easier, (1999), showing that 
prevention of proteolysis alone is insufficient for an activation phenotype and that hedgehog 
signalling is essential to allow the activator form to function. 
A further level of control over the activity of Ci is achieved by the genes costal2 {cos2), fused 
ifu) and suppressor of fused {Su(fu)). A current model for their involvement in hedgehog 
signalling is outlined in Figure 1.2. The proteins encoded by these three genes are involved 
with a microtubule bound complex that acts to tether full-length Ci in the cell cytoplasm. In 
the absence of Hh, full-length Ci is attached to microtubles via Cos2, a protein with sequence 
homology to kinesin motor proteins (Sisson et al, 1997; Robbins et al, 1997). Fused, which 
encodes a serine-threonine protein kinase, is also bound to the complex through interaction 
with Cos2 (Preat et al, 1990; Therond et al, 1993; Robbins et al, 1997; Monnier et al, 
2002). Ci is phosphorylated on several residues and this is important for cleavage and control 
of its activity. In this basal state, the repressor form of Ci can be formed by proteolysis and 
this travels into the nucleus. 
Stimulation by Hh causes the complex to dissociate from microtubules and causes inhibition 
of Ci cleavage, releasing target genes from the repressive effects of Ci^ ^ (reviewed by Ingham 
and McMahon, 2001). Su(fu) can then bind to full-length Ci in the cytoplasm, attenuating its 
activation activity by restricting its nuclear import (Monnier et al, 1998; Stegman et al, 
2000). Whether or not Su(fu) is present in the initial microtubule complex has not yet been 
resolved. In a currently accepted model, high levels of Hh also causes additional events occur 
which further modulate pathway action, including activation of the Fu kinase and 
dephosphorylation of Ci. The full-length Ci is no longer bound by Su(fu), and it is imported 
into the nucleus where it activates the expression of downstream target genes by interacting 
with CEP (for cAMP regulatory element-binding protein (CREB)-binding protein; Akimaru 
etal,\991). 
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Figure 1.2 A currently accepted model for regulation of hedgehog pathway signalling in 
Drosophila through a microtubule tethering complex. 
(A) In the absence of Hedgehog the proteins Suppressor of fused (Su(fu)) and Costal2 
(Cos2) interact with full length Ci (Ci^ ^^), retaining it in the cytoplasm via a microtubule 
bound complex involving Fused (Fu). Though it has been shown so for simplicity, it is 
still a mater of debate as to whether Su(fu) is part of the binding complex itself. While 
held in the cytoplasm much of the Ci is targeted for cleavage in a phosphorylation-
regulated process involving Protein kinase A (PKA) and Slimb. The cleavage product 
(Ci^ )^ can then travel to the nucleus and repress transcription of target genes. (B) When 
high levels of hedgehog are present the complex dissociates from microtubules and the 
Fu kinase is activated. The actions of Cos2 and Su(fu) are repressed, allowing full 
length Ci to reach the nucleus and activate transcription of Hedgehog target genes, a 
process that involves the co-factor CBP. 
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Protein kinase A (PKA) is known to be involved in hedgehog signalling, as a reduction in its 
activity in Drosophila leads to constitutive expression of Hh target genes (Jiang and Struhl, 
1995; Lepage et al, 1995; Li, W. et al, 1995; Pan, D. and Rubin, 1995). PKA exerts its 
effects by phosphorylating Ci'^^ in the absence of hedgehog, priming it for proteolysis to the 
repressor form (Aza-Elanc et al, 1997; Chen, Y. et al, 1998; Chen, C. H. et al, 1999; Chen, 
Y. et al, 1999; Methot and Easier, 1999; Price and Kalderon, 1999; Wang, G. et al, 1999; 
Methot and Easier, 2000). Although it has been proposed that Smoothened might exert its 
control by regulating PKA in a manner analogous to that used by G-coupled receptors 
(Alcedo et al, 1996; Alcedo and Noll, 1997), studies suggesting Hedgehog does not effect 
PKA activity provide evidence against this (Jiang and Struhl, 1995). 
In 1998 a further gene involved in hedgehog signal transduction, slimb, was identified and 
cloned (Jiang and Struhl, 1998; Theodosiou et al, 1998). Slimb encodes an F-boxAVD-40 
protein with homology to a yeast protein that targets cell-cycle regulators for degradation by 
the ubiquitin/proteasome pathway (Eai et al, 1996; Feldman et al, 1997; Skowyra et al, 
1997). The mechanism of slimb action is yet to be fully elucidated, but it is thought to be 
involved with Ci processing (Miletich and Limbourg-Eouchon, 2000). In the absence of 
Slimb full-length Ci accumulates in cells, though this alone is not sufficient for target gene 
activation (Wang, G. et al, 2000). 
1.2.3 Added levels of complexity and control in vertebrates 
The Hh pathway appears to be highly conserved between Drosophila and vertebrates, 
presumably highlighting the importance of Hh signalling in fundamental developmental 
processes. There are differences in pathway function in the nematode worm Caenorhabditis 
elegans, for which the genome has been sequenced in its entirety (The C. elegans Sequencing 
Consortium, 1998) and only contains obvious homologues of patched and ci, but not of hh or 
smo. However, a large number of molecules with some homology to hh have been found, and 
one or more of these may have diverged to assume the role of Hh (Eurglin, 1996; Porter et al, 
1996a; Hall et al, 1997; Aspock et al, 1999). Similarly, there appears to be no specific smo 
gene in C elegans, though sequence analysis shows a number of smo related frizzled 
homologues which may have diverged in function to take over the role of smoothened in the 
worm (Kuwabara et al, 2000). 
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In vertebrates the parallels to hedgehog signalling mechanisms in the fruit fly are striking, and 
differences are largely reflected by a number of Drosophila signalling components being 
represented by multiple vertebrate homologues (Table 1.1). For example, the single fly hh 
gene has three homologues in mammals: Desert hedgehog {Dhh), Indian hedgehog {Ihh) and 
Sonic hedgehog {Shh), the latter of which appears to play the most widespread and varied 
developmental role (Echelard et al, 1993; Krauss et al, 1993; Riddle et al, 1993; Chang, D. 
T. et al, 1994; Roelink et al, 1994). In terms of sequence Dhh is the most similar to 
Drosophila hh, while Shh and Ihh are closely related to each other and may have diverged 
later, possibly through gene duplication. Studies in other non-mammalian vertebrates have 
revealed additional hh homologues, including echidna hedgehog and tiggy-winkle hedgehog 
in zebrafish, and several hh homologues in amphibian species (reviewed by Hammerschmidt 
etal, 1997). 
In contrast to the single patched gene in flies, mammals have two ptc homologues, Ptcl, 
normally just referred to as Ptc, (Goodrich et al, 1996; Hahn, H. et al, 1996b; Johnson et al, 
1996; Marigo et al, 1996c), and Ptc2 (Carpenter et al, 1998; Motoyama et al, 1998a; Lewis, 
K. E. et al, 1999a; Smyth et al, 1999). Conservation between the Drosophila and vertebrate 
proteins is highest in the transmembrane domains and extracellular loops, suggesting that 
functionally important domains reside in these regions (Goodrich et al, 1996). 
Eoth Ptcl and Ptc2 have been shown to bind hedgehog molecules in biochemical studies 
(Carpenter et al, 1998), but their expression patterns show distinct differences that suggest 
Patchedl is the primary receptor in the majority of mammalian tissues. Ptcl has a diverse 
expression pattern in the developing mouse embryo, whereas Ptc2 is predominantly expressed 
in skin and spermatocj^es (Carpenter et al, 1998). As Dhh is expressed in the testis and few 
other sites it has been suggested that Ptc2 and Dhh may have co-evolved as partner molecules 
to specify patterning in this region (Carpenter et al, 1998). A distinct difference in the protein 
structure of the two Patched proteins is a 150 amino acid carboxyl-terminal region present in 
Ptcl that is absent in Ptc2. This has led to the suggestion that the two patched proteins may 
function in different ways (Motoyama et al, 1998b). Whether or not Ptc2 acts as a functional 
receptor or simply acts as a hedgehog-sequestering antagonist is yet to be determined in vivo. 
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Table 1.1 Key hedgehog pathway proteins in Drosophila and their corresponding 
mammalian homologues. 
Function 
Morphogen 
Hedgehog binding; 
receptor 
Hedgehog binding; 
secreted 
Signal transduction factor 
Transcription factor 
Hedgehog release 
Hedgehog travel 
(HSPG synthesis) 
Regulation of Ci/GH 
(kinesin-related protein) 
Regulation of Ci/Gli 
(serine-threonine kinase) 
Regulation of Ci/Gli 
(exact function unclear) 
Drosophila protein 
Hedgehog (Hh) 
Patched (Ptc) 
— 
Smoothened (Smo) 
Cubitus interruptus (Ci) 
Dispatched (Disp) 
Tout-velu (Ttv) 
Costal2 (Cos2) 
Fused (Fu) 
Suppressor of fused 
(Su(fii)) 
Mammalian homologues 
Sonic hedgehog (Shh) 
Indian hedgehog (Ihh) 
Desert hedgehog (Dhh) 
Patched (Ptc/Ptcl) 
Patched2 (Ptc2) 
Hedgehog interacting 
protein (Hip) 
Smoothened (Smo) 
Glil 
Gli2 
Gli3 
Dispatched A 
Dispatched E 
Exostosin (Ext) proteins 
Costal2 * 
Fused (Fu) 
Suppressor of fused 
(Su(fii)) 
* A human Costal2 homologue has been identified, but it is as yet unpublished (personal comm.; Dr. 
M. Taylor). 
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The ci gene of Drosophila is represented in vertebrates by the Gli gene family, so named 
because the first member was discovered due to its amplification in human glioma. In 
mammals there are three family members: Glil, Gli2 and Gli3 (Kinzler et al, 1987; Ruppert 
et al, 1988; Ruppert et al, 1990; Hui et al, 1994). As with ci, these genes encode zinc finger 
transcription factors able to regulate gene expression by binding to DNA sequences (Kinzler 
et al, 1988). In contrast to the situation with Drosophila Ci, which appears to be controlled 
exclusively by mechanisms acting at the protein level, Glil is regulated in a number of tissues 
at the level of transcription. Interestingly, Gli2 and Gli3 appear to be regulated by a 
combination of both transcriptional and post-transcriptional control, though the details remain 
controversial (reviewed by Villavicencio et al, 2000; Ingham and McMahon, 2001). 
A range of studies suggest that Glil is the major mediator of Shh signalling in mammalian 
cells and that Glil is directly responsible for inducing transcription of a number of 
downstream molecules (Hynes et al, 1997; Sasaki et al, 1997; Ruiz i Altaba, 1998; Ruiz i 
Altaba, 1999). A nine base pair DNA consensus sequence has been identified as a Glil 
binding motif. This, and a number of closely related sequences, can interact with Gli proteins 
(Kinzler and Vogelstein, 1990). When the consensus Gli binding motif is placed in a plasmid 
construct and transfected into mammalian cells it activates the expression of a reporter gene in 
a hedgehog directed manner, further supporting its role as a transcriptional activator (Sasaki et 
al, 1997; Yoon et al, 1998; Murone et al, 1999). 
Recent studies suggest that Gli2 and Gli3 may actually be the primary response of hedgehog 
signalling and that their regulation of Glil may secondarily regulate expression of Hedgehog 
target genes (Dai et al, 1999; Sasaki et al, 1999). This does not preclude Gli2 and Gli3 fi-om 
also having other direct actions of their own. There is evidence that Gli2 and Gli3 contain 
both activator and repressor domains (Tanimura et al, 1998; Dai et al, 1999; Ruiz i Altaba, 
1999; Sasaki et al, 1999; Shin et al, 1999; von Mering and Easier, 1999), and the existence 
of shortened forms suggests these proteins may undergo cleavage analogous to the system of 
Ci regulation in Drosophila (Dai et al, 1999; Ruiz i Altaba, 1999; Wang, E. et al, 2000). 
There is now strong evidence for a cleaved repressor form of Gli3, which is important in 
vertebrate limb development (Dai et al, 2002). 
Further support for post-transcriptional regulation of the Gli proteins comes from the isolation 
of a vertebrate homologue of Su(fu), which has been shown to bind Glil in biochemical 
studies (Delattre et al, 1999; Ding et al, 1999; Kogerman et al, 1999; Pearse et al, 1999; 
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Stone et al, 1999; Grimm et al, 2001). A human homologue of fu has recently been isolated 
(Murone et al, 2000), as has a human homologue of cos2 (personal comm., Dr M. Taylor). 
In evolutionary terms, it has been hypothesised that the Gli genes have diverged to take over 
different subsets of ci regulation and function. Several innovative studies have attempted to 
address this issue by expressing the Gli genes individually in developing Drosophila imaginal 
discs. These studies predict an activator function for Glil, an activator and a repression role 
for Gli2, and repressor functions for Gli3 (von Mering and Easier, 1999; Aza-Elanc et al, 
2000). There is emerging evidence for activator and repressor roles for Gli family members in 
vertebrates, though the exact mechanisms are still a matter of debate (reviewed by Ingham 
and McMahon, 2001). The identification of a number of alternate transcripts of GLIl in 
human tissues that are generated by skipping of various 5' non-coding exons suggests a 
further degree of control at the level of mRNA processing (Wang, X. Q. and Rothnagel, 
2001). In summary, the control of Gli gene fiinction by Shh in vertebrates is complex, with 
multiple levels of regulation giving a greater level of control in the use of hedgehog signalling 
to pattern tissues in the mammalian embryo. Studies in transgenic and knockout animals 
suggest that in vivo there is some redundancy in the functions of Gli family members (refer 
Section 1.7). 
1.2.4 Feedback via antagonistic hedgehog target genes 
In Drosophila, three key targets of hedgehog signalling are the products of the ptc, dpp and 
wg genes (discussed further in Section 1.3). Patched is also up-regulated in a range vertebrate 
tissues and cell lines in response to hedgehog signalling (Goodrich et al, 1996; Marigo and 
Tabin, 1996; Murone et al, 1999). Analysis of the patched promoter in both Drosophila and 
vertebrates has shown the presence of consensus Ci/Gli binding sites, providing evidence that 
Patched is an immediate target of hedgehog signalling (Alexandre et al, 1996). Furthermore, 
increased Patched activity inhibits hedgehog target gene expression (Ingham, 1991; Capdevila 
et al, 1994; Gailani et al, 1996; Dahmane et al, 1997; Goodrich et al, 1997). As Patched is 
both an important inhibitor of hedgehog signalling and a transcriptional target of hedgehog 
action this leads to an intriguing auto-regulatory loop whereby patched effectively represses 
its own production. 
The auto-regulatory loop is thought to provide a fiirther level of pathway control, limiting the 
effects of hedgehog action. Cells that receive the hedgehog signal rapidly produce more 
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patched mRNA. After translation, the increase in Patched protein is hypothesised to act as a 
sink by sequestering further hedgehog molecules (Chen, Y. and Struhl, 1996). This may allow 
fine control of the pathway necessary for the establishment of discrete cellular boundaries 
during development. 
A second antagonist of hedgehog function is encoded by Hedgehog interacting protein {Hip), 
a secreted molecule that inhibits the pathway by directly binding to Hedgehog (Chuang and 
McMahon, 1999). Hip appears to be exclusive to vertebrates and may provide a further level 
of complexity and control needed for fine-tuning the pathway the development of complex 
organisms. Hip is a transcriptional target of Hedgehog, and is induced by pathway activation 
in a range of cell types (Chuang and McMahon, 1999). 
1.2.5 Sending the Hedgehog signal - insights from new mutants 
Several new mutants implicated in hedgehog signalling have recently been identified in 
Drosophila, giving new insight into the movement of Hedgehog between cells and the critical 
role this plays in pathway function. One finding of interest is that of a new segment polarity 
gene that when mutated in flies gives a phenotype remarkably similar to the hh mutant. The 
gene responsible has fittingly been named dispatched, reflecting its structure and proposed 
function (Eurke et al, 1999). 
Dispatched is required for the release of Hedgehog from secreted cells. Transfected constructs 
encoding just the N-terminal "active" region of Shh (Shh-N; amino acids 24-198 of the 
human or mouse sequence) produce a biologically functioning protein that has not undergone 
auto-cleavage nor cholesterol addition and is freely secreted into the media, a characteristic 
taken advantage of in following chapters of this thesis (Eumcrot et al, 1995; Porter et al, 
1995). Endogenous hedgehog on the other hand undergoes processing and the resulting 
molecule gains a covalently attached cholesterol moiety (as previously outlined in 
Section 1.2.1). Recent mass spectrometry studies indicate a palmitic acid molecule is also 
often attached to the N-terminus of human Shh-N (Pepinsky et al, 1998). In dispatched 
mutant cells endogenous Shh accumulates, but if the immodified Shh-N is expressed it leaves 
the mutant cells without hindrance. This indicates that Dispatched is involved in the release of 
the lipid-modified form of Shh (Eurke et al, 1999). 
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Interestingly Dispatched shows structural similarity to the Patched protein. In particular, both 
contain a motif known as the sterol sensing domain. This is discussed in the following 
sections with reference to its potential involvement in hedgehog signalling (Eurke et al, 
1999). Whether or not Patched and Dispatched share a common means of interacting with 
Hedgehog protein is still a matter of much discussion. 
Within the last year, four groups have independently reported another novel component of the 
hedgehog pathway that, like Dispatched, is required by Hedgehog secreting cells. Two of the 
groups identified the new gene using screens for mutants effecting the developing Drosophila 
compound eye, and separately named the gene sightless {sit; Lee, J. D. and Treisman, 2001) 
and central missing {cmn; Amanai and Jiang, 2001). The same gene was isolated by two other 
groups and was christened with two further independent names. One of these studies screened 
for Drosophila segment polarity genes and isolated skinny hedgehog {ski; Chamoun et al, 
2001), while the other isolated the gene by screening for zygotic lethal mutations associated 
with maternal effects. The later study named the gene rasp, after the cuticle phenotype which 
displayed numerous denticles and bears resemblance to a coarse file (Micchelli et al, 2002). 
Unlike dispatched, the action of sitlcmnlskilrasp is not dependent on Hedgehog having 
cholesterol modification. The protein encoded by this gene is a putative membrane bound 
acyltransferase with homology to porcupine, a molecule known to be involved in secreting 
the morphogen wingless, implying a common mechanism for different signal transduction 
pathways. The new protein is hypothesised to be involved in further lipid modifications of 
Hedgehog, which take place on the N-terminal amino acid of the protein (discussed in 
Section 1.2.7). 
Another mutant providing clues to the mechanism of hedgehog movement is tout-velu {ttv; 
meaning "all-hairy"), which encodes a gene required for the travel of cholesterol-modified 
hedgehog between cells during Drosophila development (Eellaiche et al, 1998). The human 
homologues of this gene, members of the exostosin (EXT) family, are putative tumour 
suppressors involved in bone morphogenesis and their existence suggests a conserved 
mechanism of hedgehog transfer in vertebrates and invertebrates (Ahn et al, 1995; Stickens et 
al, 1996). The protein encoded by ttv is a membrane localised enzyme involved in the 
synthesis of heparan sulphate proteoglycans (HSPG; The et al, 1999). 
HSPGs are large molecules composed of a protein core surrounded by attached 
glycosaminoglycan chains characterised by arrays of alternating disaccharide units. The 
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chains are highly complex and can reach several hundreds of nanometers, potentially touching 
adjacent cells. HSPGs are implicated in a wide range of biological processes and their actions 
are mediated by the interaction of polysaccharides with protein sequences. Some researchers 
consider HSPGs to be the third class of biological information containing molecules (after the 
poly-nucleic acids and proteins) since the chains carry negatively charged sulphate groups 
whose position on the sugar building blocks of the polysaccharide contributes to highly 
specific interactions. There is a mounting body of evidence that HSPGs interact with a wide 
variety of extracellular proteins and can act as co-receptors for a range of ligands. Extensive 
reviews on HSPG biology are provided by Park et al, (2000) and lozzo, (2001). 
Eiochemical studies with ttv mutants have confirmed the role of Tout-velu as a heparan 
sulphate co-polymerase (Toyoda et al, 2000a; Toyoda et al, 2000b). However, the molecular 
mechanisms by which the HSPGs created by Tout-velu move cholesterol-modified Hedgehog 
proteins between cells await further study. 
1.2.6 A possible role for protein trafficking in hedgehog signalling 
Recent discoveries have led some researchers to rethink aspects of the basic dogma presented 
in Section 1.2.1, which were previously assumed to take place at the cell surface. It now 
appears that intracellular trafficking events may form a crucial part of the hedgehog signalling 
mechanism. This idea has grown from three lines of evidence. 
Firstly, as mentioned in Section 1.2.5, Patched contains a protein motif called the sterol 
sensing domain (SSD). There are a number of known proteins that share significant homology 
with patched in this large transmembrane region, including HMG-CoA reductase, SREEP 
cleavage activating protein (SCAP), and NPCl, the protein responsible for Niemann-Pick C 
disease. As such proteins are involved in cholesterol movement and homeostasis, it is possible 
that the SSD of Patched may serve a similar role. SCAP functions to transport a protein 
involved in cholesterol metabolism between the endoplasmic reticulum and the golgi 
apparatus, where it is activated by processing (reviewed by Edwards et al, 2000). In contrast, 
the NPCl gene, which is more closely related to Patched, is involved in the transport of fatty 
acids across cell membranes (reviewed by Elanchette-Mackie, 2000). This led to the early 
hypothesis that Patched, via its SSD, may be involved in transporting Hedgehog into 
receiving cells, or alternatively may be involved in sensing lipid levels and may only allow a 
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response to the Hedgehog signal after an interaction involving the SSD has occurred 
(reviewed by Strauss, 1998). 
A second independent line of evidence implicating intracellular trafficking in hedgehog 
signalling has come from analysis of the open brain {opb) mutation in mice. The opb gene 
was identified from two mutations, one spontaneous and one from an N-ethyl-N-nitrosourea 
mutagenesis screen (Gunther et al, 1994; Kasarskis et al, 1998). Open brain acts downstream 
of Hedgehog as a negative regulator of the pathway. Cloning and subsequent analysis of the 
opb gene shows it encodes Rab23, a member of a large family of proteins involved in 
vesicular transport (Eggenschwiler et al, 2001). Just how Rab23 is involved in the hedgehog 
pathway and exactly what cargo it traffics is still a matter of speculation. 
The third line of evidence for a role of intracellular trafficking comes from studies of the 
localisation of components of the Hedgehog signalling machinery. Eoth Smoothened and 
Patched appear to show changes in position within cells in response to hedgehog stimulation, 
with Patched removed from the cell surface and internalised in endosomal compartments 
when hedgehog molecules are present {Denefet al, 2000; Incardona et al, 2000; Incardona et 
al, 2002). Intemalisation of Patched is a dynamin-dependent process that is mediated by 
clathrin-coated pits (Incardona et al, 2000). 
Experiments involving mutation of the sterol sensing domain of Patched provide further 
support for vesicular trafficking of Smo, showing that this requires an intact SSD function and 
that disruption of the SSD does not affect the interaction of Patched with Hedgehog (Martin, 
V. et al, 2001; Strutt et al, 2001). In addition, studies with ptc deletion mutants in 
Drosophila provide evidence that the two large extracellular loops of the Patched protein are 
involved in Hedgehog binding, and that inhibiting the normal glycosylation of the loops 
greatly inhibits the interaction (Marigo et al, 1996a). Studies in chicken neural explants 
imply that Shh is internalised by Patched, and a similar effect is observed when Patched is 
transfected into mammalian cells (Incardona et al, 2000). 
The latest component of the hedgehog pathway to be identified, and another with strong links 
to intracellular trafficking, is the product of the Megalin gene. There is similarity in the 
neurological phenotype of Megalin mouse mutants and mouse mutants of Hedgehog, and 
biochemical investigations have now shown that Megalin binds Hedgehog with high affinity 
(McCarthy et al, 2002). Megalin is a member of the low density lipoprotein receptor gene 
family, acts as a receptor for a range of ligands including retinoids and steroids, and as an 
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endocytic receptor transporting molecules into cells (reviewed by Willnow et al, 1999; 
Christensen and Eim, 2002). Just how this fits in with transduction of the hedgehog signal is 
not yet clear. 
In summary the studies outlined have led to a hypothesis quite different from the initial model 
of Smo and Ptc in a complex at the cell surface, with conformational changes in components 
upon Hedgehog binding leading to the signal being transmitted into the cell. Instead, it 
appears that Patched interacts with Smoothened indirectly, and that intracellular movement of 
protein components plays a major role in signal transduction. It is worth noting that events 
similar to those hypothesised for the hedgehog pathway have recently been implicated in 
notch signal transduction. Like the hedgehog pathway, the notch pathway is used for 
specification of cell types in development of a range of organisms. Drosophila notch encodes 
a transmembrane receptor for a ligand encoded by delta. As suggested for the hedgehog 
pathway, reception of the Delta signal by Notched involves ligand mediated endocytosis, also 
using a dynamin-dependent process (Parks et al, 2000). Trafficking events thought to be 
involved in Hedgehog signalling may not be an isolated case, but may represent a biological 
mechanism employed by multiple signal transduction pathways during development. 
1.2.7 IVIultiple roles for cholesterol in hedgehog pathway function 
As detailed in Section 1.2.1, Drosophila Hedgehog is autocatalytically cleaved, resulting in 
the covalent attachment of a cholesterol molecule. This also occurs with vertebrate hedgehogs 
in a similar manner (Lee, J. J. et al, 1994; Eumcrot et al, 1995). A further lipid moiety, a 
palmitoyl group, has been observed in human cells attached to the opposite (N-terminal) end 
of the truncated protein chain (Pepinsky et al, 1998). A study of neural development in rats 
has shown that the N-terminal fatty-acylation of Shh enhances its ability to cause 
differentiation (Kohtz et al, 2001), but in contrast non-acylated Hedgehog maintains a high 
level of activity in developing mouse limbs (Lee, J. D. et al, 2001). Addition of the N-
terminal lipid group in Drosophila appears to be mediated by the product of the 
sitlcmnlskilrasp gene (introduced in Section 1.2.5). A major question arising from this is what 
function do these multiple lipid modifications serve, given the observation that unmodified 
recombinant protein still has sfrong biological activity in many assays (discussed in 
Section 1.2.5). 
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An initial hypothesis proposed that the attachment of cholesterol might simply act as a tether 
for Hh proteins, preventing their uncontrolled diffusion away from secreting cells. 
Furthermore, it has been suggesting that the presence or absence of lipid may provide a 
mechanism by which hedgehog could have its observed affects of both short and long 
distance signalling. Some effects of long range signalling will no doubt involve diffusion of 
secondary proteins induced by Hedgehog, and one of the goals of this thesis is to discover 
candidates for such molecules. Nevertheless, local signalling to cell neighbours and signalling 
many cell diameters away from secreting cells have both been observed as direct features of 
Hedgehog proteins in a range of species (reviewed by Johnson and Tabin, 1995; Chuang and 
Komberg, 2000; McMahon, 2000). In Drosophila, non-lipid-modified Hedgehog in the wing 
causes activation of target genes well away from the source of protein (Porter et al, 1996a). 
A paradox is found when similar experiments are conducted in developing mouse digits. In 
this case unmodified Hedgehog has limited mobility, and the cholesterol modified form is 
essential for normal patterning (Lewis, P. M. et al, 2001). It has been speculated that the 
presence of Hip in vertebrates may account for this prevention of diffusion, and that 
cholesterol may be required for interaction with Tout-velu/Ext derived HSPGs (Ingham, 
2001). A breakthrough in the understanding of how lipid-modified Hedgehog can move 
through an aqueous environment to initiate long range signalling has come from a recent 
study that found modified-Shh migrates approximately six times more slowly that expected 
for its size when investigated by chromatography. From this, a model has been proposed 
whereby molecules of Shh form hexamers such that the hydrophobic additions would remain 
buried in the centre of the complex, effectively making it soluble in the aqueous extracellular 
environment (Zeng et al, 2001). 
Initially it was thought that since Patched contains a sterol sensing domain and cholesterol is a 
sterol that Patched-Hedgehog binding would take place via an interaction between the two. 
Surprisingly, this turns out not to be the case. Patched binds Hedgehog proteins with and 
without lipid modification with equal affinity, although lipid modification does increase 
potency by about thirty fold (Pepinsky et al, 1998). This, along with studies mentioned in the 
previous section showing mutation of the SSD does not affect hedgehog binding, hint at a 
different role for the attached cholesterol moiety. 
The discovery of a number of toxins affecting cellular cholesterol has provided tools to 
explore possible functions of cholesterol in hedgehog signalling. It was noticed in the first 
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half of last century that sheep grazing on the com lily, Veratrum californicum, often gave 
birth to lambs with holoprosencephaly (a defect in brain and midline stmcture formation) and 
cyclopia, the same features that present in human babies with mutation of Shh (discussed in 
detail Section 1.6). An analysis of this plant subsequently identified the steroid alkaloids 
jervine and cyclopamine. These compounds were found to cause developmental defects and 
have a similar physical stmcture to cholesterol. Dismption of specific steps in cholesterol 
biosynthesis, as can occur with certain dmgs or with genetic defects in the pathway, also leads 
to holoprosencephaly like symptoms (Reviewed by Beachy et al, 1997; Incardona and 
Roelink, 2000). Jervine dismpts cholesterol synthesis (Eeachy et al, 1997), whereas 
cyclopamine acts on hedgehog signalling by directly inhibiting the function of Smoothened 
(Chen,J.K. era/., 2002). 
There is now strong evidence to suggest that cholesterol plays a far greater part in hedgehog 
pathway function than just a role in hedgehog processing and diffusion. This has been 
revealed by perturbations to pathways involved in cholesterol homeostasis, caused by genetic 
defects and dmgs such as jervine. Surprisingly, jervine does not inhibit normal processing of 
Hedgehog, even at levels that are sufficient to have teratogenic effects, and when neural 
explants were treated with jervine or related compounds, the cells were no longer able to 
respond to lipid modified Shh (Cooper et al, 1998). This means cholesterol has at least two 
independent functions in the hedgehog pathway, one in cells sending the hedgehog signal and 
another in the cells receiving it. 
Exactly what role cholesterol plays in hedgehog receiving cells is still a matter of much 
speculation. There is some evidence that sterol-linked Hedgehog associates with cholesterol 
rich portions of the cell membrane known as raft microdomains (reviewed by Simons and 
Toomre, 2000). This suggests that Hh may be intemalised via caveloae, lipid-raft 
invaginations of the plasma membrane that contain the cholesterol binding protein Caveolin 
(Rietveld et al., 1999, Karpen et al., 2001). One theory is that some teratogenic alkaloids may 
inhibit cholesterol function, leading to reduced levels of cholesterol that may dismpt the 
formation of normal lipid rafts, which might dismpt hedgehog signalling (reviewed by 
Incardona and Eaton, 2000). 
An alternate theory is that the sterol sensing domain of Patched may provide a mechanism to 
monitor cholesterol levels within the cell by analogy with the detection of sterols by other 
SSD containing proteins (Incardona et al, 1998). As hedgehog signalling often promotes 
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proliferation, such a mechanism could act as a checkpoint, allowing Patched to respond to 
Hedgehog only when a sufficient level of steroids are present in the cell. The tme answer to 
the secondary function of cholesterol in hedgehog signalling awaits further investigation. 
1.2.8 Pathway branching and Patched-independent Hedgehog 
responses 
As described in previous sections, a central dogma has emerged whereby Hedgehog binds to 
Patched, causing Patched to release its inhibition of Smoothened, which then signals to 
mediate expression of downsfream target genes. Though this holds tme for a number of 
known target genes in a range of cell types, there is increasing evidence that this is not 
exclusively the case. 
The first clues that Hedgehog may be able to mediate some affects independently of Patched 
came from early studies in Drosophila. Since the phenotj^e of hhlptc double mutants is 
different from that of ptc alone this implies that Hedgehog has additional functions 
independent of Patched action (Eejsovec and Wieschaus, 1993). Furthermore, not all 
Hedgehog responsive cells express detectable levels of ptc (Heemskerk and DiNardo, 1994). 
The recent discovery of Megalin as an additional receptor for Hedgehog may partially explain 
such findings (discussed Section 1.2.6); though it is likely there are further mechanisms. 
As well as bifurcation at the level of hedgehog reception, there is also evidence for multiple 
effects further down the signal transduction pathway. In particular, it has been suggested that 
the Ci/Gli transcription factors may not exclusively mediate the hedgehog signal, though this 
is an area of controversy, particularly in Drosophila. Strong evidence stands however from 
several studies showing ci mutant embryos have much milder phenotype than embryos mutant 
for hh, an observation difficult to explain if all effects of Hh are mediated through Ci 
(Nusslein-Volhard et al, 1984; Slusarski et al, 1995; Methot and Easier, 2001). In addition, 
the existence of a Ptc-independent Hh response has been reported in fly imaginal disc 
development (Ramirez-Weber et al, 2000). 
The phenotype of the embryonic lethal chicken mutation talpicf {ta^) also suggests two 
distinct "branches" of genes responding to Hedgehog proteins in vertebrates. Expression of 
various pathway genes suggests that the gene responsible for ta^ acts between Shh and 
transcription of ptc, and as recombinant Shh does not induce ectopic Ptc expression in ta^ 
limbs, it is probably involved in Shh reception (Lewis, K. E. et al, 1999b). Data supporting 
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bifurcation of the pathway comes from the observation that some aspects of the to^ phenotype 
appear to be due to a loss of Shh function (defects are reminiscent of holoprosencephaly), 
while paradoxically a subset of pathway targets are ectopically expressed (Lewis, K. E. et al, 
1999b). 
One well studied gene providing evidence of bifurcation in the Hedgehog signalling pathway 
is COUP-TFII {Chicken ovalbumin upstream promoter-transcription factor 11). Members of 
the COUP-TF family are putative steroid-thyroid orphan nuclear receptors, and have been 
found in many vertebrate species. Experiments by Krishnan and colleagues identified a region 
in the COUP-TFII promoter, which they have termed the Sonic hedgehog response element 
(ShhRE), that apparently is used to regulate COUP-TFII expression in response to Shh by a 
mechanism independent of Gli transcription factors (Krishnan et al, 1997a; Krishnan et al, 
1997b). Furthermore, the ShhRE is responsive even in the absence of protein synthesis, 
implying it is a direct target of Shh signalling (Krishnan et al, 1997b). 
Three recent studies in the developing fmit fly also support Ci independent Hh responses 
(Gallet et al, 2000; Suzuki and Saigo, 2000; Apidianakis et al, 2001). In 2001 a study 
specifically addressed the question of branching and cross talk in the hedgehog pathway. The 
Drosophila hedgehog pathway was activated by removing ptc (by mutation), and by 
subsequently removing ci the authors were able to investigate the effects of the pathway that 
were still detectable. Surprisingly, no evidence was found for any function of the pathway in 
the absence of ci at a number of developmental stages (Methot and Easier, 2001). The authors 
interpreted this as an absolute requirement for Ci in hedgehog signalling and this finding has 
been reconciled with several of the contrasting studies described above by the suggestion that 
their conclusions were misled by the nature of Ci regulation. Methot and Easier propose that 
the phenotypes of ci null mutants are mild because not only has the transcriptional activator of 
target genes been abolished, but the basal repressor action of Ci (see Section 1.2.2) has also 
been removed, giving a balancing effect on target gene activation. Put simply, removing ci 
has a combined negative and positive effect on pathway activity. The authors do concede that 
this cannot explain the observations of all previous studies supporting bifurcation, in 
particular the finding of ShhRE regions refutes Ci being a sole mediator of pathway action 
(Methot and Easier, 2001). A point that should be stressed in light of the findings of Methot 
and Easier is that their studies, by nature of their chosen method of activating the pathway, 
effectively took Patched out of the system. Therefore, this work does not preclude the 
existence of functions of Hedgehog that require neither Patched nor Ci. For example, effects 
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involving an alternative hedgehog receptor, as suggested by the comparison of hhlptc double 
and ptc single mutant flies, are still an untested possibility. 
A recent finding is the discovery that the protein encoded by sex-lethal {sxl), a hedgehog 
responsive target in Drosophila germ line cells, is post-transcriptionally regulated in a manner 
with striking parallels to Hh mediated regulation of Ci. It appears that like Ci, Sxl can form a 
Hedgehog regulated complex with Costal2 and Fused that tethers it in the cytoplasm. In 
contrast to Ci, which is protected from cleavage by the Hh signal, Sxl appears to be degraded 
upon Hh stimulation. Furthermore, this sttidy proposes that the response of Sxl to Hh in germ 
line cells is independent of Ptc and Smo activity (Vied and Horabin, 2001). 
The studies described in this section provide evidence for pathway bifurcation from a range of 
perspectives. In Hght of apparent pathway branching and the complex cross talk this pathway 
has with other pathways in fly and vertebrate development, some researchers consider it 
would be more aptly named the "hedgehog network" to reflect its tme complexity. 
1.2.9 Possible direct role for Patched in cell cycle control 
In one special case Hedgehog appears to have biological effects without requiring any direct 
transcription factor mediation. Several recent studies have identified that members of the 
cyclin family, genes responsible for regulating cell cycle control, are transcriptional targets of 
hedgehog signalling, but in an intriguing twist Patched has been found to directly bind Cyclin 
El in yeast two-hybrid studies (Eames et al, 2001). In a mechanism further linking the 
hedgehog pathway to cell cycle regulation. Patched binds specifically to phosphorylated 
cyclin El derivatives, and is able to affect their subcellular localisation. The Patched-Cyclin 
El interaction is dismpted in the presence of Shh, suggesting one level of control of the 
pathway over cellular proliferation may use a previously undiscovered signalling function of 
the Patched protein (Barnes et al, 2001). 
1.3 Role of the hedgehog pathway in the 
developing fly 
The importance of hedgehog signalling in Drosophila development is highlighted by the 
lethality of null-mutations of a number of pathway components. Hedgehog has three major 
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effects on target tissues: controlling cell survival, proliferation and differentiation. In the fly 
hedgehog signalling is initially involved in anterior-posterior patterning within the 
parasegments of the developing embryo, and later in the development of the limbs, wing 
imaginal discs and eyes where it induces long-range effects via the induction of secondary 
signalling molecules (reviewed by Ingham, 1998). 
1.3.1 Establishment of segment polarity in early development 
In the early stages of development the Drosophila embryo becomes divided along its anterior-
posterior axis into a number of segments. The genes responsible for this patterning have been 
loosely grouped into four classes, depending on the level at which they exert their affects. 
Some genes affect whole embryo anterior-posterior polarity, while others affect several 
adjacent segments (gap genes), alternate segments (pair-mle genes) or all segments (segment 
polarity genes). Mutation of a number of hedgehog pathway components causes segment 
polarity phenotypes, and such mutants tend to have deletion of portions of segments and often 
present with mirror image duplication of the pattern that remains (Nusslein-Volhard and 
Wieschaus, 1980). 
One of the primary functions of Hh in the developing parasegments is to regulate expression 
of another segment polarity gene, wingless {wg). Under the confrol of Hh, wg is expressed in 
neighbouring cells at the boundary of each parasegment (Hidalgo and Ingham, 1990; Ingham, 
1993; Ingham and Hidalgo, 1993). Like hh, wg encodes a secreted morphogen controlling a 
complex signal fransduction pathway, and phenotypes are similar when either gene is 
mutated. In both hh and wg mutants, the denticles, spiny processes that protmde from the fly 
cuticle, end up as a disorganised lawn rather than neat rows of particular sub-types of 
denticles and naked stripes. It was the spiky nature of the mutant phenotype that led to the 
initial naming of the hedgehog gene. A number of other Drosophila genes, many of them 
connected to hedgehog pathway function, have names of similar origin related to their 
disordered hair patterns (e.g. dishevelled, shaggy). Other hedgehog pathway mutants display 
the opposite phenotype, namely a reduction in denticles in specific cuticle regions, and have 
been named to reflect their bald nature (e.g. patched, smoothened). 
The hedgehog and wingless pathways are linked through an intricate feedback loop, whereby 
both genes influence expression of each other in stripes of cells at each parasegment 
boundary. Engrailed {en), a homeodomain containing franscription factor that is expressed in 
26 Chapter 1: General Introduction and Literature Review 
hedgehog producing cells on one side of the boundary, is another segment polarity gene 
involved in these interactions. Activation of the hedgehog pathway results in the induction of 
wg, which through its own signalling, stimulates en expression in the Hh secreting cells 
(Ingham et al, 1991). The loop is then established as protein from the en gene further 
stimulates hh expression (Figure 1.3). The initial expression of wg and en is set up by pair-
mle gene products, and remains long after expression of these genes fades due to the action of 
wglhh feedback. 
The closer an en expressing cell is to a wg expressing cell the more en franscription is 
stimulated. As a consequence of increased levels of the en encoded franscription factor more 
Hh is produced in the cells closest to the developing boundary. This in turn leads to increased 
wg expression in the neighbouring cells. In this way the feedback strengthens the position of 
the border until it becomes a narrow band of cells. Expression of wg and hh during this 
critical stage of patterning leads to formation of the boimdaries of the fourteen parasegments, 
each with wg expressing cells on one side and enlhh expressing cells on the other (DiNardo et 
al, 1988; Martinez-Arias et al, 1988; Eejsovec and Martinez Arias, 1991; Heemskerk et al, 
1991; Cumberledge and Krasnow, 1993; Ingham and Hidalgo, 1993). It is worth noting that 
the narrow line formed by hhlwg signalling is actually located in the cenfre of the "tme 
segments" seen from the ridges of the body on the fly itself The term "parasegment" 
boundary is used to describe the place where the key events occur, and is effectively half a 
segment out of phase with the morphological segments that finally appear. 
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Figure 1.3 Hedgehog and wingless patliway interactions in Drosophila parasegment boundary 
cells. 
Secreted Hedgehog (Hh) protein causes expression of Wingless (Wg) in cells that 
express the Patched (Ptc) receptor. Secreted Wg protein, which signals through the 
Frizzled (Fz) or Drosophila frizzled 2 (Dfr2) receptors, then causes expression of 
Engrailed (En) in neighbouring cells. Under the control of En more Hh is produced, 
leading to a positive feedback loop and establishment of the parasegment boundary 
(based on ideas first proposed by Ingham et al, 1991). 
Wg diffuses from its expression at the parasegment border to induce differentiation of specific 
types of cells responsible for secreting the larval cuticle (Lawrence et al, 1996). The wg 
morphogen is a cysteine-rich glycoprotein (Cabrera et al, 1987; Rijsewijk et al, 1987), and 
represents the single fly homologue for a large family of genes in vertebrates known as Wnts 
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(discussed in Section 1.5). The wingless pathway shares a number of similarities with the 
hedgehog pathway. Two known receptors for Wg are frizzled {fz) and Drosophila frizzled 2 
{dfz2), molecules which share some homology with smoothened (Bhanot et al, 1996; Ehanot 
et al, 1999). The binding of Wg to Frizzled receptors modulates the activity of the protein 
encoded by dishevelled {dsh), which is involved in transducing the cell surface signal to the 
nucleus (Klingensmith et al, 1994). Dsh in turn stabilises the protein encoded by the 
armadillo {arm) gene. In the absence of Wg signalling. Arm is targeted for degradation. Wg 
induced stabilisation takes place through the inactivation of a kinase encoded by the 
shaggy Izeste white 3 {zw3) gene. The products of the axin and Drosophila APC (adenomatous 
polyposis coli) gene are also involved, and may form a complex regulating the action of Zw3 
(reviewed by Eejsovec, 1999) After accumulation in the cytoplasm. Arm franslocates to the 
nucleus where it regulates the transcription regulator Pangolin (also known as dTCF), thereby 
regulating transcription of downstream target genes (Erurmer et al, 1997; Riese et al, 1997; 
van de Wetering et al, 1997). 
As with the hedgehog pathway, wingless signalling requires certain heparan sulphate 
proteoglycans to be present (reviewed by Selleck, 2000). In the wingless pathway the 
products of the sugarless {sgl; Einari et al, 1997; Hacker et al, 1997; Haerry et al, 1997) and 
sulfateless {sfl; Lin and Perrimon, 1999) genes are cmcial enzymes required for appropriate 
HSPGs synthesis. This is analogous with the requirement for tout-velu mediated HSPG 
synthesis in hedgehog pathway function. In wingless signalling two critical genes encoding 
specific HSPG core proteins, division abnormally delayed {dally) and dally-like protein {dip), 
have been identified (Lin and Perrimon, 1999; Tsuda et al, 1999; Khare and Eaumgartner, 
2000). It will be interesting to see if future studies uncover similar core proteins essential to 
hedgehog signalling. 
A striking similarity between wingless and hedgehog signalling is that both pathways appear 
to have ligands post-transcriptionally modified in similar ways. Evidence for this comes from 
the discovery of porcupine {pore), a gene essential for normal Wg function. As mentioned in 
earlier sections, j!?orc has strong similarity to sitlcmnlskilrasp, and because of this it is thought 
that like Hh, Wg may also undergo modification involving lipid addition (Hofmann, 2000). 
In summary, the hedgehog pathway has an important role in patterning the Drosophila 
embryo, largely through regulating the wingless signalling pathway. Furthermore, these two 
pathways are intricately intertwined, and have similarity in their signalling mechanisms. 
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1.3.2 Patterning of body appendages and organs 
In addition to roles in embryogenesis, the hedgehog pathway is important for specifying 
formation of adult stmctures that arise from the imaginal disks. Imaginal discs are small sacs 
of undifferentiated cells, some consisting of as few as 10 to 40 cells, which begin to 
proliferate during larval development. These differentiate during metamorphosis to give rise 
to epidermal stmctures appropriate to each segment such as legs, wings, genitals and antennae 
(reviewed by Cohen, 1993). 
As with embryonic development, the hedgehog pathway once more interacts closely with the 
wingless pathway to specify cell fate. The patterning of disc derived stmctures depends on the 
initial presence of compartment boundaries that arise due to the lineages of cells making up 
the tissue and leads to anterior (A) and posterior (P) regions. The A-P boimdary is thought to 
have an organisational role, rather than ending up at the position of any particular stmcture. In 
a system analogous to that described above for embryonic development, engrailed expression 
in posterior cells leads to transcription of hh, which acts to specify the boundary region (Lee, 
J. J. et al, 1992b; Easier and Stiiihl, 1994; Tabata and Komberg, 1994). Hedgehog secreted 
from the posterior cells reaches receptive anterior cells and those close to the compartment 
boundary are exposed to the highest local Hh concentration. These cells receive sufficient 
signal to cause wingless expression (Eaker, 1988; Couso et al, 1993; Williams, J. A. et al, 
1993; Easier and Stmhl, 1994). These cells also express ptc and decapentaplegic at high 
levels in response to Hh (Phillips et al, 1990; Posakony et al, 1991; Easier and Stmhl, 1994; 
Capdevila et al, 1994; Tabata and Komberg, 1994). In this way two populations of cells, one 
that sends an inductive signal and another that is competent to respond to it, are able to 
become organised such that a specific zone of boundary cells are specified just anterior to a 
precisely defined border (reviewed by Elair, 1995). 
Dpp, which is produced in the cells responding to the Hh signal, is itself a potent morphogen 
and encodes a protein with homology to the transforming growth factor-beta family in 
mammals (Padgett et al, 1987). Dpp was so named because it is required for patterning the 
fifteen major imaginal discs (Spencer et al, 1982). Together wg, ptc and dpp comprise the 
three key target genes induced by Hedgehog action in a range of developing fly tissues. Eoth 
wg and dpp head signalling cascades that control either division or differentiation in target 
cells, whereas up-regulation of ptc is thought to act primarily in limiting further hedgehog 
signalling or diffusion. 
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Dpp acts through the receptors encoded by the thick veins {tkv), saxophone {sax) and punt 
genes (Erummel et al, 1994; Nellen et al, 1994; Penton et al, 1994; Letsou et al, 1995) and 
may act as a long range secondary fransducer of the hedgehog signal. Downsfream effects of 
Dpp are mediated by regulation of the schnurri {shn) gene, which encodes a zinc finger 
transcription factor (Arora et al, 1995; Grieder et al, 1995). Another gene for a nuclear 
factor, brinker, encodes a DNA binding protein that interacts directly with various Dpp target 
genes to repress there expression, and is negatively regulated by Dpp (reviewed by Affolter et 
al, 2001). An important intracellular mediator of dpp signalling in Drosophila was identified 
in 1995 and named mothers against dpp {MAD) due to its matemal enhancement of mutant 
dpp phenotypes (Raftery et al, 1995; Sekelsky et al, 1995). Since then a range of related 
genes have been identified in vertebrates and have become known as the Smad family (for 
"homology to Sma and MAD"). Smads can interact with DNA and a range of transcription 
factors, allowing them to either positively or negatively regulate target gene promoters, and 
play a role in human tumourigenesis (reviewed by Shi, 2001). 
Wing development has provided a useful model for studying imaginal disc development, as 
mutant phenotypes can be resolved not only from gross deformities, but also from subtle 
changes in wing vein pattern (Figure 1.4). Hh also has Dpp independent functions in 
controlling morphogenesis of the cenfral part of the wing (Mullor et al, 1997; Strigini and 
Cohen, 1997). Here two franscription factors, collier and iroquois are activated by Hh to 
additionally regulate patterning (reviewed by Vervoort, 2000). 
In addition to patterning the wings and limbs. Hedgehog also plays a role in adult head 
formation through the regulation of vein, which encodes a ligand for the fly epidermal growth 
factor receptor (Schnepp et al, 1996; Amin et al, 1999). Hedgehog plays an important role in 
patterning the Drosophila gut (Pankratz and Hoch, 1995), gonads (Forbes et al, 1996; Zhang, 
Y. and Kalderon, 2000; Vied and Horabin, 2001), fracheal system (Glazer and Shilo, 2001) 
and the anterior brain and compound eye (Heberiein et al, 1995; Huang and Kunes, 1996; 
Chang, T.e? a/., 2001). 
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Figure 1.4 The hedgehog pathway and insect wing development. 
(A) Normal wing development in Drosophila. Left panel shows the third instar stage 
imaginal disc, which is divided into anterior-posterior and dorsal-ventral (indicated by 
dotted line) compartments. Posterior compartment cells express hedgehog (hh), as 
indicated by dark shading. The wing blade of the adult that is formed from this structure 
is shown on the right. The five longitudinal veins of the wing are numbered. Bristles 
and sensory areas (dots on vein three) are in specific positions. (B) Ectopic expression 
of hh in the anterior compartment leads to duplication of wing tissue. The highly 
abnormal wing in this example is caused when hh is ectopically expressed at the dorsal-
ventral compartment boundary in the anterior region. (C) When the normal action of 
hedgehog is removed small and poorly patterned wings are formed. Reproduced with 
permission from Capdevila and Johnson, (2000). 
In summary. Hedgehog is involved in a diverse range of developmental processes and at 
multiple stages in the formation of the fly. Furthermore, the hedgehog pathway is intertwined 
with additional signalling pathways, through which many of its actions are exerted. 
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1.4 The hedgehog pathway in mammalian 
development 
In vertebrates the hedgehog pathway controls a large number of diverse patterning events 
during embryogenesis. The following sections provide an overview of the roles of the three 
mammalian hedgehogs in mammals. Functionally, Sonic hedgehog appears to play the major 
role in mammalian development, whilst Indian and Desert Hedgehog appear to play important 
roles in skeletal development and male gonad function, respectively. 
1.4.1 Role of Sonic hedgehog 
Shh is expressed in the developing embryo at many sites of epithelial-mesenchymal 
interaction (Bitgood and McMahon, 1995). A large body of work has now been pubUshed on 
the specific role of Shh in a varied range of tissues and a complete review of all primary 
literature is beyond the scope of this introduction. Extensive reviews on Shh patterning of 
vertebrate tissues have been published by Hammerschmidt et al, (1997) and Ingham and 
McMahon, (2001). This section outlines several well studied systems that highlight the 
diverse nature of patterning, and illustrate how the Shh signal can have quite different effects 
on different tissues. 
Early in embryogenesis Shh plays a key role in the determination of cell fate along the 
midline. Shh protein is expressed from the notochord, and later the floor plate, structures that 
extend along the centre of the embryo and are involved in patterning the developing neural 
tube. In this system Shh acts as a classical morphogen with concentration differences at 
various distances from the source altering cellular responses (reviewed by Briscoe and 
Ericson, 1999). Earlier however, when the notochord causes differentiation of the floor plate 
itself, short-range Shh signalling is used and physical contact is necessary (Placzek et al, 
1993; Yamada et al, 1993). Shh induces a number of neural cell types, and in addition plays a 
role in promoting cell survival and proliferation (Echelard et al, 1993; Krauss et al, 1993; 
Roelink et al, 1994; Marti et al, 1995; Roelink et al, 1995). Other areas of the cenfral 
nervous system (CNS) are also extensively patterned by Shh, including the developing 
oligodendrocytes (myelin forming cells), various regions of the developing brain and 
associated sensory structures (reviewed by Marti and Bovolenta, 2002). Hedgehog also 
patterns the differentiation of the somites, blocks of mesodermal tissue that form adjacent to 
the neural tube. Under the guidance of Shh (and to some extent Ihh) these regions give rise to 
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a number mesodermal derived structures including the vertebrae, ribs and associated cartilage, 
the body wall, muscles and the dermis of the skin. 
Another area in which the role of Shh has been investigated extensively is in the developing 
vertebrate limbs (Figure 1.5), with data coming from avian as well as mammalian model 
systems. Correct patterning in limbs relies on signalling from a specific set of posterior 
mesenchymal cells in a region known as the zone of polarising activity (ZPA). Shh secreted 
from the ZPA acts as a concentration dependent morphogen and is the primary determinant of 
limb anterior-posterior polarity. Evidence for this came from studies showing that ectopically 
supplied Shh leads to the formation of mirror image duplication of digits, in a similar fashion 
to those induced by grafting secondary ZPA regions to the developing limb (Riddle et al, 
1993; Lopez-Martinez et al, 1995). Further support for Shh as the ZPA signal comes from 
studies showing the converse; that loss of Shh in the limb bud leads to limb truncation 
(Chiang e? a/., 1996). 
Shh expression is critical for normal hair follicle morphogenesis in mammals (St-Jacques et 
al, 1998; Chiang et al, 1999; Karlsson et al, 1999) and may have a role in post-natal hair 
cycling (Sato et al, 1999; Wang, L. C. et al, 2000). Regulation of follicle development by 
Shh is of particular interest since basal cell carcinoma, a key feature of hedgehog pathway 
disruption in humans (refer Section 1.6), is thought to arise from cells residing in or near 
follicles. 
Recent studies have identified a role for Shh in regulating aspects of the developing 
circulatory system, including both the formation of new blood vessels through angiogenesis 
(Pola et al, 2001), and confrol over haematopoietic stem cell proliferation and differentiation 
of both red and white blood cells (Detmer et al, 2000; Outram et al, 2000; Bhardwaj et al, 
2001). Other diverse roles include regulating left-right asymmetry during vertebrate 
development (reviewed by Levin, 1997). Shh also plays a key role in patterning the gut, heart, 
lungs, bladder, prostate, pancreas and a range of other internal structures. 
34 Chapter 1: General Introduction and Literature Review 
AER 
normal 
development 
Shh 
antenor 
proximal •*——• distal 
posterior 
6 
ectopic Shh 
> 
removal of Shh 
> • 
humerus 
radius 
anlenor 
proximal <——• distal 
posterior 
— Ill 
Figure 1.5 The hedgehog pathway and vertebrate limb development. 
The diagrams shown illustrate the importance of hedgehog action on vertebrate limb 
development using the chicken wing as an example. (A) The left hand diagram shows 
the limb bud after 3 days of development, at which stage it is composed of mesenchyme 
tissue surrounded by an ectodermal sheath. The apical ectodermal ridge (AER), a 
thickened epithelial structure, is labelled. Sonic hedgehog (Shh; dark shading) is 
secreted from posterior mesenchyme in a region known as the zone of polarising 
activity (ZPA). At 10 days the normal aduh structures are apparent, as shown on the 
right (digits numbered). (B) If Shh is ectopically expressed in anterior regions mirror 
image duplications occur. (C) Removal of the ZPA region that normally expresses Shh 
results in severe truncation of the limb. Reproduced with permission from Capdevila 
and Johnson, (2000). 
1.4.2 Role of Indian hedgehog 
Indian hedgehog appears primarily involved in regulating growth and proliferation of 
developing bone and cartilage (Vortkamp et al, 1996; Vortkamp et al, 1998; St-Jacques et 
al, 1999). Ihh induces its affects by stimulating parathyroid hormone-related peptide (PTHrP) 
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and bone morphogenetic proteins (BMPs), that in turn head further signalling pathways that 
regulate chondrocyte activity in bone formation (Lanske et al, 1996; Vortkamp et al, 1996; 
Zou et al, 1997; Pathi et al, 1999). PTHrP and Ihh control regulation of each other through a 
negative-feedback loop that that prevents chondrocytes fi-om exiting the mitotic cycle 
(reviewed by Kronenberg et al, 1998). 
There is also an apparent role for Ihh in the early differentiation of the visceral endoderm 
(Maye et al, 2000), and later in patterning of the gut (Ramalho-Santos et al, 2000). The gut 
displays a distinct overlap of Ihh and Shh expression during development (Bitgood and 
McMahon, 1995) and there may be some redundancy between the functions of the two 
proteins. Patterning is influenced by both genes during early bone development, heart 
morphogenesis, lateral asymmetry, vasculogenesis and haematopoesis (reviewed by Ingham 
and McMahon, 2001). Thus it appears that Shh and Ihh work in concert during development 
in some regions. 
1.4.3 Role of Desert hedgehog 
Of the three mammalian hedgehogs, Dhh displays the most restricted expression pattern. In 
mouse development it is expressed principally in the Sertoli cells of the testes and Schwann 
cells of peripheral nerves (Bitgood and McMahon, 1995). In the male germ line, Dhh appears 
to regulate various stages of spermatogenesis and is crucial for the formation of Leydig cells 
and other testicular features (Clark et al, 2000; Yao et al, 2002). In the developing CNS Dhh 
is secreted from Schwann cells and signals to fibroblasts surrounding the peripheral nerves to 
produce the perineurium, a protective sheath that surrounds nerve fibre bundles (Mirsky et al, 
1999; Parmantiere^a/., 1999). 
1.5 Downstream targets of the hedgehog pathway 
Much of what is known about Hedgehog signalling components was initially gleaned from 
studies in Drosophila, and the knowledge of downstream targets is more advanced in the fly 
than in any vertebrate system. This is largely due to the applicability of this organism to large 
scale mutation screens, and the success of a number of techniques using either mosaic animals 
or complex combinatorial mutants to reveal hierarchies of genes. There are currently many 
molecules implicated downstream of the hedgehog family in mammals, but few bona fide 
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targets. In particular, the specific molecules that signal neoplastic cell proliferation upon 
disruption of hedgehog signalling remain largely elusive. 
1.5.1 The "Universal" hedgehog target genes 
Hedgehog pathway target genes differ in different tissues, and this is one mechanism by 
which hedgehog is able to cause such diverse effects on target cells. Upon reviewing the 
literature from many organisms where the hedgehog pathway has been ectopically activated, 
two genes appear universally expressed in all responsive vertebrate tissues that have been 
studied. These are Patched and Glil, both of which are induced at the level of transcription in 
response to pathway activation (Goodrich et al, 1996; Marigo et al, 1996b; Marigo et al, 
1996c; Marigo and Tabin, 1996; Lee, J. et al, 1997; Murone et al, 1999). These molecules 
are also up-regulated in a number of tumours arising from hedgehog pathway disruption 
(Gailani et al, 1996; Dahmane et al, 1997; Unden et al, 1997; Vorechovsky et al, 1997b; 
Ghali et al, 1999; Bonifas et al, 2001). Furthermore, the up-regulation of Ptc and Glil 
transcription also holds tme when cells grown in vitro are hedgehog stimulated (Nakamura et 
al, 1997; Pepinsky et al, 1998; Taipale et al, 2000). 
A third gene. Hip (refer Section 1.2.4) has been studied less extensively but may also be a 
"universal" pathway target (Chuang and McMahon, 1999; Bonifas et al, 2001). These three 
genes were used extensively in this project, as markers of successful pathway stimulation. In 
Drosophila, which lacks a known homologue for Hip and regulates its Gli homologue ci post-
transcriptionally, ptc is the only target gene that has been observed to have mRNA up-
regulated by Hh in all responsive cell tjqpes (Hidalgo and Ingham, 1990; Tabata and 
Komberg, 1994). 
1.5.2 Additional downstream target genes 
As mentioned in Section 1.3, the key transcriptional targets of hedgehog signalling in a range 
of tissues in Drosophila are ptc, wingless and dpp, though the latter two are not necessarily 
activated in all responsive cell types. In vertebrate development the situation is thought to be 
analogous, whereby genes related to wg and dpp would play a major hedgehog mediated 
developmental role. The single wg gene of the fly is represented by a large family of 
vertebrate homologues known as the Wnt family. Likewise, the vertebrate genome contains a 
considerable number of genes related to dpp, which are known collectively as the 
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transforming growth factor p (TGPP) superfamily. In close analogy with processes in 
Drosophila, embryonic development in vertebrates depends upon critical interactions between 
Hedgehog, Wnt and TGFp family members (reviewed by Roelink, 1996). 
The sub-group of the TGpp superfamily most closely resembling dpp are the BMPs, and as 
such are considered prime candidates for regulation by the hedgehog pathway in vertebrates. 
Within the BMP family the members most closely resembling dpp stmcturally are Bmp2 and 
Bmp4, both important developmental molecules (Hogan, 1996). A strong line of evidence 
supporting BMPs as Hedgehog regulated molecules came from expression studies showing 
that BMPs and Hedgehogs are frequently expressed in adjacent regions during mouse 
development (Bitgood and McMahon, 1995). Analysis of BMP-hedgehog interrelationships is 
confounded by the fact that not only do hedgehogs appear to regulate BMPs, but BMPs 
themselves are also implicated in regulating Hedgehog expression (Arkell and Beddington, 
1997; Zhang, Y. et al, 2000; Grimsmd et al, 2001; Ohkubo et al, 2002). Direct evidence for 
Hedgehog mediated regulation of BMP genes has come from studies in a limited number of 
tissue systems (Fan, H. et al, 1997; Bhardwaj et al, 2001; Kawai and Sugiura, 2001). 
Like the BMP family, the Wnt family contains a large number of vertebrate family members. 
The mechanisms by which Wnt proteins signal show many parallels to the wingless signalling 
system in Drosophila, and this has been the subject of extensive review (Cadigan and Nusse, 
1997; Dale, 1998; Wodarz and Nusse, 1998). A recent study in the frog has shown that 
members of the Gli family, which are themselves controlled by Hedgehogs, can regulate the 
expression of Wnt5A, 7B, 7C, 8 and 8B in ectodermal explants (Mullor et al, 2001). An 
additional twist to the Hh-Wnt story is the recent finding that some molecules that act as 
antagonists or modulators of Wnt signalling are also regulated by the hedgehog pathway. 
Sfrpl and Sfrp2, members of the secreted frizzled related protein family, have been found to 
be up-regulated by ectopic Shh in developing mouse mesoderm tissue (Lee, C. S. et al, 
2000). Members of this family have a stmcture similar to the Frizzled proteins that act as 
membrane tethered Wnt receptors (refer Section 1.3.1). SFRPs lack transmembrane domains, 
can bind to specific Wnt ligands in the extracellular space, thereby modulating Wnt signalling 
(reviewed by Polakis, 2000). 
In the developing CNS an important target induced by Shh is Hepatocyte nuclear factor-3P 
{HNF-3P), a winged-helix transcription factor (Roelink et al, 1995). This is one of the few 
target genes for which regulation by Hedgehogs has been studied extensively, and is directly 
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mediated by Gli proteins (Sasaki et al, 1997). Ectopic expression of Shh up-regulates 
expression of Shh itself, and this is mediated, at least in neural tissues, by HNF-3p (Roelink et 
al, 1994; Ruiz i Altaba et al, 1995; Epstein et al, 1999). 
There is some evidence that Patched2, like Patched, may be a target of hedgehog regulation 
(Taipale et al, 2000; Pathi et al, 2001), but there is some conflict in reports of human 
PATCHED2 {PTCH2) up-regulation in basal cell carcinoma (Zaphiropoulos et al, 1999; 
Bonifas e? a/., 2001). 
Other known hedgehog responsive genes include COUP-TFII (refer Section 1.2.8) and Isletl 
(Chiang et al, 1996; Nakagawa et al, 1996; Dutton et al, 1999) in the developing neural 
tube, SWiP-1 in somitic mesoderm and limb buds (Vasiliauskas et al, 1999), Myf5 (Borycki 
et al, 1999; Gustafsson et al, 2002) and MyoD (Munsterberg et al, 1995) in muscle 
formation and Angiopoietin2 (Pola et al, 2001) in developing vasculature. Other tissue-
specific targets include members of the PAX (Ericson et al, 1996; Ericson et al, 1997; 
Borycki et al, 1998), SOX (Hargrave et al, 2000), TBX (Gibson-Brown et al, 1998; Garg et 
al, 2001), NKX (Nakagawa et al, 1996; Briscoe et al, 1999; Cai et al, 2000; Pabst et al, 
2000; Murtaugh et al, 2001) and HOX (Riddle et al, 1993) families. Recently, links between 
hedgehog signalling and regulation of the cell cycle have been uncovered with the discovery 
that several cyclins are transcriptionally regulated by Hedgehog (Kenney and Rowitch, 2000; 
Duman-Scheel et al, 2002; Yoon et al, 2002). Several genes have also been implicated in the 
pathway due to changes in expression observed in animal models. IgfZ, for example, is 
elevated in tumours of the patched knockout mouse (Hahn et al, 1998). 
1.6 The hedgehog pathway in human disease 
Perturbation of hedgehog signalling is present in a range of human diseases. Such disorders 
generally involve either developmental abnormalities (when genetic lesions or environmental 
factors dismpt signalling during embryogenesis) or tumour formation (when the pathway 
becomes abnormally activated in an individual cell by acquisition of mutations). This section 
provides an outline of diseases of interest that provide further clues to the normal function of 
the hedgehog pathway. Figure 1.6 outlines the points in the hedgehog signalling cascade 
where disease causing mutations have been identified. 
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Figure 1.6 The hedgehog pathway cascade and components implicated in human disease. 
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1.6.1 Naevoid basal cell carcinoma syndrome 
Naevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, Gorlin-
Goltz disease and basal cell nevus syndrome (BCNS), is an autosomal dominant disorder that 
is unusual in that it features a predisposition to cancer in patients that also tend to display 
developmental deformities. A major feature of the syndrome is predisposition to basal cell 
carcinomas (BCCs) of the skin, which are present in approximately 85% of cases (Famdon et 
al, 1992). In the general population BCCs tend to occur mainly at middle age or later, in 
contrast, those of NBCCS patients begin much earlier, often during the second decade of life. 
BCCs may number in the thousands over a lifetime in some patients, particularly those 
exposed to high levels of UV light or ionising radiation (Kimonis et al, 1997). 
A relationship between the presence of multiple BCCs of the skin and developmental defects 
in patients was first described by Binkley and Johnson, (1951) and by Howell and Caro, 
(1959). Gorlin and Goltz, (1960) gave a comprehensive description of NBCCS as a distinct 
clinical syndrome. The disease has been described in other ethnic groups in addition to 
Caucasians (Gotten et al, 1982; Goldstein et al, 1994; Chidambaram et al, 1996; Korczak et 
al, 1997), and analysis of mummies has provided evidence for its presence in ancient 
Egyptian populations (Satinoff and Wells, 1969). The incidence of NBCCS has been 
estimated at 1 in 56 000 and 1 in 164 000 in English and Australian populations respectively 
(Evans, D. G. et al, 1991; Shanley et al, 1994). Penetrance is estimated at 97-98%, with 
variable expressivity (Anderson et al, 1967). Approximately 60% of patients have no family 
history of the disease, indicating a high rate of new mutation (Gorlin, 1987). 
NBCCS patients also have an increased risk of a number of other tumour types including 
fibromas of the ovaries and heart, cysts of the skin and mesentery and cancers of the central 
nervous system (reviewed by Gorlin, 1995). It is estimated that 1 to 2 percent of 
meduUoblastomas are attributable to the syndrome (Evans, D. G. et al, 1991). Another 
feature highly prevalent in NBCCS is the presence of odontogenic keratocysts of the jaw, 
benign lesions which often begin to appear in the first decade (Gorlin, 1987) and have 
historically resulted in dentists identifying a large percentage of NBCCS patients. 
In addition to tumours, NBCCS individuals often present with a diverse array of 
developmental abnormalities. These include skeletal defects such as rib, craniofacial, 
vertebral and shoulder problems, as well as cleft palate and generalised overgrowth. A 
characteristic facial appearance is also a feature of NBCCS, and may involve macrocephaly, 
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arched eyebrows, a broad nasal ridge and ocular hypertelorism. Pitting of the hands and feet is 
frequently present and Polydactyly and syndactyly occasionally occur (reviewed by Gorlin, 
1995). Extensive surveys of the NBCCS phenotype have been conducted in Britain, the USA 
and Australia (Evans, D. G. et al, 1993; Shanley et al, 1994; Kimonis et al, 1997). A lower 
average age of BCC onset is observed in Australian patients, and is attributed to greater levels 
of UV light exposure (Shanley et al, 1994). 
In 1996 the gene responsible for NBCCS was independently identified by positional cloning 
(Hahn, H. et al, 1996b) and a positional candidate approach (Johnson et al, 1996), and was 
found to be a homologue of the Drosophila patched gene. Both studies confirmed mutation of 
human PATCHED {PTCH) in the germ-line of NBCCS patients and fine mapping showed the 
gene to contain 23 exons spanning a region of 34 kb on chromosome 9q22.3 (Hahn, H. et al, 
1996b). Further studies have identified a diverse array of PTCH mutations in NBCCS 
individuals (Chidambaram et al, 1996; Unden et al, 1996; Lench et al, 1997; Wicking et al, 
1997a; Wicking et al, 1997b; Aszterbaum et al, 1998; Hasenpusch-Theil et al, 1998). 
Approximately 75 percent of germline mutations carried by NBCCS individuals lead to 
protein truncation, and there is no apparent genotype-phenotype correlation (Wicking et al, 
1997b). 
Several familial syndromes have been identified which involve skin tumours (reviewed by 
Hauck and Manders, 1994). Bazex syndrome, an X-linked dominant condition, features 
multiple BCCs, as does a related autosomal condition, Rombo syndrome. Another disorder, 
basal cell carcinomas with milia and coarse sparse hair, was originally identified during a 
search for NBCCS patients but is clinically distinct (Oley et al, 1992). Ferguson-Smith 
syndrome, like NBCCS, also features multiple epidermal tumours, though in this case they are 
self-healing squamous cell carcinomas. Both diseases map to the same chromosomal region 
(Goudie et al, 1993), and though it has been speculated that the two could be allelic disorders 
(Gailani et al, 1992), mutation searches have provided no evidence that this is the case 
(Richards ef a/., 1997). 
Some individuals have been identified who do not present with enough features to be 
categorised as classical NBCCS cases, but nevertheless show a familial tendency to develop 
numerous BCCs (Shanley et al, 199A). These cases are interesting as they may represent an 
allelic form of NBCCS, or alternatively may represent mutants for another important gene in 
the hedgehog pathway. 
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1.6.2 Non-NBCCS Patched mutations 
A significant proportion of sporadic (non-NBCCS) BCCs also contain PTCH mutations, 
highlighting the importance of Patched as a cancer causing gene in the general population 
(Gailani et al, 1996; Hahn, H. et al, 1996b; Johnson et al, 1996; Wolter et al, 1997; Daya-
Grosjean and Sarasin, 2000; Evans, T. et al, 2000). PTCH mutations have also been 
identified in a range of other cancer types including meduUoblastoma (Pietsch et al, 1997; 
Raffel et al, 1997; Vorechovsky et al, 1997a; Wolter et al, 1997; Xie et al, 1997; Dong et 
al, 2000), trichoepitheUoma (Vorechovsky et al, 1997b), invasive bladder carcinoma 
(McGarvey et al, 1998) and esophageal squamous cell carcinoma (Maesawa et al, 1998). 
Such findings, along with mutation of other pathway components in a number of cancers 
(discussed below) imply that disruption of normal hedgehog pathway signalling is of critical 
importance in the formation of a range of human neoplasms. 
1.6.3 Hedgehog mutations in human disease 
Shh is one of several genes known to be responsible for the developmental disorder 
holoprosencephaly (HPE), with a variety of missense, nonsense, insertion and deletion 
mutations in Shh described in association with this abnormality (reviewed by Wallis and 
Muenke, 2000). HPE is a defect in formation of the forebrain and structures around the facial 
midline. It can occur sporadically or can be familial with several possible inheritance patterns. 
The phenotype is highly variable, and can be caused by a number of genetic lesions or 
environmental factors. At its most extreme the forebrain completely fails to cleave into left 
and right hemispheres and cyclopia is present with a proboscis structure above the eye. The 
nose may be absent or may present as a single nostril. At the other end of the spectrum mildly 
affected patients may display hypotelorism and a single central incisor in the upper jaw 
(reviewed by Muenke and Beachy, 2000; Roessler and Muenke, 2001). HPE is observed in 1 
in 250 aborted foetuses and in milder forms in approximately 1 in 8300 live births (Matsunaga 
and Shiota, 1977; Croen et al, 1996). Knockout mice for the Shh gene display a similar 
phenotype to severely affected HPE individuals (Chiang et al, 1996). Analysis of several 
human tumour types has revealed a mutation in Shh suggesting that it can act as a dominant 
oncogene (Oro et al, 1997), although two more recent and extensive studies have failed to 
detect Shh mutation in any tumours analysed (Wicking et al, 1998; Vorechovsky et al, 
1999). 
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Mutations in both Desert {Dhh) and Indian hedgehog {Ihh) have been reported in human 
syndromes. Heterozygous missense mutations have been identified in the amino-terminal 
signalling domain of Ihh in affected members of three families with brachydactyly type A-1 
(BDA-1), a disorder featuring abnormal digit formation on the hands and feet and short 
stature (Gao et al, 2001). Recently a Dhh mutation has been identified in a patient with 
46,XY partial gonadal dysgenesis and minifascicular neuropathy (Umehara et al, 2000). The 
disease features fit well with the known expression pattern of Dhh in the developing testis and 
peripheral nerves (Bitgood and McMahon, 1995). 
1.6.4 Smoothened can act as an oncogene 
Patched mutations are thought to result in a failure to inhibit Smoothened (Smo) activity, and 
therefore it stands to reason that Smoothened itself could act as a dominant oncogene if 
activated by mutation. Indeed this has been found to be the case, with 3 out of 47 BCCs in a 
recent study found to harbour human SMOOTHENED {SMOH) mutations (Xie et al, 1998). 
In two of these the genetic lesion was identical, a G-to-T transversion at base pair 1604 (in 
exon 9) changing codon 535 from Tryptophan to Leucine (Xie et al, 1998). The Trp535Leu 
mutation has been identified in three BCCs in another study, whilst further SMOH mutations 
were identified in one BCC and a primitive neuroectodermal tumour (PNET) of the central 
nervous system (Reifenberger et al, 1998). Further investigations have shown expression of 
mutant SMOH in the skin of transgenic mice gives a skin morphology reminiscent of BCC, 
and dramatically increases the level of patched mRNA in basal skin cells (Xie et al, 1998). A 
later study in a Chinese population found 20% of sporadic BCCs to harbour Trp535Leu (Lam 
et al, 1999). Although there appears to be an activating mutation "hotspof at this position, 
the frequency may be quite different to Caucasian populations. In China BCCs are far more 
rare than in European populations, where BCCs are the most common tumour type (Lam et 
al, 1999). Functional studies have provided evidence that two of the reported SMOH 
mutations (Trp535Leu and Arg562Gln) indeed display a reduced sensitivity to inhibition by 
Patched, and as such may cause the pathway to become constitutively active (Murone et al, 
1999). 
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1.6.5 Gli genes in human disease 
The Gli family was first implicated in human disease with the discovery of GLIl 
amplification in the brain tumour glioblastoma (Kinzler et al, 1987). Elevated GLIl 
expression is present in a range of human bone and soft tissue carcinomas, in odontogenic 
keratocysts, and in both NBCCS and sporadic BCCs (Hahn et al, 1998; Ghali et al, 1999; 
Stein et al, 1999; Bonifas et al, 2001; Zedan et al, 2001). Glil transcript elevation is also 
observed in tumours firom hetrozygous patched knockout mice (Hahn et al, 1998). Transgenic 
mice over-expressing Glil or Gli2 in skin develop BCC-like tumours (Grachtchouk et al, 
2000;Nilssone?a/.,2000). 
The third member of the Gli family, GU3, is also involved in disease, causing three distinct 
developmental syndromes dependent on the protein domains affected by mutation (reviewed 
by Ming et al, 1998). Large deletions or translocations are present in Greig 
cephalopolysyndactyly syndrome (GCPS), a rare autosomal dominant disorder affecting limb 
and craniofacial development (Vortkamp et al, 1991). Several spontaneous mouse mutants, 
referred to as extra-toes, harbour deletions in Gli3 and show phenotypes remarkably similar to 
human GCPS (Vortkamp et al, 1992; Hui and Joyner, 1993). GCPS is thought to be due to 
haploinsufficiency for the transcription factor that GU3 encodes, as most causative mutations 
are presumed functionally null. GU3 is also mutated in Pallister-Hall syndrome (PHS), where 
most mutations are single base changes resulting in fi-ameshifts (Kang et al, 1997). Both 
disorders share similar features but are clinically distinct. Truncated proteins produced in PHS 
may lose their specificity and be able to activate the transcription of non-target genes in other 
developmental pathways (Kang et al, 1997). A third syndrome, postaxial Polydactyly type A, 
also involves GU3 mutation (Radhakrishna et al, 1997). A recent study that has identified 
further GU3 mutations in patients with various digit abnormalities challenges the current 
dogma, suggesting that genotype-phenotype correlations are not evident and that the range of 
phenotypically overlapping GU3 disorders should be referred to collectively as "GLI3 
morphopathies" (Radhakrishna et al, 1999). 
A disorder showing phenotypic similarities to GCPS is Rubinstein-Taybi Syndrome (RTS), 
which is also characterised by abnormal development of the extremities (such as broad 
thumbs and overgrown toes). RTS is caused by mutations in the CBP {CREB binding protein) 
gene (Petrij et al, 1995). It has been hypothesised that as CBP acts as a coactivator for the Gli 
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homologue Ci in Drosophila, disrupted CBP interactions with Gli proteins may be responsible 
for features of the human RTS phenotype (Akimaru et al, 1997). 
1.6.6 Disease caused by other hedgehog pathway genes or 
putative downstream targets 
In addition to the major pathway components mentioned previously, a number of other 
members of the hedgehog signalling cascade and putative downstream genes have been 
implicated in human disease. In particular the Wnt pathway, whose members are strongly 
linked to hedgehog signalling, plays a key oncogenic role. This is particularly striking in a 
familial syndrome where mutational inactivation of the Adenomatous polyposis coli (APC) 
gene results in activation of a Wnt response, which in turn leads to stabilisation of P-catenin, 
the vertebrate homologue of Armadillo (as discussed in Section 1.3.1). The Wnt induced 
increase in stable P-catenin leads to inappropriate activation of a LEF/TCF mediated 
transcriptional response, which appears to contribute to the development of colorectal cancer. 
Other components of Wnt signalling, and Wnt genes themselves, have been implicated in 
carcinogenesis (reviewed by Polakis, 2000; Taipale and Beachy, 2001). Genes involved in 
signalling by TGF^s, the vertebrate homologues of Drosophila dpp (refer 1.3.2) are also 
implicated in human tumourigenesis. DPC4, a pancreatic tumour suppressor, shows 
homology to the Drosophila mad {mothers against dpp) gene (Hahn, S. A. et al, 1996). 
Another Smad gene, MADR2, is mutated in colorectal carcinomas (Eppert et al, 1996). 
Mutation of the EXT-1, 2 or 3 genes in humans, homologues of Drosophila tout-velu, causes 
multiple exostoses syndrome, which is characterised by bone outgrowths and a predisposition 
to bone cancers (Ahn et al, 1995; Stickens et al, 1996). It has been proposed that the features 
of this disorder may be caused by problems with the movement of Indian hedgehog, the major 
hedgehog expressed in bone (Bellaiche et al, 1998). Other pathway components implicated in 
tumourigenesis include PTCH2, which has been shown to be mutated in a BCC and a 
meduUoblastoma, and Su(fu) which is mutated in meduUoblastoma (Smyth et al, 1999; 
Taylor, M.D.e? a/., 2002). 
1.6.7 Links to defects of cholesterol metabolism 
As outlined in Section 1.2.7, cholesterol plays crucial roles in normal hedgehog signalling, 
and it is not surprising that human disorders caused by defects in cholesterol metabolism 
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display phenotypes reminiscent of hedgehog pathway disruption. An example is Smith-Lemli-
Opitz syndrome, which is caused by mutation of A^-dehydrocholesterol reductase (7DHCR), 
an enzyme that catalyses the final step in cholesterol synthesis. This disorder leads to a range 
of malformations including mild HPE, a phenotype often associated with perturbation of the 
hedgehog signalling pathway (Tint et al, 1994; Kelley et al, 1996; Fitzky et al, 1998). 
1.7 Mouse models of hedgehog pathway disruption 
A number of mouse models, both knockout and over-expression, have been produced to 
investigate aspects of hedgehog pathway signalling. As expected for molecules with such 
important developmental roles, lethal phenotypes are observed for homozygous mice null for 
Shh (Chiang et al, 1996; St-Jacques et al, 1998), Smo (Zhang, X. M. et al, 2001) or Patched 
(Goodrich et al, 1997; Hahn et al, 1998). These models display a multitude of anomaUes 
affecting regions such as the CNS, gut, limbs and lungs. Interestingly, a number of mice 
heterozygous for null Patched mutation survive and display may features seen in NBCCS 
patients, such as tumour and cyst formation, limb defects and generalised overgrowth 
(Goodrich et al, 1997; Hahn et al, 1998). Mice heterozygous for a null Shh mutation are still 
bom with no obvious abnormalities, and are present in greatly reduced numbers at birth 
compared with their expected frequency (Chiang et al, 1996). 
In contrast to Shh, mice homozygous for a Dhh-nvXX mutation are viable. Females show no 
obvious phenotype but males are infertile displaying an absence of mature sperm (Bitgood et 
al, 1996). A knockout of Ihh function has also been created for which a number of the 
homozygous animals die during embryogenesis and the remainder die at birth due to 
respiratory failure. Animals surviving until birth display shortened bodies and tails, rounded 
skulls and severe dwarfism of the limbs (St-Jacques et al, 1999). In addition, transgenic 
overexpression models have been created for several hedgehog pathway genes, with 
overexpression of Shh in mouse skin leading to BCC like lesions that show up-regulation of 
target genes including Bmp4 (Fan, H. et al, 1997; Oro et al, 1997). 
Mouse models have provided evidence that Gli proteins appear to have partially redundant 
functions. Glil knockout mice appear normal, whilst Gli2 and Gli3 knockouts have severe 
deformities. Additionally, it has been shown that the Gli2 hetrozygous phenotype is more 
extensive in the presence of Glil mutation. Ectopic expression of Gli genes in various 
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locations leads to up-regulation of markers of hedgehog pathway activation, and in some 
tissues, to tumour formation. Such findings come from extensive studies with animal models 
for Glil function. Comprehensive discussion of these is beyond the scope of this thesis, and 
readers are referred to recent extensive reviews (Koebemick and Pieler, 2002; Ruiz i Altaba et 
al, 2002). 
1.8 Cancer as a genetic disease 
Cancer is a term used to describe a collection of distinct diseases that share the common 
feature of uncontrolled proliferation of cells. Such cells are said to have undergone neoplastic 
transformation and are no longer subject to the regulatory mechanisms that normally prevent 
them dividing indefinitely. Such "immortalised" cells often have the ability to form tumours. 
Tumours may be benign, in which case they remain localised in a mass and do not invade 
surrounding tissue, or malignant ("true cancers") which are invasive. The later either infiltrate 
tissues at the site of formation, or spread to distant sites through the blood or lymphatic 
systems by a process called metastasis. Cancers are classified into two broad classes: 
carcinomas, which arise from surface linings (epithelia), and sarcomas, which arise fi-om solid 
tissues. 
1.8.1 Genetic lesions and mechanisms of cancer initiation 
In normal growth cell division is controlled by many molecules working together to maintain 
a level of cell division needed for growth and repair. Mutations in the genes encoding such 
molecules, or in genes which secondarily regulate their fimction, can upset this delicate 
balance. Genes that may cause cancer when mutated are classified into two classes depending 
on whether they have a negative or positive effect on cell proliferation. Tumour suppressor 
genes tend to act as inhibitors of growth and act in a recessive fashion. Proto-oncogenes on 
the other hand tend to be growth stimulating, and can act in a dominant manner. The tumour 
suppressor genes are often considered to fall into two subcategories: gatekeeper genes and 
caretaker genes. Gatekeepers are defined as genes that have a direct inhibition on cell growth, 
whereas the affect of mutations in caretaker genes can be indirect, such as maintenance of 
genome stability or DNA repair (Kinzler and Vogelstein, 1997). 
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The "two-hif hypothesis first proposed by Knudson in 1971 provides the most 
straightforward model of genetic mutation leading to cancer formation, and the classic 
example of this is mutation of the retinoblastoma {Rb) tumour suppressor. Based on 
epidemiological studies Knudson hypothesised that people who had a familial predisposition 
to the tumour carried a germ-line mutation in one allele of Rb, and a single fiirther mutation in 
the other Rb allele was all that was required to form retinoblastoma. In contrast non-familial 
retinoblastoma is rare, reflecting the extremely low chance of a normal individual receiving 
random mutations of both wild-type copies of Rb in a single cell (Knudson, 1971). 
Most human cancers appear to arise by a more complex model, whereby multiple hits in a 
number of genes are required for tumour progression. In recent years the "multi-hif 
hypothesis has arisen, largely from the work of Kinzler and Vogelstein, who have 
demonstrated the progression of mutations (or "hits") required in the formation of colorectal 
cancer (reviewed by Kinzler and Vogelstein, 1996). In such a model, the progression of a 
cancer requires mutation in a number of successive genes in order for cells to reach their fiill 
destructive potential. An initial mutation may provide a cell with a selective advantage over 
its neighbours. Secondary chance mutations in another gene can then occur within one of the 
members of the expanded pool of precursor cells. In some cases such mutations lead to an 
increased mutation rate by disrupting a checking mechanism or causing genetic instability 
(reviewed by Cahill et al, 1999). The descendants of these cells would then attain fiirther 
genetic lesions at a higher rate than for surrounding cells, resulting in a bypass of normal cell-
cycle regulation. There are many similar scenarios envisaged by which multiple gene hits can 
lead to tumourigenesis in different tissue types. As tumours grow, their requirements become 
more complex and they must establish their own blood supply to keep oxygen and nutrients 
reaching the centre of the mass. Such features may require further mutations in genes 
controlling processes such as vasculogenesis or angiogenesis. 
1.8.2 Basal cell carcinoma 
BCC is widely regarded as the most common cancer occurring in Caucasian populations 
(Miller, 1991; McKee, 1996; Freedberg et al, 1999). Risk factors include sun exposure, 
ionising radiation, presence of scar tissue and exposure to arsenic salts. BCCs have a slow 
growth rate and rarely metastasise, but are locally invasive and usually require surgical 
removal (reviewed by Miller, 1995). With the exception of rare cases involving palm pits in 
NBCCS patients, BCCs occur almost exclusively in hair bearing skin; though within these 
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regions they can arise from both follicular and interfollicular sites (Dobson, 1963; Zackheim, 
1963). 
The cellular origin of BCC is yet to be fully elucidated. Histologically, tumours consist of 
masses of uniform undifferentiated cells with large nuclei and resemble basal keratinocytes 
(Grimwood et al, 1986). Various lines of evidence implicate the slow cycling basal 
keratinocytes that populate the bulge region of the outer root sheath of hair follicles as BCC 
progenitors (CotsareHs et al, 1990; Leshin and White, 1990; Asada et al, 1993; Ponten et al, 
1994; Taylor, G. et al, 2000; Fuchs et al, 2001). Molecular studies investigating keratin 
expression support this, but do not exclude the possibility the BCCs arise from pluripotent 
keratinocyte stem cells that have then differentiated towards a follicular morphology (Markey 
et al, \991). 
There is an important relationship between BCC cells and the surrounding stroma, and it 
appears that tumour cells cannot be grown independently of this requirement (Grimwood et 
al, 1986). In vivo the connective tissue stroma proliferates with the tumour, and is arranged in 
parallel bundles around it (Pinkus, 1965). Researchers have encountered difficulty 
propagating BCCs in tissue culture, which may be due to both the requirement for the 
surrounding stroma and the slow growth rate of cells. A requirement to be near the dermis in 
vivo may also explain the low metastasis rate. The lack of an adequate animal or tissue culture 
model makes studies on human BCC difficult. Some investigators have utilised human BCCs 
grafted onto nude mice, however the low frequency of growth means that this animal model is 
impractical for most studies (Grimwood et al, 1986). In future studies BCC-like lesions that 
form on mice over-expressing Glil or Gli2 in skin may provide a usefiil investigative system 
(Grachtchouk et al, 2000; Nilsson et al, 2000). 
Approximately 30 to 40 percent of sporadic BCCs harbour detectable PTCH mutations while 
over 50 percent contain mutations in P53, a tumour gene encoding a cell cycle regulator that 
is implicated in more than half of all human cancers (Lacour, 2002). Two studies have 
identified SMOH mutations in human BCC, one estimating the incidence at 6 percent (Xie et 
al, 1998) and another at 20 percent (Lam et al, 1999). Since ectopic expression of Gli family 
members in skin leads to BCC-like tumours in various animal models, this suggests mutations 
directly affecting Gli gene expression may also be involved in BCC initiation in humans 
(Dahmane et al, 1997; Grachtchouk et al, 2000; Nilsson et al, 2000). Overall it appears that 
disruption of normal hedgehog pathway signalling is a key determinant the formation of BCC, 
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and this features in a large proportion of cases. In this way hedgehog signalUng can be 
thought of as a "gatekeeper" pathway, with disruption at any of a number of levels sufficient 
for BCC formation. 
1.8.3 Origin of NBCCS related tumours 
The high percentage of functionally null PTCH truncation mutations found in NBCCS 
patients suggests that the developmental features of NBCCS arise from haploinsufficiency of 
the Patched protein product (Wicking et al, 1997b). Tumours are thought to arise when 
additional mutations disrupt the remaining wildtype Patched allele, with Patched acting as a 
classical tumour suppressor. 
NBCCS tumours and related sporadic tumours frequently display loss of heterozygosity 
(LOH) on chromosome 9q22, the region containing PTCH. LOH represents a genomic change 
disrupting the normal set of alleles at a particular locus, generally occurring due to loss of 
DNA encoding some or all of the allele sequence on one chromosome. When one copy of a 
gene is missing by a process such as deletion, a single point mutation the remaining copy can 
be sufficient to cause disease. LOH has been found combined with a mutation in the 
remaining PJC//allele in a number of sporadic basal cell carcinomas (Gailani et al, 1996). 
Inactivation of both copies of PTCH in a particular cell is probably not the only mechanism 
by which NBCCS related tumours arise. Mutations in other genes that cause further 
perturbation of the hedgehog pathway, or in genes of other functionally interacting pathways, 
may work in concert with a single PTCH mutation to lead to tumourigenesis. Evidence for 
this comes from studies that have attempted to find mutations in the germ-line wild-type 
patched allele in NBCCS patients or knockout mouse model tumours. One such investigation 
used an animal model of NBCCS (heterozygous Pa^c/^ e J knockout mice) in order to sequence 
RNA from the remaining Patched allele in CNS tumours that were formed after a "second 
hif. Nucleotide analysis failed to find any mutations in the wild-type allele in the tumours 
analysed, suggesting that either a single mutation is sufficient for tumour formation in mice, 
or that second "hits" in genes other than Patched can act together with a single mutated 
Patched allele in tumour formation (Wetmore et al, 2000). These additional hits could occur 
in other genes involved in hedgehog signal transduction, or may affect other pathways 
intertwined with hedgehog pathway function, or pathways controlling similar downstream 
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targets. Direct mutation of downstream target genes or their control regions may also lead to 
tumour formation. 
1.9 Aims and objectives 
At the time this project was initiated, around eighteen months after the identification of 
Patched as the gene responsible for NBCCS, very few mammalian genes regulated by the 
patched-hedgehog pathway were known. Though studies into the mechanisms of Hedgehog 
transduction via Patched and other members of the signalling cascade were already well 
advanced, largely due to the body of knowledge aheady existing from studies of Drosophila 
development, the targets regulated by the pathway in mammals remained largely elusive. 
By analogy with hedgehog signalling in the fruit fly, members of the TGpp and Wnt gene 
families are implicated as potential mammalian targets. Just which members of these large 
families are regulated by Hedgehog was only beginning to be investigated. It was clear 
however that as the pathway in vertebrates has many added levels of complexity over the 
arthropod system, particularly in the numbers of proteins involved, there would likely be a 
number of vertebrate target genes. 
The primary aim of the work described in this thesis was to discover downstream components 
of the hedgehog pathway and investigate the response of identified targets to Shh stimulation. 
Hedgehog proteins can be thought of as molecular switches, master controllers who by 
signalling to particular cells at particular times in development start a cascade of events 
leading to the expression of genes directly involved in growth and patterning. It is these genes 
that are crucial to identify if we are to understand how activation of the pathway at 
inappropriate times leads to the phenotypes observed in human disease and cancer. Not only 
is the identification of these target genes essential if we are to understand the fundamental 
biological mechanisms of this important pathway and its role in animal development, but it 
may also reveal crucial targets for therapeutic intervention in a range of human disorders and 
common tumour types. 
Initial studies in this project concentrated on cultured skin keratinocytes as a model system for 
hedgehog target gene discovery because of the strong implications that it is this cell type from 
which basal cell carcinoma originates. Recombinant Shh protein was produced in mammalian 
cells with the aim of stimulating the pathway in such cells in a controlled manner. The basic 
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premise fundamental to this thesis is the fact that exposing responsive cells to hedgehog will 
have a biologically comparable effect on gene expression as a knockout of Patched function. 
Thus stimulation with hedgehog should replicate the gene expression pattern in NBCCS-
related tumour cells. Initial sttidies indicated that keratinocytes are not competent to receive 
the hedgehog signal in vitro, and that it was difficult to produce purified recombinant Shh 
protein with high biological activity. At this stage it became clear that alternative methods of 
pathway activation and a different model system would be vital to the success of the project. 
A breakthrough came two years into the work, largely from the establishment of an 
embryonic mouse mesodermal cell system in the laboratory following the findings of a 
Japanese research group who showed the cell type, C3H/10T1/2, was responsive to Shh 
(Nakamura et al, 1997). This provided a number of biological advantages over basal 
keratinocytes (as outlined in Chapter 3). In particular, the pluripotent nature of this cell type 
promised access to a larger and potentially more diverse pool of hedgehog targets genes. 
Several alternate methods, involving either transfection of key genes or addition of Shh 
conditioned media produced in the C3H/10T1/2 system, were subsequently shown to be 
successful in activating the hedgehog pathway response, as shown by analysis of several 
downstream markers. The aim was then to examine the response in detail, particularly with 
regard to timing. Selection of relevant timepoints was imperative to the success of the planned 
comparative gene expression studies. In concert with this work, a fiirther goal was to 
investigate the potential role of a number of candidate target genes. The purpose of this was 
two-fold. Firstly, the potential response of genes of interest could be investigated to see if they 
were indeed targets in the C3H/10T1/2 cell line, and secondly, such findings would provide 
further data for the refinement of activation strategies and for relevant timepoint selection for 
further investigations. 
Microarray technology was intended from the outset to be the major method of generating 
lead genes implicated as hedgehog regulated targets, but delays in the availability of essential 
resources and equipment allowed time to undertake the alternative strategy of construction 
and analysis of subtractive cDNA libraries. Once microarray resources became available 
analysis was begun in earnest on hedgehog simulated cells, and the project became fruitful in 
meeting its primary aim. The studies detailed in this thesis outline the search for downstream 
target genes regulated by the hedgehog pathway, strategies for their biological validation and 
subsequent studies exploring the response of the newly implicated genes. The combination of 
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C3H/10T1/2 cells and microarray based differential expression analysis provided a powerful 
system for hedgehog target gene discovery. 

Chapter 2: Strategies for Hedgehog 
Pathway Activation and Initial Studies 
in Keratinocytes 
2.1 Introduction 
In order to undertake detailed studies of differential gene expression it is critical that the two 
populations being compared are identical except for the variable under investigation. For this 
reason, work with the aim of hedgehog target gene discovery needed to be undertaken in a 
model system where variables could be strictly controlled, eliminating undesired differences 
between cell populations investigated that may have led to a high level of false positives. 
2.1.1 Selection of epidermal keratinocytes as an initial model 
system for hedgehog pathway activation 
A number of biological systems were initially considered to maximise the chance of 
identifying downstream targets of the hedgehog pathway in mammals. After consideration of 
a number of factors (discussed below) cultured epidermal keratinocytes were chosen as the 
initial system. 
Animal models of hedgehog pathway defects, or transgenics over-expressing Hedgehog, were 
considered as a possible system for investigation, but were not available to the author at the 
commencement of work. 
Human tumour samples would have provided an interesting system for investigation, but due 
to a number of limitations were not used. Firstly, there are complications in obtaining pair 
matched non-affected tissue. This is a particular limitation with human patients as donation of 
non-tumour tissue raises a number of ethical, medical and consent issues. Secondly, normal 
tissue near a tumour is often an entirely inappropriate control for differential expression 
analysis. Cancer is made up of clonal cells, and the particular cell type a tumour arises from 
may make up only a small percentage of the cells present in the surrounding tissue. Thirdly, if 
such an approach were undertaken it would be essential to establish that the particular 
tumours studied indeed featured hedgehog pathway disruption, and the time and resources 
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required for genotyping or otherwise classifying such samples (for example by preliminary 
expression investigations of each tumour) was prohibitive. 
At the commencement of studies described in this chapter mammalian systems known to be 
responsive to Hedgehog were limited largely to embryonic models and tissue explants. Few 
responsive cell lines had been described. Due to the strong implication of basal skin 
keratinocytes as the cellular origin of BCCs (as discussed in the previous chapter), studies 
were initiated with this cell type. The major advantage of this strategy was that any identified 
targets would potentially have direct relevance to epidermal tumourigenesis. 
2.1.2 Potential levels at which to activate the hedgehog signalling 
cascade 
When hedgehog signalling is activated in cells changes in the expression of downstream 
target genes occur. By comparing gene expression patterns before and after stimulation, genes 
specifically activated by the pathway can be identified. There are a number of levels at which 
the hedgehog signalling pathway could potentially be activated to achieve this goal, and these 
are summarised in Figure 2.1. 
The most straight forward method would be to directly stimulate cells with a Hedgehog 
protein, so that cells respond as they would during normal growth and development. There are 
also a number of other possibilities. If the action of proteins with an inhibitory affect on the 
pathway activity is reduced, this should also lead to pathway activation. This is the expected 
mechanism of tumour formation in Patched knockout mice and their human equivalent - the 
cells of NBCCS patients who have gained a mutation in their second PTCH allele. It is 
difficult to knockout the fiinction of a protein like Patched in an experimental setting, but the 
opposite strategy, enhancing the effect of positive effectors of pathway function, is much 
more amenable to manipulation. 
Over-expression of Smo, or factors involved in mediating the Smo regulated franscriptional 
response, should activate the pathway in cultured cells, and support for this comes from the 
fact such genes can act as oncogenes in human tumours. There is some debate as to whether 
an increased level of wild-type Smo can cause the pathway to become activated, but there is 
evidence that certain dominant oncogenic mutants may be sufficient for this to occur (Xie et 
al, 1998; Lame?a/., 1999). 
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Figure 2.1 Points at which the Shh pathway could potentially be activated to initiate a 
transcriptional response in downstream genes. 
Interactions for which there is substantial evidence are shown with solid arrows. 
Possible interactions for which there is some evidence, but which are not yet well 
understood, are shown as lighter dashed arrows. Blocked arrowheads represent 
inhibition. PotentSl levels for experimental manipulation in order to elicit a hedgehog 
transcriptional response are indicated with red arrows. These represent: (A) Over 
expression of Shh, (B) Overexpression of a constitutively active oncogenic Smoothened 
mutant, (C) Over-expression of the transcription factor Glil. 
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Another ahemative is the overexpression of transcription factors such as Glil. At the 
commencement of this project it appeared that Glil was the primary mediator of hedgehog 
signalling in mammals, and the role of the other Gli proteins was unclear. Further more the 
ectopic expression of Glil in skin in animal models leads to BCC-like tumour formation 
(Dahmane et al, 1997; Nilsson et al, 2000). Glil was therefore considered a good candidate 
to provide a "hedgehog mimicking" transcriptional response. 
In terms of the first strategy, stimulation with Hedgehog itself, there are options as to which 
mammalian Hedgehog to use. Shh plays the major developmental role in mammalian 
embryonic development and was considered to be of more interest than Ihh or Dhh for initial 
investigations. 
Direct stimulation of the pathway with Hedgehog protein was chosen as the strategy of choice 
and much early effort in the project went into preparing materials for testing this strategy. 
Stimulation with Shh has a number of advantages over activating the pathway at more distal 
levels in the signal transduction cascade. Firstly, it has been well studied in the regulation of 
downstream target genes in a number of developmental systems (refer Chapter 1). Secondly, 
by activating directly with Shh genes that are regulated independently of Patched-Smoothened 
signalling can still potentially be identified, as can genes regulated by transcription factors 
other than members of the Gli family (Figure 2.1). 
Time was also spent on two alternate strategies, firstly to provide a backup plan should 
problems arise with the primary strategy, and secondly to have them available as tools for 
further investigation of pathway activation at later stages of the project. The first alternate 
strategy involved expression of the oncogenic SMOH mutant encoding a Trp to Leu change at 
codon 535 (as described in Section 1.6.4) in cells. This mutant is hereafter referred to as 
SMOH^'^^'^. The other strategy was exposing cells to increased levels of Glil to directly induce 
transcription of downsfream target genes. 
2.1.3 Transfection and direct protein addition as approaches to 
patliway activation 
The primary strategy chosen for pathway activation, direct exposure to Shh protein, could 
potentially be achieved in several ways. The preferred option was to add recombinant Shh 
protein directly to the growth media of the cultured cells, ensuring all cells in the dish would 
be simultaneously exposed to an equal concentration of Hedgehog. Several groups have 
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published studies using recombinant Shh protein, and two have provided expression 
constructs for use in this project (see below). 
An alternative way to expose cells to Hedgehog is to transfect them directly with an 
expression construct encoding the protein. As hedgehog is a secreted molecule transfected 
cells will produce Shh that will then have the potential to activate all cells in a culture, not just 
those that express the expression construct. This technique has a number of limitations 
compared with direct protein addition for differential expression studies. Firstly, transfection 
is a stressfiil procedure for cells, as is often evident fi-om their physical appearance during and 
after treatment, and there is always a risk that the stressed cells may no longer respond to 
some stimuli as they would in an undisturbed state. Secondly, the procedure itself may trigger 
a range of transcriptional responses that may be due to introduction of the foreign DNA, to the 
chemicals or physical procedures involved in transfection, or changes in the surrounding 
environment such as the need to withdraw serum in many commonly used techniques. While 
these issues are not a problem in a well controlled study of gene expression changes, there is a 
risk of them leading to false-positives if extreme care is not taken. 
In studies such as those detailed in this thesis the goal is to detect changes in the expression of 
a small number of genes of interest upon a background of tens of thousands of genes that 
maintain their current expression state regardless of whether or not the stimulus of interest is 
applied. When expression changes other than those induced by the stimulus occur, but are 
equivalent in both the stimulated and control cells, they effectively cancel out and have no 
effect on the identified "genes of interest". The danger comes when transfection induces gene 
expression changes unrelated to the stimulus of interest and these are not of equal magnitude 
in the stimulated and control cells. To minimise DNA based effects it is critical that the 
negative control construct to be used be as close as possible in size and content to the 
stimulating construct, and so the control construct should have the same promoters and other 
protein binding regions as the treatment plasmid. It is difficult to ensure that impurities in 
DNA preparations, which will inevitably be present, are at the same level for treatment and 
control samples. Such impurities may include residual reagents fi-om the extraction process or 
bacterial compounds carried through from DNA amplification in E. coli. To minimise this 
threat it is essential that DNA preparations are produced and processed in parallel. Where 
possible, they should be grown in the same strain, incubated the same way and processed the 
same day, with the same extraction method to minimise potential differences. Other 
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limitations with transfection include a lack of control over the level of exposure to the 
produced protein and lag time after transfection before maximal expression. 
For the above reasons, it was decided that the addition of purified recombinant protein would 
provide a more precise system than transfection of a Shh expression consti-uct. A known 
concentration of protein could be added without cell stress, and the risk of false positives and 
complicating factors would then be much lower than with transfection. 
This chapter details the production of recombinant Shh protein in two biological systems, 
along with a number of experiments conducted at the outset of the project using keratinocytes 
as a model system for hedgehog pathway activation. During the investigations a number of 
issues necessitated a move to a transfection based system even though, as discussed above, 
this is not ideal. However, as studies detailed in the remainder of this thesis show, transfection 
based systems can be powerful when additional control validation measures are put into place 
to ensure results obtained are genuine. 
2.2 Production of recombinant Shh protein 
Two different methods were used to produce recombinant Shh protein (refer Materials and 
Methods for details). Shh protein was subsequently added to the growth media used in the 
culture of basal keratinocytes. 
2.2.1 Purification from transfected C0S7 cells 
Recombinant Shh (rShh) was produced by transiently transfecting the Cos7 cell line (SV40 
transformed kidney cells from the African green monkey) with a Shh expression construct 
(pShh-N-PMT21; a gift of the late Dr. T. Yamada) encoding the N-terminal active region of 
Shh (codons 1-198 of the mouse cDNA). Shh was secreted into the growth media, from which 
it could be partially purified and concentrated by centrifiigation with a size selective 
membrane. Western blotting was used as a tool during the optimisation of transfection 
procedures to ensure Shh was indeed being produced by the treated cells, and final batches 
were quantified against BSA standards (Figure 2.2). A number of independent batches of 
protein were produced using this methodology. 
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Figure 2.2 Recombinant Shh protein produced by transfected Cos? cells. 
(A) Western blot showing rShh is produced and secreted into the media by Cos? cells 
transiently transfected with pShh-N-PMT21. Media concentrated five fold prior to 
t; 1 loading. The anti-Shh antibody was a kind gift of the late Dr. T. Yamada (anti-Shh-N 
rabbit polyclonal H4, Ericson e/ al., 1996). Ladder is "pre-stained broad range 
standards" (Bio-Rad). (B) Coomassie-blue stained protein gel of Cos? produced rShh 
after 50 fold concentration. Ladder is "kaleidoscope pre-stained standards' (Bio-Rad). 
The final product is still a complex protein mixture, but a large proportion of the protein 
present is Shh. The batch shown in Panel B is estimated at approximately 200 ng/|il by 
comparison to BSA standards. In both panels the control was produced from cells 
transfected in parallel with an empty vector control construct. 
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2.2.2 C0S7 produced protein has low biological activity 
When this work was initiated the author did not have access to a biological system suitable for 
quantitative assay of the biological activity of the produced rShh. Instead the activity of the 
protein was investigated by its ability to up-regulate key targets of hedgehog signalling in 
keratinocytes, as assessed by northern blotting. However, no up-regulation was observed. 
From this result it was not possible to determine whether the lack of response was due to a 
characteristic of keratinocytes in vitro, or simply reflected a lack of biological activity of the 
produced protein. In order to assess the quality of the produced protein a collaborator, the late 
Dr. T. Yamada, analysed the Shh protein for activity in a chick neural explant assay. This 
semi-quantitative assay is based on the induction of specific neural cell fates by Shh when 
ectopically applied to developing embryonic tissues (Yamada et al, 1993). Dr. Yamada 
reported that the produced protein did have some biological activity in this system, but that in 
all cases it was "very low" (personal comm.). Later when the C3H/10T1/2 cell system was 
established (refer Chapter 3) the protein was able to be assayed in another biological model of 
hedgehog pathway function. In this case the mesodermal cells, which are a less sensitive Shh 
assay system than chick neural tissue, failed to show any response with the Cos7 produced 
protein (data not shown). 
2.2.3 Production of HIS-tagged Shh in Bacteria 
Due to the difficulties encountered with producing rShh protein with high biological activity 
in Cos7 cells, an alternative production method was attempted which involved production of 
Shh in bacterial cells, followed by specific purification by means of an encoded histidine 
(HIS) tag (Marti et al, 1995). The Shh expression construct used in this work (pETmShhl98) 
and protocols for protein production were kindly provided by Dr. A. McMahon. 
Yields with this method were extremely high (Figure 2.3). A number of batches produced in 
this way were also tested for biological activity in the C3H/10T1/2 system, but none of them 
showed any detectable activity in terms of alkaline phosphatase induction (data not shown; 
see following chapter for assay principle). As discussed at the end of this chapter, it was 
decided at this stage that a different approach to Shh pathway activation would need to be 
undertaken if the project was to meet its primary aim, since attaining Shh protein with high 
biological activity was problematic. 
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Figure 2.3 Recombinant Sonic hedgehog (rShh) protein produced in E. colL 
(A) Coomassie stained protein gel showing that after harvest Shh makes up a large 
proportion of the total cellular protein. Right hand lane shows the produced rShh protein 
after HIS-tag purification procedure. (B) Coomassie stained protein gel quantification 
against BSA standards show large amounts of rShh protein of high purity are produced 
by this method. Protein batch shown in this gel was estimated at 0.25 |ig/^l. Typically, 
yields ranged from 1 to 9 mg rShh protein per 100 ml of LB culture, depending on 
induction conditions and growth parameters. Ladder is Benchmark pre-stained protein 
ladder (Gibco BRL). 
2.3 Studies in basal keratinocytes 
As discussed in Section 2.1.1, keratinocytes were chosen as a model system for initial 
investigations into the hedgehog pathway response. The first experiments performed in this 
cell type involved the protein described above, which is now known to be of low activity. 
Meaningful conclusions were not able to be drawn from these experiments and necessitated a 
move to transfection based approaches. . 
Two types of keratinocytes were used in parallel for Shh treatment experiments. The first 
were primary cultures of murine basal keratinocytes, isolated from the skin of neonatal mice 
(see Materials and Methods, Chapter 8). Secondly, experiments were performed in the human 
keratinocyte line HaCaT (Human Adult low Calcium high Temperature), a spontaneously 
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transformed non-tumourigenic cell type. This line originated from normal upper back skin 
isolated near the site of a melanoma, and retains a normal keratin profile and differentiation 
potential (Boukamp et al, 1988). A previous study has shown regulation of hedgehog target 
genes in normal keratinocyte cells when retrovirally transduced with Shh and grafted onto 
immune deficient mice (Fan, H. et al, 1997). This supports the fact that keratinocyte are able 
to respond to hedgehog in vivo. 
2.3.1 Basal expression level of key pathway genes in keratinocytes 
To ensure that the model systems used in this chapter were appropriate for pathway studies, 
the background expression level of several key genes were investigated. It is essential that the 
cells express Patched, so that they will have the potential to respond to Shh. Patched 
expression is readily detected in both primary keratinocytes and the HaCaT line by RT-PCR 
and on poly(A)"^ northern blots (Figure 2.4, Figure 2.5). Another desirable feature was a lack 
of detectable Shh expression in both cell types (data not shown). Two murine Glil transcripts 
were detected in primary HaCaT keratinocytes on poly(A)^ northern blots, but at extremely 
low levels (data not shown). Patched2 transcription was observed in murine keratinocytes, but 
again at a low level (Figure 2.4). 
Since the level of known hedgehog target gene expression in keratinocytes is not high this 
means that the pathway is not already in a state of high stimulation. This makes the cell type 
of interest for further study. 
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Figure 2.4 Basal expression of key hedgehog pathway genes in cultured murine keratinocytes. 
(A) Expression of multiple Patched mRNA transcripts in cultured neonatal 
keratinocytes (Kera), as detected by poly(A)'^  northern blot hybridisation. (B) 
Expression of Patchedl on the same blot shown in panel A. The smallest transcript 
either may be unique to each of the genes or may represent a cross-hybridising 
sequence. (C) Glil is expressed at a low level in cultured neonatal keratinocytes (Kera), 
as shown by RT-PCR (35 cycles). Mouse Glil primers were modified from those 
published by Walterhouse et al., (1993), in that the superfluous overhangs were 
removed and a miss-match between GenBank sequences and the published reverse 
primer was corrected. Template for each reaction was cDNA transcribed from 200 ng of 
total RNA. Negative control represents the same volume of a "no RNA" control cDNA 
synthesis reaction. Positive control PCR template was 0.5 ng of a plasmid containing 
the mouse Glil cDNA. Ladder is "1 kb ladder" from Gibco BRL. Samples from various 
adult mouse tissues are included in each panel for comparison. 
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Figure 2.5 Basal expression of key hedgehog pathway genes in the human HaCaT 
keratinocyte cell line. 
(A) Expression of PATCHED {PTCH) mRNA in HaCaT cells, as detected by poMA)"" 
northern blot hybridisation. (B) GUI expression is not detected in HaCaT cells when 
investigated by poly(A)'^  northern blot hybridisation (one week exposure). Cells 
transiently transfected with human GUI (pRK7-N-Myc-hGli; right hand lane) provide 
positive control for Glil probe. 
2.3.2 Exposure of primary murine keratinocytes to recombinant 
Shh-N 
As mentioned previously, a number of early experiments were conducted that involved 
addition of Cos7-derived rShh protein to primary cultures of neonatal murine keratinocytes. 
Shh-N was added at a concentration of 100 nM, ten times higher than the level at which 
Shh-N has been shown to saturate binding to Patched in biological systems (Marigo et al, 
1996a). None of these studies showed evidence of any detectable change in the level of 
transcription of Ptc, GUI or Bmp4 on poly(A)^ northern blot over a range of times (data not 
shown). Since the Shh used in these studies was later shown to have very low biological 
activity (Section 2.2.2), conclusions on the responsiveness of primary keratinocytes grown in 
vitro could not be drawn from the negative findings of this work. As an alternative strategy to 
activate this cell type, which was not suitable for transfection, the human GUI coding region 
2.3 Studies in basal keratinocytes 67 
(a kind gift of Dr. K. Kinzler) was cloned into a retroviral expression vector (pLXSN, a gift of 
Dr, M. Wei) for use in transduction experiments. Under the supervision of Dr. M. Wei (Sir 
Albert Sakzewski Virus Research Centre, Brisbane) the resulting construct was transfected 
into a producer line capable of producing infectious but non-replicating virus particles. This 
work was discontinued once the C3H/10T1/2 cell line system (detailed in Chapter 3) was 
found to be a far simpler system in which to elicit a hedgehog response, and the focus of this 
project was moved to this alternative cell type. 
2.3.3 Investigation of hedgehog pathway activation in IHaCaT cells 
Studies in the HaCaT cell line were conducted in parallel with the work on primary murine 
keratinocytes. This cell type was much more amenable to manipulation than primary cells, 
although the immortal nature and long term culture of this cell line mean it may not reflect 
true keratinocyte biology as accurately as primary cells. Transfection based studies were 
conducted to establish whether the hedgehog pathway could be activated in this cell type. 
Northern blotting was conducted with RNA derived from cells transfected with constructs for 
either mouse Shh-'N, human GUI or the oncogenic SMOH mutant 1604, collected over 8 
timepoints ranging from 1.5 hours to 6 days. Detailed explanations of the constructs used and 
the basis for their use are provided in Chapters. Blots were probed with human PTCH 
(Figure 2.6) as an indicator of hedgehog pathway activation. With the exception of apparent 
up-regulation of PTCH following GUI transfection at the 1 and 2 day timepoints, there was 
little evidence of activation with any of the strategies (there may be slight up-regulation of 
PTCH with Shh-'N and SMOH mutant transfections at 2 days, though densitometry data, 
shown in Figure 2.6, suggests this is weak at best and only at a single timepoint). Transfected 
cells were also investigated with antibodies to Patched and to Smoothened. Smo in 
Drosophila is controlled post-transcriptionally under the influence of Hedgehog, making it of 
interest for investigation at the protein level (Alcedo et al, 2000). Investigation of the proteins 
by immuno-fluorescence did not reveal any evidence of a pathway response with any of the 
three activation strategies attempted. As the hedgehog pathway response, if any, was subtle in 
HaCaT cells, the work with transient transfection was not continued. 
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Figure 2.6 Investigation of PATCHED {PTCH) mRNA expression in HaCaT cells after 
transfection witli GLIl, Shh or an oncogenic SMOH mutant. 
Northern blots are of RNA harvested from cells transfected with pShh-N-PMT21 
(Shh-N), pRK7-N-Myc-hGli (GLIl) or pcDNA3-hSmo-mutl604 (SMOH 1604) at 
various timepoints post-transfection. (A) One and two day timepoints. (B) Three and 
four day timepoints. Transcript 1 represents the full length PTCH mRNA. Earlier 
timepoints were also investigated (data not shown). Numbers indicate PTCH fold 
change data for the labelled lane (compared to the control lane for that timepoint), as 
estimated by GAPDH normalised densitometry. 
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In parallel with this work attempts had been made to produce a stable GLIl expressing 
HaCaT line by co-transfecting the human GUI expression construct (pcDNA3-hGlil; for 
more information refer to Section 3.3.5) and a 0418 resistance construct. Twenty independent 
G418 resistant cell lines were investigated by northern blotting. When compared to G418 
resistant negative control lines, none of these showed evidence of construct driven GUI 
expression nor PrC/f up-regulation by northem blotting. 
Interestingly, growth media collected from HaCaT cells transiently transfected with Shh-N 
had potent hedgehog activity in the C3H/10T1/2 assay system (Figure 2.7, assay principle 
described in detail in the following chapter). This showed that transfection had been 
successful in the experiments involving Shh-N, indicating that the HaCaT cells responded 
only weakly (if at all), even though they had been exposed to a high level of active Shh 
protein. 
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Figure 2.7 Histochemical alkaline phosphatase assay in C3H/10T1/2 cells shows transfected 
HaCaT cells express Shh protein with potent biological activity. 
(A) Media collected from HaCaT cells that have been transfected with pShh-N-PMT21 
induces alkaline phosphatase activity in C3H/10T1/2 cells, as indicated by blue staining. 
(B) Media collected in parallel from a negative control transfection has no detectable 
effect on alkaline phosphatase activity in C3H/10T1/2 cells. The principle of the 
C3H/10T1/2 alkaline phosphatase assay is described in detail in Chapter 3. The media 
used was collected from the cells for which RNA was obtained for the northem blot 
shown in Figure 2.6. Media was collected 24 hours post-transfection. The above result 
shows that the lack of a convincing response to Shh in HaCaT cells was not due to any 
problems with the construct or transfection procedure, as it confirms that the cells were 
exposed to high levels of active Shh protein during the experiments. 
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2.4 Discussion 
Basal skin keratinocytes were considered a cell type of interest for studies of the hedgehog 
pathway due to their probable involvement in the formation of basal cell carcinoma. Both of 
the keratinoc)^e systems investigated, primary murine cells and the immortal human line 
HaCaT, expressed Patched and Smoothened at readily detectable levels, suggesting they could 
potentially receive the Shh signal. However, neither cell type was successfully stimulated 
with rShh N-terminal protein. Subsequently the Cos7-derived rShh-N used for this work was 
found to have very low biological activity, and thus the results could not be considered 
conclusive. Preliminary transfection studies in HaCaT cells did not yield convincing data to 
indicate they were responsive to Shh when Patched was investigated as a marker of pathway 
activation, even when the cells were exposed to Shh-N shown to have high biological activity. 
Transfection of a constitutively active SMOH mutant also failed to elicit an obvious response. 
There was an apparent induction in the level of PTCH in response to stimulation with GLIl, 
but this was so slight that extensive replicated studies to see if the response was significant 
were not performed. 
A subtle change in a key indicator would have made for a poor model system in terms of 
hedgehog target gene discovery. At this stage a different tissue system involving embryonic 
mesodermal cells was found to be extremely amenable to hedgehog pathway activation, and it 
was decided that resources should be devoted to this alternative cell type (as described in the 
following chapter). 
A recent publication has reported up-regulation of pathway markers in HaCaT cells in 
response to stimulation with GLIl, with maximal induction of PTCH mRNA observed 48 
hours after treatment (Regl et al, 2002). Thus, it appears that HaCaT cells can indeed display 
a response when the pathway is activated at a level of the signalling cascade more distal than 
hedgehog itself The greater magnitude of PrC//induction in this study compared with GLIl 
experiments such as that shown in Figure 2.6 may reflect differences in GLIl stimulation 
methods. Regl and colleagues used a stably transfected line such that GUI expression could 
be tightly controlled using a tetracycline sensitive construct. 
It is possible that keratinocytes do indeed respond directly to Shh in vivo, but that this 
response is retarded when keratinocytes are grown in monoculture. In an animal, basal 
epidermal keratinocytes sit near the interface with the dermal tissue layer. Here they would be 
exposed to any cofactors potentially secreted by the dermal cells. Interestingly, BCCs are 
2.4 Discussion 71 
recalcitrant to being grown in a tissue culture environment and this may be for similar 
reasons. It is also possible that the human HaCaT cells did not show a strong up-regulation of 
PTCH in response to Shh because the transfected construct encoded the mouse protein, 
though this is considered unlikely given the high homology between the mouse and human 
proteins at the amino acid level. HaCaT cells exhibit trisomy of the long (q) arm of 
chromosome 9 (Boukamp et al, 1988), and as such presumably have three copies of PTCH. If 
all three are transcribed then elevated Patched protein levels could potentially lead to either 
increased inhibition of Smo, or increased sequestering of Shh, thereby contributing to the lack 
of a convincing response upon stimulation with Shh. One study has shown that the hedgehog 
pathway can be activated in human keratinocytes, though in this case a full length human Shh 
construct was retrovirally expressed in cultured cells before they were differentiated into a 
skin layer and grafted onto immune deficient mice (Fan, H. et al, 1997). 
Due to the difficulties in eliciting a clear cut hedgehog pathway activation response in the 
keratinocytes used in this work further studies were conducted in an alternative system, a 
embryonic mouse mesodermal line called C3H/10T1/2. This line proved highly amenable to 
pathway activation and is discussed in detail in the following chapter. 

Chapter 3: C3H/10T1/2 as a Model 
System for Hedgehog Target Gene 
Discovery 
3.1 Introduction 
The experiments outlined in the previous chapter indicated that basal keratinocj^es present 
some difficulties in terms of their use as a model for hedgehog pathway activation. In 
addition, production of biologically active purified recombinant Shh protein proved difficult. 
At this stage in the project it was decided that a change in both activation methodology and 
cell type was essential to maximise the chance of discovering novel hedgehog target genes. 
When this project was initiated most known hedgehog responsive systems involved organ 
explant culture. In 1997 two cell lines, C3H/10T1/2 clone 8 (hereafter referred to as lOTl/2) 
and MC3T3-E1, were reported to be responsive to Shh (Kinto et al, 1997; Nakamura et al, 
1997). Both cell lines were investigated and their responsiveness to Shh confirmed. Unlike 
lOTl/2 cells, which are pluripotent, MC3T3-E1 cells are aheady committed to the 
osteoblastic lineage. For this reason lOTl/2 cells were chosen as the system of interest, as 
they would potentially express a more diverse suite of target genes in response to Sonic 
hedgehog. The lOTl/2 cell line is examined extensively in this chapter and was found to be 
particularly suitable as a model to meet the aims outlined in Chapter 1. 
Studies in lOTl/2 cells have led to a greater understanding of the fimctions of Shh (Pepinsky 
et al, 1998; Katsuura et al, 1999; WilHams, K. P. et al, 1999; Pepinsky et al, 2000; Saeki et 
al, 2000), Smo (Murone et al, 1999) and Gli family members (Ruiz i Altaba, 1999), as well 
as providing a means to investigate comparative effects of vertebrate Hh proteins (Pathi et al, 
2001). In the work described in this thesis, the use of lOTl/2 cells has been extended to 
provide a useftil model system for the discovery of novel downstream target genes regulated 
by the Hh pathway. 
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3.1.1 Origin and characteristics of the 10T1/2 cell line 
The lOTl/2 cell line was initially estabhshed and characterised by Reznikoff e? al, (1973). 
The line was isolated from a pool of 14 to 17 day old C3H mouse embryos using a 
methodology that selects for cells showing inhibition of cell division upon confluence 
(Aaronson and Todaro, 1968), and was named following the convention of Todaro and Green, 
(1963). The lOTl/2 line is clonal. Cells are adherent and motile and when sub-confluent 
display a fibroblast-like morphology. lOTl/2 cells are pluripotent, having the ability to 
differentiate into a number of mesodermal lineages, including myoblasts, adipocytes, 
chondrocytes and osteoblasts, upon stimulation with various growth factors or chemicals 
(Taylor, S. M. and Jones, 1979; Katagiri et al, 1990; Asahina et al, 1996). The plasticity of 
lOTl/2 cells makes them of particular interest for hedgehog target gene discovery, since they 
have the potential to express a number of genes of critical importance to cell fate 
determination in embryogenesis. 
The cell line undergoes a low level of spontaneous differentiation and displays occasional 
transformation to a non-contact inhibited phenotype. The latter leads to "foci", small piles of 
proliferating cells within the otherwise single cell thickness monolayer observed in confluent 
populations. If this cell type reaches high cell density the morphological appearance of the 
cells becomes changed, and this change remains even after re-seeding and further passaging. 
To maintain the features of the cell line and to minimise the build up of imdesirable 
transformed and differentiated cells, lOTl/2 stocks were never allowed to reach confluence 
and were only used at early passage. 
3.1.2 Known responses of 10T1/2 cells to hedgehog stimulation 
Initial studies exposing lOTl/2 cells to Shh protein showed that this causes a large percentage 
of cells to enter the osteoblastic lineage, as measured by the induction of the osteoblastic 
marker alkaline phosphatase (AP), and that the resulting cells able to induce ectopic bone 
formation in mice (Kinto et al, 1997). Other studies have taken advantage of the induction of 
AP in response to Shh to provide a measure of hedgehog pathway activation that can be 
readily assayed (Nakamura et al, 1997; Pepinsky et al, 1998; Spinella-Jaegle et al, 2001). 
Nakamura et al, (1997) demonstrated induction of Patched by RT-PCR after Shh stimulation, 
and this induction has been confirmed by other studies (Williams, K. P. et al, 1999). 
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Transcriptional responses to Shh in lOTl/2 cells have also been reported for Ptc2 and Hip 
using RT-PCR (Pathi et al, 2001). Glil has also been established as a target of Shh signalling 
in lOTl/2 cells through several approaches (Murone et al, 1999; Pathi et al, 2001). As with 
Shh, exposure to Bmp2 causes lOTl/2 cells to become osteoblastic (Katagiri et al, 1990). 
BMPs are implicated as candidate targets regulated by the hedgehog pathway, but surprisingly 
Bmp-2, 4, 5, 6 and 7 have been found to show no significant expression changes in lOTl/2 
cells upon stimulation with Shh (Nakamura et al, 1997). This suggests that genes other than 
BMPs are critical in inducing the osteoblastic phenotype in this cell type. When Bmp2 and 
Shh added in combination to lOTl/2 cultures they produce a synergistic effect on osteoblastic 
differentiation, much greater than for either protein alone. Furthermore, expression of the 
BMP inhibitor Noggin abolished osteoblast differentiation in Bmp2 treated cells, while 
Noggin does not inhibit Shh induced differentiation (Spinella-Jaegle et al, 2001). 
Though a large percentage of lOTl/2 cells stimulated with Shh have been shown to enter the 
osteoblastic lineage, little is known about the differentiation of cells to other mesodermal cell 
types under Shh control. It is clear however that treatment with Shh inhibits the ability of the 
pluripotent cells to enter the adipocytic lineage (Spinella-Jaegle et al, 2001). 
3.2 Basal expression of key pathway genes in 
10T1/2 cells 
Before initiating pathway activation studies in the lOTl/2 cell line investigations were made 
into the basal level of key pathway genes. Though this line is already known to be responsive 
to Shh, it was thought prudent begin with such work. The basal level of Shh expression had 
not previously been addressed in the literature, nor had several other genes of interest. Ptc 
expression in lOTl/2 has previously been vaguely described as "low" (Nakamura et al, 1997) 
and "not highly expressed" (Pepinsky et al, 1998), with the later work going so far as to 
suggest that other Hedgehog receptors may contribute to the response of the cell line. Initial 
northem blotting studies used the mouse Ptc probe "mPtcl263", a 1263 base pah Pvull 
restriction fragment fi-om the mouse Ptc cDNA beginning midway through the first 
extracellular loop and extending through transmembrane domains 2 to 6. On untreated 
poly(A)^ RNA, this probe detected a band of the size expected for the fiill length Ptc 
transcript. In addition, several smaller bands were observed, all of which remained bound at 
high stringency. These additional bands are of particular interest as some appear, along with 
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the full length transcript, to be Hedgehog regulated. For northem blot data showing basal 
Patched expression in lOTl/2 cells the reader is referred to Figure 3.11 and Figure 3.13. 
Further studies investigating the level of Patched protein in lOTl/2 cells by immuno-
fluorescence showed a diffiise pattem of cell staining, indicating that the produced mRNA is 
indeed translated under basal conditions (data not shown). 
Basal Smoothened expression was also assessed by northem blotting (Figure 3.1), revealing a 
single band of a size comparable to the 3.7 kb transcript previously reported in rat tissues 
(Traiffort et al, 1998). Immuno-fluorescence indicated that Smoothened protein, like Patched 
protein, is produced at detectable levels in untreated lOTl/2 cells (data not shown). 
28s RNA 
(4.7 kb) 
18s RNA 
(1.9 kb) 
Smo 
Figure 3.1 lOTl/2 cells express Smo mRNA, as shown by northern blotting of total RNA 
harvested from untreated cells. 
Glil is not detected by northem blot in untreated lOTl/2 RNA, even after long exposure (data 
not shown); however, it can be readily detected by RT-PCR (Figure 3.2). Shh expression was 
investigated by northem blotting, using a probe known to detect the gene in spiked samples. 
Expression was not detected in lOTl/2 cells (data not shown). 
Taken together the finding of significant Patched and Smoothened expression, along with 
extremely low basal levels of Glil and Shh in lOTl/2 cells make the lOTl/2 line suitable for 
pathway activation studies. 
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Figure 3.2 RT-PCR showing Glil is expressed in untreated lOTl/2 cells. 
Mouse Glil primers were modified from those published by Walterhouse et al., (1993), 
in that the superfluous overhangs were removed and a miss-match between GenBank 
sequences and the published reverse primer was corrected. Template for lOTl/2 
reaction template was cDNA transcribed from 70 ng of total RNA. Negative control 
represents the same volume of a "no RNA" control cDNA synthesis reaction. Positive 
control PCR template was 1 ng of a plasmid containing the mouse Glil cDNA. PCR had 
35 cycles. Ladder is "1 kb ladder" from Gibco BRL. 
3.3 Comparison of potential pathway activation 
strategies 
As outlined in Section 2.1.2, there are a number of levels at which the hedgehog pathway 
could potentially be activated in mammalian cells. Although addition of "home-made" 
recombinant Shh protein was chosen as the ideal method of stimulation, the results outlined in 
Chapter 2 highlighted a nimiber of difficulties with achieving this. At the stage where the 
work moved its primary focus from keratinocytes to lOTl/2 cells, various strategies were 
compared to determine the best altemative activation strategy. 
3.3.1 Alkaline phosphatase and Patched as key indicators of 
pathway activation 
The success of different treatments in activating the hedgehog pathway was compared by 
investigating the induction of AP activity and the up-regulation of Patched transcription in 
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lOTl/2 cells. The increase in AP activity provided a robust measure of hedgehog induced 
osteoblastic differentiation, which was readily amenable to both histochemical and 
quantitative spectrophotomeric assays. Changes in the level of Patched transcription were 
assessed in parallel. Initial studies with semi-quantitative RT-PCR indicated this method was 
not robust, displaying a high level of variability in amplification between replicates and 
frequent lack of reproducibility between experiments. At the time this work was conducted 
real-time quantitative PCR systems were not accessible to the author, and it was felt that the 
more laborious task of northem blotting was worthwhile for all experiments due to its ability 
to yield high quality quantitative data when coupled with densitometry. Patched was chosen 
as the primary gene to analyse in initial studies comparing activation methodologies due to its 
status as a universal marker of hedgehog stimulation (refer Section 1.5.1). 
3.3.2 Alternate recombinant protein based strategies for pathway 
activation 
Although the techniques outlined in the previous chapter failed to produce rShh protein with 
high levels of biological activity, the addition of pure Shh protein was still seen as the ideal 
method of pathway stimulation. For this reason, other sources of suitable protein were sought 
both commercially and through collaborators. Once established the lOTl/2 system allowed 
straightforward testing of Shh protein from various sources. 
A small amount of commercially available mouse rShh protein (461-SH) was purchased fi-om 
R&D Systems (Minneapolis, USA) and used as a positive control in a limited number of 
small scale experiments. This protein proved active, and provided a benchmark by which to 
judge the quality of recombinant Shh from other sources (Figure 3.3). The commercial protein 
was not viable for use in any fiill scale experiments involving RNA harvests, nor the project 
as a whole, as its cost was prohibitive. 
Recombinant Shh potentially available for fiill scale experiments was sourced fi-om two 
collaborating groups. A small amount of baculovims produced Shh protein, made by the 
method of Ericson et al, (1996) was obtained (a kind gift of the late Dr. T. Yamada). When 
assayed in the lOTl/2 system this protein was shown to have potent biological activity (data 
not shown), however due to unforeseen circumstances fiirther supplies were unable to be 
obtained for the remaining experiments. A fiirther source of recombinant protein, HIS-tagged 
mouse N-terminal Shh produced in bacteria (a kind gift of Dr. P. Bartlett), was obtained and 
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assayed. This protein had no detectable activity in subsequent lOTl/2 assays (data not 
shown), and at this stage perseverance with a purified protein based approach was abandoned. 
Time constraints meant that the project had to move immediately to assessing altemative 
activation strategies. 
One available option was the production of cmde Shh-N conditioned media. The possibility 
of producing this successfully was based on the assumption that biological activity of this 
molecule was difficult to maintain during purification procedures, but that if it was secreted 
into growth media that was then used directly, then this obstacle could be overcome. This 
indeed proved to be the case. Conditioned media was produced in lOTl/2 cells to ensure that 
any secondary secreted products induced by Hedgehog stimulation were limited to the suite of 
molecules that the target cell type would normally produce. 
Initial studies involved collecting post-transfection growth media from lOTl/2 cells 
transfected with the constmct pShh-N-PMT21 (this constmct encodes the N-terminal active 
region of mouse Shh and is discussed in detail in Section 3.4), or an empty vector control 
constmct. Media was collected after various time periods of conditioning, and found to have 
potent activity when assayed for AP induction (Figure 3.3). 
3.3.3 Shh transfection strategy 
In parallel to work on conditioned media (outlined above), various fransfection based 
strategies were investigated to determine which were suitable for studying expression changes 
caused by hedgehog pathway activation. The strategies investigated were those infroduced in 
Section 2.1.2. Direct fransfection of lOTl/2 cells with the constmct pShh-N-PMT21 ehcited a 
strong pathway response, with dramatic induction of both AP activity (Figure 3.4) and 
Patched transcription. These responses are fiirther investigated in Section 3.5, where figures 
detailing the profile of induction are presented, along with the responses of other known target 
genes. Shh transfection proved to be a robust sfrategy to achieve pathway activation. 
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Figure 3.3 Shh conditioned media has potent biological activity when compared to 
commercially available Shh protein in the lOTl/2 alkaline phosphatase (AP) 
induction assay. 
(A) Commercially obtained rShh protein (461-SH, R&D Systems) causes a substantial 
increase in AP enzyme activity in lOTl/2 cells. Assay was performed 7 days after 
addition to growth media. The effect was most dramatic when the growth media was 
changed and fresh Shh added half way through the growth period. At low 
concentrations the effect increased in magnitude with increasing Shh concentrations, 
before starting to plateau at 1 |j,g/ml. (B) Shh conditioned growth media (Shh CM) 
collected for various time periods after transient transfection of lOTl/2 cells with pShh-
N-PMT21, is highly active. The three batches of conditioned media tested in this 
experiment showed higher activity, in terms of AP induction, than the commercially 
available protein at 5 \iglm\. Error bars are not included on these graphs as the author 
only had access to a very limited amount of rShh from R&D systems and this did not 
allow replication. The results are intended simply as an indication that the conditioned 
media produced did have significant biological activity. The actual conditioned media 
used for stimulation in large scale experiments (outlined in the following chapters) was 
collected over an even wider time period that that used in the above investigative 
assays, and fully replicated experiments showed it also had dramatic AP inducing 
activity (data not shovra). 

82 Chapter 3: C3H/10T1/2 as a Model System for Hedgehog Target Gene Discovery 
GLI1 
%r' / 
o 
(S 
M 
m 
m 
^ 
% 
< # 
A 
••.'•- i W V 
Neg Control 
• . 5 . 
J r . 
. . ^ • ' ' 
4^ 
T . - , ^ ' ^ •* 
•M' 
..",. 
Figure 3.4 Histochemical assay shows lOTl/2 cells transfected with Shh or GUI show marked 
induction of AP enzyme activity. 
Cells transfected with an empty vector have very low AP activity, whereas activity in 
cells transfected with mouse Shh (pShh-N-PMT21) or human GLIl (pRK7-N-Myc-
hGli), indicated by blue staining, is greatly increased. Assay was performed four days 
post-transfection. 
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3.3.4 Oncogenic Smoothened mutant transfection strategy 
A full length human SMOH expression construct containing the base pair 1604 G-to-T 
transversion (SMOH^^^^; as discussed Section 1.6.4) was kindly provided by Dr M. Narang, 
who had introduced the mutation into a wild-type construct, originally the gift of Dr. F. de 
Sauvage. The mutated insert was cloned into the expression vectors pcDNA3 (Invitrogen, 
Carlsbad, USA) and pEFBOS (Mizushima and Nagata, 1990) and the resulting constructs, 
pcDNA3-hSmo-mutl604 and pEFBOS-hSmo-mutl604, were transiently transfected into 
lOTl/2 cells. RNA was harvested from these cells (and appropriate controls) at a number of 
timepoints after transfection and AP enzyme assays were also performed (Figure 3.5). 
Negative Control SMOH 1604 GLM 
-if t 
« 
if lh 
Figure 3.5 lOTl/2 cells transiently transfected with an oncogenic Smoothened mutant show no 
evidence of AP induction. 
Assay shown was performed 5 days post-transfection on cells treated with pEFBOS-
hSmo-mutl604 (SMOH^^ "^^ ). An empty vector (negative control) and GLIl transfections 
provide negative and positive controls respectively. A range of timepoints gave similar 
results. A negative result was also obtained when the alternate construct pcDNA3-
hSmo-mut 1604 was used (data not shown). 
Surprisingly, expression of SMOH^^^"^ did not result in detectable changes in either Patched or 
Hip expression (data not shown) or in AP enzyme activity. This implied that pathway 
activation was not occurring through expression of this allele, or that if a response was 
occurring it was partial and did not cause either the up-regulation of Patched expression nor 
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osteoblastic differentiation. Immuno-fluorescence studies indicated that the construct was 
indeed expressed at high levels, and the lack of response was not simply a consequence of 
poor transfection or a defect in vector fimction (Figure 3.6). 
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Figure 3.6 Immuno-fluorescence studies show transfection with mutant Smoothened 
construct was successful. 
Transfection of the pcDNA3-hSmo-mutl604 construct (Panels C and D) into lOTl/2 
cells leads to an increase in the level of Smoothened protein present compared to cells 
treated with a negative control construct (Panels A and B). Cells shown 1 day post-
transfection. Panels A and C show labelling of Smoothened (using a-Smoothened 
rabbit-"Edith" antibody, a gift of the late Dr. M. Gailani), visualised via a Cy3 
conjugated secondary antibody. Panels B and D show signal from DAPI, which stains 
cell nuclei, for the fields shovra in A and C respectively. 
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3.3.5 Gli1 transfection strategy 
Transfection of GUI into lOTl/2 cells proved to be a potent method of inducing markers of 
hedgehog pathway activation. Two fiill length GUI clones were obtained. One of these, 
pGli-K12, was a kind gift of Dr, K. Kinzler and contained the GUI coding region originally 
cloned from a human glioma cell line harbouring GUI amplification (Kinzler et al, 1988). 
The insert from this clone was moved to the expression vector pcDNA3, creating construct 
pcDNA3-hGlil ready for use in transfection studies. A second clone, pRK7-N-Myc-hGli, 
contained Myc-tagged human GUI and was kindly provided by Dr. F. de Sauvage. 
Initial transfection studies confirmed the findings of Murone et al, (1999), who had reported 
induction of AP activity in lOTl/2 cells upon transfection of pRK7-N-Myc-hGli. The increase 
in AP activity, as indicated by both histochemical and quantitative spectrophotomeric assays, 
was strong and reproducible. This was in contrast to the results of transfection with pcDNA3-
hGlil, for which a significant change in quantitative AP activity was not detected. In 
corresponding histochemical AP assays, positively stained cells were observed that were not 
seen in control transfections, but they were at a much lower frequency and with considerably 
fainter signal than those observed with pRK7-N-Myc-hGli transfection (data not shown). For 
all fijrther investigations the more potent of the two available constructs, pRK7-N-Myc-hGli, 
was used. 
Transfection with pRK7-N-Myc-hGli gave a pattem of AP induction distinct to that given by 
Shh transfection when investigated by histochemical assay (Figure 3.4). In the case of GUI 
transfection the cells tended to have very intense staining when a response was observed. In 
contrast, the AP staining pattem after Shh transfection was distinct, with both darkly stained 
cells and a larger number of more lightly stained cells. The former presumably represent the 
transfected cells themselves, whilst the additional cells are thought to represent cells that have 
secondarily responded to Shh protein secreted fi-om the primary transfectants. 
GUI transfection into lOTl/2 cells leads to an increase in Pa/c/ze J transcription, indicating 
hedgehog pathway activation (Figure 3.7). The increase in Patched expression in response to 
GUI expression occurs within six hours, much more rapidly than that observed after 
transfection with Shh (compare Figure 3.7 below, with Figure 3.11). 
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Figure 3.7 Up-regulation of Patched expression in lOTl/2 cells in response to Glil. 
Northem blots contain RNA obtained from cells transfected with pRK7-N-Myc-hGli 
(GLIl), or from control cells. GAPDHprohQ provides loading control. 
Sequence data from the pcDNA3-hGlil and pRK7-N-Myc-hGli constmcts was analysed to 
see if any obvious cause for the dramatic difference in potency between the plasmids could be 
found. During these investigations a nucleotide sequence difference between the two cDNA 
clones was identified. However, fiirther investigations (refer to Appendix C) showed that this 
probably represents a common human GUI polymorphism. As such, it is unlikely that this 
change is responsible for any difference in fiinction between the two constmcts. A number of 
other factors could altematively account for the poor function of pcDNA3-hGlil, such as 
differing cloning positions with reference to the promoter regions of the vectors, differences 
in promoter activity, or differing transfection efficiencies between the two plasmids. The 
pRK7-N-Myc-hGli plasmid, which has the stronger effect on pathway activation markers, was 
used for all subsequent experiments involving Glil. 
3.4 Mutant Shh control construct 
When investigating differential expression patterns it is of utmost importance that expression 
differences between the cell population of interest and the control population are only due to 
the treatment of interest. Any other factors influencing one population but not the other may 
lead to false positive results. With transfection studies great care must be taken, as differences 
can arise at a number of levels. It is important that untreated cells are not used as the reference 
population for transient transfection studies, since these cells would not have experienced the 
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events and stresses of the transfection procedure. The use of untreated cells would therefore 
represent a scenario where there would be a high risk of false positive results. 
Transfection of pShh-N-PMT21 (encoding the N-terminal active region; amino acids 1 to 198 
of the mouse Shh protein) was chosen as a key strategy for hedgehog target gene discovery 
experiments, complemented by studies using Shh conditioned media. For this reason, 
constmcting a negative control to complement pShh-N-PMT21 transfection was of particular 
importance. For this work a null-mutant control constmct was designed so the cell would 
produce a near fiill length Shh-N mRNA and translate this into a tmncated protein. This was 
used, rather than an empty vector control, to ensure the general transcription and translation 
mechanisms of the cells were stimulated in both cell populations to be compared. 
The negative control constmct to complement pShh-N-PMT21 was created by deleting the 
64 base pair EcoBI to Smal region from the original constmct, followed by blunting of the 
EcoBJ site and re-closure of the vector (Figure 3.8). This removed the start ATG codon, and 
the resulting constmct was named pA64-Shh-N-PMT21. This constmct was expected to be a 
fiinctional null mutant as the next in frame ATG is not present until approximately half way 
through the Shh N-terminal active region coding sequence. In addition, the deleted region 
contained the signal peptide, so even if protein were produced it would not be targeted 
properly for processing and subsequent secretion. Test experiments confirmed that the new 
constmct was indeed fiinctionally null. The pA64-Shh-N-PMT21 constmct gave no detectable 
increase in AP activity when transfected into lOTl/2 cells (Figure 3.9 and Figure 3.10), and 
subsequent investigations of a range of markers of pathway activation yielded negative results 
for this constmct by northem blotting (as outlined in experiments forming the remainder of 
this Chapter). 
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Figure 3.8 Regions of mouse Shh encoded by the expression construct pShh-N-PMT21 and 
the negative control mutant pA64-Shh-N-PMT21. 
Both constmcts are in the vector PMT21, with expression in mammalian cells driven by 
the adenovirus major late promoter. The functionally null mutant (bottom) was created 
from pShh-N-PMT21 (top; originally constructed by the late Dr. T. Yamada) by 
deleting a 64 bp region from the initial plasmid such that the first 63 base pairs of the 
Shh-N coding region were removed. Control cells transfected with pA64-Shh-N-PMT21 
express a near fiill length mRNA, however the protein these cells could hypothetically 
produce (based on the position of the next in-fame ATG start codon) is a truncated 
protein lacking the first 97 amino acids. Further studies showed the mutant control 
construct lacked any detectable Shh activity. 
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Figure 3.9 Quantitative AP assay shows mutant Shh construct is functionally null. 
Transfection with Sonic hedgehog (pShh-N-PMT21) greatly increases AP activity after 
transfection into lOTl/2 cells, where as AP levels after transfection of the mutant 
constmct (pA64-Shh-N-PMT21) remain at basal levels (indicated by transfection with 
the empty expression vector or untreated cells). Assay was performed 8 days post-
transfection. The results in this small scale (2 replicates for transfections, 1 for 
untreated) quantitative experiment showing that the mutant constmct had no detectable 
effect on osteoblastic differentiation were supported by the results of a number of large 
scale histochemical studies that were subsequently performed (including that shown in 
Figure 3.10). 
3.5 Profile of the Hedgehog Response in 10T1/2 
cells 
Current methods investigating differential gene expression between a treated and control 
population give data for a particular snapshot in time. For such studies it is of critical 
importance that timepoints are chosen carefully. In terms of hedgehog target gene discovery 
looking too long after the pathway has been stimulated gives the risk of only identifying 
products of terminal differentiation, whereas by looking too early the risk is that the response 
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may not yet have occurred and targets may not be discovered at all. Using known markers of 
the hedgehog response as indicators, it has been possible to profile the response in lOTl/2 
cells after transient transfection. For the initial studies, timepoints at intervals ranging from 
three hours to five days were investigated using AP and Patched induction as markers. From 
the knowledge gained from these and other markers, timepoints of interest were able to be 
selected for analysis of differential gene expression patterns after stimulation by N-terminal 
Shh transfection. 
3.5.1 Profile of the alkaline phosphatase response 
The increase in AP enzyme activity after transfection with pShh-N-PMT21 was investigated 
over time, using both histochemical and spectrophotomeric methods. A marked delay was 
observed after transfection before induction of AP was detected in a number of independent 
experiments. The induction was detectable three days post-transfection and became stronger 
over following days (Figure 3.10). A similar induction profile was seen when Shh conditioned 
media was added to cells at the same starting density as that used for transfection 
(approximately 80 percent confluent). Transfected cell cultures tended to have some intensely 
staining cells and a larger number of fainter cells. Presumably these represent the initially 
transfected and secondarily responding cells respectively. Some cells treated with Shh 
conditioned media did not show AP staining. This may be because such cells did not elevate 
AP above the level of detection at the investigated timepoints, that they did not respond at all 
to Shh, or that they differentiated into a non-osteoblastic cell type. 
Figure 3.10 AP induction over time in lOTl/2 cells transfected with Shh or treated with Shh 
conditioned media. 
At 48 hours post-transfection with pShh-N-PMT21 (Shh) or pA64-Shh-N-PMT21 (Neg 
Control Mutant), or with conditioned media collected from cells expressing the same 
constmct (bottom panels), no increase in AP activity was observed. By 72 hours AP 
positive cells (indicated by blue staining) became apparent in Shh transfected and Shh 
conditioned media treated cultures, and by 96 hours AP activity strong staining was 
observed in these cultures. Conditioned media used in this experiment was harvested 
after 4 days contact with expressing cells, and added to cells diluted 1:1 with fresh 
growth media. Treatment (either transfection or conditioned media addition) was 
initiated when the cells were approximately 80% confluent. 
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3.5.2 Induction of Patched and Gli1 in 10T1/2 cells 
The Patched (Figure 3.11) and Glil (Figure 3.12) genes were used as key markers to 
investigating the timing of the hedgehog response by northem hybridisation, as both genes 
had previously been observed as targets in lOTl/2 cells (refer Section 3.1.2). As expected, 
both genes were strongly induced by transient transfection of pShh-N-PMT21. Transfection, 
and subsequent northem blotting analysis, was conducted on several independent occasions to 
assess the amount of variation in the timing of the responses between experiments. Figure 
3.11 shows induction of Patched in response to Shh in a typical transfection experiment, with 
induction of an 8.5 kb transcript first observed two days post-transfection. The observed 
8.5 kb sized band is in accordance with that reported by other researchers as representing the 
full length Patched mRNA (Goodrich et al, 1996). In addition to a strong effect on the full 
length transcript, bands estimated at 3.7 kb and 3.1 kb showed induction. In contrast, a 
transcript of approximately 950 base pairs showed no change in response to Shh. 
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Figure 3.11 Up-regulation of Patched in lOTl/2 cells in response to Shh. 
Northem blot of RNA obtained from cells transfected with pShh-N-PMT21 (Shh-N) or 
pA64-Shh-N-PMT21 (mutant) plasmids. Full length Patched wRNA (transcript 1) and 
alternate transcripts (2 and 3) are up-regulated in response to Shh. Transcript 4 is not 
regulated by Shh treatment. A GAPDH probe provides loading control. 
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Figure 3.12 Up-regulation of Glil in lOTl/2 cells in response to Shh. 
Northem blots of RNA obtained from cells transfected with pShh-N-PMT21 (Shh-N) or 
pA64-Shh-N-PMT21 (mutant) plasmids, or treated with conditioned media collected 
from cells expressing the same constmcts. GAPDH probe provides loading control. (A) 
Up-regulation of Glil transcripts in response to Shh stimulation by transfection and 
conditioned media treatment shown on total RNA. (B). Four day post-transfection 
poly(A)"^ RNA from a second independent experiment. When run in the absence of 
ribosomal RNA, the Glil transcripts have apparent sizes of 4.2 kb (major transcript) and 
3.5 kb (minor transcript). 
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GUI Up-regulation in response to hedgehog signalling was initially observed two days post-
transfection by northem hybridisation (Figure 3.12). However, as basal expression of this 
gene is below the threshold for detection by northem blot, it is possible that some degree of 
up-regulation had occurred before this time. A doublet of induced Glil transcripts were 
observed with sizes estimated at 4.2 kb (major transcript) and 3.5 kb (minor transcript). 
Previous studies have also reported two Glil transcripts in some mouse tissues, with previous 
size estimates of 4.0 and 4.7 kb (Walterhouse et al, 1993) and 4.0 and 4.4 (Hui et al, 1994) 
for the major and minor transcripts respectively. 
To further investigate the origin of the smaller bands revealed by the Patched probe, poly(A)^ 
RNA was harvested from untreated cells and used to make a set of high quality northem blots 
with the aim of giving strong signals even with very small probes. Four new sub-probes were 
designed that together covered the region in mPtcl263. These probes were made by RT-PCR 
from lOTl/2 RNA, and used individually on the lOTl/2 poly(A)^ blots. The probe ends were 
placed at exon boundaries where possible. Figure 3.13 shows the pattem of bands hybridised 
by the sub-probes. As expected, all four probes hybridise to the full length Patched transcript, 
but there were some differences in detection of the other bands. In particular the 
approximately 950 base pair transcript appears to have homology to the regions in sub-probes 
C and D (the large intracellular loop, and to a lesser degree to the preceding transmembrane 
regions). Probe B recognises a number of medium sized transcripts while probe A, 
representing part of the first extracellular loop, only detects the fiill length transcript. Overall, 
at least six different sized transcripts can be clearly distinguished. Probing of untreated 
lOTl/2 RNA with a probe to Patched2 exon 12, a region with minimal homology to Patched, 
gave a major band at approximately 4.7 kb, along with several smaller transcripts (Figure 
3.14). Since the Patched probes bind more transcripts that can be accoimted for by cross-
hybridisation to Patched2, this suggests the existence of highly homologous related genes or 
complex altemate slicing of Patched transcripts in vivo. BLAST algorithm searches of the 
NCBI nucleotide database do not reveal other genes with strong homology to the mPtcl263 
probe region, suggesting the majority of the bands represent altemately spliced Patched 
transcripts. 
3.5 Profile of the Hedgehog Response in lOTl/2 cells 95 
28s RNA 1 
(4.7 kb) • 
18s RNA -
(1.9 kb) • 
:.. E 
A 
m 
Pvull 
1 
B 
^^ 
^ 
C 
1 
i ^4— 
D 
i 
• -
Probe A region 
Probe B region 
Probe C region 
Probe D region 
Figure 3.13 Probes to different regions of mouse Patched highlight different transcript patterns 
in untreated lOTl/2 RNA when investigated by northern blot hybridisation. 
Panels A to D show northern blots containing 2 jiig of untreated lOTl/2 poly(A)^ RNA, 
each hybridised with a small cDNA probe containing sequence corresponding to regions 
of the Patched protein, as indicated in the schematic (Panel E). Numbers indicate 
transmembrane domains (as proposed by Goodrich et al., 1996). Probe mPtcl263 (as 
used in Figure 3#1) corresponds to the entire 1263 bp region between the two Pvull 
sites indicated. PCR primers were designed to split this region into four sub-probes for 
investigation (probe D extends slightly beyond the end Pvull site). All probes bind the 
full length 8.5 kb transcript, but differ in their specificity for detecting smaller 
transcripts. 
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3.5.3 Induction of Patched2 in 10T1/2 cells 
Up-regulation of Ptc2 after Shh stimulation was observed in lOTl/2 cells, but was more 
difficult to detect by northem blotting than the response observed for Ptc (Figure 3.11). Ptc 
was elevated to such high levels by Shh that the induced transcripts for a range of timepoints 
gave strong signals when total RNA was used for blot constmction. This was the case even 
for exposures of a few hours. In contrast, the signal with Ptc2 on the same blots was very 
faint, even after a two week exposure, and could not be reproduced as a figure. It appeared 
from these investigations that Ptc2 was induced with Shh conditioned media four days post-
treatment, however signals were too weak to allow meaningfiil quantitative analysis. 
In order to obtain conclusive data on the status of Ptc2 as a Shh target in lOTl/2 cells 
(particularly for directly transfected samples which had extremely faint total RNA northem 
bands) poly(A)+ RNA was prepared from the four day transfection timepoint. Subsequent 
poly(A)'^ northem blotting showed that these samples had undergone considerable mRNA 
enrichment, and that Ptc2 transcripts were now readily detected (Figure 3.14). 
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Figure 3.14 Up-regulation of Patchedl in lOTl/2 cells in response to transfection with the Shh 
expression construct. 
Poly(A)* blot of pShh-N-PMT21 (Shh-N) or pA64-Shh-N-PMT21 (mutant) transfected 
RNA at 4 days post-transfection. Three transcripts (estimated at 4.7 kb, 2.0 kb and 
1.5 kb) were observed in lOTl/2 cells. The 4.7 kb transcript (transcript 1) is 
significantly up-regulated by Shh when assessed by G/^PZ)//normalised densitometry. 
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The data shown in Figure 3.14 provides support for the induction of Ptc2 by Shh in the 
lOTl/2 cell type, an observation previously only reported from a single RT-PCR study (Pathi 
et al, 2001). Ptc2 may represent a later target of Shh stimulation than Ptc, although until 
fiirther studies are performed it cannot be mled out that Ptc2 mRNA levels may also rise, 
albeit to very low amounts, at earlier timepoints. 
Figure 3.14 shows that the largest Ptc2 transcript (4.7 kb) is much smaller than that for Ptc 
(8.5 kb). A recent genomic study identified 3.8 kb of exonic sequence for mouse Ptc2 plus a 
final exon of unknown size (Frohlich et al, 2002), suggesting the 4.7 kb band does represent 
the fiill length Ptc2 mRNA. 
3.5.4 Investigation of Hip induction by Shh reveals a possible Hip 
related target gene 
As discussed in Section 3.1.2, Hip has previously been reported as a target of hedgehog 
pathway stimulation in lOTl/2 cells, though it has only been detected by an RT-PCR study 
for which the data was mentioned but not shown (Pathi et al, 2001). The induction of Hip by 
Shh was confirmed by northem blotting in lOTl/2 cells. This gene did not show a detectable 
change until late in the timecourses that were investigated, typically not until around the 
fourth day after transfection (Figure 3.15). However, as for Glil, the basal expression of Hip 
was below the level of northem detection, and some degree of up-regulation may have 
occurred before the bands became visible using this technique. 
Northem blot hybridisation with a Hip probe has not previously been reported in the 
literature. Two non-overlapping probes for mouse Hip were generated by designing PCR 
primers to the 2.7 kb published cDNA sequence (GenBank entry AFl 16865; Chuang and 
McMahon, 1999). These probes were used to interrogate northem blots of lOTl/2 RNA 
harvested at various timepoints after transient transfection with pShh-N-PMT21. Both gave 
identical results, in that they detected a cluster of three induced bands with estimated sizes of 
3.8 kb, 3.4 kb and 3.0 kb (Figure 3.15). Surprisingly, an additional band of a much larger size, 
estimated at approximately 10 kb, was also induced by Shh in a similar timeframe to the 
smaller Hip transcripts (also observed with both independent probes). It seems unlikely that 
this transcript would represent an altemate splice, since the entire Hip protein coding region is 
only 2.1 kb long, although it is possible that this transcript may be franscribed from some 
distant upsfream promoter, giving it an unusually large 5' leader sequence. Another 
98 Chapter 3: C3H/10T1/2 as a Model System for Hedgehog Target Gene Discovery 
possibility is that the 10 kb band represents partially processed or raw transcript that has not 
yet been fiiUy spliced. This too seems unlikely, given such processing occurs in the nucleus 
and RNA was only isolated from the cytoplasmic fraction. It is possible that nuclear RNA 
could contaminate cytoplasmic preparations, though evidence for this was not seen with any 
other genes investigated. Several attempts were made to constmct a large insert cDNA library 
from Shh stimulated lOTl/2 cells in order to try to isolate the transcript represented by the 
large northem band; however these have not yet been successfiil. 
RNA from cells transiently transfected with pRK7-N-Myc-hGli was included on some 
northem blots, and showed that all four transcripts detected with the Hip probes were also 
induced with this freatment. This provides the first known evidence that Hip is regulated 
through a G/i7-mediated mechanism (Figure 3.15). 
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Figure 3.15 Hip is up-regulated in lOTl/2 cells in response to Shh or Glil. 
Multiple transcripts that hybridise to a Hip probe are up-regulated by pShh-N-PMT21 
(Shh-N) or pN-Myc-hGli-PRK7 (GLIl) expression in lOTl/2 cells. GAPDH probe 
provides loading control. Transcript 4 is of note, being much larger than the other three 
induced transcripts. 
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3.5.5 Investigation of putative pathway targets - candidate gene 
approach 
To complement the studies outlined in following chapters, which undertake a differential 
expression analysis approach to hedgehog target gene discovery, investigations were 
conducted with several genes implicated as targets from other systems for which probes were 
available. These included genes that have been identified as hedgehog targets in other cell 
types and members of gene families implicated by analogy to findings in Drosophila. This 
"candidate gene approach" was undertaken using northem blotting to detect expression 
changes after pSlih-N-PMT21 transfection, which has already been shown in experiments 
discussed above to be a robust method of pathway activation. 
Bmp2 and Bmp4 were investigated due to their close homology with dpp, a key target of 
hedgehog signalling in Drosophila. Probes were made from mouse BMP clones kindly 
provided by Dr. A. McMahon. In lOTl/2 cells Bmp2 showed no change in expression upon 
hedgehog stimulation, supporting the findings of Nakamura et al, (1997). However, in 
contrast with this previous study, evidence was found suggesting a down-regulation of Bmp4 
(Figure 3.16). This response was subtle, but was observed consistently on four replicate 
northem blots containing RNA from independent transfection timecourse experiments. At 
four days post-transfection the average (geometric mean) fold change was 1.4 fold down-
regulation (with a data range of 1.2 to 1.6 fold down-regulation). Further evidence for this 
effect came from investigation of Shh conditioned media stimulated cells that showed a 1.5 
fold down-regulation in Bmp4 expression (data not shown). 
Recent studies have implicated a member of the SWiP (SOCS box and WD-repeats in 
protein) family as a target of hedgehog signalling in somitic mesoderm (Vasiliauskas et al, 
1999). Clones representing this gene (called SWiP-1 and WSBl by different groups), and the 
closely related gene WSB2, were kindly provided by R. Richardson for investigation in the 
lOTl/2 system. Evidence was not found for regulation of either gene by Shh in the lOTl/2 
system, though WSBl was induced strongly by the transfection procedure itself (data not 
shown). Another gene reported as a key hedgehog target in developing somites, Paxl 
(Borycki et al, 1998; Murtaugh et al, 1999), was also investigated. A clone for Paxl (kindly 
donated by Dr. P. Koopman) did not show any significant expression change after Shh 
transfection for the timepoints investigated when used as a northem probe. 
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Figure 3.16 Bmp4 shows subtle down-regulation in response to Shh in lOTl/2 cells. 
Northem blots contain RNA obtained from cells transfected with pShh-N-PMT21 
(Shh-N) or pA64-Shh-N-PMT21 (Mutant) plasmids. GAPDH probe provides loading 
control. GAPDH normalised densitometry on this blot indicated subtle down-regulation 
in response to Shh. This is superimposed on a trend for Bmp4 expression to increase 
with increasing cell density and quiescence. Numbers indicate fold change estimates for 
Bmp4, obtained by GAPDH normalised densitometry, for each timepoint on this blot. 
"-" is shown to indicate response to Shh is a down-regulation. Consistent subtle down-
regulation oiBmp4 was also observed on three other independent blots. 
HNF-3P is a key target of Shh in developing neural tissues. A clone representing this gene 
(obtained from Dr. S. Grimmond), was used to probe RNA from stimulated cells and found to 
be up-regulated in the lOTl/2 system (Figure 3.17). Since HNF-3P is a transcription factor 
known itself to regulate Shh expression in the developing CNS (refer Section 1.5.2), this 
raises the possibility that Shh may regulate its own induction via a positive feedback loop with 
HNF-3P in lOTl/2 cells. Experiments were conducted to investigate whether this is the case. 
When cells were treated with Shh conditioned media or transfected with GUI, which is 
known to up-regulate HNF-3fi (Hynes et al, 1997), no induction of endogenous Shh 
expression was observed (data not shown). This suggests that Shh does not induce its own 
expression in lOTl/2 cells, which is in contrast to the situation in some embryonic neural 
tissues. 
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Figure 3.17 Up-regulation of HNF-Sp in lOTl/2 cells in response to Shh. 
Northem blots contain RNA obtained from cells transfected with pShh-N-PMT21 
(Shh-N) or pA64-Shh-N-PMT21 (Mutant) plasmids, or treated with conditioned media 
collected from cells expressing the same constructs. GAPDH probe provides loading 
control. 
Smo expression was investigated, due to its reported up-regulation in BCCs, and not found to 
show any detectable expression change upon stimulation by Shh or GUI transfection in 
lOTl/2 cells (data not shown). 
Whilst this work was in progress another Shh target gene, Angiopoietin2, was identified as 
downstream of Shh by an independent group investigating the pathway in vascular 
development (Pola et al, 2001). Investigation in the lOTl/2 system indicated Angiopoietin2 
was also a target in embryonic mesodermal cells (Figure 3.18). The Angiopoietin2 response 
was observed with Shh conditioned media, but not by Shh fransfection at the timepoints 
examined. This may reflect a need for a certain level of Shh stimulation to initiate a response 
for this target gene. 
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Figure 3.18 Up-regulation of Angiopoietinl in lOTl/2 cells in response to Shh. 
Northem blots contain RNA obtained from cells transfected with pShh-N-PMT21 (Shh-
N) or pA64-Shh-N-PMT21 (mutant) plasmids, or treated with conditioned media 
collected from cells expressing the same constructs. GAPDH probe provides loading 
control. 
3.5 Profile of the Hedgehog Response in lOTl/2 cells 103 
3.5.6 Summary of genes implicated by literature now established 
as downstream targets of Sonic hedgehog in 10T1/2 cells. 
The known target genes investigated in this section that have been confirmed by this work as 
Shh targets in lOTl/2 cells are summarised in Table 3.1. 
Table 3.1 Summary of Shh target genes known or implicated from other studies that have 
been confirmed in this work as having a transcriptional response to Shh in the cell 
Une lOTl/2. 
Gene 
Patched 
Patched2 
Glil 
Hip 
HNF-3P 
Angiopoietin2 
Bmp4 
Basal expression in lOTl/2 
cells (by northern blotting; 
relative*) 
Low 
Low 
Below detection level 
Below detection level 
Low 
Low 
Low 
mRNA level in lOTl/2 cells 
after Shh stimulation 
Up-regulated 
Up-regulated 
(possibly with slow induction 
kinetics) 
Up-regulated 
Up-regulated 
(with slow induction kinetics) 
Up-regulated 
Up-regulated 
Down-regulated (subtle) 
* "low" indicates took several days with fresh isotope and standard protocol (as described in Materials and 
Methods) to give strong signal on fihn. "Below detection level" indicates that basal expression is not readily 
detected even after ten day exposure. 
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3.6 Cell density as a competency factor for the 
hedgehog response in 10T1/2 cells 
From the results of the experiments involving transient transfection of Shh into lOTl/2 cells, 
it became apparent that there was a substantial lag after treatment before effects were 
observed. Up-regulation of Patched and Glil were among the earliest responses, but were not 
observed until two days post-transfection. This was surprising, and suggested that lOTl/2 
cells may not become fully responsive to Shh until the cells near or reach confluence, an event 
that correlates with this timeframe. This was also suggested by other observations such as the 
fact that lOTl/2 cells treated with Shh conditioned media show more rapid response times 
with several markers if the cells are already confluent at the time of Shh addition (data not 
shown). 
Media recovered from pShh-N-PMT21 transfected cells just thirteen hours after transfection 
was shown to have potent activity in AP assays (with a seven day readout), showing the delay 
is not caused by a lag in the construct reaching the nucleus or being expressed by transfected 
cells (refer Figure 3.3). 
Experiments were conducted to investigate a possible relationship between cell density and 
the ability of these cells to respond to Shh. Using AP activity as a marker of Shh-induced 
osteoblastic differentiation, cells were found to respond more strongly as initial seeding 
density was increased prior to stimulation with Shh conditioned media (Figure 3.19 Panel A). 
To show that this effect was due to cell density, and did not simply reflect a higher percentage 
of cells being stimulated from the outset, a second experiment was conducted where the level 
of cell contact was limited. This was achieved by continuously stimulating pools of cells, all 
with the same initial seeding level, and trypsinising every third day to control cell density. 
Cells that were allowed to reach confluence displayed a strong AP response, while cells for 
which contact was limited throughout the nine day stimulation period had no detectable 
increase in AP activity (Figure 3.19 Panel B). These results suggest that cell-to-cell contact is 
a prerequisite for the fiill Shh response in lOTl/2 cells. 
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Figure 3.19 Effect of cell contact on the Shh response in lOTl/2 cells. 
Error bars represent +/- 1 standard deviation. (A) AP assays performed on cells at a 
range of initial densities and stimulated for seven days with Shh conditioned media 
show a correlation between increasing starting cell density and AP activity. Each data 
point represents four replicate wells. (B) AP assays performed on pools of cells with 
equal starting densities but differing degrees of allowed density, show cell contact is 
required for a full response to Shh. Cell pools were trypsinised every three days. Cells 
permitted to reach confluence were allowed to re-adhere at current density, whilst cells 
for which contact was limited were passaged over a number of dishes. Stimulation with 
Shh conditioned media was maintained for nine days prior to assay. Cells were counted 
prior to assay to ensure equivalent numbers were harvested at end of growth period and 
each data point represents three replicate pools of cells. 
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3.7 Discussion 
Activation of the hedgehog pathway in lOTl/2 cells was successfully achieved at two levels: 
by stimulation with Shh, and by exposing cells to the transcription factor Glil. For the first 
method, a number of strategies were able to induce a response. Shh was able to stimulate cells 
when supplied in conditioned media, and when added as pure recombinant forms obtained 
either commercially, or from collaborators. The recombinant protein, though effective, was 
only available for use in a small number of pilot AP experiments in a very limited format, and 
was unable to be obtained in suitable quantities for fiill scale experiments. The conditioned 
media could be produced as required, proved to be very stable, and was extremely potent. 
Transient transfection with the N-terminal Shh expression construct pShh-N-PMT21 was 
effective in giving strong pathway activation, as measured with a range of markers. 
Hedgehog pathway activation as a result of human GUI expression in lOTl/2 cells was also 
successfiil, though there were marked differences in potency between different constructs. 
The clones contained sequence differences in their coding regions, though investigation of a 
number of normal individuals showed that these refiect common polymorphic alleles. The 
differences in the strength of the response are most likely related to differences between the 
vectors and differences in the positions that the constructs have been cloned in, relative to the 
contained promoter and enhancer sequences. The construct eliciting the strongest response 
was chosen for all fiirther GUI activation experiments. 
Transfection with a construct expressing a known human oncogenic mutant SMOH clone did 
not cause any detectable change in the levels of AP enzyme or Pa^ c/zefS? transcripts. This was 
surprising, given that the same human mutant has been shown to activate a luciferase-based 
reporter of Gli activity in lOTl/2 cells (Murone et al, 1999), and that it can activate the 
pathway when expressed in the skin or developing neural tube of transgenic mice (Xie et al, 
1998; Hynes et al, 2000). Another group has also found that the same human SMOH mutant 
fails to give an AP response when transfected into lOTl/2 cells (Dr. F. de Sauvage, personal 
comm.). The lack of a Patched response, which is considered a universal marker of pathway 
activation, suggests a response to SMOH^^ °'* did not occur in the studies described in this 
chapter. Although the construct was shown to cause an increase in Smoothened expression, it 
may be that this did not reach a critical threshold level, or altematively may reflect an 
inability for the oncogenic protein to cause a fiill pathway response in lOTl/2 cells. Either 
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way, the expression of SMOH^^^^ was deemed unsuitable for studies aiming to discover 
hedgehog pathway targets, and was not continued. 
The major aim of the work presented at the beginning of this chapter was to select the 
pathway activation strategy that would give the best chance of success in discovering new 
hedgehog pathway genes. Each of the successful activation strategies has advantages and 
disadvantages as a model biological system for this purpose. It was decided that pathway 
stimulation at the level of Shh would be used in the experiments described in the following 
chapters, which aim to identify novel target genes. This was for two major reasons. Firstly, 
although Glil is known to be a major mediator of hedgehog signalling in vertebrates evidence 
suggests that some hedgehog responses may be Gli-independent (refer Section 1.2.8 and 
Figure 2.1). If this is the case, then using Glil as a means of stimulation would mean a 
reduced pool of potential hedgehog downstream genes from which targets could be 
discovered using differential expression analysis, compared with activation of the pathway 
with Shh. Secondly, stimulating the pathway by exposure to Shh leaves Glil transfection open 
as a potential method of independently verifying some of the discovered Shh targets, since at 
least a proportion of these would be expected to be regulated through Gli family members. 
As discussed in earlier sections of this thesis, pathway activation by Shh transfection or by 
using crude Shh conditioned media both have disadvantages over the ideal situation of 
stimulation with pure recombinant protein. It was decided to concentrate primarily on the 
transfection based approach, but for the microarray work to conduct experiments in parallel 
with conditioned media. By initially performing experiments with a transfection based 
approach conditioned media could be produced as a by-product without additional cost, and 
the conditioned media was then able to be used for secondary experiments. The use of both 
strategies aimed to minimise the chance of false positives, since the two approaches have 
weaknesses in different areas and should complement each other for genuine downstream 
genes. 
From the results described in this chapter it is clear that lOTl/2 cells display expression 
changes in a number of genes in response to stimulation by Shh. Investigations with a range 
of markers has allowed a response profile to be obtained after transfection with the construct 
pShh-N-PMT21. Patched, Patched2, Glil, Hip, Angiopoietin2 and HNF-3p all showed 
induction in terms of an increase in cellular mRNA levels. Alkaline phosphatase enzyme 
activity was also shown to be induced. Bmp4 was found to display a subtle down-regulation in 
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mRNA level. This result is in contrast to that of Nakamura et al, (1997), who reported no 
change in Bmp4 transcript levels in response to Shh in lOTl/2 cells. However, the method 
employed by Nakamura and colleagues lacked the power to detect this response as they used 
semi-quantitative RT-PCR, a technique that has inherently low reliability for detecting 
changes of less than two fold. Previously human skin keratinocytes have been shown to up-
regulate Bmp4 in response to Shh (Fan, H. et al, 1997), the opposite response to that observed 
in the lOT 1/2 system. 
A number of other candidate target genes were investigated for which no evidence of 
regulation by Shh was found in the lOTl/2 system. Of note, Shh does not seem to be a target 
of itself in lOTl/2 cells as it is in the early development of neural tissue, at least not mediated 
through Glil. Smo was not found to be regulated by Shh or Glil at the level of transcription, 
even though a study has reported up-regulation of SMOH in a large percentage of human 
BCCs (Kallassy et al, 1997). These differences presumably reflect the fact that different 
targets may be specific to particular cell types, a feature that allows hedgehog to orchestrate 
such diverse effects in a range of developing tissues. 
The discovery of a nuniber of different sized transcripts hybridising with Patched probes was 
of particular interest. Altemate spicing of exons at the 5' end of Patched has previously been 
reported (Hahn, H. et al, 1996a; Hahn, H. et al, 1996b; Johnson et al, 1996; Kogerman et 
al, 2002). However, the variants described to date are not expected to produce transcripts as 
reduced in size from the full length band as those observed in this work. There is evidence 
that altemate splicing of Patched may confer different functions to resulting proteins 
(Kogerman et al, 2002). It will be of interest in future work to further explore this 
phenomenon in light of the finding that several of the transcripts are differentially expressed 
in response to hedgehog. 
The experiments outlined in this chapter demonstrate that lOTl/2 cells need to reach high 
density before a full response to Shh is initiated. A similar effect has previously been 
described in the NIH-3T3 cell line (Taipale et al, 2000), and it will be interesting to see if 
density-dependent cofactors of Shh activation are identified in future studies. One suggestion 
is that such a molecule may be an undiscovered ligand for Smoothened, since Smoothened 
has a stmcture reminiscent of a receptor. Though such a ligand for Smoothened has not yet 
been discovered, if one does exist it may further fine-tune hedgehog signalling by modulating 
the action of Patched in response to Hedgehog binding. Whatever the mechanism, the 
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experiments performed using AP as an indicator suggest that cells must reach a critical 
density before they can undergo osteoblastic differentiation under the control of Shh. As AP is 
a marker of a single cell lineage, it is important to note that this does not preclude other 
undetected responses occurring prior to the critical density being reached, but it does indicate 
that cell contact is essential for the complete response to Shh that normally occurs in lOTl/2 
cells. Direct transfection with GUI was able to induce Patched transcription in six hours 
(whilst cells were still sparse), showing that the low density insensitivity to Shh can be 
bypassed by activating the cascade more distally. 
The investigations into the timing profile of the response to Shh in lOTl/2 cells fulfilled two 
major goals. Firstly, the studies highlighted the potential of the lOTl/2 cell type for discovery 
of novel hedgehog target genes, in that the response was strong, reproducible and involved 
expression changes in a range of known targets of the pathway. The rationale is that if a 
number of known targets show altered expression, then under the same conditions it is likely 
that a number of as yet undiscovered targets would also show expression changes and these 
genes should be able to be detected by differential expression analysis. Secondly, the data 
provides cmcial information on the timing of expression changes for key markers of pathway 
activation in response to transfection of an N-terminal Shh expression constmct. This allowed 
timepoints of interest to be selected for microarray studies, as outlined in Chapter 5. Clearly 
there are distinct phases of the Hedgehog response, with the earliest markers, for example 
Glil and Patched, induced by two days post-transfection. Hip, in contrast, is induced more 
than a day later. It was unexpected that Hip would be induced with such a lag after the first 
markers, especially since it is a key target of hedgehog signalling in several different cell 
types and is imlikely to represent a terminal differentiation marker. AP enzyme activity was 
also found to be induced late in the timecourse, though this was expected since AP is a marker 
of cellular differentiation. 
It is still possible that there are as yet undiscovered targets of hedgehog signalling that are 
induced prior to Glil and Patched. If a target upsfream of Glil were to exist this would be of 
particular interest, and in order to allow for this possibility microarray studies were conducted 
for a range of timepoints beginning prior to the up-regulation of the earliest markers and 
stretching out until the time at which the late responses were detected. The microarray studies 
are described in detail in Chapter 5. 
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It is imperative to note that the timing of responses discussed in this chapter will show 
considerable variability in the hands of different researchers in different laboratories, but the 
relative order of responses should remain constant. The results described in this chapter were 
conducted under a set of standardised conditions that could be replicated for experiments to 
generate RNA samples for differential expression analysis. lOTl/2 cells display different 
growth rates and subtle changes in morphological appearance when any of a number of 
conditions are changed. They show marked differences in doubling time when grown in 
different brands of semm, and different lot numbers of serum from the same manufacturer 
also give significant growth differences (data not shown). For this reason variables were 
controlled as closely as possible during the experiments described in this chapter, and those in 
subsequent chapters. Such precautions involved the use of the same lot numbers of reagents 
and chemicals, the same incubators and standardised procedures for all manipulations. The 
lOTl/2 cells were always used at early passage number (less than passage 20) and cultured 
under a strict regimen to ensure they maintained their characteristics for all experiments. 
In light of the finding that lOTl/2 cells show a long delay after transfection before expression 
changes are observed with a number of markers, it is probable that the absolute time from 
transfection to a response for any particular marker may be particularly influenced by the cell 
density at "time zero" (liposome addition). The specific fransfection protocol used may also 
alter timings, since different techniques stress cells differently, for example length of time 
without semm, altering the time it takes them to recover to their normal growth rate. This in 
tum will affect how long after transfection critical cell density is obtained. 
Two findings of note in this chapter were the confirmation of both Patched2 and Hip as 
downstream targets of Shh in lOTl/2 cells. Whether or not Patched2, like Patched, is induced 
by Shh had previously been controversial. The pattem of transcripts bound by Hip probes was 
intriguing, revealing three transcripts of approximately the expected size that were all induced 
by hedgehog. The finding of an additional induced transcript of considerable size warrants 
further investigation as it may represent a Hip related gene. 
In summary, the work outlined in this chapter has meet its two major aims. Firstly, 
investigation of potential pathway activation approaches resulted in the identification of 
successful methodologies. From these, a sfrategy was formed on how best to stimulate cells 
for the experiments involving comparative analysis of gene expression outlined in the 
following chapters. Secondly, the studies provided data on the timeframe of known responses 
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under a defined set of conditions to be used in subsequent experiments, so that relevant 
timepoints were able to be selected that would maximise the chance of identifying new 
downstream target genes regulated by the hedgehog pathway. 

Chapter 4: Subtracted Library Based 
Approach to Hedgehog Target Gene 
Discovery 
4.1 Introduction 
Biology has undergone a number of technological revolutions in recent decades. Major 
advances have occurred that have transformed the way biological questions are approached, 
particularly in genetics and developmental biology. In recent years DNA sequencing, which 
previously had been the bottleneck in many projects, has become highly automated such that 
mass sequencing of entire genomes is now feasible. In light of such progress, a key question 
now challenging scientists is finding when and where particular genes are expressed. 
Traditional approaches to assessing levels of gene expression, such as northem blotting, are 
only amenable to analysis of one (or at most a couple) of genes at a time, making large scale 
screening studies highly laborious and largely limiting studies to known genes. A number of 
techniques have been developed that allow dissimilarities in gene expression between two 
populations of interest to be investigated on a genome-wide scale. In this way, subtle 
differences that involve changes the expression of just a handful of genes can be detected 
upon a background of many thousands of genes whose expression remains unchanged by the 
variable under study. Such studies are referred to as investigations of differential gene 
expression (DGE). This and the following chapters describe efforts identify changes in gene 
expression caused by deliberate activation of the hedgehog signalling pathway. 
4.1.1 Techniques for analysis of differential gene expression 
In the 1990s a number techniques were developed with the aim of profiling transcriptional 
changes between RNA populations. These include subtractive hybridisation methodologies 
such as representational difference analysis and PCR-Select, differential display, serial 
analysis of gene expression (SAGE) and microarray technology. Each technique has sfrengths 
and weaknesses, and the best choice in a particular situation depends largely on the type of 
biological question being addressed. 
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One of the first of the new techniques to gain popularity was differential display. This 
involves conversion of mRNA samples of interest to cDNA, followed by PCR amplification 
of each with a combination of oligo(dT) and random primers. The resulting products are 
separated by electrophoresis such that the pattem of resulting bands can be compared. Bands 
that have intensity differences between the samples are then isolated, cloned and sequenced 
(Liang and Pardee, 1992). A key advantage of this method is the ability to find changes in 
previously undescribed, as well as known, genes. However, it is laborious and highly prone to 
false positive results, though recent modifications to the technique have attempted to reduced 
the error rate (Sompayrac et al, 1995; Martin, K. J. et al, 1998). 
SAGE represents a bmte-force approach to finding expression differences as it involves 
generating a comprehensive transcript profile for cells of interest followed by statistical 
comparison of observed expression to detect differences. Traditional approaches using such a 
philosophy have involved making cDNA libraries from cells to be compared, then sequencing 
large numbers of individual clones. Historically such approaches have been hindered by the 
number of sequencing reactions required to give a statistically meaningfiil snapshot of 
transcriptional activity. SAGE overcomes this limitation by producing short (9 to 20 
nucleotide) sequence tags for each transcript, then concatenating these together in long 
sfretches such that information on numerous transcripts can be obtained from each sequencing 
reaction (Velculescu et al, 1995). The short tags are generated from linker ligated cDNAs 
using a type II restriction enzyme that cuts a defined distance away from its recognition site in 
the linker sequence, and contain enough information to imiquely identify genes during 
database searching. SAGE data can be accumulated and used to compare a number of 
samples, a distinct advantage over previous methods that are often only amenable to pairwise 
comparisons. Despite its advantages SAGE has not been adopted widely, and this may reflect 
a number of limitations inherent to the approach. These factors have been reviewed 
extensively by Yamamoto et al, (2001), and include technical difficulties in producing high 
quality concatenated tag libraries, difficulties in isolating unknown genes from the short tags 
and bioinformatics issues relating to sequencing error frequencies and gene assignment. 
A number of altemative techniques designed to detect transcriptional differences based on 
subtractive hybridisation have been developed. The premise is that by using cleverly designed 
hybridisation strategies the genes expressed in one population (the "driver") can effectively be 
removed when hybrids form with cDNAs produced from a second population (the "tester") 
under controlled conditions. The cDNA sequences remaining unbound represent genes 
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expressed exclusively or at much higher levels in the tester population. These methods have 
the inherent advantage that they feature direct selection of the sequences of interest, be they 
known or previously unknown genes. Initially described methods employed techniques such 
as chromatography, oligo(dT)-latex bead separation and avidin-biotin binding for separation 
of the desired non-hybridised sequences, often after multiple rounds of hybridisation (Sargent 
and Dawid, 1983; Davis et al, 1984; Hedrick et al, 1984; Duguid and Dinauer, 1990; Hara, 
E. efa/., 1991). 
This concept has been adapted for use with ligated linkers and subsequent PCR-based 
amplification that allow studies to be undertaken with relatively small amounts of starting 
material, in a methodology termed representational difference analysis (RDA; Lisitsyn and 
Wigler, 1993; Hubank and Schatz, 1994). RDA bypasses the need for physical separation of 
single and double-stranded cDNA, greatly simplifying the process. Without normalisation, 
highly expressed genes tend to be over-represented and changes in lowly expressed transcripts 
hard to detect. A new method, termed suppression subtractive hybridisation (SSH) was 
recently developed and has the advantage of normalisation and subfraction in a single 
procedure, overcoming a major technical limitation of previous subtractive methodologies 
(Diatchenko et al, 1996; Gurskaya et al, 1996). This normalisation uses suppression PCR, an 
effect whereby inverted terminal repeats attached to DNA suppress amplification of 
undesirable sequences (Siebert et al, 1995). In SSH "target" (differentially expressed) cDNA 
sequences are amplified whilst non-target DNA amplification is simultaneously suppressed, 
leading to enrichment for cDNAs of interest in the final pool. 
Microarrays address the question of DGE using a methodology quite distinct from the 
approaches outlined above, and with a number of advantages in terms of the aims of this 
thesis. Microarray methods are used extensively in the work described in the following 
chapter, where they are outiined in detail. This chapter deals with the use of suppression 
subfractive hybridisation as one strategy in the quest to identify genes regulated by Shh. 
4.1.2 PCR-Select cDNA subtraction as a strategy to investigate 
Shh target gene expression 
At the outset of the work described in this thesis, microarray methodologies were planned as 
the method of choice to investigate DGE between cells in which the hedgehog signalling 
pathway had been deliberately activated, and cells in the unstimulated state. However, access 
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to appropriate clone sets and microarray "chips" (thousands of DNA sequences gridded onto 
glass slides) from collaborators was delayed. In addition, the specialised equipment required 
for the scanning and analysis of such chips (which is detailed in the following chapter) was 
not available until much later than originally anticipated, making it impossible to speed up the 
procedure by obtaining microarray chips from another source. The postponement of the 
microarray experiments provided an opportunity to try another DGE analysis technique, 
giving an additional opportunity for Hedgehog target gene discovery. 
Suppression subtractive hybridisation was chosen as the most appropriate strategy for studies 
to complement the microarray work for a number of reasons in addition to the advantages 
already outlined above. In particular, SSH requires no specialised equipment, it does not 
require the extensive post-analysis cloning of differential display, nor does it have the 
bioinformatic burden of SAGE. In addition, at the commencement of the work described in 
this chapter a number of studies successfiilly employing SSH had appeared in the literature 
(examples include Chen, Z. et al, 1997; Chu, Z. L. et al, 1997; von Stein et al, 1997; Wong 
et al, 1997; Yokomizo et al, 1997; Kuang et al, 1998; den Hollander et al, 1999; Hufton et 
al, 1999; Yang, G. P. et al, 1999). At this time Clontech Laboratories (Palo Alto, Califomia), 
whose researchers pioneered the SSH technique (Diatchenko et al, 1996) had released a 
commercial SSH kit called "PCR-Select" that contained the enzymes, primers and buffers 
required for the technique, along with positive controls. The remainder of this chapter 
describes constmction and analysis of cDNA libraries constmcted with the PCR-Select 
methodology. 
4.2 Influences on early timepoint selection 
PCR-Select libraries were constmcted for analysis of differentially expressed genes twenty 
four hours post-transfection with pShh-N-PMT21. Resources were initially available to 
constmct libraries suitable for the analysis of a single timepoint. The decision to use a twenty 
four hour timepoint was made in order to search for responses at the earliest time after a 
known hedgehog response was detected. At the time the decision was made, the profile of 
downstream responses presented in the previous chapter were not yet fully complete. With 
hindsight, two critical factors had not yet been uncovered. Firstly, initial studies investigating 
Bmp2 expression gave northem hybridisation pattems erroneously suggesting Bmp2 was up-
regulated one day after pShh-N-PMT21 transfection. The second factor that influenced 
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timepoint selection was that at the time subtracted library work was initiated, the discovery of 
the density dependence of the hedgehog response of lOTl/2 cells (outlined in Section 3.6) 
was still to be made. 
The decision was also fuelled by the preference for detecting early targets of hedgehog 
signalling rather that late ones, which would more likely represent products of terminal 
differentiation. In retrospect, had the complete body of knowledge presented in Chapter 3 
been known when the work presented in the following sections was initiated, a later timepoint 
would have been selected. However, this was not the case and the libraries that form the basis 
of this chapter used mRNA harvested one day after transfection. 
4.3 Subtracted library construction 
Subfracted libraries were constmcted using the PCR-Select cDNA Subfraction Kit (catalogue 
number Kl 804-1, Clontech). High quality poly(A)^ RNA purified from transfected cells was 
used as source material. The procedure is outlined in Figure 4.1. Initially, poly(A)"^ RNA from 
the Shh treated (tester) and reference (driver) cell populations was converted to cDNA, then 
digested with Rsal. The tester cDNA was then split into two pools, each of which was ligated 
to a different adaptor sequence. Two hybridisation steps are then performed. Firstly, each 
sample of tester is hybridised separately with an excess of driver. After denaturation and 
annealing, molecules of types a, b, c and d (Figure 4.1) are formed. Normalisation of high and 
low abundance sequences occurs because type "a" molecules anneal to matching sequences 
faster for abundant cDNAs. During this hybridisation, enrichment for differentially expressed 
sequences also occurs with single stranded type "a" molecules remaining for such genes. In 
contrast, when a gene is expressed in both the tester and driver populations sequences are 
removed as type "c" hybrids form. 
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Figure 4.1 Outline of the PCR-Select suppression subtractive Iiybridisation procedure. 
Solid lines represent Rsal digested tester of driver cDNA. Solid boxes represent the 
outer part of adaptor 1 and the corresponding PCR primer PI sequence. Shaded boxes 
represent the outer part of adaptor 2 and the corresponding PCR primer P2 sequence. 
Empty boxes represent the iimer part of the adaptors and corresponding nested PCR 
primer sequences. In addition to the a, b and c type molecules shown, similar molecules 
are also formed with the other adaptor (not shovra). Reproduced with permission from 
Diatchenko et al, (1996). Copyright 1996 National Academy of Sciences, USA. 
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Next, the two hybridisation samples, each of which involved addition of a different adaptor, 
are mixed together without denaturation and again allowed to hybridise. This is performed in 
the presence of more denatured driver to allow fiirther enrichment. This is the key step of the 
procedure, because the only molecules that can form hybrids with a different adaptor on each 
end (type "e" molecules; Figure 4.1) are type "a" molecules from the first hybridisation which 
tend to represent differentially expressed genes. After end filling, these sequences are 
preferentially PCR amplified using primers to the adaptors. Due to suppression PCR effects, 
type "b" molecules form loops that prevents their amplification, while other sequences either 
lack primer sites altogether, or are only amplified linearly, A secondary PCR step with nested 
primers fiirther enriches for the differentially expressed sequences. After constmction the 
libraries made in this way were ligated into a plasmid vector and transformed into E. coli. 
In total four libraries were created using this method. As subtraction is a unidfrectional 
procedure it was necessary to make libraries as pairs, one forward and one backwards (in 
terms of which population is considered tester and driver) so that both down-regulated and 
up-regulated target genes of Shh could potentially be identified. 
Constmction of the first pair of normalised subtracted libraries was begun before the mutant 
Shh control constmct (pA64-Shh-N-PMT21; refer Section 3.4) was made, and transfections 
for library constmction initially used an empty vector control. Investigations indicated that the 
procedure did not normalise for the large level of ectopic Shh transcription derived from the 
expression constmct, resulting in a library made up largely of Shh derived cDNA clones 
(approximately 87 percent of the first forward subtraction library contained Shh sequences). 
For this reason another pair of libraries were constmcted, but this time employing pA64-Slih-
N-PMT21 as a control constmct for pShh-N-PMT21, which expressed the N-terminal active 
region of Shh (refer Section 3.4). Quality control procedures outlined in the PCR-Select 
procedure showed that library constmction had been successfiil and subfraction had taken 
place (refer Materials and Methods, Chapter 8). Normalised subtracted PCR products were 
cloned into a plasmid vector and the libraries transformed into ultra-competent E. coli cells 
for analysis. 
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4.4 Analysis of subtracted libraries 
The normalised subfracted libraries were used as a tool in an attempt to identify clones 
representing genes differentially regulated by hedgehog signalling. 
4.4.1 Direct cloning of obvious PCR bands prior to transformation 
When normalised subfracted PCR products from the forward direction libraries were checked 
by gel electrophoresis (before ligation and transformation into E. coli) a number of bands 
were apparent against the background "smear" of numerous different sized products. These 
bands were excised from agarose gels, purified, and cloned directly. In both the first and 
second constmcted libraries these clones all represented different size sequences from the Shh 
cDNA. This indicated, particularly in the case of the second library where a constmct 
producing a near full length mRNA was used as a driver, that these highly expressed 
sequences were not normalised as well as had been expected. The normalisation inherent to 
the procedure is designed to reduce the representation of highly expressed sequences so that 
lowly expressed genes are well represented in the final libraries. 
4.4.2 Removal of highly represented Shh clones 
To bypass the problem whereby Shh cDNA sequences themselves were highly represented 
the libraries were pre-screened using a rapid colony lift hybridisation procedure known as 
"Turbo" lifts (refer Materials and Methods, Chapter 8). Clones were manually gridded into 96 
well plate format and 1200 clones were investigated. Clones representing Shh sequences were 
identified by probing turbo lifts with the N-terminal Shh region present in pShh-N-PMT21, 
and the remaining non-Shh clones used for fiirther analysis. 
4.4.3 Differential screening of subtracted libraries 
As a fiirther screening procedure to narrow the clones of interest to those most likely to 
represent tme differentially expressed genes, non-Shh clones were gridded onto replicate 
nylon blots and interrogated using a differential screening approach (as in Wang, Z. and 
Brown, 1991; Lukyanov et al, 1996). This method gets around the problem of loss of 
information on lowly expressed genes by using forward and reverse subtracted cDNA probes. 
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rather than directly using the source RNA derived cDNAs, for hybridisation comparisons of 
the library clones (Wang, Z. and Brown, 1991; Lukyanov et al, 1996). Genes that showed 
apparent differential expression were then considered of particular interest. Plasmid 
preparations were made for these clones, which were sequenced to establish then identity. 
4.4.4 Confirmation northern blot screening of subtracted library 
derived putative target genes 
Overall, 80 subtracted library derived clones were sequenced, 41 of them from the second 
library after extensive secondary screening. In total, 60 separate clone inserts were used to 
screen northem blots containing RNA made using the same transfection freatments and 
twenty four hour timepoint as the initial source RNA for library constmction. Of these insert 
probes, 36 were from sequences from the second (mutant Shh negative control) library. 
Unfortunately, in all cases these genes represented false positives, showing no apparent 
differential expression in response to Shh stimulation. It was observed that almost all the 
probes bound transcripts of genes that were extremely highly expressed. This suggests 
inherent problems with the normalisation procedure inherent to the PCR-Select technique. At 
this stage work was halted on the subtracted library approach. 
4.5 Discussion 
The subtractive library approach was unsuccessful in the identification of downstream genes 
regulated by Shh. A number of factors contributed to its failure in meeting this goal. 
First and foremost, the libraries were constmcted from RNA collected from a timepoint that, 
with the benefit of hindsight, was far earlier than would have been optimal. This point has 
already been addressed in detail in Section 4.2. The timepoint used for the libraries was prior 
to the cells reaching full confluence, and the cells at this stage would not have been competent 
to mount a fiill response to Shh. The fact that no target genes at all were identified at twenty 
four hours suggests that lOTl/2 cells may not just show a reduced response to Shh prior to 
reaching high cell density, but actually may not be able to respond at all at this time point. 
The normalisation of the libraries was not as successful as was anticipated, as most of the 
false positive genes (after removal of carry-over Shh sequences) represented very highly 
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expressed genes when investigated by northem blot. With efficient normalisation, false 
positives would be expected to be representative of a wide range of gene expression levels. 
The abundance of Shh-derived clones present in the libraries is indicative of problems with 
using a subtractive methodology with transfected samples. Slight differences between 
transfection efficiency and mRNA sizes between the Shh and mutant constmcts ended up 
being reflected in the normalised subtracted library clones. All quality control procedures, 
including radioactive label incorporation for cDNA synthesis monitoring and analyses 
checking that high abundance genes such as GAPDH had decreased after subfraction, 
indicated the procedure had worked. Apparently normalisation did occur, but not effectively 
enough to meet the aims of this work. 
In retrospect the subtractive methodology appears a poor choice for situations where RNA is 
prepared by transfection. Transcripts from the transfected constmct itself end up making up a 
large percentage of the cellular RNA pool in such cells, and is not able to be normalised well 
enough to avoid sequences from the gene under investigation confounding the analysis. In 
hindsight treatment with conditioned media would have provided a much better starting point 
for these studies, though the timepoint chosen would presumably have still hampered attempts 
at target discovery. 
Since this work was carried out the initial excitement in the literature over normalising 
subtractive hybridisation has been subdued by recent work that has highlighted some inherent 
flaws in the procedure. It appears that such techniques are able to find sfrong "off to on" 
responses, but are weak at identifying changes in expression in genes that are expressed in 
both populations (Moody, 2001). Many successful studies employing this technique have 
been performed in systems where dramatic differences in some genes are apparent, such as 
direct comparisons of tissues (for example Bowles et al., 2000), and in these cases the 
technique is useful. Comparison of very closely related mRNA populations, such as that in 
this study, can lead to a high level of false positives. It has been suggested that the SSH 
procedure may not have the power in its current form to identify changes less that six fold, 
and that genes with small cDNAs that lack a cut site for the enzyme used in a critical 
digesting stage of this technique {Rsal; refer Figure 4.1) may escape detection (Wang, Z. and 
Brown, 1991). 
After the libraries in this work were constmcted, a paper was published reporting the 
discovery of a major flaw in current subtractive methods (Wang, S. M. et al, 2000). This 
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Study demonstrated that the long stretches of poly(A)"^ RNA present in most eukaryotic 
mRNAs cause serious problems during subtractive hybridisation steps. Cross hybridisation 
between such sequences in the tester and driver populations leads to loss of template 
sequences for subsequent PCR, an effect that leads to the loss of many low abundance RNAs 
from the analysis. 
Another inherent limitation of the normalised SSH procedure is that no quantitative 
information is obtained on the expression differences uncovered. Altemative techniques, such 
as northem blotting or ribonuclease protection assays, must be subsequently performed to 
obtain information on relative expression levels between the cell populations of interest. The 
limitations encountered with the SSH approach in this work were largely overcome at the 
technical level by moving to microarray analysis. Biological limitations were overcome by the 
expansion of the work to include later timepoints and multiple Shh stimulation 
methodologies. The following Chapter outlines the microarray approach and its success in 
identifying novel targets of the hedgehog pathway. 

Chapter 5: Discovery of Novel Sonic 
Hedgehog Responsive Genes by 
IVIicroarray 
5.1 Introduction 
This chapter describes the use of cDNA microarray hybridisation to profile gene expression 
changes when lOTl/2 cells are stimulated by Shh, resulting in the discovery of a number of 
novel downstream transcriptional targets of the hedgehog pathway. Microarrays provide a 
hybridisation based method that allows the relative mRNA level of thousands of genes to be 
analysed simultaneously. Procedures consequently used to validate genes as genuine 
Hedgehog targets are also outlined and the strengths and limitations of the approach are 
addressed. 
5.1.1 The birth and breadth of microarray technology 
Microarrays provide a powerful platform for transcriptional profiling, and allow what is 
widely referred to as a "functional genomics approach": an investigation of gene fiinction on a 
global scale making use of the body of bioinformatic resources that have arisen from previous 
genomic investigations (Hieter and Boguski, 1997). DGE analysis using microarray 
techniques has become popular in the scientific community following the publication in 1995 
of pioneering work from the laboratory of Patrick Brown (Schena et al, 1995). The 
development of the technique has really been a progression of concepts originally used for 
other purposes, brought together with new ideas to address biological issues of interest on a 
large scale. 
In summary, microarray experiments involve large scale screening of biological molecules 
attached to physical supports at very precisely known locations. The binding between these 
arrayed molecules and molecules of interest from cells under investigation can be assayed. 
This involves chemically tagging cell derived molecules with a fluorochrome and allowing 
them to hybridise to the microarray under controlled conditions, after which binding levels 
can be assessed by stimulation and measurement of the fluorescent compound. If two cellular 
populations of molecules (such as RNA or proteins) are labelled with different tags and 
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hybridised simultaneously to arrays, then relative binding at a particular location will give 
useful data on the biology being investigated. 
This chapter describes the application of microarray technology to investigating comparative 
levels of gene expression between cell samples. In this case, DNA of known sequence is 
bound to the support and the hybridising molecules are cDNA sequences reverse transcribed 
from the mRNA present in the cell populations to be compared. The applications of 
microarray technology are far reaching and by no means limited to studies of differential gene 
expression or even nucleic acid hybridisation. Some of the diverse applications of microarray 
technology include RNA in situ hybridisation directly on arrayed tissue samples, binding of 
protein transcription factors to potential DNA binding regions and protein immobilisation on 
arrays to detect protein-protein or antibody interactions (recent reviews of note include Blohm 
and Guiseppi-Elie, 2001; Horvath and Henshall, 2001; Kallioniemi, 2001; Mitchell, 2002; 
Templin et al, 2002). In a recent twist, living cell microarrays have been created using 
microarray technology to transfer expression constmcts clones onto a support on which a 
lawn of living cells can be grown. The cells can be transfected with DNA deposited at each 
position leading to "living factories" that express the encoded proteins ready for further 
analysis (Ziauddin and Sabatini, 2001). 
The microarray technique in its initial conception, as a method to perform parallel 
hybridisations on numerous genes simultaneously, is an extension of various dot blot 
methodologies that have existed for decades. Advances in robotics and their application to 
biology have been paramount to the success of the technique, allowing liquid handUng and 
manipulation on a large scale and gridding at a density never previously possible. By the early 
1990's publications using an array format in conjunction with gene expression analysis were 
beginning to appear (Augenhcht et al, 1991; Hoog, 1991; Gress et al, 1992). Progress in the 
development of a "DNA chip" and a move away from arraying on nylon or other traditional 
formats was fuelled by the desire to create hybridisation based methodologies to provide a 
rapid method for DNA sequencing and mutation detection (reviewed by Southem, 1996). 
Such work led to the development of various coatings allowing DNA sequences to be 
attached to glass, and by using photolithographic methods (adapted from the semiconductor 
industry) protocols were established for the light directed synthesis of DNA directly on 
subsfrates. The use of multiple fluorochromes for DNA detection was modified from 
protocols already in use for hybridisation to chromosomes (du Manoir et al, 1993). Since the 
birth of microarray technology for comparative gene expression profiling in its current form 
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(Schena et al, 1995), a large number of laboratories have adopted the technique. Early studies 
exemplifying its success include Schena et al, (1996), DeRisi et al, (1997), Spellman et al, 
(1998), Chu, S. et al, (1998) and Golub et al, (1999). Though microarrays are not without 
limitations (refer Section 5.6.4), the accomplishments of such works has led to an explosion 
of microarray literature in recent years, a frend which shows no sign of slowing. 
5.1.2 Microarrays as a global approach to analysis of gene 
expression 
Microarray based expression analysis involves isolation of RNA from two populations that 
are to be compared. The mRNA is then reverse transcribed to cDNA at which time 
fluorescent molecules with different emission wavelengths (or reactive groups that can later 
be linked to such fluorescent molecules) are incorporated to distinguish the two populations. 
The two complex pools of labelled cDNA are then mixed and hybridised to so called 
microarray "chips" - glass slides upon which many thousands of specific DNA sequences 
have been gridded at known locations. In the form used in experiments described in this 
thesis, the gridded DNA sequences represent PCR amplified inserts from cDNA library clones 
(so called "cDNA arrays"). Spotted cDNA sequences can correspond to genes of known 
function or libraries containing uncharacterised clones, allowing dfrect discovery of novel 
genes with specific responses of interest. 
Synthesis of specific oligonucleotides in situ, as used on commercial "GeneChips" made 
popular by Affymetrix (Santa Clara, Califomia), or their subsequent attachment post-
synthesis is an altemative methodology ("oligonucleotide arrays"). The use of Affymetrix 
chips or nylon membrane based approaches is fundamentally different to the use of cDNA 
arrays. In the former, measures of gene expression are made independently (on separate chips 
or with sequential membrane probing), and then compared. With cDNA arrays the dual 
labelling leads to relative expression estimates and this eliminates many sources of 
experimental error, although the pairwise nature of comparisons does limit the types of 
experimental design. The remainder of this chapter deals with cDNA arrays, which were the 
technology platform available for the experiments described in this work. Figure 5.1 gives an 
overview major steps in the use of cDNA microarrays. 
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Figure 5.1 Overview of steps involved in cDNA Microarray experiments that allow 
identification of genes that are differentially expressed between test and reference 
RNA populations. 
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Microarrays are conceptually the reverse of many fraditional hybridisation methodologies. 
They can be considered like a massive number of reverse dotblots mn in parallel. For this 
reason it is logical to think of microarrays as having "probes" or "elements" that are bound to 
the support and that the "target" is the labelled sample that is free in solution. This 
nomenclature is used throughout this thesis, as recommended by the editors of The Chipping 
Forecast, (1999). It is important to note however that the opposite nomenclature also occurs in 
the literature. 
Hybridisation occurs in a thin film of liquid on the slide surface and can take place in an 
extremely small volume. This allows experiments to be conducted with relatively small 
amounts of starting RNA. Sequences in the labelled cDNA pools form hybrids with matching 
clones at specific locations on the array chips following standard hybridisation kinetics. A 
gene that is highly represented in one cDNA pool (and therefore highly expressed in one set 
of original cells) will form hybrids with the DNA on the corresponding microarray "spot" at a 
higher rate than lower represented sequences of the same gene present in the second 
population. After hybridisation the microarray chip is washed and quantitative data from the 
fiuorochromes gathered separately for each chaimel by laser confocal scanning. Specialised 
image analysis software is then used to collect numerical data on the intensity of pixels in the 
scanned image and to calculate an overall intensity level for each of the chaimels at each spot 
position (reviewed by Yang, Y. H. et al, 2001). The data can also be pseudocoloured and 
examined visually (Figure 5.1). 
Typically the fluorochromes used are the cyanine dyes Cy3 (emission 570 nm; orange) and 
Cy5 (emission 670 nm; far-red), which exhibit sharp emission spectra that are easily 
separated. It has become convention to pseudocolour resulting grey-level intensity images 
green and red respectively to represent the two channels, resulting in yellow when both are 
overlaid if the gene is not differentially expressed. If a particular gene had higher expression 
in one sample than the other, then the pseudocoloured spot would be shifted toward either 
green or red, depending on the dye that had been used to label each population. 
5.1.3 Analysis of microarray derived expression data 
Though the data can be scmtinised visually, this is normally only used to ensure spot 
boundaries are located accurately by the automated software, and to allow manual flagging of 
poor quality spots that should be excluded from the analysis (for example due to dust. 
130 Chapter 5: Discovery of Novel Sonic Hedgehog Responsive Genes by Microarray 
scratches or smearing). Actual data analysis is performed mathematically on the spot intensity 
levels. Normalisation of signal levels is required to correct for discrepancies in such factors as 
fluorochrome incorporation, reverse transcription efficiency and to adjust for differences in 
quantum yield (efficiency of energy transfer from absorption to emission fluorescence) 
between the different dyes (reviewed by Bilban et al, 2002). 
Further forms of mathematical and statistical analysis are then required to identify genes that 
are putatively up or down-regulated in a population of interest. As dual colour microarrays are 
bidirectional platforms, such questions can be asked of either population in relation to the 
other. This is a distinct advantage over technologies based on subtractive hybridisation, which 
are unidirectional, requiring separate libraries to find up-regulated and down-regulated genes 
in one population relative to another. The types of data analysis used for gene expression 
microarrays fit into two main categories: methods to find pattems of dependent genes, for 
example genes that tend to have similar expression pattems after certain treatments or in 
certain tumour subtypes (so called "clustering" methodologies such as k-means and self-
organising maps), and methods for analysis of differential gene expression (reviewed by 
Tsodikov et al, 2002). This chapter is concemed with differential gene expression. 
If the two channels of data in a microarray experiment are derived from cell populations A 
and B, then dividing the signal sfrength of channel B by the signal strength of channel A for 
any particular probe spot gives an estimation the relative transcript abundance in populations 
A and B for the corresponding gene. If the gene of interest is equally expressed in both 
populations then the ratio will be close to one. If a particular gene is up-regulated in 
population B relative to A then the ratio will be significantly greater than one, and if a gene is 
down-regulated the converse will be tme. Further analyses are required to compare replicate 
hybridisations and generate final normalised data for each investigated gene (Tseng et al, 
2001; Yang, Y. H. et al, 2002). 
The most challenging aspect of microarray technology is how to interpret the vast amounts of 
normalised ratio data that can be generated from even a simple pairwise experiment with a 
single variable and a single timepoint. Though it is relatively easy to identify genes amongst 
the data that show dramatic expression differences between the cellular populations of 
interest, it is a much more complex task to identify more subtle changes in expression and 
determine the likelihood of these being biologically meaningfiil. There is no absolute solution 
to this problem, nor is there likely to be. Like most areas of statistical analysis, the goal is to 
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adopt procedures that allow the best estimate of the probability that a particular piece of 
information accurately reflects the tme state. The mining of biologically relevant data from 
microarray data has become a discipline, with a number of research groups now devoted to 
optimising statistical methodologies for this purpose (examples include Chen, Y. et al, 1997; 
Ideker et al, 2000; Baldi and Long, 2001; Kerr and Churchill, 2001a; Newton et al, 2001 and 
Pan, W., 2002). 
5.2 Experimental design to maximise chance of 
hedgehog target discovery using microarrays 
Microarray projects typically require a large investment in time and resources with the 
microarray chips themselves often being expensive, or in the case of this work, in limited 
supply. It is therefore critical that experiments are carefully designed to give the researcher 
the greatest chance of answering the biological question of interest with the available 
resources. 
5.2.1 Content, source and availability of cDNA microarray chips 
When the work outlined in this thesis was initiated the objective was to use custom cDNA 
microarray chips containing large arrayed clone sets (such as the National Institute of Aging 
15 000 clone set) along with all the known targets of Shh in lOTl/2 cells (as investigated in 
Chapter 3) as positive controls, plus a range of previously untested candidate genes. Such 
chips did not become available in time for the work described in this thesis, and instead 
experiments were performed using smaller altemate chips (described below) which were 
produced by Dr. S. Grimmond, Dr. L. Fowles and Mr. A. Forrest. Slides consisted of PCR 
amplified clone inserts, the templates for which were E. coli containing plasmids of interest. 
The provided chips contained 3936 spots that were duplicated in separate blocks on each 
slide, effectively giving two "half slides", together totalling 7872 elements. These represented 
1594 cDNA clones from the mouse UniGene set (Research Genetics), 1920 cDNA clones 
from a normalised mouse embryonic branchial arch library (NMEBA; constmcted by B. 
Soares, University of Iowa), and a further 422 spots including control spots (e.g. GAPDH 
clones, various buffer spots, cy-labelled positive controls) and various mouse and human 
clones that were of interest to a number of developmental biologists in the local scientific 
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community. Access to the newly constmcted NMEBA library gave the potential for novel 
gene discovery, since NMEBA should be rich in developmental molecules expressed during 
embryogenesis. This is in contrast to the UniGene set, which in most cases contained known 
genes. Branchial arches, from which the NMEBA library was derived, give rise to 
craniofacial stmctures. This is an embryonic processes in which Shh plays a role, as 
evidenced by the severe facial midline deformities observed in holoprosencephaly (refer 
Section 1.6.3). 
5.2.2 Assessment of cDNA chip quality 
One UniGene/NMEBA chip was hybridised on both channels with a split sample of untreated 
lOTl/2 RNA in order to assess chip quality before embarking on experiments involving the 
use of experimental sample material (data not shown), using the protocol outlined in 
Chapters. The untreated-against-self hybridisation gave yellow pseudocoloured overlay 
signals for spots that showed hybridisation, as expected when the two channels are from the 
same sample. In general, spots were well shaped with clearly defined boimdaries. Occasional 
UniGene regions showed more diffiise spots of a larger size, but these were a minority. There 
was a pronounced difference in the average intensity of hybridising spots in the UniGene and 
NMEBA sections of the chip, with all NMEBA blocks showing lower hybridisation signals 
on average. This was particularly apparent when examining the images visually. The fact that 
the UniGene derived blocks gave higher signals shows that reverse transcription of RNA and 
labelling was successful, indicating the difference was a characteristic of chip manufacture. 
Various factors may have led to the dim signals including low efficiency of PCR 
amplification or problems during purification and printing of the NMEBA set (variables that 
were out of the author's control). As these chips were the only resource available in the 
timeframe required for completion of this thesis they were used for subsequent experiments. 
As expected all experiments gave better signals for UniGene than NMEBA clone spots (as 
illustrated in Figure 5.3 in Section 5.4.1). 
5.2.3 Balancing scientific and logistical constraints 
Microarrays generate vast amounts of primary data; however, no amount of data will allow a 
particular biological question to be addressed if hybridisations are not conducted in an 
informative way. It is of cmcial importance that issues of experimental design are considered 
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carefiilly before embarking on microarray experiments, to ensure that the information gained 
is relevant to the aim of the study and that statistical confidence in the data is as high as 
possible. The primary aim of the work described in this chapter was to identify novel 
downstream targets showing changes in gene expression upon stimulation with Shh. 
Logistical constraints were a major issue in terms of experimental design. In particular, 
microarray chips were a scarce resource at the time this work was undertaken. In an ideal 
world microarray experimental design should be finalised before the researcher begins any 
bench work. In this project only a small number of array chips were able to be obtained (for 
reasons outlined in the previous section). Altemative array chips from another source were 
expected to be available in relative abundance in the near future, and in this respect the 
experiments planned with the initially available chips were seen as an exploratory measure to 
obtain more targets to fine tune the timepoints selected for further experiments. In this way, 
future experiments would aim for high statistical confidence in detecting subtle changes by 
employing large numbers of replicates at a specific timepoint of interest. These chips did not 
become available and therefore the 4k UniGene/NMEBA chips form the basis of the 
described work. 
Only six chips were available at the outset of the work, though it was known there was a 
possibility more would be available several months later. This necessitated use of a 
experimental design strategy that was flexible in terms of addition of more hybridisations to 
the sfrategy at a later date. 
It was established in Chapter 3 that Shh transfection and Shh conditioned media would be 
used as complementary methods of hedgehog pathway activation for microarray studies. At 
the time work was initiated it was decided that the six available chips would best be used in a 
"hedging of bets" sfrategy. That is, rather than extensive replication with a very small (or 
single) treatment-timepoint combination, it was better to have less robust data over a greater 
range of timepoints to maximise the number of hedgehog target genes likely to be identified. 
Put more simply, there is little point in having "statistically magnificent" data with enormous 
power to discriminate subtle differences if there are no differences to detect under the chosen 
experimental condition. The approach actually undertaken, of spreading the chips over several 
timepoints, is less robust in terms of statistical reliability of data, but this is compensated for 
by a much reduced risk of identifying no targets at all. From the profile of known responses to 
hedgehog gained in Chapter 3 it was hypothesised that the earliest expression changes (which 
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are likely to be the most interesting) would be occurring approximately two days post-
transfection. It was quite possible that only a small number of genes would have shown 
changes at this time, and if by chance none of this small handfiil of genes were gridded on the 
array then changes would not be detected. There was no way of knowing a priori if this 
would be the case, so a largely exploratory sfrategy over a range of timepoints was undertaken 
to maximise the change of Shh target gene discovery. 
5.2.4 Chosen microarray experimental design 
Within the above framework a number of experimental designs were possible, depending on 
which samples were hybridised together and in which combinations. Figure 5.2 outlines 
possible design strategies considered for this work, given that four transfection timepoints (1, 
2, 3 and 4 days) and two conditioned media timepoints (3 and 4 days) would be investigated, 
in accordance with the results obtained in Chapter 3. The range was chosen to maximise the 
chance of finding novel early target genes by beginning one day prior to the observation of 
any known response. The timepoints were extended out to four days post-transfection to allow 
detection of genes responding similarly to Hip, for which an elevation in mRNA level is not 
observed until this time. 
Figure 5.2 Panel A outlines a widely used microarray strategy where each hybridisation is 
performed with a sample of interest and a common reference RNA. Typically the reference 
RNA is an easily obtained source, such as mouse embryonic RNA from a particular stage. 
Such a methodology is termed "indirect" as the comparisons of biological interest are inferred 
by the differences in each of the freatments of interest and the common reference. A major 
advantage of this strategy is that comparisons can be made a posteriori, even between 
experiments by different researchers in different laboratories or further hybridisations done at 
a later date, provided the reference RNA is the same (Simon et al, 2002). The basic premise 
is that if a gene for treatment "Y" is three fold higher than in the reference population, and the 
same gene in treatment "Z" is six fold higher than in the reference population, then that gene 
is estimated to have two fold higher expression in treatment Z than treatment Y. Such a 
strategy also allows effective comparison across a timecourse. However, the indirect nature of 
comparisons has a downside: a decreased statistical confidence in final ratios compared with 
the same data gathered from a direct comparison (Yang, Y. H. and Speed, 2002). Without a 
large number of replicates such analysis is prone to error. 
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Another major limitation of reference designs is that if a particular gene is not expressed in 
the reference population then calculating a ratio would involve dividing by zero. For this 
reason such spots are uninformative, as there is no way relative expression for two treatments 
of interest can be inferred. Since any particular tissue only expresses a sub-set of the genome 
this "loss of data" can affect a large proportion of the spotted sequences in any particular 
experiment. Some laboratories have addressed this issue by pooling samples from a range of 
tissues for their universal reference RNA, though this requires great care to ensure 
consistency between all hybridisations to be compared (Simon et al, 2002). 
The technical and statistical limitations outlined above, made the indirect reference sfrategy 
unsuitable for this work. Additionally, lOTl/2 cells undergo distinct changes in 
morphological appearance both as cell density increases and after confluence. Presumably this 
correlates with a number of changes in gene expression over time since seeding, a few of 
which have already been identified (Melkonyan et al, 1997). In the case of transfection, 
fiirther effects on gene expression are expected due to the stress of the procedure itself. In a 
microarray strategy such as that illustrated in Figure 5.2 Panel A there is no confrol for these 
factors and such genes would be confounded with real Shh target genes. The only way to use 
such a strategy and minimise false positives would be to include further hybridisations 
between control treated cells at each timepoint, increasing the required number of 
hybridisations by a factor of two. Insufficient microarray slides were available to instigate 
such a strategy even if a single replicate were used for each combination, making it 
impractical for this project. 
Figure 5.2 Panel B shows a related design, but in this case using untreated lOTl/2 RNA for 
every hybridisation, rather than a biologically irrelevant reference population. Such a design 
shows many similarities to that in Panel A and suffers many of the same limitations in terms 
of the question posed in this thesis, and it was rejected for similar reasons. 
Panel C shows a different approach. In this case each sample is hybridised in a sequential 
fashion with the previous sample in the timecourse. Such a strategy has an increased power to 
detect changes across timecourses compared with those described above, since comparisons 
between adjacent timepoints are direct. Various "loop" designs could also be considered (Kerr 
and Churchill, 2001b), and a simple example is outlined in Panel D. In such cases direct 
hybridisations provide some of the data, while indirect comparisons (with lower confidence) 
can also be made. Again both sfrategies are sub-optimal for this project as they do not address 
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the major issue of appropriate biological control discussed above, and could result in an 
undesirable number of false positives. 
Panel E of Figure 5.2 summarises the experimental design chosen to best meet the primary 
aim of the project, a multiple "all-pans" sfrategy in which all comparisons of biological 
interest are direct. This sfrategy has less statistical confidence in inferring differences across 
the timecourse than the sfrategies outiined above, but has a much higher chance of detecting 
genuine changes in gene expression due to Shh, as it incorporates the use of pair matched 
biological control RNA produced in parallel with each treated sample. Strategy E also has a 
number of additional inherent advantages: each pair is effectively an experiment in itself and 
is unaffected by failed hybridisations of other pairs (which can be catastrophic in sequential or 
loop designs) and additional levels of replication could easily be added as more chips became 
available. 
Figure 5.2 Graphical representation of considered microarray experimental designs. 
Each arrow represents a dual colour hybridisation between the connected boxes. Each 
box represents an RNA sample. For simplicity replication is not indicated. U = 
untreated, R = common reference, T = transfection, M = conditioned media, subscript = 
days post treatment, c = pair-matched negative control. (A) Indirect comparison via 
common reference. (B) Indirect timecourse comparison to untreated cells. (C) 
Sequential timecourse comparison. (D) A possible loop design. (E) Multiple "all-pairs" 
direct comparison. (Display format as used by Kerr and Churchill, 2001b; Yang, Y. H. 
and Speed, 2002). 
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5.2.5 Chosen design incorporates effective biological pseudo-
replication at two independent levels 
It was known at the outset of this work that cDNA chips would be in extremely short supply, 
and that in a worst case scenario replication might be extremely limited. For this reason the 
experimental design chosen for experiments (Figure 5.2 Panel E) was particularly appealing, 
though it was recognised that independent validation of genuine target genes would be 
essential. In such a microarray sfrategy there is a high level of biological pseudo-replication, 
giving increased power to detect genuine downstream targets of hedgehog signalling. This 
pseudo-replication is present at two distinct levels. 
Firstly, the use of two different activation strategies, one using Shh transfection and the other 
using Shh conditioned media, complement each other in that genuine downstream targets are 
likely to be induced by both treatments. This may not exclusively be the case: the occasional 
real target may be induced in one, but not the other, due to differences in stimulation such as 
an effective higher Shh concenfration with conditioned media or due to timing differences, 
but in general it should be tme for a reasonable proportion of tme targets. Following such 
logic, if a particular spotted element shows a putative expression change with Shh 
transfection, and the same spot indicates an expression change with independent stimulation 
using Shh conditioned media, then it is highly probable that the corresponding gene is a 
genuine hedgehog target and not a false positive. 
A second level of biological pseudo-replication is provided by the fact that the pairwise 
comparisons involve sequential timepoints of the same freatment. Different targets are 
expected to show different response profiles over time. Some may be activated early in the 
response, and others may not change expression until later, in analogy with the results for Hip 
shown in Chapters. Some genes may have a distinct peak of expression that is only 
detectable at one timepoint while others may undergo an expression change that remains 
across the rest of the investigated timecourse once it is initiated. The latter has been the case 
for all the targets showing expression changes in Chapter 3, most noticeably Patched and Glil 
which are up-regulated by the second day post-transfection and for which the response 
continues to get stronger over the following days. It is reasonable to assume that a proportion 
of unknown targets will also follow a similar pattem. Indeed, this tumed out to be the case, as 
the results of this chapter show (see later sections). In such cases, different timepoints, 
particularly those late in the timecourse at three and four days, are loosely coupled at a 
5.3 Overview of experimental procedure 139 
Statistical level (non-independent). If a gene is up or down-regulated at two timepoints then it 
is likely to show as a putative target from both sets of hybridisations. 
These pseudo-replication factors can also be considered in combination. If lists of putative 
hedgehog targets, so called "lead genes", contain a particular gene that is implicated by both 
independent treatments, as well as by multiple timepoints within these treatments, then it is 
extremely likely that the sequence at that grid position represents a tme downstream target of 
the hedgehog pathway. Such biological pseudo-replication has recently been noted as 
advantageous by Yang, Y. H. and Speed, (2002), who termed it "effective replication" for 
microarray studies of an exploratory nature, which this project primarily is. 
As the microarray slides themselves were made up of two replicated blocks, the "half slides" 
can effectively be treated as technical replicates (Tsodikov et al, 2002). Fortunately, 
sufficient slides were eventually obtained to allow replication of each hybridisation, giving 
data from four independent spots for each cDNA element in each pairwise comparison. 
5.3 Overview of experimental procedure 
Preparation for microarray hybridisation requires many steps and the purpose of this section is 
to give an overview of the procedures used between the growth of cells and the generation of 
expression data, and the special care taken to avoid introduction of experimental bias. The 
section is not intended to provide detailed methods, for which the reader is referred to 
Chapter 8 (Materials and Methods). 
5.3.1 Minimising transcriptional differences unrelated to the 
biology of interest 
As outlined in Section 3,4, a mutant Shh constmct (pA64-Shh-N-PMT21) was created as a 
control constmct to use in parallel to transfections involving the Shh expression plasmid 
(pShh-N-PMT21). Likewise, the non-fimctional mutant was used to produce negative control 
media for complementary Shh conditioned media studies. The advantages of such a system in 
minimising transcriptional differences unrelated to hedgehog pathway activation have afready 
been discussed (refer Chapter 3). 
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RNA samples for microarray analysis were collected at 1, 2, 3 and 4 days post-transfection, 
and at 3 and 4 days post-treatment for conditioned media. "Time zero" for conditioned media 
studies was when the cells were at the same density as at the time of liposome addition in the 
transfection strategy. In each case the Shh treated lOTl/2 cells, and the corresponding 
negative control treated cells, were handled and manipulated in parallel at every step to 
minimise the chance of any non-hedgehog dependent expression differences. 
5.3.2 Microarray hybridisations and replication 
For every batch of transfected cells, and every round of conditioned media stimulation, glass 
coverslips from culture dishes were removed prior to harvest of the plates for RNA. At seven 
days post treatment these were assayed for AP activity to ensure that the treatment had been 
successfiil in terms of eliciting a strong Shh response, and that the confrol treated cells were 
indeed negative. RNA was processed in parallel for each Shh-control pair with the same 
procedure and solutions. 
Microarray hybridisation was carried out using standard procedures (refer Chapter 8). Six 
hybridisation experiments were initially performed, following the experimental design 
outlined in Figure 5.2 Panel E. At a later time additional cDNA chips were used to perform 
fiirther hybridisations to allow replication of each hybridisation pair. For the replicate 
hybridisations labelling was repeated independently on a different day. Hybridisations for all 
timepoints and treatments were successfiil, except for the second replicate at 48 hours for 
transfection stimulation, during which the array chamber leaked during hybridisation. 
5.4 IVIicroarray data analysis and prioritisation of 
lead genes 
5.4.1 Image acquisition and transformation to quantitative data 
Glass microarray slides were scanned for Cy3 and Cy5 fluorescence as stated in Chapter 8. A 
typical pseudocoloured image is presented in Figure 5.3, and shows the difference in 
hybridisation sfrengths encountered between the UniGene and NMEBA spotted regions. 
Image data for each hybridisation was converted to numeric signal strengths using the 
ImaGene package, as described in Chapter 8. 
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Predominantly NMEBA 
clone set 
Figure 5.3 Typical pseudocoloured microarray hybridisation image (whole chip and close up). 
In general, stronger signals were obtained from regions containing UniGene and 1MB 
clones than from those containing NMEBA clones. Each chip contained 3936 spots in 
duplicate. 
5.4.2 Analysis by spreadsheet calculation 
When data analysis was initiated the author did not have access to sophisticated data analysis 
packages, so normalisation and investigations of differential gene expression were performed 
manually using the spreadsheet program Excel (Microsoft, Redmond, USA). 
The final data set contained dual channel information from eleven hybridisations each 
containing 3936 spots in duplicate, giving 173184 data points to be analysed. For each data 
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point the ImaGene estimated local background was subfracted from the mean signal strength, 
giving the background corrected intensity for each channel. Normalisation was performed 
using a linear transformation whereby the data from each slide was scaled according to the 
total background corrected signal for all spots, such that the mean signal strength was equal 
for both chaimels. This procedure has recently been reviewed by Hegde et al, (2000) and 
Bilban et al, (2002). Such an approach has been used successfiilly by a number of research 
groups (Marton et al, 1998; Alizadeh et al, 2000; Roberts et al, 2000; Ross et al, 2000; Yue 
e^  a/., 2001). 
This global normalisation strategy is based on the assumption that although some spots will 
show intensity differences between the channels, the majority will not be differentially 
expressed, and fluctuations will average out when a large number of spots are investigated. 
Such a strategy would not be appropriate for a gene set with bias towards genes of putative 
interest to the biology being studied, such as when candidate genes of interest make up a 
considerable proportion of the elements on a particular chip. Since in this work the number of 
cDNA spots is relatively large, and the libraries spotted are not expected to contain many 
target genes, such a sfrategy is appropriate (Bilban et al, 2002). 
Figure 5.4 illustrates the effect of the procedure on data from a typical hybridisation, while 
Figure 5.5 shows the same data upon which spots representing genes later found to be genuine 
Shh target genes have been labelled, in order to illusfrate the usefiilness of visualising the data 
in graphical form. In practice it is also useful to prepare similar graphs on a logarithmic scale. 
Figure 5.4 Graphical illustration of microarray data normalisation procedures. 
Example shown is for a single replicate block of a typical hybridisation (Shh 4 day 
conditioned media freatment). (A) Raw signal sfrengths. (B) Data after correction for 
local background noise. (C) After global normalisation the data becomes approximately 
cenfred on a 45 degree line, such that non-differentially expressed genes yield a 
Cy5/Cy3 signal ratio near one. 
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Figure 5.5 Example of a post normalisation XY plot showing position of genes later verified as 
genuine downstream targets of Shh in lOTl/2 cells. 
The data shown is taken from the same example as that in the previous figure, and as 
such, represents a single block of a single hybridisation experiment (four day Shh 
conditioned media freatment). This is a close up of the bottom left quadrant of panel C, 
Figure 5.4. A number of data points are labelled, all of which correspond to sequence 
verified genes later found to be genuine targets of Shh signalling at the mRNA level. 
The validation of these genes is described in detail in Section 5.5. Four separate graphs 
of this type were able to be produced from the replicate hybridisation data for each 
freatment/timepoint combination. They provided a useful way to visualise the data, 
complementing the numeric analysis approaches undertaken. Note that multiple 
independent clones for some genes were present on the microarray chips. The two solid 
diagonal lines represent an arbifrary two fold change. 
At any particular snapshot in time a particular cell will only be expressing a subset of genes in 
the genome. This means that spots will be present on the arrays for which no expression data 
will be obtained, since a proportion of the clones will correspond to non-expressed genes. The 
signal obtained from such spots is made up entirely from noise inherent to the procedure, and 
attempts to calculate ratios from such numbers are extremely misleading. To filter such 
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non-informative genes from the analysis a threshold was set two standard deviations above 
the average background signal, in accordance with Hegde et al, (2000) and Li, X. et al, 
(2002). Assuming the data is normally distributed such a filter would be expected to remove 
over 97 percent of data corresponding to spots representing non-expressed genes. 
Unlike Hegde et al, (2000) and other groups which filter data such that only spots with 
intensities above the threshold on both channels are considered for fiirther analysis, this work 
considered spots of interest if either of the two channels was above the threshold. The reason 
for this was that the former approach results in loss of data for genes which show a dramatic 
expression change whereby the expression of a gene is not detected on one channel, but is 
highly expressed on the other. Such genes are of particular interest to this work; however, it 
was imperative that such data was noted simply as showing "extreme" differential expression, 
rather than trying to infer accurate fold change estimates for any such spots. Ratios in such 
cases are numerically meaningless, being composed of large number divided by a near zero 
noise derived value. Ratios were considered meaningful when both signal strengths were 
above the two standard deviation threshold. 
Ratios were calculated by dividing the normalised filtered data for the Cy5 channel, which 
represented the Shh treatment in each case, by the corresponding Cy3 data, which represented 
the reference channel. Thus for ratios presented in the remainder of this thesis numbers above 
one represent Shh induced genes, and numbers below one represent Shh repressed genes. 
The average fold induction or repression for each treatment timepoint was calculated as the 
geometric mean of the four replicate ratio data points in each case (or frirther information on 
the use of the geometric mean refer Appendix A). Using logic statements in conjunction with 
the Excel auto-filter and conditional formatting commands it was possible to generate lists of 
genes meeting particular expression criteria, and to explore similarities in the sets of induced 
and repressed genes occurring at multiple timepoints, or with both treatment strategies. 
5.4.3 Prioritising microarray generated lead genes 
It was the intention from the outset of the project that no genes would be considered genuine 
targets of Shh signalling until they had been verified by an independent methodology. This 
then posed the question of which genes should be considered the highest priority for 
undergoing the validation procedure, which was labour intensive. 
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Spotted clones were given the highest priority for further investigation if they met one of the 
following criteria: 
1. A geometric mean greater than 3 or less than 0.33 for any timepoint of either 
Shh treatment method. 
2. A geometric mean greater than 2 or less than 0.5 for any timepoint with both 
transfection and conditioned media stimulation methods. 
3. A geometric mean greater than 2 or less than 0.5 at two or more timepoints 
with either Shh treatment methodology. 
Genes not aheady chosen were given the next level of priority if they met one of the 
following criteria: 
1. A geometric mean greater than 2 or less than 0.5 for any timepoint of either 
Shh treatment method. 
2. A geometric mean greater than 1.5 or less than 0.67 for any timepoint with 
both transfection and conditioned media stimulation methods. 
3. A geometric mean greater than 1.5 or less than 0.67 at two or more 
timepoints with either Shh treatment methodology. 
Finally, where time permitted, some genes were also investigated that had a geomefric mean 
greater than 1.5 or less than 0.66 at a single timepoint of either Shh freatment, where the 
signal sfrengths of each channel were well above the two standard deviation noise threshold. 
Such genes were often found to be false positives, showing such criteria were nearing the 
statistical limits of the project with the small number of replicates that were able to be 
employed. Lists of prioritised clones attained with the above criteria are given in 
Appendix Bl. Appendix B2 shows a data matrix approach used to highlight clones showing 
apparent differential expression in multiple treatments or timepoints. 
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5.4.4 Analysis with the GeneSpring software package 
During the validation phase of the project access to the specialist microarray analysis software 
GeneSpring (Silicon Genetics; Redwood City, USA) became available. This was used to 
explore the 173184 data points to see if findings were comparable to those uncovered with the 
"by hand" Excel analysis. GeneSpring allowed complex normalisation and filtering, and 
generally indicated the same key cDNA spots highlighted by the previous spreadsheet 
analysis. Per-spot normalisation was used to calculate ratios, using background corrected 
signals normalised using the median of the distribution of all genes as a synthetic positive 
control. 
Importing of the ImaGene generated numeric data into GeneSpring was hindered by 
differences in the output format caused when the available version of ImaGene was upgraded 
during the work. The particular format of the gene identification and spot location file 
obtained from the manufacturers of the microarray chips was interpreted slightly differently 
between the two versions, such that GeneSpring was unable to directly interpret gene names 
from both version outputs as being from the same spot when this was the case. This problem 
was overcome through collaboration with D. Ingram, who kindly created software specifically 
to address this issue. "ArrayPolisher" allowed ImaGene outputs in any format to have 
colunms of interest specified by a user extracted automatically. Spot identifiers were 
converted to a common format regardless of there origin in accordance with grid position 
information supplied as a text file. The use of this software, "ArrayPolisher", gave the added 
bonus that as errors in spot identity were uncovered by sequencing, they could be corrected in 
an automated fashion in the ImaGene output files that had already been created, without the 
need for extensive manual editing or re-processing of images. A second application, 
"ArrayJoiner", allowed rapid pair-matching of data from the two channels of any particular 
experiment and their assembly into a single text file in an automated fashion. This program 
used components of the original file names as a matching key, and greatly reduced the chance 
of human error in pair-matching data for importation into GeneSpring, and greatly simplified 
the process. 
One notable difference in the exploration of the data with GeneSpring and the analysis of data 
by hand was that the in-built expression level ("noise") filter for GeneSpring used a restrictive 
one-sided approach, based upon whichever of the chaimels was defined as the "confrol 
channel" when loading an experiment. This meant that any genes showing extreme down-
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regulation by Shh were easily identified, but genes showing extreme up-regulation were 
discarded as poor data, as the signal on the control channel was below the threshold. Since the 
aim of this project was to identify both up and down-regulated genes this required loading the 
data in reverse, if using the in-built normalisation options, or creating custom filters to explore 
the data with a two sided approach to avoid missing these highly differentially regulated 
genes. Clones of interest not already identified by the spreadsheet approach, were added to 
lists of clones for validation. In addition, the GeneSpring approach allowed variation between 
replicate data points to be taken into account in prioritising clones for investigation using its 
inbuilt t-statistic based tests. 
5.5 Confirmation of genuine targets of Shh 
Since microarray analysis of differential gene expression came to the fore in the mid 1990s a 
substantial number of studies have been published in which findings have not been verified by 
an independent methodology, or for which only a proportion of the findings have been 
independently confirmed. 
In the authors opinion "stand alone" microarray findings can only be considered conclusive if 
the following criteria are met: 
1. There are a sufficient number of biological and technical replicates to 
identify significant expression differences with a high level of statistical 
confidence. 
2. That the clones that make up the arrayed elements come from a sequence 
verified set. 
3. That contamination does not occur in the bacterial clone sets during 
handling and replication at any time after sequence verification has been 
undertaken. 
4. There is no contamination during PCR amplification that could lead to 
mixed products being gridded onto the microarray slides. 
5. That gridded cDNA sequences do not contain motif regions that could give 
misleading results due to cross-hybridisation with other related genes. 
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6. There are no human errors leading to incorrect co-ordinates for the gridded 
elements (for example arising from incorrect labelling or positioning of 
plates for robot pickup, wrong physical orientation of multi-well plates or 
slides, or errors in data file generation). 
Though the first point can be addressed by good experimental design, the remaining issues are 
much harder to control, especially if the chips are provided by a third party (as is the case in 
this work). From the work undertaken in the remainder of this chapter it became apparent that 
a number of the above criteria were not met for the chips used for this work. For this reason, 
and from a standpoint of good scientific practice, a vigorous validation procedure was used to 
ensure only genuine downstream targets of the hedgehog pathway were reported and false 
positives eliminated. 
5.5.1 Identity of many microarray clones not as expected 
Clones corresponding to gridded elements of interest were ordered from the 1MB microarray 
facility and supplied as plasmid containing bacterial cultures inoculated from the glycerol 
plates used to provide template for the PCR reactions during chip manufacture. Unfortunately, 
in some cases clones were unable to be obtained. Clone management, sequencing and 
database searching were as outlined in Chapter 8. 
During the sequencing of clones corresponding to microarray spots of interest it became 
apparent that many did not match the accession numbers and descriptors provided by the chip 
manufacturers for their grid positions. This problem was worst with the UniGene clones, for 
which 16% of the sequenced clones had errors in there expected identity. There were also a 
number of discrepancies in the plasmids obtained corresponding to the "in-house" genes of 
interest. In contrast all clones obtained from the NMEBA set were as expected, and this 
probably reflects the fact that this "young" library was only recently obtained from the 
laboratory in which all clones were sequence verified, and had only undergone minimal 
manipulations since arrival. 
The discrepancies in expected identity could have arisen from any of the following events: 
1. Errors or mix-ups in the initial sequencing conducted by original suppliers 
of clones, or in their subsequent data management. 
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2. Mix-ups in plate identity, position or orientation during robotic replication 
of the master plates. 
3. Cross-contamination of bacterial clones during any replication or liquid 
handling steps. 
The presence of such discrepancies highlights the importance of sequence verification of 
genes of interest. Without such measures completely irrelevant genes could be credited as 
responses to hedgehog signalling. 
Upon sequencing several lead gene clones were found to be chimeric, containing sequence 
from the expected gene at one end but an entirely unrelated gene at the other. This highlights 
the importance of sequencing clones from both ends, since chimera can occasionally occur 
during the construction of cDNA libraries. Such inserts were split into two probes and 
hybridised separately to northem blots ensure the correct gene was credited with any 
response. 
5.5.2 Confirmation strategy 
In order to assess whether apparent differential expression changes were indeed genuine 
responses to hedgehog signalling, genes were analysed using a vigorous confirmation 
procedure. Lead genes (meeting the criteria established in Section 5.4.3) were only considered 
bona fide downstream targets of Shh if they passed both of the following validation criteria. 
1. Significant induction or repression by northem blot analysis (as assessed by 
GAPDH normalised densitometry of autoradiographs) of RNA samples 
from cells treated independently to those used for microarray analysis for at 
least one fransfection and/or conditioned media timepoint. 
2. Significant induction or repression replicating the above findings on 
additional northem blots for which RNA was obtained from cells 
transfected with second independent preparations of the Shh expression and 
control plasmids, or with conditioned media from an independent batch 
produced similarly. 
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More than 70 genes were used as probes in the first round of the northem blotting 
conformation procedure. Many were false positives (without a detectable change in mRNA 
level with either treatment at any investigated timepoint) and were not investigated further. In 
cases where there was any doubt in the interpretation of the results, or the response was 
subtle, a further RNA blot from cells treated with independently produced conditioned media 
was probed (RNA purification, electrophoresis and transfer for this particular blot was 
performed in conjunction with K. McCue). In general identified responses were more 
dramatic with conditioned media compared with direct transfection. On rare occasions when 
the northem bands for a particular gene were faint even after long exposure, the hybridisations 
were repeated with poly(A)"^ northem blots to obtain a better signal for densitometry analysis. 
Clones that represented genes already investigated in Chapter 3 {GUI and Bmp4) were not 
explored fiirther. Although several independent spotted clones were present on the chips for 
Patched none of these spots hybridised successfully. Since Patched has been shown to be 
very highly expressed after hedgehog treatment in the RNA samples used this suggests some 
spots were of low quality on the chips, and had suffered either poor PCR amplification or 
problems during slide printing. 
5.5.3 Validated downstream targets of Shh in pluripotent 
embryonic mesoderm 
Northem blot screening of lead genes implicated from the microarray experiments led to the 
discovery of eleven hedgehog responsive genes that passed all the validation criteria given 
above. Seven of the newly identified genes are induced {Thrombomodulin {Thbd), 
Glucocorticoid induced leucine zipper {Gilz), Brain factor 2 {Bf2), Nuclear receptor 
subfamily 4, group A, member 1 {Nr4al), Insulin-like growth factor 2 {Igf2), Peripheral 
myelin protein 22 {Pmp22), Um and SH3 Protein 1 {Laspl)), and four are repressed by Shh 
{Secreted frizzled related proteins 1 and 2 {Sfrpl and Sfrp2), Macrophage inflammatory 
protein-1 gamma {Mip-ly), and Anti-mullerian hormone {Amh)). Summary data for both 
microarray and northem blot estimates of fold change for these genes are shown in Table 5.1 
for four day transfection and four day conditioned media timepoints, which generally 
represent maximal responses. It is interesting to note that in this work the microarray data 
tended to give a lower estimate of fold change than northem blots. The cause and implications 
of this are discussed in Section 5.6.6. A more detailed summary of fold change microarray 
data for individual clones at specific timepoints is included in Appendix B. 
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Table 5.1 Downstream targets of Shh in lOTl/2 cells as identified by microarray approach 
and confirmed by northern blotting. 
T = transfection, CM = conditioned media. Fold changes shovra are geometric mean of 
normalised microarray ratios (MA) or northem blot densitometry data after 
standardising to a GAPDH loading control (Nth). N/A indicates signal strength below 
noise threshold at timepoint. Values in brackets indicate data range (min,max) from 
microarray analysis. "-" indicates down-regulation. A value of one represents no 
change. 
A) Downstream targets induced by Sonic hedgehog 
Gene Induced by Sonic Hedgehog 
Glucocorticoid induced leucine 
zipper {Gilz) 
Brain factor 2 {Bf2) 
Thrombomodulin (Thbd) 
Nuclear receptor subfamily 4, 
group A, member 1 {Nr4al) 
Insulin-like growth factor 2 {Igf2) 
Peripheral myelin protein 22 
{Pmp22) 
Lim and SH3 protein 1 {Laspl) 
Function 
Putative transcriptional 
regulator; protein-protein 
interactions 
Winged helix/forkhead 
transcription factor 
Membrane receptor; regulation 
of blood coagulation; putative 
growth factor 
Orphan nuclear receptor; 
putative transcription factor 
Regulation of somatic growth 
and cellular proliferation 
Myelination in the peripheral 
nervous system; putative 
growth factor 
Binds actin; role in signalling 
pathways organising 
cytoskeleton 
4dayT 
MA 
1.9 
(1.2,3.0) 
1.9 
(1.7,2.1) 
2.2 
(1.3,3.3) 
3.8 
(2.0,8.3) 
N/A 
N/A 
1.6 
(0.4,9.1) 
Nth 
3.8 
4.3 
3.3 
1.7 
2.5 
2.0 
1.1 
4 Day CM 
MA 
3.3 
(2.1,5.3) 
2.2 
(1.2,3.9) 
2.6 
(1.8,3.6) 
1.5 
(1.3,1.7) 
3.1 
(2.0,3.6) 
1.8 
(1.5,1.9) 
1.9 
(1.7,2.3) 
Nth 
7.4 
6.6 
6.7 
1.4 
7.8 
2.9 
2.0 
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Table 5,1 continued... 
B) Downstream targets repressed by Sonic hedgehog 
Gene Repressed by Sonic 
Hedgehog 
Secreted frizzled related protein 1 
{Sfrpl) 
Secreted frizzled related protein 2 
{Sfrp2) 
Anti-Mullerian hormone {Amh) 
Macrophage inflammatory protein-
1 gamma {Mip-If) 
Function 
Wnt signalling 
antagonist/regulator 
Wnt signalling 
antagonist/regulator 
TGFp family glycoprotein; 
regression of mullerian duct 
Chemokine; pyrogen 
4dayT 
MA 
-9.4 
(-6.1,-14) 
-6.8 
(-2.1,-15) 
-5.9 
(-5.5,-6.3) 
-5.8 
(-1.7,-3.0) 
Nth 
-6.3 
-6.7 
-6.1 
-2.2 
4 Day CM 
MA 
-3.8 
(-3.2,-5.7) 
-4.6 
(-1.7,-14) 
-3.5 
(-2.3,-6.2) 
-2.5 
(-1.8,-4.3) 
Nth 
-4.1 
-19.0 
-6.1 
-3.8 
Notes on interpretation: The microarray results shown summarise data from multiple 
spots in cases where independent clones representing a particular gene were present on 
the chips. Only data points passing visual inspection on image files and numerically 
above noise threshold filters on both channels were included in calculations. Noise 
threshold for this display data is less stringent than that used for the initial screening 
procedure. Individual data point ratios of high trust in direction but low trust in actual 
magnitude (where the numerator represented a high signal but the denominator was 
below the noise threshold for a particular spot, leading to an extreme ratio) are not 
included in the displayed geometric mean or range. In this regard the microarray values 
shown represent conservative estimates of fold change. 
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Validated targets were identified from within all three sets of genes present on the 
microarrays, with data for Gilz, Bf2, Igf2 and Sfrp2 obtained from multiple independent clone 
spots. Clones for Gilz, Bf2 and Sfrp2 were present in both the NMEBA and UniGene sets. 
Only Pmp22 was identified exclusively from the NMEBA set. The Shh targets showed 
detectable expression changes in the range of two to four days, with the majority of the genes 
showing a detectable response at three days. No northem blot validated target responses were 
identified at twenty four hours. As with known targets investigated in pilot studies, the earliest 
observed responses appear to correlate with the time the cells form a confluent monolayer. 
Figure 5.6, Figure 5.7, Figure 5.8, and Figure 5.9 show northem blot hybridisation results for 
the induced and repressed target genes. The Shh induced genes tended to show increased 
changes in differential expression as the timecourse progressed. The two Shh repressed SFRP 
genes had an interesting response profile, and behaved in a similar fashion to each other. In 
the absence of Shh these two genes showed an increase in expression level with increasing 
cell density or time in a monolayer environment. Upon stimulation with Shh, this increase in 
expression over time was inhibited (Figure 5.6). A number of the gene probes bind multiple 
transcripts on northem blots, though in all cases there was an obvious primary transcript of 
the size expected from the literature and/or apparent fiill cDNA clones in the GenBank 
(NCBI) database. A number of such genes also displayed apparent differential expression of 
one or more of these minor transcripts in response to Shh (as is the case for Sfrpl, Sfrp2, 
Mip-ly and Gilz). The biological implications of the findings are addressed in detail in 
Chapter 7. 
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Figure 5.6 Northern blots of validated downstream targets of Shh in lOTl/2 cells (1). 
RNA obtained from lOTl/2 cells transfected with pShh-N-PMT21 (Shh-N) or pA64-
Shh-N-PMT21 (Mutant) plasmids, or treated with conditioned media collected from 
cells expressing the same constructs (independent experiments to those used for 
microarray investigations). GAPDH probe provides loading control. Peripheral myelin 
protein 22 (Pmp22), Brain factor 2 (Bf2) and Glucocorticoid induced leucine zipper 
(Gilz) show up-regulation, whilst Secreted frizzled related protein 1 and 2 (Sfipl and 
Sfip2) show an inhibition in the increased expression level observed in control cells 
over time. 
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Figure 5.7 Northern blots of validated downstream targets of Shh in lOTl/2 cells (2) . 
RNA obtained from lOTl/2 cells transfected with pShh-N-PMT21 (Shh-N) or pA64-
Shh-N-PMT21 (Mutant) plasmids, or treated with conditioned media collected from 
cells expressing the same constructs (independent experiments to those used for 
microarray investigations). GAPDH probe provides loading control. Thrombomodulin 
(Thbd) and Lim and SH3 Protein 1 (Laspl) show up-regulation. The maximum fold 
change for Laspl by GAPDH normalised densitometry for the blot shown above was 
2.0 fold at the 4 day conditioned media timepoint. Though the response of Laspl is 
subtle it was reproducible on multiple independent northem blots and is considered 
genuine. 
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Figure 5.8 Northern blots of validated downstream targets of Shh in lOTl/2 cells (3). 
RNA obtained from lOTl/2 cells transfected with pShh-N-PMT21 (Shh-N) or pA64-
Shh-N-PMT21 (Mutant) plasmids, or treated with conditioned media collected from 
cells expressing the same constructs (independent experiments to those used for 
microarray investigations). GAPDH probe provides loading control. (A) Nuclear 
receptor subfamily 4, group A, member 1 (Nr4al) is up-regulated by Shh. (B) Insulin-
like Growth Factor 2 (Igf2) is up-regulated by Shh. 
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Figure 5.9 Northern blots of validated downstream targets of Shh in lOTl/2 cells (4) . 
RNA obtained from lOTl/2 cells transfected with pShh-N-PMT21 (Shh-N) or pA64-
Shh-N-PMT21 (Mutant) plasmids, or treated with conditioned media collected from 
cells expressing the same constructs (independent experiments to those used for 
microarray investigations). GAPDH probe provides loading control. Top row illustrates 
the observed down-regulation in Macrophage inflammatory protein-1 gamma (Mip-ly), 
and middle row shows down-regulation of Anti-Mullerian hormone (Amh), in response 
to Shh. Some additional bands are observed with Mip-ly, and these may represent 
minor transcripts that also appear to show some degree of down-regulation. 
5.5.4 A number of lead genes eliminated as false positives by 
validation procedure 
The northem blotting validation procedure was successful in identifying a number of genuine 
targets of hedgehog signalling, as well as leading to the rejection of a number of lead genes 
meeting the criteria of Section 5.4.3. Genes were prioritised so that those with the most 
dramatic responses were analysed first, followed by genes with more moderate apparent 
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differential expression. As envisaged a number of the lead genes showing small changes and 
observed only at a single timepoint tumed out to be false positives. 
Surprisingly, a number of clones of interest tumed out to be false positives when 
independently checked by northem blotting even though showed highly convincing 
microarray data. Some of the corresponding spots gave microarray data indicating strong 
differential regulation for every data point on every slide for several timepoints with both 
conditioned media and transfection stimulation. It is hard to explain such conflicting data by 
chance variation alone. Such genes give consistent high quality microarray data indicating 
substantial differential regulation, but this cannot be replicated by northem blot with either 
stimulation by transfection nor conditioned media addition. The implications of this are 
discussed in Section 5.6.5. 
5.5.5 Insights from a gene rejected at late stages of the validation 
procedure 
The strict validation procedure outlined in Section 5.5.2 included not only the investigation of 
RNA preparations obtained from cells treated independently to those used for microarray 
studies, but also from further independent samples stimulated with different preparations of 
the transfection plasmids. This was done to ensure that differences in gene expression caused 
by impurities in one of the pair of plasmid preparations would not be incorrectly interpreted as 
being due to hedgehog. This stringent validation procedure proved to be pmdent, as illustrated 
in the case described below. 
Analysis of microarray data from the twenty four hour transfection timepoint indicated a 
strong induction of the gene Early growth response 1 {Egrl), for which two independent 
clones were present on the microarray chips. This induction was confirmed by northem 
blotting, and was only seen early in the timecourse (twenty four hours and earlier). If tme this 
would represent a very early response occurring prior to cell confluence. 
The primary validation result with Egrl aroused suspicion since the induction was strong by 
transfection but did not occur with conditioned media at the timepoints investigated. When 
Egrl reached the final stage of the validation procedure, which involved checking the 
response on northem blots for which independent plasmid preparations were used for 
stimulation, the response could not be reproduced. This suggests that the differential 
expression observed on the microarrays and initial northem studies was not due to hedgehog 
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but rather was an artefact caused by a factor present in one of the initial plasmid preparations. 
This highlights the importance of the stringent validation procedures without which the gene 
described above would have been erroneously reported as a downstream target of Shh. 
It is of interest to note that three other genes passed some but not all of the validation criteria, 
showing apparent regulation on northem blots of some stimulation experiments. There still 
exists the possibility that these genes {Brain-derived neurotrophic factor {BDNF), Tenascin-C 
and Thymopoietin) may be genuine targets of hedgehog with subtle expression changes, but 
they are not reported as Shh target genes as there is currently insufficient evidence to classify 
them as such. Unlike Egrl these genes showed apparent subtle induction with both 
conditioned media and transfection on microarrays and in the primary round of northem blot 
validation. However, no significant changes were observed on secondary northems from 
independent experiments. This thesis takes a conservative approach where targets must pass 
all validation procedures before being classified as genuine and as such these genes have not 
been included in the lists of bona fide Shh targets reported in this work. 
5.6 Discussion 
In summary, microarrays containing 3936 clones from a normalised mouse embryonic 
branchial arch (NMEBA) library, the mouse UniGene set, and a number of other known genes 
were screened. Pair-matched experiments were conducted with Shh-N and a null-mutant 
control to obtain RNA for microarray analysis at 24, 48, 72 and 96 hour timepoints for cells 
stimulated by transient Shh transfection, and at 72 and 96 hours for cells treated with Shh 
conditioned media. Conditioned media experiments complemented the transfection studies to 
maximise the chances of target gene discovery and provide a fiirther level of confirmation for 
Shh responsive genes. Twelve microarray experiments were performed, with two dupHcate 
RNA samples hybridised to slides at each timepoint for both conditioned media and 
transfection studies. Each slide contained two duplicate sets of the spotted clones, positioned 
in separate blocks. The null-mutant control constmct was designed so that the cell would 
produce a near fiill length Shh-N mRNA but a highly truncated protein. This was used rather 
than an empty vector control to ensure the general transcription and translation mechanisms of 
the cells were stimulated in both the reference and test RNA populations, minimising false 
positive results. This section discusses the success of this approach as well as its limitations 
with respect to the identification of new Shh target genes. 
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5.6.1 Success of the microarray approach in hedgehog target gene 
discovery 
In this work cDNA microarrays have proved an extremely powerfiil tool for the discovery of 
downstream targets of Shh. The technique allowed a large number of genes to be screened, 
and validation of leads by northem blotting established eleven targets of Shh stimulation in 
lOTl/2 cells. Seven of these were induced {Thbd, Gilz, Bf2, Nr4al, Igf2, Pmp22 and Laspl), 
and four were repressed by Shh {Sfrpl, Sfrp2, Mip-ly and Amh). The majority of these 
represent novel downstream genes not previously reported as targets of Shh. The newly 
identified genes, their fiinctions and relevance to hedgehog signalling are discussed in detail 
in Chapter 7. All of the newly identified targets are known genes present in the GenBank 
database. 
The work presented in this Chapter highlights both the success of microarray technology and 
the validity of the lOTl/2 cell line as a model system for hedgehog target gene discovery. 
5.6.2 Corroboration of previously identified hedgehog targets 
Several target genes discovered by the microarray approach have previously been described in 
other systems. Igf2 is implicated as a Hh target due to its elevation in rhabdomyosarcoma and 
normal tissue from Patched knockout mice (Hahn et al, 2000). The corroboration of such 
findings further validates the lOTl/2 model system. Sfrpl and Sfrp2 have previously been 
reported as targets in presomitic mesoderm where both genes are induced by Shh (Lee, C. S. 
et al, 2000). In contrast, Shh inhibited the expression of both genes in lOTl/2 cells, showing 
that target genes may respond differently in different tissue contexts, presumably under the 
control of additional factors. 
5.6.3 Additional putative Shh target genes 
It is important to note that some genes present on the chip but not listed in the tables of 
validated targets above may still respond to hedgehog stimulation. This work has deliberately 
been biased toward investigating the genes which gave the most dramatic changes by 
microarray, and some clones not yet followed up may display subtle changes in response to 
hedgehog that are below the 1.5 fold microarray cut off Such responses may still be 
biologically important, however their discovery would best be met by further microarray 
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Studies with larger clone sets and a large degree of replication to obtain highly robust data for 
a specific timepoint of interest. 
Secondarily, a number of microarray spots with promising data have not yet been 
investigated. Some of these are already known from other work to be highly expressed in 
lOTl/2 cells, and the trend has been that such genes are frequently found to be false positives. 
Some other clones of interest have not been independently validated due to time constraints, 
and conservatively have not been included in this work as genuine targets of Shh, though 
ftiture studies may show them to be so. 
5.6.4 Limitations of the experimental approach and importance of 
validation 
Through the use of microarray technology a number of new targets of the hedgehog pathway 
have been able to be identified, however it is important to note there are limitations to this 
approach. 
An inherent danger in using a transfection system with a microarray approach is that any 
contaminating substances (for example E. coli products not fiilly removed during plasmid 
preparation) may be present in unequal amounts in control and treatment plasmid stocks. In 
addition, differences in the demand on the machinery of the cell in producing the encoded 
product could be reflected in gene expression differences unrelated to the treatment of 
interest. In this study risks were minimised by using several plasmid preparations of each 
constmct for independent confirmation experiments, and by utilising a negative control 
constmct that still forced the cell to produce a near fiill length mRNA and have this translated 
into protein, albeit in a shortened form. Stimulation with conditioned media was used to 
complement and fiirther control the transfection studies. It generally gave a much stronger 
target response than transfection and enabled some targets with subtle transfection changes to 
be identified, that would otherwise not have been pursued. 
As reported in Section 5.5.5 the procedures put in place to prevent erroneous classification of 
genes regulated by biological factors other than Shh itself have proved pmdent, with one 
"single DNA preparation" induced gene being detected and rejected. This highlights the 
importance of strict confirmatory measures to ensure putative targets from microarray studies 
are indeed genuine responses to the treatment of interest. The stringent confirmation 
procedures also led to three other genes being rejected late in the validation process. These 
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genes showed some significant but small changes in some but not all procedures, and unlike 
Egrl showed an apparent response to conditioned media in one experiment. It remains a slight 
possibility that these genes represent real targets with a subtle response but to commit 
resources to them and engage in fiirther experiments in order to mle conclusively was not 
possible given time consfraints. The question would most efficiently be addressed by 
including them on new microarray slides for reassessment in future studies with sufficient 
replication to detect subtle changes. 
A number of problems were encountered with the microarray chips and associated clone sets 
used in this work. In particular, the UniGene clone set spotted on the microarrays used in this 
study was found to have approximately 16% of clones for which the plasmid present did not 
match its expected identity. Similar observations with arrayed cDNA clone sets have been 
reported by other researchers (Halgren et al, 2001). It was therefore cmcial to individually 
sequence and validate pure plasmid species from each clone of interest to determine tme 
identities. 
In retrospect, it may have been pmdent not to obtain single pure streaked colonies of each 
supplied clone, but rather to prepare multiple plasmids preparations from a number of isolated 
colonies for every supplied clone. Though laborious, this would have been useful in cases 
where strong differential expression was observed for spots for which the expected clone at 
that position was found not to be responsible, allowing the possibility of identifying 
contaminating clones that may have been tme target genes. 
Another complication was a high rate of false positives from the microarray experiments, 
even when the supplied clone sequence matched its expected identity at the particular spot 
position. Some spots that consistently displayed dramatic changes in gene expression at 
multiple timepoints, each with multiple replicate chips, and with both transfection and 
conditioned media stimulation, showed no detectable changes in expression by northem blot. 
This could be due to signal resulting from an undetected contaminating species, for example 
contaminating plasmid in the PCR reaction step of chip manufacture. Such problems lead to 
the undesirable situation where unexpected PCR products end up at a particular microarray 
locus. Altematively, such problems may be due to human errors in the provided spot position 
information. This highlights the danger in microarray experiments of presenting data not 
validated by an independent methodology, and hence only sequenced genes showing 
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consistent and repeatable induction or repression, confirmed independently by northem 
blotting, are presented as Shh targets. 
One limitation of the work presented in this thesis is the small number of replicate 
experiments performed, which were limited by the scarcity of suitable microarray chips at the 
time the work was initiated. Had more chips been available then hybridisations with dye 
swaps and more technical and biological replication could have been performed to obtain 
better estimates of expression level differences between hedgehog treated and confrol cells. 
The number of replicates used (two slides each with fiilly duplicated spot sets, giving four 
data points in each situation) is however in accordance with the recommendations of 
Grimmond and Greenfield, (2001). Other statistical research indicates that at least three 
repUcates should be performed for every hybridisation in order to gain robust data suitable for 
subtle data mining (Lee, M. L. et al, 2000), however the scarcity chips made this impossible. 
It is important to note however that lower levels of replication are often adequate when all 
results are followed up with an independent verification methodology (Yang, Y. H. and 
Speed, 2002), as is the case in this work. As outlined in Section 5.2.5, it was considered 
advantageous in this work not to use all the chips available to gain exfremely robust data for a 
single timepoint, but rather to employ biological pseudo-replication across a timecourse to aid 
in lead gene identification, and to minimise the risks associated with concenfrating all 
resources on a single timepoint in terms of the biological responses that may or may not be 
occurring at a particular time. This approach proved successfiil. 
Another limitation is that the methods employed in this study for prioritising clones based on 
absolute cut offs for fold change are overly simplistic. Statistically such cut offs are not ideal 
as the magnitude of fold change that can be detected with high confidence is different for 
genes expressed at different intensity levels (Tsien et al, 2001). For example, a fold change of 
two may be easy to identify in a highly expressed gene, but for lowly expressed genes noise 
and measurement error has a greater effect and such a fold change may not be meaningfiil. 
Nevertheless many researchers use arbitrary cut-offs, largely because statistical research on 
appropriate altematives is still in its infancy and many of the methods proposed to address this 
issue are mathematically complex. In this study statistical software for microarray analysis 
was not available until well into the validation procedure, too late to be used extensively. 
Arbitrary cut offs were employed in the spread sheet analysis of the data but these were set 
relatively low, at 1.5 fold and 2 fold, and backed up with an extensive screening and 
validation procedure. This was a somewhat "bmte-force" approach leading to the 
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identification of a number of false positives, but was conservative in that it minimised the risk 
of false negatives (real targets being missed by setting the threshold too high). 
Selection and prioritisation of lead genes based upon replicate to replicate variabiUty is also 
an issue that was not addressed in statistical detail in this work. There is currently much 
interest in how variability in microarray data should be mathematically interpreted. Many 
"traditional" statistical measures like t-tests are not ideal for the analysis of array data because 
firstly they make parametric assumptions, and second they only make gene by gene estimates 
and ignore the large number of genes available for variance estimates. Additionally such 
methods tend to be overly conservative in the case of few replicates. A detailed review of the 
merits and deficiencies of published techniques for data analysis in replicated microarray 
experiments is provided by Pan, W., (2002). As discussed above, this work had only four data 
points per treatment per spot and such analysis was not particularly appropriate. Various 
published methods that use variance analysis in the interpretation of microarray data assume 
that little variation between replicates is a good thing and indicates robust data. This is 
commendable, however the work in this thesis suggests that such a philosophy may risk 
putting low emphasis on some differentially regulated genes which often have consistently 
extreme ratios but huge variability between replicates. How the spread of data is best taken 
into account in microarray analysis is still a matter of debate. In this thesis a cautious 
approach was taken whereby genes were considered of interest for validation even if replicate 
data points had considerable variation so long as the implied fold change was consistently 
high. 
5.6.5 Paradox of false positive genes with dramatic differential 
expression by microarray 
The high level of false positive lead genes rejected by the validation procedure, even when 
microarray data was extremely convincing (refer Section 5.5.4), was surprising. 
It is known that microarray data from any single hybridisation is subject to a large level of 
inherent experimental variation (Hoheisel and Vingron, 2000). One study found as many as 
five percent of genes can have no signal due to failures in labelhng or hybridisation steps. In 
addition false signals (so called "ghosts") have been estimated for as many as ten percent of 
spots from individual slides in confroUed studies (Lee, M. L, et al, 2000). However, given 
that four data points were available for any particular timepoint-treatment combination in this 
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work, the level of false positives obtained was much higher than anticipated. What was even 
more unexpected was that a number of these "false positive" genes had microarray data that 
was highly significant at multiple timepoints and with both conditioned media and 
fransfection stimulation (refer Appendix B2). Had these genes all had weak signals they could 
be explained by low intensity variability combined with a low cut off ratio (Tsien et al, 
2001), but this was frequently not the case. Such findings were hard to explain as "random 
variations" since some occurred with six or more independent hybridisations and involved 
cDNA spots of excellent morphology with sfrong reproducible signals. 
Putting aside the easily explained false positives that have relatively low signal strength, the 
presence of false positive clones that show highly significant differential expression by 
microarray analysis is of concem. This suggests a problem during chip production or errors in 
the grid location file supplied by the chip manufacturer. This would mean that the wrong 
clones would be provided for certain grid locations, such that certain genes may bear no 
relevance to the actual differentially expressed clones responsible for the differential 
expression seen by microarray. Another possibility is that one or more of the "genuine" Shh 
targets may have contaminated the "false positives" at some stage during chip manufacture. 
Either way these problems could not have been foreseen and were out of the author's control. 
After validation experiments were underway the chip manufacturer provided a new spot 
position file for the chips, after the discovery that the file initially given to the author had the 
wrong coordinates for 7.5% of the chip grid positions. Such a problem was unfortunate, and 
some clones with promising data (refer Appendix B) now remain unchecked since there was 
insufficient time to repeat the validations with the actual clones that corresponded to the spots 
of interest. All microarray data presented in this thesis and its appendices has been updated to 
take into account this correction. Evidence suggestive of additional errors in the grid position 
file or spot contamination comes from the fact that a number of negative confrol spots without 
DNA gave signals well above background, suggesting they actually contained some DNA. 
This finding reinforces the fact that any information gained from a microarray experiment is 
highly dependent on the quality of the chips used and the reliability of the grid position 
information supplied with them. 
It is also of interest that a number of "false positive" spots discovered in this work were foimd 
to correspond to genes that had extremely high basal expression by northem blot (summarised 
in Appendix B). This is most likely due to either inadequacies in the normalisation procedure 
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for coping with extreme data, or aspects of the hybridisation kinetics themselves with very 
highly expressed genes. 
5.6.6 The biological significance of microarray derived estimates 
of fold change 
One observation apparent from the estimates of fold change presented in Table 5.1 is that 
values from northem blotting generally appear higher than those obtained by microarray 
analysis. 
One important factor with respect to the studies in this thesis is that the fold change estimates 
were not made from the same RNA populations. Northem blots deliberately employed RNA 
from samples independent to those used for microarray investigation, and some degree of 
biological variation observed may be due to chance. 
Another reason for the differences in fold change estimates is the way in which the microarray 
averages were calculated. In the presented summaries only data points giving ratios of high 
tmst (those for which both channels had signal above the noise filter threshold on both 
channels) were included. In some cases many data points were excluded from the geometric 
mean as they were rejected due to the signal on one channel falling below the noise threshold 
(due to low expression), even though the signal on the other chaimel was highly significant 
(very high expression). When calculating a ratio in such cases one of the signals is a number 
near zero with a high noise component, and this tends to make ratios both extreme and 
untmstworthy. Clearly the information from such a data point is still very informative since it 
indicates a large degree of differential expression, however the actual magnitude of the 
change cannot be estimated with confidence. For this reason such data points were not 
included in the geomefric mean estimates of fold change included in Table 5.1. The net effect 
is that the presented data reflects a conservative interpretation of the microarray data, and 
could account for some differences between the microarray and northem blot estimates. 
Determination of the cut-off signal level ("noise threshold") for the data can have an influence 
on the final estimate of fold change for particular genes. As with most statistical problems 
there is no absolute answer as to how this should be determined. In this work the screening 
threshold was determined using the standard deviation of local background measurements as a 
guide to the disfribution of noise (refer 5.4.2), but there are also other ways such a signal 
sfrength could be determined. If the position of a noise threshold line is "high", less data 
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passes the noise filter and the average is calculated with less replicate data points. If the 
threshold is set "low", more data passes, allowing spots with smaller signals on the lowly 
expressed channel (and potentially more untmstworthy ratios) through the net. Genes such as 
Sfrpl and 2 were affected most by this phenomena as their response was the most dramatic of 
the target genes identified in this study. The important point here is that the expression 
threshold level can have a large effect on the interpreted average fold change for genes which 
essentially go from "on" to "off (or visa versa) in response to the treatment of interest, a 
calculation which is often meaningless in such situations anyway. 
Another issue that can have an influence on fold change estimates is the particular data 
normalisation strategy employed. The strategy used in the spreadsheet analysis used to 
generate leads for this thesis was relatively simplistic (refer 5.4.2). A more complex 
non-linear method may have been superior in terms of ratios most accurately reflecting the 
real biological situation, however the derivation and application of complex statistical 
algorithms for microarray data analysis is beyond the scope of this thesis. Even now as papers 
are beginning to be published solely on the statistical basis of microarray normalisation and 
prioritisation of lead genes there is debate as to which methodologies are most appropriate. 
It is also possible that microarrays may inherently underestimate ratios in some 
circumstances. To date the author knows of no extensive studies where microarray data has 
been compared to data obtained from fraditional methodologies where both have been 
conducted with a large enough number of biological and technical replicates to address this 
question with confidence. It is assumed that the kinetics of microarray hybridisation are linear 
with respect to target concenfration (such that ten times the amount of one labelled target 
bound to a spot compared to the other represents a ten fold difference in transcript levels in 
the original cells under comparison). Whether or not this actually holds tine for values over 
the flill range of signal detection is another issue that has not yet been extensively explored. 
To a large extent in this project, where the main aim was discovery of novel target genes, any 
discrepancy between microarray derived and "real" fold change, even if it does exist, is of 
little importance. In this work the goal was to detect genes showing significant and 
reproducible differential expression in response to Shh. The absolute magnitude of the 
response is much less critical. A gene undergoing a subtle change in response to hedgehog 
could end up having just as much influence on the consequent biology of a cell as a large 
expression change in a less important gene. 
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5.6.7 Inherent limitations of microarray technology 
The microarray approach outlined in this thesis has been successfiil in identifying a number of 
novel downstream targets of the hedgehog pathway, and as such has provided tools for fiirther 
investigation of the response. Additionally, the studies have demonstrated the power of the 
lOTl/2 cell line as a model system for hedgehog target gene discovery. The new information 
paves the way for fiiture microarray studies with chips representing a larger proportion of the 
genome. Though microarrays allow studies of the hedgehog pathway response to be 
conducted on a level never before possible, it must be noted that the technology itself has a 
number of inherent limitations. 
Firstly, the technology in its current form is limited to detection of the relative concenfration 
of franscripts present in the cytoplasm at harvest. Thus microarrays do not directly measure 
the level of transcription of a particular gene. Rather, they give the comparative information 
on the net level of a transcript that may also be influenced by other processes such as mRNA 
stability and degradation. Additionally cDNA microarrays are impervious to any effects of 
hedgehog stimulation that occur post-franscriptionally. 
There is increasing evidence that many genes have very short poly(A)"^ tails, and that some 
genes lack them altogether. Such genes are not only absent from many libraries gridded onto 
chips, but also are absent from the labelled target when oligo(dT) is used to prime reverse 
franscription (Hoheisel and Vingron, 2000). Additionally a large number of franscribed RNA 
molecules have biological fiinctions even though they not franscribed into proteins. It has 
been suggested that such molecules may make up more than half of the franscriptional output 
of cells, and that many such molecules are developmentally regulated (reviewed by Mattick 
and Gagen, 2001). Not only do such franscripts lack poly(A)"^ tails, but they may remain in the 
cell nucleus to carry out their fiinction. Such sequences are not only unlikely to find there way 
into gridded clone sets, but also would tend to be absent from the target populations since 
current microarray protocols employ cytoplasmic mRNA preparations. 
One inherent weakness of current microarrays comprised of sequences from cDNA libraries is 
that usually no attempt has been made to exclude clone sub-sequences containing common 
sequence motifs. If multiple genes with regions of sequence similarity or altemate transcripts 
of a single gene happen to have significant homology to a spotted DNA at a particular 
location the data will be superimposed. When a particular gene sequence, encoding a zinc 
finger for example, is gridded at a particular position how do we know the resulting 
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microarray data is from the original gene and does not contain a component of signal from 
another gene that just happens to have a similar zinc finger stincture? This is a confounding 
factor in microarray analysis that is often not considered in the literature. Such a potential 
problem provides even more reason to undertake a validation procedure such as northem 
blotting that will indicate cross-hybridization by giving multiple hybridising bands. If a band 
showing differential expression is not of the expected size for the franscript encoded in the 
spotted clone then this can indicate that the real response may actually be due to another gene. 
One factor in the researchers favour is that spotted clones are generally sourced from 
oligo(dT) primed expression libraries, and as such tend to contain a proportion of 3'UTR 
sequence which is far more discriminating than coding sequence. However, the proportion of 
UTR to coding material varies considerably, and many such clones still contain long sfretches 
of coding sequence. 
The information gained from any microarray experiment, no matter how well replicated and 
statistically robust the data gained from the experiments is, is only as good as the clone set 
gridded onto the arrayed chips. If the clone set does not contain genes of interest, then no 
information will be obtained from them. In the experiments outlined in this chapter the only 
chips available were relatively small, but had the advantage that 1920 of the arrayed clones 
were obtained from the NMEBA library. This library is highly enriched for developmentally 
important molecules, and contains a large number of clones corresponding to currently 
undescribed genes (Dr. L. Fowles; personal comm.); though to date all of the validated Shh 
target clones from this set represent known genes. 
Overall microarrays have proved an invaluable tool in the search for transcriptional targets of 
the Sonic hedgehog response, and have uncovered downsfream genes with a diverse range of 
putative functions. The majority of the identified targets are novel in that they have never 
before been implicated in the hedgehog pathway. Microarrays have allowed screening for 
such genes on a scale never before possible, without the need for any a priori biological 
implication of their involvement. The rapid expansion in microarray technology, both at the 
experimental level and of corresponding data analysis techniques, along with recent progress 
in genome sequencing and the bioinformatics field, promises much fiiture use of this 
technique in diverse areas of the biological sciences. Used in conjunction with the lOTl/2 
model system microarrays have lead to the identification of eleven genes which provide 
insight into the processes occurring during Sonic hedgehog induced differentiation of 
embryonic mesoderm. 
Chapter 6: Further Investigation into 
Regulation of Identified Hedgehog 
Target Genes and Related Family 
Members 
6.1 Introduction 
The investigations described in this chapter were undertaken with the aim of understanding 
more about the regulation of the newly discovered target genes by Sonic hedgehog. Studies 
were performed in order to explore the effect of Glil stimulation on the Shh regulated genes, 
and for one gene of particular interest the potential Shh regulation of related family members 
was explored. 
6.1.1 G/7z-related genes have previously been implicated in the 
hedgehog response 
Glucocorticoid induced leucine zipper {Gilz, D'Adamio et al, 1997), was identified in the 
present study as an up-regulated target of Shh signalling. In terms of sequence homology, it 
belongs to a group of genes known as the TSC-22 family. In mammals this family includes 
two other characterised members. Transforming growth factor p stimulated Clone-22 
{TSC-22, Shibanuma et al, 1992;, and TSC-22 homologue 1 {Thgl, called Thg-lpit in mouse, 
Kester et al, 1999; Fiorenza et al, 2001). A fourth and as yet unnamed human gene also has 
homology to regions of the above proteins (Kester et al, 1999). Members of the TSC-22 
family contain two distinguishing features: a leucine rich protein-protein interaction domain 
(the leucine zipper) and a highly conserved region of unknown fiinction, termed the TSC-22 
box. Members of this family can dimerise via their leucine zipper domains, either to 
themselves or to other leucine zipper containing proteins, and they are thought to act as 
franscriptional regulators (Kester et al, 1999). 
In Drosophila the TSC-22 family is represented by a single gene, bunchedlshortsighted 
(bunlshs), which is implicated in decapentaplegic {dpp) signalling in the developing eye, and 
is regulated in a Hedgehog dependant manner (Treisman et al, 1995; Dobens et al, 1997; 
Dobens et al, 2000). The mammalian homologue TSC-22 was recently reported as down-
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regulated by stable Glil expression in rat kidney cells (Yoon et al, 2002). Combined with the 
results of Chapter 5 that identify another bunlshs homologue, Gilz, as a Shh target, this makes 
the TSC-22 family of particular interest in terms of hedgehog pathway biology. The first part 
of this chapter outiines experiments investigating the response of TSC-22 family members to 
Sonic hedgehog in lOTl/2 cells. This was done to investigate whether other family members 
behave similarly to Gilz. 
6.1.2 Glil as a tool for further investigation of the regulation of 
genes downstream of Shh 
As discussed in Chapter 1, there is sfrong evidence to suggest that hedgehog signalling is 
frequently mediated by the Gli franscription factors, but this is not exclusively the case. The 
newly identified target genes in lOTl/2 cells were investigated to find out whether their 
overall franscript abundance is altered by an elevation in Glil protein levels. 
The reasons for undertaking this investigation were two-fold. Firstly, evidence for regulation 
by Glil would provide fiirther insight into the mechanism of control of the new Shh target 
genes mediated by hedgehog signalling. Secondly, any evidence of Glil regulation of any of 
the Shh targets would add fiirther weight to the conclusion that such genes are indeed genuine 
downsfream targets of the hedgehog pathway. The latter part of this chapter outlines 
preliminary investigations into Glil stimulation of lOTl/2 cells, and provides evidence that a 
number of the new Shh target genes are indeed regulated via this mechanism. 
6.2 GHz appears to be the only characterised 
TSC-22 family member regulated by Shh in 10T1/2 
cells 
All three characterised members of the TSC-22 family were investigated in the lOTl/2 system 
to see if there was any evidence for their regulation by Shh. A plasmid insert from the 
microarray clone set was used as the probe for Gilz, while probes for the other two 
characterised family members were obtained by RT-PCR (refer Chapter 8). While the 
induction of Gilz on microarrays and northem blots was strong and reproducible, no evidence 
was found of detectable change to the basal expression level of TSC-22 or Thgl on northems 
when cells were stimulated with Shh (Figure 6.1). 
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Figure 6.1 Investigation of Slili regulation of members of the TSC-22 gene family. 
Northem blots of RNA from lOTl/2 cells transfected with pShh-N-PMT21 (Shh-N) or 
pA64-Shh-N-PMT21 (mutant) plasmids, or treated with conditioned media collected 
from cells expressing the same constructs. GAPDH probe provides loading control. 
Glucocorticoid induced leucine zipper (Gilz) was identified by microarray as a 
downstream target of Shh, and shows up-regulation by northem blot when stimulated by 
Shh transfection or conditioned media treatment. In contrast, two other known members 
of this gene family, TGFfi-stimulated clone 22 (TSC-22) and TSC-22 homologue 1 
(Thgl), do not show regulation by Shh in lOTl/2 cells (as accessed by GAPDH 
normalised densitometry) at the timepoints investigated. 
6.3 Gli1 regulates expression of a number of the 
newly identified Shh target genes 
6.3.1 Over-expression of human GLI1 in 10T1/2 cells 
All eleven Shh target genes identified in the previous chapter were investigated as to whether 
they showed evidence of regulation by the transcription factor Glil. The human GLIl 
expression construct (pRK7-N-Myc-hGli) was used to transfect lOTl/2 cells, with control 
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cells transfected in parallel with empty vector. Transfections were monitored by alkaline 
phosphatase assays to ensure a high level of pathway activation had been achieved. RNA 
from transfected cells was collected at 12, 24, 48 and 72-hour timepoints, and used to 
construct northem blots. 
6.3.2 At least four of the Shh target genes are regulated by Gli1 
Four of the eleven genes investigated showed clear regulation in response to an elevated level 
of Glil transcription. In each case the change in expression was in the same direction to the 
response with Shh. Insulin-like growth factor 2 {Igf2) and Brain Factor 2 {Bf2) showed an 
increase in transcription in response to either Shh or Glil, while Anti-mullerian hormone 
{Amh) and Secreted frizzled related protein 2 {Sfrp2) were down-regulated by both molecules. 
Three of the remaining Shh target genes, Thrombomodulin {Thbd), Lim and SH3 Protein 1 
{Laspl) and Macrophage inflammatory protein-1 gamma {Mip-ly), did not appear to show 
any significant response to Glil transfection at the timepoints investigated (data not shown). 
Results for the remaining target genes. Secreted frizzled related protein 1 {Sfrpl), Peripheral 
myelin protein 22 {Pmp22) and Nuclear receptor subfamily 4, group A, member 1 {Nr4al) 
were difficult to interpret, with several displaying large oscillations in mRNA levels at early 
timepoints for both Glil treated and negative control samples (data not shown). In several 
cases hybridisations did not give sufficient signal to allow accurate densitometry estimates to 
be obtained. In contrast, the results for Igf2, Bf2, Amh and Sfrp2 were conclusive, with data 
from multiple timepoints clearly indicating these genes are regulated by Glil (Figure 6.2). 
Figure 6.2 Evidence for Glil mediated regulation of four of the newly identified Shh target 
genes. 
Northem blots of lOTl/2 cells transiently transfected with a human GLIl expression 
constmct (pN-Myc-hGli-PRK7) or empty vector control show newly identified Shh 
target genes also regulated by Glil. (A, B) Expression of Insulin-like growth factor 2 
(Igf2) and Brain factor 2 (Bf2) is induced by Glil. (C, D) Expression of Secreted 
frizzled related protein 2 (Sfip2) and Anti-mullerian hormone (Amh) is repressed by 
Glil. All genes shown gave greater than 1.5 fold changes in expression at two or more 
timepoints when quantified by G.r4PZ)//normalised densitometry. Numbers indicate fold 
change estimates for each timepoint. "-" is shown to indicate response to Glil is a 
down-regulation. N/A indicates expression below detection level. 
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6.4 Analysis of upstream and intronic gene 
sequences obtained from the Celera database 
DNA binding studies have indicated that human GLIl binds the nine base pair consensus 
sequence GACCACCCA (Kinzler and Vogelstein, 1990). This motif and a number of closely 
related sequences have been identified in the upstream regions of several hedgehog target 
genes in vertebrates (Sasaki et al, 1997; Gustafsson et al, 2002; Yoon et al, 2002). Motifs in 
mammals that have been shown to be functional, in terms of either binding Gli proteins in 
vitro or allowing activation of reporter constructs in biological systems, are summarised in 
Table 6.1 (bases differing from the initially reported Gli consensus motif are shown in white). 
The consensus binding motif is well conserved between species, and is also found in 
regulatory regions of Ci target genes in Drosophila (Alexandre et al, 1996). 
The Gli binding motif acts as an enhancer element, and as such does not need to be in the 
immediate vicinity of the promoter region of target genes in order to influence transcription. 
As an example, a single copy of the Gli consensus related sequence GACCACCAA in the 
enhancer region of Myf5 is able to direct expression of the gene in a hedgehog dependent 
manner during muscle development, even though it is positioned 6.6 kb upstream of the 
transcriptional start site (Gustafsson et al, 2002). 
Table 6.1 Gli binding consensus motif and related mammalian sequences which have been 
shown to be functional in Gli protein binding or reporter activation studies. 
Motif 
G A C c A C c c A 
G A A c A C c c A 
G A C c A c c A A 
C A C c A c c c A 
G A c c T c c c A 
Gene or origin 
CONSENSUS 
HNF-3P 
Myf5 
Plakoglobin 
Cyclin D2 
Osteopontin 
Species 
human 
mouse 
mouse 
human 
human 
rat 
Reference 
Kinzler and Vogelstein, 1990 
Sasaki e? a/., 1997 
Gustafsson et al, 2002 
Yoon ef a/., 2002 
Yoon effl/., 2002 
Yoon etal, 2002 
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6.4.1 Identification of known and putative Gli protein binding 
motifs 
Genomic DNA sequence from regions in and adjacent to each of the eleven newly identified 
Shh target genes was obtained from the Celera mouse genome database. Sequence 
information for Patched, Patched2, Hip and COUP-TFII was also obtained. Analysis was 
performed using the sub-sequence searching procedures in the DNA analysis software 
package Mac Vector (Accelrys). 
Table 6.2 summarises the findings for the Shh induced genes when sequence extending from 
the first exon to 30 000 base pairs upstream was searched for either the Gli consensus binding 
site or regions differing from it by a maximum of one base. Intronic gene regions were also 
investigated. Table 6.3 shows similar Gli motif location data obtained for the Shh repressed 
genes. Sequences known to be functional (as summarised in Table 6.1) are indicated using the 
name of the gene they were first investigated in (column two of Table 6.1) as an identifier. 
Putative and known Gli binding motifs are present in each of the four Shh target genes shown 
to be regulated by Glil in the previous section, and are also observed to varying degrees for 
the other Shh responsive genes. 
The 30 000 base pair cut off point for upstream sequence was set at an arbitrary distance, and 
it is worth mention that enhancer region binding sites for certain transcription regulating 
proteins have been reported to function at even greater distances for some genes (reviewed by 
Blackwood and Kadonaga, 1998). 
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Table 6.2 Putative Gli binding motifs in murine genomic sequence surrounding genes 
induced by Shh in lOTl/2 cells. 
"-" indicates the region is upstream of the first exon of the gene under investigation. 
STATUS 
G
lil
 
In
du
ce
d 
by
 
N
or
th
em
 
N
/A
 
G
lil
 
In
du
ce
d 
by
 
N
or
th
em
 
G
lil
 
In
du
ce
d 
by
 
N
or
th
em
 
G
lil
 
In
du
ce
d 
by
 
N
or
th
em
 
GENE 
Patched 
Patchedl 
Hip 
Bf2 
Igft 
REGION 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
MOTIFS OF NOTE 
1 X Functional "HNF-Sp type" motif 
1 x Functional "Osteopontin type" motif 
16 x 1 bp variant from Consensus motif 
1X CONSENSUS 
1 X Functional "Osteopontin type" motif 
2 X CONSENSUS 
2 X 1 bp variant from Consensus motif 
1X CONSENSUS 
4 X 1 bp variant from Consensus motif 
1X CONSENSUS 
1 X Functional "Osteopontin type" motif 
1 X 1 bp variant from Consensus motif 
1X CONSENSUS 
1 X 1 bp variant from Consensus motif 
1X CONSENSUS 
1 X Functional "HNF-3p type" motif 
1 X Functional "MyfS/Plakoglobin type" motif 
1X CONSENSUS 
1 X Functional "HNF-3p type" motif 
2 X Functional "MyfS/Plakoglobin type" motif 
2 X Functional "Cyclin D2 type" motif 
9 X 1 bp variant from Consensus motif 
1 X 1 bp variant from Consensus motif 
— — 
1 X Functional "MyfS/Plakoglobin type" motif 
— — 
— — 
1 X Functional "Cyclin D2 type" motif 
1 X 1 bp variant from Consensus motif 
1 X 1 bp variant from Consensus motif 
1X CONSENSUS 
4 X 1 bp variant fi:om Consensus motif 
— — 
— — 
1 X 1 bp variant firom Consensus motif 
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Table 6.2 continued... 
STATUS 
N
/A
 
N
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ev
id
en
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o
f r
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GU
I 
N
/A
 
N
/A
 
N
o
 
ev
id
en
ce
 
o
f 
re
gu
la
tio
n
 
by
 
GU
I 
GENE 
Gilz 
Thbd 
Nr4al 
Pmp22 
Laspl 
REGION 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
MOTIFS OF NOTE 
— — (3' exon position unclear) 
1X CONSENSUS 
— — 
1 X Functional "Osteopontin type" motif 
1 X Functional "HNF-3P type" motif 
4 X 1 bp variant firom Consensus motif 
— — 
— — 
2 X 1 bp variant from Consensus motif 
2 X 1 bp variant fi-om Consensus motif 
3 X 1 bp variant from Consensus motif 
— — 
1 X Functional "Osteopontin type" motif 
2 X Functional "MyfS/Plakoglobin type" motif 
1 X 1 bp variant from Consensus motif 
2 X CONSENSUS 
4 X 1 bp variant from Consensus motif 
1 X Functional "Osteopontin type" motif 
1 X Functional "MyfS/Plakoglobin type" motif 
1 X Functional "HNF-3p type" motif 
1 X 1 bp variant from Consensus motif 
— — 
— — 
2 X Functional "Cyclin D2 type" motif 
2 X 1 bp variant from Consensus motif 
1X CONSENSUS 
1 X Functional "Osteopontin type" motif 
3 X Functional "Cyclin D2 type" motif 
8 X 1 bp variant from Consensus motif 
— — 
2 X 1 bp variant from Consensus motif 
2 X 1 bp variant fi-om Consensus motif 
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Table 6.3 Putative Gli binding motifs in murine genomic sequence surrounding genes 
repressed by Shh in lOTl/2 cells 
STATUS 
G
lil
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by
 
N
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em
 
G
lil
 
Re
pr
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se
d 
by
 
N
or
th
em
 
N
/A
 
N
o
 
ev
id
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ce
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re
gu
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tio
n
 
by
 
GU
I 
GENE 
Amh 
Sfrp2 
Sfrpl 
Mip-ly 
REGION 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
Intronic Sites 
0 to -2 000 bp 
-2 000 to-10 000 bp 
-10 000 to-30 000 bp 
MOTIFS OF NOTE 
1 X 1 bp variant fi-om Consensus motif 
2 X 1 bp variant from Consensus motif 
1 X 1 bp variant firom Consensus motif 
1X CONSENSUS 
2 X 1 bp variant firom Consensus motif 
1 X 1 bp variant firom Consensus motif 
1 X Functional "MyfS/Plakoglobin type" motif 
1 X 1 bp variant fi-om Consensus motif 
— — 
1 X 1 bp variant from Consensus motif 
1 X Functional "HNF-3p type" motif 
3 X 1 bp variant from Consensus motif 
1 X 1 bp variant from Consensus motif 
1X CONSENSUS 
1 X Functional "Osteopontin type" motif 
1 X Functional "Cyclin D2 type" motif 
4 X 1 bp variant from Consensus motif 
1 X 1 bp variant from Consensus motif 
— — 
1 X 1 bp variant from Consensus motif 
2 X 1 bp variant from Consensus motif 
6.4.2 Absence of the Sonic hedgehog response element (ShhRE) 
Available genomic sequence for each of the newly identified Shh target genes was 
investigated to see if any of them contained the eighteen base pair Shh response element 
(ShhRE, refer Section 1.2.8). The ShhRE (GTTCTACATAATGCGCCG) is reported to direct 
transcription of the Gli-independent Shh target gene COUP-TFII (Krishnan et al, 1997b). 
Though published work on the ShhRE was conducted in chicken, analysis of Celera upstream 
sequence of the corresponding mouse gene showed the motif is conserved between the two 
species. The motif was not identified in any of the eleven Shh target genes identified in the 
previous chapter, nor were any related motifs found when searches allowing for up to three 
base pair changes from the published sequence were performed. 
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6.5 Discussion 
6.5.1 TSC-22 family members display tissue dependent responses 
to Shh stimulation 
Gilz is a strongly up-regulated target of the hedgehog pathway in the embryonic mesodermal 
cell line lOTl/2. The two other characterised members of this family, TSC-22 and Thgl do 
not appear to be transcriptional targets of Shh in this cell type. The structure and biological 
functions of Gilz, along with its relevance to the hedgehog pathway, is discussed in the 
following chapter. 
Interestingly, one of the Gilz clones present in the UniGene set on the microarray chips used 
in Chapter 5 was annotated in the supplied grid position information file as "5' similar to 
SW;TSC2_M0USE Q00992 putative regulatory protein TSC-22". When the clone 
corresponding to this location was sequenced it was found to correspond to the expected 
accession number and was indeed similar to TSC-22. However, BLAST searching revealed it 
was actually far more similar (100 percent) to Gilz. This highlights the fact that it is important 
in microarray studies to check not only that a clone represents the EST it should, but that 
current databases are checked for any clones that do not already show a complete match to a 
known gene. In this way it can be ensured that the correct gene, and not a near relative, is 
attributed with a particular response. If sequence validation and BLAST searching of the 
current GenBank database had not been performed on all microarray derived lead gene clones 
TSC-22, rather that Gilz, may have been attributed with the Shh response in lOTl/2 cells 
reported earlier in this thesis. 
The absence of a response of TSC-22 to Shh in lOTl/2 cells, even though TSC-22 is a known 
target of Glil, highlights the fact that different hedgehog response profiles are present in 
different tissue systems. Variations in the genes responding to Hedgehog in different cell 
types, as well as in other spatial and temporal situations, may help explain how a single 
molecule such as hedgehog can cause such a diverse range of responses in patterning of the 
mammalian embryo. 
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6.5.2 Gli1 regulation in the control of Shh target genes 
The finding that at least four of the eleven newly identified targets of Shh signalling are also 
regulated by Glil further supports the conclusions of the previous chapter. It adds weight to 
the evidence that the microarray approach, and subsequent validation procedures, did indeed 
yield genuine targets of the hedgehog signalling pathway. 
In addition the finding of a response to Glil is of interest as it provides evidence that Igf2, 
Bf2, Amh and Sfrp2 are regulated by what is considered the "classical" hedgehog response, 
with Shh acting (presumably through Patched and Smoothened) to control members of the Gli 
gene family, which then orchestrate further responses. An altemative mechanism, by which 
the hedgehog pathway bifurcates at some point (as discussed in Chapter 1, Section 1.2.8) may 
explain why some of the other newly identified hedgehog target genes do not show evidence 
for any response to Glil. They may be regulated instead by other transcription factors. 
However, this is not the only possibility to explain the absence of a detectable response to 
Glil. It is possible that the other Shh targets are regulated by Glil at timepoints outside of 
those investigated in this study, or are only regulated via Gli2 or Gli3 but not Glil. 
Furthermore, the level of Glil stimulation may have failed to reach some critical threshold for 
some genes which did not show an apparent response. It is relatively straightforward to show 
that a factor does cause a transcriptional effect, but very difficult to prove the converse. 
6.5.3 Gli1 can act as both an activator and a repressor 
The finding that GLIl expression in lOTl/2 cells can cause an increase in transcript 
abundance, as it does in the case of Bf2 and Igf2, or that it can decrease mRNA levels, as is 
the case with Sfrp2 and Amh, provides evidence that Glil has both activator and repressor 
actions. This supports similar observations first made by Yoon et al, (2002). It is not yet 
known if Glil itself directly causes the repression. It remains a possibility that Glil may 
induce transcription of a secondary inhibitory factor that then mediates negative effects on the 
transcription of Shh repressed genes. 
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6.5.4 Insights from genomic sequence analysis 
Each of the genes shown conclusively in this chapter to be regulated by Glil {Patched, Hip, 
Bf2, Igf2, Sfrp2 and Amh) display a higher number of Glil consensus related sites in 
surrounding genomic regions than would be expected by chance. 
The presence of putative and known Gli interacting sequences in the upstream regions of Igf2, 
Bf2, Amh and Sfrp2 suggests that positive and negative regulation of these newly identified 
Shh target genes via Glil may occur by a direct mechanism. It is also possible that Gli2 or 
Gli3 may interact with the identified sequences. It is interesting that a number of the putative 
and known Gli binding sites occur in the intronic regions of the investigated genes, a 
phenomenon also observed for other enhancers (Blackwood and Kadonaga, 1998). 
The finding of a number of known and putative Gli binding motifs in the newly identified Shh 
target genes other than the four shown conclusively to be regulated by Glil suggests the 
actual number of Gli regulated genes may be higher. If so a number of factors may have 
prevented their identification in transient transfection studies with Glil. The level of Glil 
stimulation may not have reached high enough levels to initiate a response, the expression of 
Gli family members other than Glil be necessary, or the timepoints investigated may not have 
been appropriate to detect the response. In the case of Sfrpl there were problems in obtaining 
northem blot data for inclusion in this work, however the presence of a number of Gli binding 
sites (induing a consensus motif and sequences known to be functional in the HNF-3fi, 
Osteopontin and Cyclin D2 genes) suggests that Sfrpl, like Sfrp2, may be Glil regulated. 
The number of consensus and known functional Gli binding motifs identified in the introns 
and upstream regions of Patched2 were striking, suggesting that Patched2, like Patchedl, will 
prove to be a Glil regulated gene. Of the four newly identified Shh target genes that were 
demonstrated to be regulated through Glil, only one. Brain factor 2, had no Gli consensus 
related sequences of note, either within the gene, or within 2000 base pairs upstream of the 
first exon. Of particular note however was the existence of a tight cluster of five perfect Gli 
consensus sites (plus several closely related sequences) approximately 360 kilobase pairs 
upstream of the Bf2 gene. This putative enhancer region is located within the intron sequence 
of another gene, Rho-guanine nucleotide exchange factor {Rgnef). Whether or not this cluster 
acts as an extremely long distance enhancer for Bf2, or whether it actually regulates Rgnef 
will be an interesting question to address in future investigations. 
114 Chapter 6: Further Investigation into Regulation of Identified Hedgehog Target Genes and Related Family Members 
It is important to stress that the finding of Gli consensus related motifs that putatively control 
the regulation of genes in a hedgehog directed manner is currently speculative and awaits 
detailed functional studies such as gel shift analysis or reporter activation studies. Though a 
number of the identified motifs match those previously found to be functional in other studies, 
it is important to note that function may be considerably effected by surrounding DNA 
sequences. Enhancer action in general is not yet well understood, particularly with regard to 
the actual mechanisms transcriptional control and how such elements can act at considerable 
distances firom target gene promoters. 
The most important findings of this chapter are that Bf2, Igf2, Sfrp2 and Amh have been 
shown to be able to be regulated under the control of the Glil transcription factor, firmly 
establishing their role as downstream targets of the hedgehog pathway and providing clues to 
the mechanism of their transcriptional regulation. The fact that Glil expression in lOTl/2 
cells was able to elicit either activation or repression, depending on the particular Sonic 
hedgehog target gene under investigation, is a significant finding. 
Chapter 7: Discussion - Discovered 
Hedgehog Target Genes and Overview 
The major aim of this thesis, the identification of novel downstream targets of Sonic 
hedgehog, has been met with the identification and validation of eight genes that have not 
previously been described in the literature as being involved in the hedgehog pathway. In 
addition, microarray generation of lead genes and their subsequent verification led to the 
corroboration of three other genes already implicated in hedgehog pathway biology firom 
other studies. 
The eleven genes confirmed as genuine targets of Shh in this work encode a wide range of 
proteins with diverse putative functions. All are "known genes" in that they have previously 
had their full coding sequence recorded in the NCBI GenBank database. Whilst some of them 
have been intensively studied with regard to their function, others have only recently been 
named and published with far less known about their biological roles. In this chapter each of 
the hedgehog responsive genes is discussed with particular emphasis on the eight genes not 
previously described as having links to the hedgehog pathway. The biological implications of 
the findings are discussed, along with known links to aspects of human disease. 
The remainder of this chapter provides an overview of the conclusions drawn in this thesis 
and their implications, a critical review of the strategies employed and a discussion of 
possible future studies leading on from the findings of this work. 
7.1 Possible roles of identified pathway targets and 
links to human disease 
7.1.1 Brain factor 2 (Bf2) 
Bf2 has not previously been linked to the hedgehog pathway. Bf2 is a member of the winged-
helix (W-H)/forkhead box (FOX) family of transcription factors and is expressed in small 
number of embryonic tissues including developing CNS and kidney (Hatini et al, 1994), 
Winged-helix proteins, named fi^om the conserved protein stmcture of their DNA binding 
domains, have been shown to have important roles in the control of cell growth, proliferation 
and differentiation. Some family members are capable of inducing a transformed phenotj^e in 
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cells and have a role in neoplasia (reviewed by Vogt et al, 1997). Homozygous Bf2 knockout 
mice die within a day of birth, having severely malformed kidneys and anomalies of the 
forebrain, retina and adrenal gland (Hatini et al, 1996). 
Several other members of the W-H/FOX family have been implicated downstream of Shh, the 
best studied being HNF-3p (refer Section 1.5), which is a well known target of Shh signalling 
in neural tissues and a gene also shown to be a transcriptional target in lOTl/2 cells fi-om the 
work presented in Chapter 3. HNF-3J3 transcription is controlled via Gli binding sites in its 
promoter (Sasaki et al, 1997). Recently another member of the family, FoxMl, has been 
shown to be up-regulated in basal cell carcinoma and regulated through a Gli dependent 
mechanism (Teh et al, 2002). The data presented in Chapter 6 shows Bf2 is also GHl 
regulated, suggesting a common mechanism of regulation for winged-helix genes under the 
transcriptional control of Shh. 
When lOTl/2 cells respond to Shh, many cells differentiate down the osteoblastic lineage. 
Interestingly, several other winged-helix members have been implicated in regulating 
osteogenesis, and one of these, Mfh-l, is thought to directly stimulate a forkhead response 
element in the AP promoter (Yang, X. L. et al, 2000; Hatta et al, 2002). It will be of 
particular interest in future studies to obtain a full length clone of Bf2 to investigate whether 
its expression in lOTl/2 cells is sufficient for their induction to the osteoblastic lineage, or 
whether Bf2 represents a more general component of the hedgehog response. In Xenopus, Bf2 
expression can convert cells from an epidermal to neural cell fate, and it may play a similar 
role in patteming the mammalian CNS (Mariani and Harland, 1998). Since Bf2 is a 
transcription factor it presumably in tum controls the transcription of its own target genes, a 
mechanism that may be either mled or fine tuned by the actions of Shh. 
7.1.2 Glucocorticoid induced leucine zipper (Gilz) 
Gilz was found to be induced in lOTl/2 cells in response to Shh stimulation. It has already 
been discussed in Chapter 6 with relevance to homology to related genes, some of which are 
also implicated as downstream targets of hedgehog signalling in other systems. 
As discussed previously members of the TSC-22 family, which includes Gilz, contain a 
leucine zipper region, a motif commonly found in transcription factors. However, unlike most 
leucine zipper proteins, members of the TSC-22 family lack an obvious DNA binding domain 
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and it is thought that they regulate transcription indirectly through the formation of 
heterodimers with various other transcription control proteins, 
Gilz was independently discovered by groups using two different biological approaches, and 
its nomenclature can be confusing. Initially its existence was determined by researchers who 
isolated it as an unexpected protein bound by an antibody to the nine amino acid Delta sleep 
inducing peptide (DSIP) in porcine brain tissue (Sillard et al, 1993). Though Gilz and DSIP 
cross react immuno-chemically they were found to have no similarity in protein sequence and 
at that time the function of Gilz, then called DSIP-immunoreactive peptide (referred to as 
DSIPI or DIP), remained elusive (Sillard et al, 1993). Later the gene corresponding to this 
new protein was cloned and recognised as a member of the TSC-22 family (Vogel et al, 
1996). Meanwhile, the gene was isolated independently by researchers investigating 
modulation of apoptosis in T-lymphocytes under the control of glucocorticoids, a group of 
steroid hormones produced by the adrenal cortex. From this work it gained its currently 
accepted name of Glucocorticoid induced leucine zipper (D'Adamio et al, 1997). Recent 
work on Gilz has highlighted further aspects of its involvement in apoptotic control in T-cells, 
including links to the NF-KP and Fas/FasL systems (Ayroldi et al, 2001; Riccardi et al, 2001 
and earlier studies reviewed by Riccardi et al, 1999). 
In contrast to the above studies little work has been published on the role of Gilz outside of 
the immune system, though it is known to be expressed in a wide range of human tissues 
(Vogel et al, 1996). Northem blot studies on a small number of mouse tissues conducted in 
this work have shown that Gilz is expressed in skin keratinocytes and brain, and at a lower 
level in kidney and spleen (data not shown). 
As yet transgenic and knockout animal studies on Gilz have not been published, making this a 
particularly interesting area to initiate future work. Given that mutation of the single 
Drosophila TSC-22 family homologue, bunchedl shortsighted (refer references in previous 
Chapter), causes defects in embryonic development, it will be interesting to see if mutation of 
Gilz in a mammalian system results in a similar phenotype. In this way it will be possible to 
deduce more about the fiinction of Gilz in a developmental setting. Given the importance of 
Gilz in apoptotic control, it may also be informative to monitor and compare apoptotic 
markers in lOTl/2 cells after Shh or Gilz expression, to see if up-regulation of Gilz in 
response to Shh has an effect on cell survival in embryonic mesodermal cells. 
188 Chapter 7: Discussion - Discovered Hedgehog Target Genes and Overview 
7.1.3 Thrombomodulin (Thbd) 
One of the most intriguing responses identified in this work is the induction of Thbd 
transcription upon Shh stimulation. Thbd encodes an endothelial cell membrane receptor that 
forms a 1:1 complex with thrombin, changing its conformation and converting it from a 
procoagulant to an anticoagulant molecule. Thrombin then catalyses activation of Thrombin-
activatable fibrinolysis inhibitor (TAFI) and Protein C, which in tum cleaves activated 
cofactors mediating coagulation. In this respect Thbd acts as an anticoagulant, slowing blood 
clotting (reviewed by Wu and Matijevic-Aleksic, 2000). 
It is initially unclear what role such a gene might play in embryonic pluripotent mesodermal 
cells, however clues come fi-om Thbd knockout mice which display embryonic lethality 
before the cardiovascular system develops, suggesting a fiinction in growth and development 
independent of its anticoagulant activities (Healy et al, 1995). Follow up studies using a 
reporter gene linked to the Thbd promoter revealed expression in the murine trophoblast, as 
well as in mesodermal precursors of the endothelial cell lineage, suggesting Thbd may play a 
developmental role during vascular differentiation (Weiler-Guettler et al, 1996). Other 
studies have revealed that in addition to the well known expression of Thbd in endothelial 
cells, Thbd is also transcribed in osteoblasts (Maillard et al, 1993) as well as several other 
cell types (reviewed by Zhang, Y. et al, 1998). In keratinocytes and some other cells Thbd is 
proposed to play a role in cellular differentiation (Mizutani et al, 1994; Raife et al, 1994). 
Recently studies have proposed mechanisms by which both Thbd and Thrombin may be 
involved in signalling to control cell proliferation (reviewed by Freedman, 2001). Although a 
direct link to the Hh pathway has not previously been described there is evidence that TGFp 
family members (which have some homology to the key Drosophila Hedgehog target dpp) 
can down-regulate Thbd expression in neural tissue (Tran et al, 1999). 
In terms of neoplasia Thrombomodulin is a hedgehog target gene of interest, given that it 
shows expression changes in a variety of human cancers where it has been hypothesised to 
play a role in tumour invasion and metastasis (Wilhelm et al, 1998; Zhang, Y. et al, 1998). It 
also appears to regulate the growth of tumour cells using mechanisms other than its 
anticoagulant fiinctions (Zhang, Y. et al, 1998). 
This gene will be of interest for fiiture studies, in particular if embryos from homozygous Shh 
knockout mice can be obtained for in situ hybridisation analysis. Possible changes in Thbd 
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expression could be informative to understanding the biological link between Hedgehog and 
Thrombomodulin during mammalian development, whilst its investigation in tumours with 
and without associated hedgehog pathway dismption would be informative. 
7.1.4 Nuclear receptor subfamily 4, group A, member 1 (Nr4a1) 
Another newly identified Shh target, Nr4al, is a growth factor inducible orphan nuclear 
receptor, that functions as a transcriptional regulator mediating mitogenic effects, and also 
regulates apoptosis by a secondary independent mechanism (Li, H. et al, 2000). A name for 
this gene has yet to become standardised and it is referred to in the literature by a multitude of 
different aliases including NGFl-B, Nur77, NAK-1, NIO and TR3. 
Nr4al is an inducible orphan nuclear receptor, a member of the steroid receptor family with 
an unknown ligand. It consists of an N-terminal AFl trans-activation domain, a double zinc 
finger DNA binding motif and a C-terminal ligand binding region. It is known to bind an 
eight base pair consensus DNA sequence directly, and it can also regulate transcription by 
modulating the activity of other orphan steroid receptors, (reviewed by Winoto and Liftman, 
2002). Nr4al is induced by a variety of factors, suggestive of a role in a range of biological 
fiinctions. Several target genes of Nr4al have been identified that play a role in steroid 
metabolism (reviewed by Sladek and Giguere, 2000), further hinting at the "steroid theme" 
that comes up often in aspects of hedgehog pathway biology. It is thought that orphan steroid 
receptors probably have some degree of redundancy in function, since Nr4al deficient mice 
have no observable phenotype (Lee, S. L. et al, 1995). 
Nr4al has not previously been described as a hedgehog target gene, though it is generally up-
regulated by a range of cellular growth factors. Another orphan steroid hormone receptor, 
COUP-TFII (refer Section 1.2,8), is a known target of hedgehog regulated independently of 
the Gli transcription factors, and it will be interesting to see if Nr4al is also regulated by a 
COUP-TFII-like mechanism. 
Also of note, Nr4al shares several functional properties with Gilz, another new Shh target 
described above. Both are involved in the response to steroid hormones, both are regulators of 
transcription, and both are important regulators of cellular apoptosis. It is possible that both of 
these genes are induced to address a similar biological goal. 
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7.1.5 Insulin-like growth factor 2 (Igf2) 
Igf2 was identified as an up-regulated target of Shh. By chance this gene was represented on 
the microarrays by four independent clones, and when the data from the experiments was 
followed up by northem blots the induction in lOTl/2 cells in response to hedgehog 
stimulation was found to be dramatic. 
Igf2 provides an example of a gene already implicated in the hedgehog response that has been 
corroborated by this work. Previous studies suggested Shh mediates Igf2 expression due to the 
observation of increased Igf2 mRNA levels in both normal tissues and tumours arising on 
hetrozygous patched mutant mice (Hahn et al, 1998), with further studies suggesting that Igf2 
is indispensable in the formation of both meduUoblastoma and rhabdomyosarcoma in mice 
(Hahn et al, 2000). The work presented in Chapters strongly supports these findings, and 
additionally shows that Igf2 is up-regulated by Glil, firmly establishing its role as a 
transcriptional target of the hedgehog pathway. 
Igf2 is a member of the insulin-like growth factor (IGF) family, whose other members include 
Igfl and Insulin itself Like Insulin, Igfl and IgfZ have effects on metabolism, but they also 
play a role in the control of cellular proliferation. A number of IGF-binding proteins have 
been identified and these modulate the IGF response, which is mediated by binding to the IGF 
receptor/g/^7i?. Binding activates the receptor's tyrosine kinase activity, triggering changes in 
downstream molecules (reviewed by Le Roith and Butler, 1999). 
A long history of studies exist showing increased expression of Igf2 in a diverse range of 
human tumour types (reviewed by Toretsky and Helman, 1996). Increased Igf2 in cancer 
often arises from mechanisms involved with loss of imprinting or from transcriptional 
activation, the latter of which is likely to be associated with hedgehog pathway activation. It is 
thought that increased expression of Igfl in some cancers sets up an autocrine feedback loop 
such that cell proliferation is continuously stimulated, and Igf2 may act similarly (Chen, J. C. 
et al, 1994). Igf2 can also act synergistically with other growth factors and steroids to 
antagonise the effects of anti-proliferative molecules in cancer cells (Yu and Rohan, 2000). 
The importance of this gene in human neoplasia makes it a prime suspect as a gene directly 
involved in tumour initiation when the hedgehog pathway is activated. 
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7.1.6 Peripheral myelin protein 22 (Pmp22) 
Studies presented in this thesis have shown Pmp22, also known as Growth arrest-specific 3 
{Gas3), is up-regulated in lOTl/2 cells in response to hedgehog. 
Pmp22 was first cloned during a screen to identify genes induced during the semm starved 
growth arrest of NIH 3T3 fibroblasts (Manfioletti et al, 1990), and is a member of a larger 
protein family, members of which are hydrophobic molecules featuring four conserved 
transmembrane domains. It is widely expressed during embryonic development as well as in 
adult tissues, with the highest expression in the Schwann cells of the peripheral nervous 
system (reviewed by Jetten and Suter, 2000), Pmp22 protein forms a component of the myelin 
sheath of peripheral nerves where it regulates various aspects of Schwann cell biology. 
Several lines of evidence suggest that Pmp22 is a dual function protein that also plays a more 
general role in growth control and apoptosis regulation in non-neuronal tissues (Jetten and 
Suter, 2000), 
A number of natural mouse mutants are known for the Pmp22 locus, and its dismpted 
function is involved in several human diseases. The Trembler {Tr) mouse was identified more 
than half a century ago, followed later by another mouse, Trembler-J {Tr-J) with an 
independent mutation (Falconer, 1951; Henry et al, 1983; Henry and Sidman, 1983), Both 
mutants represent missense mutations in Pmp22 that dismpt normal protein trafficking, and 
phenotypically they exhibit shaking and muscle control abnormalities. In humans mutation of 
PMP22 is associated with several neuropathies including Charcot-Marie-Tooth neuropathy 
type 1 (a chronic demyelination disorder), Dejerine-Sottas disease (featuring severe infantile-
onset demyelination) and Hereditary neuropathy with liability to pressure palsies, an 
autosomal dominant disorder that results in episodic demyelinating neuropathy (reviewed by 
^e\is etal, 1999). 
Pmp22 has not previously been implicated in Hh signalling and it will be interesting to see if 
its expression can be induced by hedgehog molecules other than Shh. In particular future 
studies will aim to see if Pmp2 2 might also be a downstream target of Desert hedgehog. Dhh 
has a greatly restricted expression pattem compared to the other mammalian hedgehog genes, 
but one specific area it is involved in is patteming of the peripheral nerves where it is 
involved in formation of the peripheral nerve sheath (Parmantier et al, 1999). The possibility 
exists that Pmp22 might be regulated by Dhh during this developmental process. 
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It is of note that another gene. Growth arrest specific 1 {Gasl), was identified whilst this 
work was in progress as a protein that can bind to Shh and act as an antagonist of the 
hedgehog pathway (Lee, C. S. et al, 2001). Although the Gas genes are part of a similar 
fiinctional grouping it is important to note that Gasl and Gas3 are quite distinct in sequence 
and protein stmcture and are not directly related. 
7.1.7 Lim and SH3 Protein 1 (Laspl) 
Laspl, also called Metastatic lymph node 50 {MLN50), is a unique member of the LIM 
protein family featuring an N-terminal LIM domain and a C-terminal Src homology region 3 
(SH3) motif (Tomasetto et al, 1995a). The LIM domain (named from the Lin-11, Isl-1 and 
Mec-3 genes) is a cysteine-rich double zinc finger consensus sequence implicated in 
mediating protein-protein interactions (reviewed by Dawid et al, 1998). The SH3 domain is 
thought to serve a similar function and is found in cytoskeleton-associated molecules and 
signal transduction t5n-osine kinases (reviewed by (Mayer, 2001). Given that both ends of the 
Laspl protein feature regions using in protein-protein interactions it is possible that Laspl 
may function as an adaptor molecule with a role in cellular signal transduction pathways or in 
regulating the architecture of the cytoskeleton (Schreiber et al, 1998). Recent work suggests 
that phosphorylation of Laspl could potentially regulate actin-associated ion transport 
activities (Chew et al, 2000). 
In this study Laspl was found to be an up-regulated target of Shh in lOTl/2 cells. Although 
the response occurred from a relatively high basal expression level it was subtle but 
significant (refer Chapter 5 and Appendix). This gene showed a lower magnitude fold change 
to that observed with the other newly identified target genes discussed in this chapter, but 
nonetheless it may play an important biological role. 
Laspl was originally isolated from a differential screen of clones from a human metastatic 
lymph node cDNA library to identify genes involved in breast cancer progression (Tomasetto 
et al, 1995b). It was found to be located on the long arm of human chromosome 17, between 
ql l and q21.3, a region known to contain the oncogene c-erbB-2 oncogene and the BRCAl 
breast cancer susceptibility gene, and overexpression of all three is dependent on gene 
amplification in breast cancer cell lines. Further work showed that Laspl is frequently over 
expressed in breast carcinomas, where it is hypothesised to cause cytoskeletal changes during 
neoplastic transformation (Bieche et al, 1996). 
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Given that Laspl is a relatively late target of Shh in lOTl/2 cells there is a possibility that 
changes in its expression relate to architectural changes in cell stmcture during Shh induced 
differentiation, however its apparent importance in human cancer formation warrants further 
investigation. 
7.1.8 Secreted frizzled related proteins 1 and 2 (Sfrpl and Sfrp2) 
Of all the Shh target genes identified in this work the most dramatic responses (in terms of 
fold change) were for Secreted frizzled related protein-1 {Sfrpl; also known as Sarp-2) and 
Secreted frizzled related protein-2 {Sfrp2; also known as Sarp-1 or SdfS), on which Shh had a 
strong inhibitory effect on transcription. In addition one of these genes, Sfrp2, has been 
conclusively shown as a downstream target mediated through the actions of the transcription 
factor Glil, providing further information of the mediation of the signal between Shh and 
Sfrp2. The author also had access to a Sfrp3 clone; however this gene did not appear to be 
regulated by hedgehog in lOTl/2 cells when tested by northem blotting even though 
microarray data was promising (refer Appendix and data not shown). 
As discussed in Chapter 5, Sfrpl and Sfrp2 have previously been implicated as Shh targets 
from a study using presomitic mesoderm (Lee, C. S. et al, 2000). In this tissue both genes are 
induced by Shh, the opposite response to that seen in the lOTl/2 system. 
The transcriptional response of the two Shh target genes is intriguing since they already show 
extreme changes in expression in untreated cells across the timepoints investigated in this 
study. The action of Shh is superimposed over the natural expression pattem, which is a 
dramatic increase in Sfrpl and Sfrp2 expression as the cells reach high density and age in the 
cellular monolayer. The expression of SFRPs in quiescent but not in exponentially growing 
lOTl/2 cells that was encountered in this work had previously been observed by other 
researchers (Melkonyan et al, 1997). When exposed to Shh this natural increase in Sfrpl and 
Sfrp2 expression was greatly diminished. As with most of the observed responses this was 
most apparent with conditioned media stimulation. 
It is important to note that SFRP gene responses would have been missed if the microarray 
studies had simply used untreated "time zero" cells (which were not fully confluent) as the 
reference RNA on each chip. In this case the Shh response for these genes would mimic the 
expression pattem seen at lower cell density, masking the sfrong inhibitory effect. Put more 
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simply it is not possible to detect a decrease in the expression of a gene, no matter how strong 
the inhibitor, if the sample compared to does not express the gene in the first place. It was a 
strength of the experimental design, which involved meticulous pair-matching of confrols 
over each timepoint in the timecourse, that allowed this response to be readily detected. 
The SFRP family, also known as SARPs (secreted apoptosis-related proteins), feature a 
cysteine rich domain homologous to that found in the transmembrane Wnt receptors known as 
Frizzled proteins, however unlike the hydrophobic Frizzled receptors, SFRPs are secreted 
molecules. The family was first discovered with the identification of four members {Sfrpl to 
4) on the basis of this homology (Rattner et al, 1997). SFRPs are expressed in mesenchymal 
condensates and in a range of subsequent epithelial stmctures during murine embryogenesis 
(Leimeister et al, 1998). Members of the family bind Wnt proteins outside of cells and are 
thought to antagonise, or in some cases enhance, Wnt fiinction. Vertebrate SFRPs, like the 
frizzled receptors themselves, exhibit fiinctional specificity with respect to various Wnt 
proteins, (reviewed by Polakis, 2000; Jones, S. E. and Jomary, 2002). 
The Wnt pathway, and the genes controlled by it, are strongly implicated in cancer formation, 
particularly in colorectal cancer, where mutations in the tumour suppressor APC activate a 
Wnt response through the stabilisation of P-catenin (reviewed by Taipale and Beachy, 2001). 
A direct link between the hedgehog and Wnt pathways has been known for some time in 
Drosophila, whereby the orthologous Wnt gene wingless is a key target of Hedgehog 
signalling. More recently Hedgehog mediated expression of Wnt genes has been established 
in higher organisms (refer Chapter 1). It is not unexpected therefore, that SFRPs would be 
involved in cancer given there close functional relationship to Wnt signalling pathway, and 
indeed it appears that this is the case. In lOTl/2 cells, Sfrpl and Sfrp2 are both involved in 
modulating cellular sensitivity to apoptotic stimuli, dismption of which may also influence 
tumour formation (Melkonyan et al, 1997). SFRPs are hypothesised to act as tumour 
suppressors, and abnormally low expression of various SFRPs has been reported in tumour 
samples from kidney, ovary and breast (Jones, S. E. and Jomary, 2002). Although there are 
not yet any studies directly associating SFRP mutation with human disease, a recent study of 
non-medullary invasive breast carcinomas found loss of SFRP-1 expression in more than 80% 
of cases (Ugolini et al, 2001). The hedgehog pathway may provide a mechanism to fine tune 
Wnt signalling in vertebrates through the regulation of Sfrpl and Sfrp2, and predispose cells 
to neoplasia when this control is dismpted. 
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7.1.9 Macrophage inflammatory protein-1 gamma (Mip-ly) 
Mip-ly was found to be down-regulated by Shh in lOTl/2 pluripotent mesodermal cells. As 
with all Shh target genes reported in this work, the response was observed both by Shh 
transfection and by stimulation with Shh conditioned media. 
Since its identification in the mid 1990s by several groups (Hara, T. et al, 1995; Poltorak et 
al, 1995; Youn et al, 1995) Mip-ly has become known by a myriad of names in human and 
mouse including CCF18, Small inducible cytokine A9 {Scya9), Small inducible cytokine AlO 
{ScyalO), Chemokine C-C motif ligand 9 {Ccl9), and Macrophage inflammatory protein-
related protein-2 {MRP-2). The role of Mip-ly is not yet fiilly understood. 
Mip-ly is a member of the superfamily of chemokines, a group of secreted molecules that act 
as chemo-attractants for various cells involved in haematopoiesis and inflammation by 
binding to target cell surface receptors of the G protein-coupled family. Specifically Mip-ly 
belongs to the C-C (cys-cys) group of chemokines, named due to the stmcture of their 
consensus protein sequence. Mip-ly is closely related to the chemokines Mip-la, Mip-lfi, and 
CIO and it displays inflammatory, pyrogenic and chemokinetic properties. Unlike other C-C 
cytokines Mip-ly is constitutively expressed by a wide range of tissues in adult mice and 
circulates in normal blood (Poltorak et al, 1995). 
The inhibition of Mip-ly mediated by Shh is intriguing. Some cytokines are produced by 
osteoblasts, which is what many lOTl/2 cells become after Shh exposure, however in this 
case the opposite is observed. Whether of not the down-regulation of Mip-ly is correlated 
with mesodermal differentiation or a more general response of the hedgehog pathway awaits 
further investigation. 
7.1.10 Anti-Mullerian hormone (Amh) 
In this work Amh, also known as Mullerian inhibiting substance {MS), was found to be a 
down-regulated target gene of Shh in lOTl/2 cells that is regulated imder the control of Glil. 
Amh encodes a glycoprotein with a critical role in mammalian sex determination. In male 
embryos Amh is produced by the Sertoli cells of the foetal testes, causing regression of the 
Mullerian duct that would otherwise form into female stmctures (reviewed by Josso et al, 
2001). Male mice mutant for Amh develop into intemal pseudohermaphrodites, having both 
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male and female reproductive organs (Mishina et al, 1996), while mutations in human AMH 
have been linked to persistent Mullerian duct syndrome in a number of patients (Knebelmann 
et fl/., 1991; Imbeaud et al, 1994). Amh is expressed in the aduh gonads of normal males and 
females, though at much lower level than that observed in foetal testes (Teixeira et al, 1999). 
In contrast to its role in the development of sex organs the role of Amh in adults is less clear. 
There is some evidence that Amh may be involved in oocyte maturation, blocking granulosa 
cell proliferation and reducing steroidogenesis in the ovary (Kim et al, 1992; Seifer et al, 
1993). The phenotypes of transgenic and knockout mouse models for Amh, and an Amh 
receptor, provide support for Amh playing a role after birth in maintaining steroid hormone 
balance in both male and female gonads (Behringer et al, 1990; Behringer et al, 1994; 
Mishina et al, 1996). Recent work has shown a direct effect of Amh at the transcriptional 
level in regulating an enzyme involved in androgen biosynthesis (Teixeira et al, 1999). 
A possible link to hedgehog biology is suggested by the fact that Amh is a member of the 
TGFp superfamily distantly related to Drosophila dpp; however, to the author's knowledge 
this work provides the first evidence for Amh as a downstream transcriptional target of the 
hedgehog pathway. Shh acts to inhibit the expression of Amh observed in quiescent lOTl/2 
cells, however the roles that Amh might play in embryonic mesodermal cells are unclear. At 
this stage it is not known what phenotypic changes the reduction in Amh transcript levels 
under the control of Shh and Glil might have in a developmental context. 
7.1.11 Summary of Hedgehog target genes: common themes 
The eleven Shh target genes identified in this work as downstream targets in pluripotent 
embryonic mesoderm represent molecules with a diverse range of protein stmctures. Many of 
the genes represent important developmentally regulated molecules and there are a number of 
common themes apparent in terms of their putative functions. Three genes, Bf2, Gilz and 
Nr4al are transcription factors or are involved in regulating transcriptional responses. These 
genes, under the influence of Shh, may confrol fiirther cascades of secondary target molecules 
through which Shh exerts its action. The majority of the genes have putative roles in the 
regulation of cell growth and survival. Thrombomodulin, Nr4al, Igf2 and Pmp22 are thought 
to have important roles in the regulation of cellular proliferation, while Gilz, Nr4al, Amh and 
the two Sfrp genes have known functions in the regulation of apoptotic cell death. Aberrant 
expression of any of these downstream targets when the Hh pathway is perturbed could be a 
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factor in the uncontrolled cell growth leading to tumour formation. In addition, a number of 
the downstream targets of Shh identified in this work (including Thrombomodulin, Igf2, 
Laspl, and the Sfrps), show altered expression in human cancer tissue, or are known to be 
involved in tumourigenesis. 
7.2 Importance of a well characterised response 
profile to the success of comparative gene 
expression studies 
With the rapid advances in microarray technology, and the reaching of a stage where 
laboratories without specialised robotic equipment can now access microarray slides by 
commercial means, many groups are now embarking on microarray based projects. One factor 
that must not be overlooked is that the final data obtained will only be as relevant to the 
specific biological question being asked as the cell populations themselves are at the time of 
harvest. This applies to the use of any technique used for the analysis of differential gene 
expression. The two most important factors in addressing this in terms of investigating the 
response to a factor are: 
1. Selection of suitable model tissue or cell system. 
2. Selection of the optimal reference (negative control) cell population. 
3, Selection of suitable treatment sfrategy that avoids introducing irrelevant 
transcriptional effects, 
4, Selection of relevant timepoints for investigation. 
Unless all of the above decisions are made carefiilly there is a risk that any analysis of gene 
expression will not actually provide answers to the question of interest, no matter how 
meticulously the data is collected. On one hand a particular response may be missed 
completely and on the other hand poor choices involving points two and three above can lead 
to a high level of false positives. 
In order to make these decisions correctly the researcher needs to be armed with an adequate 
body of knowledge about the biological system of interest so that decisions on experimental 
design can be made in an informed way. For this reason much of the research conducted in 
198 Chapter 7: Discussion - Discovered Hedgehog Target Genes and Overview 
this thesis aimed to establish a framework of knowledge so that comparative gene expression 
studies would yield as much useful information as possible on the transcriptional response to 
hedgehog stimulation. 
The above points have been discussed in detail in Chapters 2 and 3, In particular the 
knowledge gained in Chapter 3 regarding the kinetics of the response based on a range of 
known hedgehog target genes has been critical to the success of this project. Without this 
knowledge it is likely that timepoints within a matter of hours from treatment would have 
been selected, as is usually the case in fransfection studies. If it had not been shown that 
lOTl/2 cells have a cell density dependent component to their competence to respond to 
hedgehog that dramatically delays the response of any known pathway marker tested, then it 
is possible that new target genes may have been missed completely. 
In hindsight the work involving the subtracted library approach for detection of differentially 
expressed transcripts was conducted at too early a timepoint, as the libraries were constmcted 
before the discovery of density dependence was made. The choice of timepoint for this 
approach was made on the basis of Bmp2 expression data at an early stage that was later 
found to be artefactual (refer Chapter 4). By the time microarray work was initiated a much 
larger body of knowledge had been accumulated, as summarised in Chapter 3, and this 
ultimately made the discoveries of Chapter 5 possible. 
7.3 Power of the 10T1/2 system as a tool for 
hedgehog target gene discovery 
7.3.1 Plasticity of the 10T1/2 line and diverse nature of hedgehog 
target genes 
The corroboration of genes previously implicated in hedgehog signalling, along with the 
finding of novel targets, demonstrates both the validity and power of using the lOTl/2 system 
for Shh target gene discovery. The wide range of target genes found to be regulated by Shh in 
this cell type is probably a reflection of its pluripotent nature. A number of the targets, 
discovered either by microarray or via the candidate gene approach in Chapter 3, are known 
to be important in developing neural tissues (for example HNF-3fi). It will be interesting in 
fiiture studies to see if lOTl/2 cells have a role as progenitors of a tissue involved in neural 
development, or altematively if such genes play non-neural roles in embryonic mesoderm. 
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The use of lOTl/2 cells has allowed the identification of Shh target genes potentially involved 
in decisions of cell fate during embryogenesis. Few mammalian cell lines are known to be 
Hedgehog responsive, and those that are known tend to be differentiated cell types. These 
would be expected to have a more limited response profile in terms of the types of target 
genes able to be regulated. lOTl/2 cells, on the other hand, are known to have the ability to 
form a number of cell types including chondrocytes, osteoblasts, myoblasts and adipocytes. In 
particular, the large percentage of Shh stimulated lOTl/2 cells entering the osteoblastic 
lineage raises the possibility that some of the genes identified in this work may be involved in 
regulating embryonic bone development. It will be of interest in fiiture work to express flill-
length cDNA constmcts of each of the newly identified Shh target genes in lOTl/2 cells to 
see if any are sufficient themselves to induce an osteoblastic phenotype. 
Overall lOTl/2 cells have provided an ideal model system for investigation of the hedgehog 
response and fiiture studies with microarrays containing a large percentage of the mouse 
genome should allow even more detailed analysis of role of the transcriptional response to 
hedgehog signalling. 
7.3.2 Implications of the density dependence of 10T1/2 cells to the 
hedgehog response 
The discovery that lOTl/2 cells must reach a critical cell density before showing any 
detectable hedgehog response has interesting implications in terms of hedgehog pathway 
biology. It suggests that some critical event occurs in this cell type that acts as a switch to 
allow them to mount a fiill response to the Shh stimulus. It will be particularly interesting in 
future studies to attempt to understand this molecular mechanism. 
A number of mechanisms can be envisaged that could account for this phenomena. It may be 
that certain pathway components or essential cofactors are not expressed until a certain level 
of cell contact is reached. On the other hand the change might involve a post-transcriptional 
mechanism, such as the movement of essential factors spatially within the cell. Another 
hypothesis is that this competence to Shh may involve the direct interaction of a contact 
induced cofactor with the Smoothened protein. As discussed in Chapter 1, Smoothened has a 
stmcture highly reminiscent of a receptor molecule, though a ligand has never been identified. 
If this hypothesis were correct then lOTl/2 cells harvested at low and high density would 
provide negative and positive confrol populations for further studies. Methods that detect 
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protein interactions, such as yeast two hybrid screening, could then be employed to see if such 
a ligand could be isolated. 
The mechanism controlling the density dependence of the Shh response in lOTl/2 cells must 
act upstream of Glil, since expression of Glil can bypass the effect. Transient transfection of 
Glil results in an up-regulation of Pa/c/zet/transcription within six hours, a time at which the 
cells are still well below confluence. 
It is important to note that while the work in Chapter 3 has established that high cell density is 
essential for a full response to Shh in lOTl/2 cells, this does not preclude some as yet 
undiscovered aspects of the response still being present at earlier times. For this reason an 
open minded approach was taken in the microarray studies, with one timepoint investigated 
that was earlier than any responses had previously been detected. However, the early 
timepoint (24 hours) did not lead to the identification of any Hedgehog responsive genes. 
7.4 Comparison to recently published studies with 
related aims 
Two recent sttidies have also used microarrays to investigate aspects of the Hedgehog 
signalling pathway. Kato et al, (2001) transfected a neuroepithelial cell line, MNS-70, with a 
Shh expression constmct and screened chips containing 2304 mouse clones from day 14 
embryos and adult brain. From this work two Shh responsive genes were isolated: the metal-
binding protein Ceruloplasmin {Cp) and the serine protease inhibitor Inter-alpha-trypsin 
inhibitor heavy chain H3 {ITIH3). Both were confirmed using RT-PCR. The RT-PCR 
approach was extended to explore the response of these genes to Glil, though the resuhs of 
this procedure may not be conclusive given in that the results of Kato and colleagues appear 
to show that that Glil fransfection did not up-regulate Glil itself Neither of the genes 
reported in this paper had previously been reported as Shh targets. 
One criticism of the above study is that inadequate negative control populations were used to 
provide reference RNA for the microarray experiments, and that this deficiency was carried 
through to the "validation" procedure. In this fransfection based study, untreated cells were 
used as a reference population rather than cells that had also undergone the transfection 
procedure in parallel with a negative confrol plasmid. Microarrays are very powerful and do 
not discriminate between the origins of expression changes, they simply report them. While 
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the response of ITIH3 was shown to be regulated by Glil, Cp was not and while it may be a 
Gli independent target of Shh the authors have made no attempt exclude the possibility that 
Cp may be regulated by the stress of the transfection procedure itself, or as a general response 
to the introduction of foreign DNA. This study was quite preliminary, investigating a single 
timepoint without the support of any data as to why this particular timepoint was chosen. 
The second and more comprehensive study, Yoon et al, (2002), aimed to identify target 
genes regulated through Glil, and used transformed foci generated by stable Glil expression 
in a rat epithelial kidney cell line (RK3E) as a source of experimental material. In this case 
4608 rat UniGene clones were screened, revealing 30 differentially expressed targets (15 up-
regulated and 15 down-regulated). Seven of the genes (one of them being Patched) were 
independently verified, two were shown to display up-regulation in tumours with Gli 
amplification, and the rest were presented solely on the basis of microarray data. One 
substantial difference between the experimental design of Yoon et al, (2002) and the current 
study is that this work, while powerful in finding permanent gene expression changes in 
transformed foci cells, lacked the power to detect direct but transient expression changes 
which may not occur after long term continued stimulation. 
The genes identified in both of these previous studies are distinct from those reported in this 
work. This may reflect tissue specific pathway responses, differences in potency and timing of 
stimulation methods, or a lack of overlap between cDNA sets used in studies to date. 
A further study, Zhao et al, (2002), also involved microarray analysis of cells freated with 
Shh, though in this case the specific goal was to identify genes expressed in immature granule 
cell neuron precursors that were maintained by Shh expression. This study used mouse tissues 
and employed oligonucleotide rather than cDNA microarrays. From 13179 genes, 76 were 
reported as up-regulated. None of the eight new target genes discovered in this work were 
amongst these, and given the number of genes investigated in this work this may reflect 
differences between the genes regulated in neonatal cerebellum compared with pluripotent 
embryonic mesoderm. 
7.5 Future directions 
The findings of this work will provide a basis for a range of investigations to further 
understand the biological roles of the newly discovered hedgehog responsive genes. Such 
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Studies would initially involve a thorough investigation of the normal expression of the genes 
in developing mouse tissues, using techniques such as RT-PCR and in situ hybridisation, 
especially for genes such as Gilz where little expression data has previously been reported. 
Genes which show developmentally regulated expression in tissues known to be pattemed by 
hedgehog will be of particular interest for more detailed experiments. 
Expression studies in existing animal models of hedgehog pathway dismption will be a key 
aspect of future research. Such studies would provide useful information as to whether the 
new target genes are Shh responsive in tissues other than embryonic mesoderm. Systems of 
interest would include mice over- or under-expressing Shh in specific tissues, for example the 
spontaneous extra-toes mutant, which shows ectopic Shh expression in the developing mouse 
limb (Buscher et al, 1997), or man-made models such as that provided by Oro et al, (1997). 
Heterozygous and homozygous Patched knockout mice (Goodrich et al, 1997; Hahn et al, 
1998) and various Gli gene under- and over-expression models already reported in the 
literature would also be informative in assessing the status of the newly identified targets in a 
range of tissues. Long term studies could involve production of transgenic mice over-
expressing Shh target genes of interest. Specific promoters could be used, for example to 
target ectopic expression to skin in cases where expression studies suggest the gene may be of 
importance in BCC formation. In other cases knockout mice for Shh target genes that prove to 
be of particular research interest will be more relevant, and where not already in existence 
these could be produced. 
One limitation with complete knockout animal models is that these sometimes show dramatic 
phenotypes, and when gene function is critical to development this may be embryonically 
lethal. This is the case for mouse models of genes such as Shh and Ptc (refer Section 1.7) and 
some of the newly identified pathway targets may behave similarly. In such cases it is not 
possible to infer functions that the particular gene may have in older embryonic or adult 
tissues. To address this problem methods such as Cre-lox technology can be used to create 
"conditional knockouts", which ablate expression of the target gene only at a specific time 
and in a specific tissue of interest. Emerging methods, such as double-stranded RNA and 
morpholino antisense technologies, may potentially be employed for future spatial and 
temporal "transient knock down" studies of gene expression in vivo. For the newly identified 
target genes, and known components of the hedgehog pathway signalling mechanism, these 
methods may provide a more elegant and powerfiil means to examine gene function than is 
provided by a complete knockout model. 
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Studies in animal models would be complimented by an investigation of relative expression 
differences between normal and tumour tissues from human patients for selected target genes. 
In situ hybridisation of human homologues of the target genes will allow identification of 
those which show altered expression in BCCs and other NBCCS related tumours. Genes with 
known roles in cellular proliferation and apoptosis control, especially those which have 
historically received little research attention in studies of tumours, would be priorities for such 
analysis (for example Gilz, Sfrpl and Sfrp2). Consistent finding of altered expression for any 
of the targets would warrant mutation searching of the corresponding gene, if it occurred in 
tumours known not to harbour detectable mutations in other pathway genes such as Patched 
and Smoothened. This would help determine if any of the target genes can act as tumour 
suppressors or oncogenes in their own right. Mutations could be identified using single 
stranded conformational polymorphism analysis, chromatography methods or direct 
sequencing. 
Detailed functional studies would provide fiirther clues to the biological roles of each of the 
new hedgehog target genes. Further experiments in lOTl/2 cells, particularly with relevance 
to osteoblastic differentiation, are of interest. Over-expression of the target genes will show if 
any are sufficient to induce an osteoblastic phenotype in the absence of hedgehog stimulation. 
Bf2 would be of particular interest for such experiments, since it has homology with other 
proteins known to be involved in bone development. Osteoblast inducing molecules would 
provide key information about the mechanism of Shh mediated bone development, which is 
currently not well understood. Investigation of the response of each target gene after Shh 
stimulation in responsive tissue explants, or in cell lines other than lOTl/2, will be useflil in 
determining if the genes are also targets in other cell types. This could be assessed by northem 
blot or RNase protection assay analysis, or by employing a "mini" microarray chip to assess 
multiple targets at a time, to see if they warrant further investigation in the particular cell 
system. 
Other anticipated functional studies could involve identification of proteins physically 
interacting with the products encoded by the new target genes, using techniques such as yeast-
two-hybrid analysis or fluorescence resonance energy transfer. This would be of particular 
interest for molecules known to have protein-protein interaction motifs for which the exact 
partners are not known, such as Gilz and Laspl. 
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Studies investigating regulation of the Shh induced genes in this work could be extended to 
the protein level, for example using immuno-fluorescence analysis, in order to see if the 
changes at the mRNA level are indeed reflected in a detectable variation in the amount of 
corresponding protein produced by cells. Stimulation of lOTl/2 cells with Shh protein after 
treatment with cycloheximide would be useful to determine if any of the discovered Shh 
regulated genes are direct transcriptional targets. Similar studies in P19 (mouse embryonic 
carcinoma) cells have shown that induction of COUP-TFII by Shh does not require new 
protein synthesis, and it will be interesting to see if any of the eleven new targets are regulated 
similarly. For the genes found to be regulated by Glil it would be of interest to perform gel-
shift binding experiments or reporter activation assays with the discovered upstream motifs 
related to the Gli binding consensus sequence, to determine if they are indeed fimctional. 
There are a number of other findings from this work that warrant further investigation. The 
presence of a number of transcripts hybridising to the mouse Patched probe, at least three of 
which are induced by Shh stimulation, is intriguing, particularly since several are substantially 
shorter than the frill length mRNA. Isolation of cDNA clones corresponding to these 
transcripts and their subsequent sequence analysis would indicate whether these represent new 
genes with homology to Patched, or whether they represent altemate splice variants of 
Patched itself. If the latter is tme, then evaluating which motifs are missing from the resulting 
protein sequences, if they are indeed translated, will give clues to their putative function. 
Preliminary work has indicated that similar sized transcripts are present in other mouse tissues 
(data not shown). Isolation of a clone corresponding to the large Shh induced transcript 
hybridising with mouse Hip probes will also be of interest. Such issues would be able to be 
addressed after the constmction of a cDNA library from Shh stimulated lOTl/2 cells. Such a 
library would also provide a key resource for the isolation of fiill length clones corresponding 
to the newly discovered Shh regulated genes, in cases where such clones are otherwise 
unavailable. 
The establishment of a robust lOTl/2 based system for discovery of hedgehog target genes 
provides the opportunity for more detailed gene discovery studies. In particular, future 
microarray experiments, with a chips containing a much larger proportion of the mouse 
genome, should yield more Shh responsive genes. The experimental system will also provide 
a usefiil platform for studies comparing the set of target genes regulated by Shh with those 
controlled by Indian hedgehog and Dessert hedgehog. 
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7.6 Overall conclusions 
The reporting in this thesis of eleven Sonic hedgehog target genes, eight of them novel, in 
lOTl/2 cells provides a significant contribution to the current body of knowledge of the 
fiinction of the hedgehog pathway. In every case these genes were validated by multiple 
independent studies both in terms of the method of analysis and stimulation technique. In 
addition, the response of a number of downstream targets of Sonic hedgehog signalling 
implicated either by analogy to the pathway in the fruit fly, or known from other tissue 
systems, has been investigated. 
The finding that a number of the discovered hedgehog targets are regulated through Glil 
provides fiirther weight to there importance as Shh regulated genes. The discovery that Glil 
can not only cause up-regulation of Shh induced targets, but that it can also cause inhibition of 
the expression of Shh repressed targets provides evidence supporting initial observations by 
Yoon et al, (2002), suggesting that Glil has both activator and repressor actions. It is not 
known whether these actions are direct for the genes identified in this study, but the presence 
of sequences with close homology to the consensus Gli binding motif in upstream regions of 
these genes, some of them known from previous studies to bind Glil, suggests this may be the 
case. However, until fiinctional binding studies are conducted with the motifs identified in this 
work in the context of surrounding sequences, the direct nature of the regulation mechanism 
remains speculative. 
The approach taken in this work, of using cDNA microarrays in conjunction with a vigorous 
verification strategy to identify hedgehog target genes has proved pmdent. Microarray 
technology was used to investigate a number of pairwise comparisons at different time points, 
and with independent activation sfrategies. This provided a robust screening sfrategy whereby 
false positive genes unrelated to the biology of interest where minimised, and when they did 
occur they were readily identified and discounted. Microarrays used in this work contained a 
relatively small percentage of genes from the mouse genome, and future studies will be 
possible with substantially larger cDNA sets. Such studies will provide even more Hedgehog 
responsive genes, relieving a bottleneck that has hindered previous studies trying to 
imderstand the role of the hedgehog pathway. 
Overall the findings of this work have provided a substantial number of markers for use in 
fiirther studies of hedgehog pathway biology. In the past the lack of knowledge of such targets 
has limited our ability to understand both the mechanism and consequences of hedgehog 
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signalling in mammalian cells. In particular, the identification of novel Sonic hedgehog 
responsive genes provides clues as to how hedgehog pathway dismption causes 
developmental defects and tumour formation in humans. As well as providing fundamental 
knowledge on events in embryonic development, continuation of this work may ultimately 
pinpoint key potential targets for therapeutic intervention in cancer treatment. 
Chapter 8: Materials and Methods 
8.1 Source of materials 
8.1.1 General reagents and chemicals 
All chemicals were of Analar grade or equivalent, and in most cases were purchased 
from Sigma Chemical Co. (St Louis, USA). Restriction enzymes were sourced from 
New England BioLabs (Beverly, USA), while the sources of other specific enzymes 
were as stated in the following sections. Custom oligonucleotides were synthesised by 
Pacific Oligos (later renamed Genset; Brisbane, Australia) and Geneworks (Adelaide, 
Ausfralia). 
8.1.2 Radioisotope 
Radioisotope labelled nucleotide [a- PJdCTP was obtained from Geneworks (Adelaide, 
Australia). 
8.1.3 Microarray chips 
Glass microarray slides were a kind gift of Dr. L. Fowles, and were manufactured by Dr. 
L. Fowles and A. Forrest under the guidance of Dr. S. Grimmond (then at the 
Queensland Institute of Medical Research). Slide manufacture used a four pin arraying 
robot and involved printing onto poly-L-lysine coated glass slides using standard 
protocols (Grimmond et al, 2000), except that PCR amplification was performed using 
a small volume of bacterial culture as the template for each reaction. 
8.1.4 Tissue culture reagents and cell lines 
C3H/10T1/2 clone 8 cells were obtained from the American Type Culture Collection 
(ATCC; Manassas, USA) at passage 10. Cos7 cells were also from ATCC. HaCaT cells 
were from Dr. N. Fusenig and MC3T3-E1 cells were a gift of Dr. T. Martin. Reagents 
used in mammalian tissue culture are outlined in Section 8.3.11, and were all of cell 
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culture grade. Cells were grown on gamma irradiated disposable plastic ware (TPP 
brand. Life technologies. Paisley, UK). 
8.1.5 Bacterial strains 
The two following E. coli stains (obtained from Invitrogen, Carlsbad, USA) were used 
as standard hosts for storage and amplification of plasmid DNA (genotype indicated on 
right): 
ToplOF' F'[lact^ TnlO (Tet^)] mcrA A{mrr-hsdRMS-mcrBC) 
mOlacZAMlS MacXlA deoRrecAl araDl39 A{ara-leu)7697 
galU gallL rpsL end Al nupG 
DH5a F- O80/acZAM 15 A{lacZYA-arg¥)U 169 deoR recA I end A1 
hsdRll{r\i^', m^)phoA supEAA thi-l gyrA96 relAl X 
The following E. coli strain (obtained from Novagen, Madison, USA) was used for 
production of recombinant Shh protein: 
BL21 (DE3)pLysS ¥' ompT hsdSn (rs" ms") gal dcm (DE3) pLysS (Cm^) 
8.1.6 cDNA clones and gene expression constructs 
The source of plasmid vectors containing clones of key importance has been 
acknowledged as each constmct has been introduced in the main text. Further clones 
(used only as probes) are acknowledged in Section 8.5. 
8.2 Buffers, solutions and media 
Solutions were generally sterilised by autoclaving, except in cases where the 
components were not heat stable. In these instances sterilisation was achieved by passing 
solutions through 0.22 |j,m gamma irradiated filter units (from Millipore, Watford, UK). 
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8.2.1 Buffers 
TAE (DNA electrophoresis buffer). 50x stock 
2 M Tris-acetate, 50 mM EDTA 
TE (DNA storage buffer) 
10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
Phosphate Buffered Saline (PBS) 
Tablets were obtained from Amresco (Solon, USA). Final solution (pH 7.4) contained 
137 mM NaCl, 2 mM KCl with 10 mM phosphate buffer. 
Tris Buffered Saline (TBS) 
140 mM NaCl, 3 mM KCl, 25 mM Tris 
MOPS buffer (RNA electrophoresis buffer) 
0.2 M MOPS, 0.05 M Sodium acetate, 0.01 M EDTA, adjusted to pH 7.0 with Glacial 
acetic acid 
Tris-Glvcine mnning buffer (protein electrophoresis buffer) 
25 mM Tris, 192 mM Glycine, 0.1% SDS 
Saline Sodium Phosphate EDTA buffer (SSPE). 20x stock 
3.0 M NaCl, 0.2 M NaH2P04, 0.02 M EDTA, adjusted to Ph 7.4 with NaOH 
Church hybridisation buffer 
3.5% SDS, 325 mM Sodium dihydrogen orthophosphate, 0.5 mM EDTA, pH adjusted to 
7.2 with NaOH 
Orange loading buffer (for DNA/RNA electrophoresis), 6x 
0.25% orange-G dye in 30% (v/v) glycerol 
Blue loading buffer (for DNA/RNA electrophoresis), lOx 
0,25% bromophenol blue and 0.25% xylene cyanol dyes in 50% (v/v) glycerol 
210 Chapter 8: Materials and Methods 
Laemmli loading buffer (for protein elecfrophoresis), 5x 
67 mM Tris-HCl (pH 6.8), 2.2% SDS, 11% (v/v) glycerol, 0.1% bromophenol blue, 
5% (v/v) P-mercaptoethanol (added immediately before use). 
SDS gel-loading buffer (for cell Ivsis and protein electrophoresis), 2x 
100 mM Tris-HCl (pH 6.8), 4% SDS, 20% (v/v) glycerol, 0.2% bromophenol blue, 
200 mM DTT (added immediately before use). 
Mammalian cell lysis buffer 
100 mM Tris-HCl pH 8.8, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 100 i^g/ml 
Proteinase K (added immediately before use). 
8.2.2 General solutions and reagents 
Denhardt's solution (50x stock) 
1% (w/v) Bovine semm albumin (BSA), 1% (w/v) Ficoll 400, 1% (w/v) 
Polyvinylpyrrolidone in sterile water. Solution was not sterilised, but was kept in 
aliquots at -20°C and thawed immediately prior to use. 
Sheared salmon sperm DNA 
Lyophilised salmon sperm DNA (Sigma Chemical Co., St Louis, USA) was resuspended 
in sterile water at 10 mg/ml (by heating to 65°C for several hours), then sonicated 
(approximately 10 minutes in 30 second bursts) until in the 100 to 3000 base pair range. 
Solution aliquots were stored at -20°C and denatured by heating to 100°C for 5 minutes 
immediately prior to use. 
20x SSC 
3 M NaCl, 0.3 M tri-Sodium citrate, adjusted to pH 7.0 with HCl. 
Water saturated phenol 
Crystalline phenol (Wako Pure Chemical Industries, Osaka, Japan) was melted at 65°C, 
followed by addition of an approximately equal volume of RNA grade water. After 
mixing well the phases were allowed to separate for several hours, the aqueous phase 
was removed, and the procedure repeated two fiirther times. After the final separation 
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much of the aqueous phase was removed, leaving about 1/5 the volume of water. 
Aliquots were frozen in polypropylene tubes at -20°C. 
4% Paraformeldehvde (PFA) 
PFA used for fixation of mammalian cells was made as an 8% (w/v) stock in water, and 
heated at 65°C until dissolved. Aliquots were stored at -20°C and thawed on the day of 
use. An equal volume of 2x PBS was added to give a 4% PFA/lx PBS working solution. 
Coomassie blue protein staining and destaining solutions 
0.25% Coomassie brilliant blue in 45% (v/v) Methanol, 10% (v/v) Glacial acetic acid 
[Destain is same solution without Coomassie brilliant blue.] 
Turbo Juice 
2x SSC, 5% SDS 
Solution D 
4M guanidine thiocyanate, 25 mM sodium citrate (pH 7.0), 0.5% sarcosyl with 0.1 M 
P-mercaptoethanol added immediately prior to use. 
This solution was not autoclaved (forms toxic fiimes if heated). It was stored at 4°C, 
protected from light. 
8.2.3 Media 
General bacterial growth media 
Liquid Luria Bertani (LB) broth was made from powder (USB Corporation, Cleveland, 
USA), as per the manufacturers instmctions, and sterilised by autoclaving. For plates 
agar was added at 15 g/1. When required for selection, ampicillin was added at 
100 |j,g/ml. For "blue-white" (beta-galactosidase a-complementation) screening of 
colonies 1 mg of IPTG (in aqueous solution) and 1 mg of X-gal (in dimethylformamide) 
were top spread on solidified 10 cm diameter LB plates. 
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Hanahan SOC Media (for incubation of .g. coli cells post transformation) 
2% Bactotiyptone, 0.5% Yeast exfract, 8.5 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
sterilised by autoclaving. 10 mM MgS04 and 20 mM Glucose added just before use 
from sterile solutions. 
Growth media for mammalian cell culture 
All reagents were cell culture grade and Gibco BRL brand (Life technologies. Paisley, 
UK) unless otherwise stated. Details of specific media are given in Section 8.3.11. 
8.3 Procedures and Techniques 
8.3.1 DNA extraction and purification 
Small scale plasmid DNA preparation ("miniprep") 
Bacteria harbouring plasmids of interest were sfreaked to ensure single colonies, which 
were used to inoculate 5 ml LB/Amp broth and grown ovemight (37°C, shaking 
225 rpm). Plasmid DNA was isolated by alkaline lysis followed by binding to silica, 
using the Ulfraclean mini plasmid preparation kit (Mo Bio Laboratories Inc., Carlsbad, 
USA), and re-suspended in 10 mM Tris (pH 8.0). 
Large scale plasmid DNA preparation ("maxiprep") 
Bacteria harbouring plasmids of interest were sfreaked to ensure single colonies, which 
were used to inoculate 5 ml LB/Amp broth, and incubated approximately 10 hours 
(37°C, shaking 225 rpm). Starter was used to inoculate 250 ml of LB/Amp and grown 
(with shaking) ovemight. Cells were spun down and media removed before bulk plasmid 
purification using "Jetstar maxi" columns (Genomed, Bad Oeynhausen, Germany) as per 
the manufacturers instmctions, prior to re-suspension in TE and storage at -20°C. 
"Heat and Spin" PCR grade plasmid DNA preparations from bacterial colonies 
This method was used to obtain DNA to rapidly screen large numbers of transformed 
colonies for a sequence of interest by PCR, for which cmdely prepared plasmid was 
sufficient. Half the bacterial mater from each colony of interest (grown over night on 
LB/Amp plates) was transferred to a tube containing 100 |j,l sterile water. This was 
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mixed, heated at 95 °C for 5 minutes, vortexed vigorously, chilled on ice, then spun at 
12 000 g for 5 minutes. 1 /il of supematant was subsequently used in each 20 jiil PCR 
screening reaction. 
Phenol-chloroform DNA purification 
DNA to be purified was extracted once with tris equilibrated phenol (pH 7.9), once with 
a mixture of tris equilibrated phenol/chloroform/isoamyl alcohol (25:24:1 v/v), and once 
with chloroform/isoamyl alcohol (24:1 v/v). Each exfraction involved mixing the DNA 
solution with the exfraction mixture by vortexing, followed by separation of phases by 
centrifiigation (12 000 g for 15 minutes) and recovery of the aqueous phase. 
DNA precipitation 
DNA precipitation was generally performed by adding 1/10 volume of 3M sodium 
acetate (pH 5.2) and 2 volumes ethanol, followed by precipitation at -20°C. DNA was 
recovered by centrifiigation (12 000 g for 20 minutes), then washed with 70% ethanol. 
DNA was dried prior to re-suspension as required. 
General PCR product and enzvmatic reaction purification 
Purification of PCR amplified DNA was carried out with the Ulfraclean PCR clean-up 
kit (Mo Bio Laboratories Inc., Carlsbad, USA), as per the manufacturers instmctions. 
Procedure was based on DNA absorption to silica column filters. DNA from enzymatic 
reactions was frequently purified using the same procedure. 
Post-agarose gel purification 
DNA from bands excised from agarose gels was purified by binding to glass milk after 
dissolving agarose in Nal solution, using the GeneClean procedure (Biol 101, La Jolla, 
USA), as per the manufacturers instmctions. 
Buccal cell "PCR quality" human DNA preps 
Genotj^jing of human DNA was performed on PCR products amplified using buccal cell 
DNA as a template. DNA was obtained from inner cheek scrapes using disposable 
plastic fransfer pipettes. Recovered material was mixed with 1 ml of PBS and spun for 5 
minutes at 800 g, resuspended again in 1 ml of PBS and spun again. The cell pellet was 
resuspended in approximately 40 /il of PBS, followed by 300 /il of mammalian cell lysis 
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buffer, and incubated at 37°C ovemight prior to purification by ethanol precipitation 
(without additional salt). After washing, the pellet was resuspended in 30 /xl of water and 
3 /il was used per PCR reaction. 
8.3.2 Quantification of nucleic acid concentration 
Nucleic acids were quantified by spectrophomeric absorbance measurement at 260 nm 
against an reference blank of the appropriate resuspension solution. The 260 nm/280 nm 
absorbance ratio was used for assessment of purity. The following conversions were 
used for concentration determination (for spectrophotometer path length of 1 cm): 
Concentration of DNA = A260 x 50 ng//il 
Concentration of RNA = A260 x 40 ng//il 
Altematively, DNA concentration was estimated by comparison to standards of known 
mass (Gibco BRL "low DNA mass ladder". Life Technologies, Paisley, UK) mn in 
parallel on ethidium bromide stained agarose gels. 
8.3.3 General molecular techniques for cloning and manipulating 
DNA sequences 
Unless otherwise stated, all standard molecular manipulations were performed as in 
Sambrooke?a/.,(1989). 
Agarose gel electrophoresis 
Nucleic acids were separated in agarose gels submersed in Ix TAE buffer and nm at 50 
to 125 V. Agarose was sourced from Amresco (Solon, USA) or Progen Indusfries 
(Brisbane, Australia). Agarose concenfration depended on the expected size range of 
DNA under analysis (0.8 to 1.5%). Nucleic acid was stained with ethidium bromide (0.5 
/ig/ml) prior to viewing under UV light. For separation of DNA prior to ligation 
reactions 0.65% low melt agarose (Progen Industries, Brisbane, Ausfralia) was used. 
Restriction digests 
Restriction enzyme digests were performed as per the enzyme manufacturers 
recommended conditions (New England BioLabs, Beverly, USA). 
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End filling of protmding single stranded DNA termini 
DNA (in any of the four standard New England BioLabs restriction enzyme buffers 
supplemented with 33 |xM each dNTP) was incubated for 15 minutes at 25 °C with DNA 
polymerase I large Klenow fragment (1 U/|j,g DNA, New England BioLabs, Beverly, 
USA) in order to fill in bases complementary to 5' overhangs. This created blunt ends 
where required for subsequent ligation reactions. 
Ligation of DNA fragments 
General ligations were carried out using T4 DNA Ligase (New England BioLabs, 
Beverly, USA) using the manufacturers recommended protocol. Gel derived fragments 
were ligated directly in low melt agarose, which was melted and mixed with buffer and 
enzyme. Blunt ligations were incubated at room temperature, while reactions involving 
complementary sticky overhangs were incubated at between 10 and 16°C (depending on 
overhang base composition). Where necessary, digested plasmid vectors were 
dephosphorylated using Shrimp alkaline phosphatase (Boehringer Mannheim, 
Mannheim, Germany). PCR derived products were ligated by means of generated 3'T 
overhangs into the "pGEM-T Easy" vector (Promega corporation, Madison, USA) using 
the supplied buffer and enzyme at 4°C. 
8.3.4 Establishment of RNase free conditions 
Preparations to avoid RNase degradation of RNA 
All equipment that came into direct contact with RNA during its manipulation was 
treated to remove any RNase activity. Reusable plastic ware and elecfrophoresis tanks 
were decontaminated by 10 minutes contact with 3% H2O2. Glassware was baked for 
8 hours at 180°C. Sterile disposable plastic ware was assumed RNase free. 
DEPC treatment of water and solutions 
RNase free water was prepared by addition of 0.02% DEPC, residual traces of which 
were removed by autoclaving after ovemight reaction. Solutions for RNA work were 
made in sterile RNase free bottles from sterile RNase free components and were not 
autoclaved. 
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8.3.5 RNA extraction and purification 
RNA was prepared by several altemative techniques depending on the intended use. 
"Solution D" method for total RNA preparation 
RNA was prepared using the method of Chomczynski and Sacchi, (1987). Briefly, tissue 
or cultured cells were homogenised with Solution D prior to addition of 1/10 volume 2 
M sodium acetate, 1 volume of water saturated phenol and 1/5 initial volume of 
chloroform/isoamyl alcohol (24:1 v/v). After chilling and subsequent centrifiigation at 
4°C (15 minutes at 12 000 g) the aqueous phase was recovered. RNA was precipitated 
with an equal volume of isopropanol, washed in 70% ethanol, then resuspended in 
solution D for a second isopropanol precipitation. The final pellet was resuspended in an 
appropriate volume of RNase free water. 
RNeasy total RNA preparation 
For microarray and northem blot analysis, cells were washed with PBS prior to lysis 
directly on culture plates with buffer "RLT" (Qiagen, Hilden, Germany). Lysates were 
stored at -80°C prior to purification using the RNeasy procedure (Qiagen, Hilden, 
Germany), as per the manufacturers instmctions. RNA was eluted in RNase free water 
ready for use in subsequent procedures. Residual DNA contamination was avoided by 
including a DNase digestion step during purification (using RNase free DNase I, Qiagen, 
Hilden, Germany). 
Poly(A)"^ RNA purification 
Poly(A)'^  RNA was used in the constmction of subtracted libraries and for northem blot 
analysis of lowly expressed franscripts. Total RNA was prepared using one of the above 
techniques, and after quantification was purified by oligo(dT) cellulose chromatography 
using the Message Maker reagent assembly (Gibco BRL, Life Technologies, Paisley, 
UK). Two rounds of selection were performed. Efficiency of purification was assessed 
after quantification by separating equal amounts of total and poly(A)"^ purified RNA by 
gel elecfrophoresis and observing the reduction in ribosomal RNA present. 
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8.3.6 PCRandRT-PCR 
Polymerase chain reaction (PCR) 
PCR was performed using 1 U Taq DNA polymerase (Boehringer Mannheim, 
Mannheim, Germany) and 2.5 ng/|j,l of each oligonucleotide primer per 20 |xl reaction. 
Reactions were performed under mineral oil in thin walled tubes. Standard buffer was 
20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCb, 0.2 mM each dNTP. Peltier 
thermal cycling was performed in the PTC-200 "DNA Engine" (MJ Research, 
Watertown, USA). 
cDNA svnthesis 
Total RNA was reverse transcribed to cDNA using Moloney murine leukaemia vims 
reverse transcriptase (M-MLV; Invitrogen, Carlsbad, USA). Reactions with 1 |xg total 
RNA input were performed in a 30 p-l volume with 100 U of enzyme. Reaction buffer 
contained 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 6.5 mM MgCb, 0.83 mM each dNTP 
and 90 U/|xl random hexamers (Amersham Pharmacia, Little Chalfont, UK). Synthesis 
was performed at 42°C for 1 hour. Produced cDNA was stored at -20°C. 
Reverse Transcription - Polvmerase chain reaction (RT-PCR) 
Reactions were performed as for standard PCR (above), except that buffer with reduced 
Mg^ was used so that the high level of carryover Mg"^ from the cDNA synthesis step 
did not take the Mg"^ level out of its normal working range. Between 0.5 and 6 i^l of 
cDNA was used per 20 i^l PCR reaction, as optimised for the primer set of interest. 
8.3.7 Transformation of plasmid DNA into E. Coli 
Plasmid constmcts were infroduced into chemically competent E. coli cells prepared 
using the method of Inoue et al, (1990). DNA of interest was added to cells, chilled on 
ice for 20 minutes, then heat shocked at 42°C for 1 min. Cells were immediately 
retumed to ice for 2 minutes prior to the addition of 900 p,l of SOC media and outgrowth 
without antibiotic for 1 hour (37°C, shaking 225 rpm). Cells were then plated on 
LB/Agar plates containing the appropriate antibiotic (usually ampicillin), and where 
appropriate reagents for blue-white screening (refer Section 8.2.3). After incubation of 
plates (37° ovemight) colonies were picked and streaked to ensure pure isolates were 
obtained. 
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For long term storage of plasmids in E. coli, glycerol (final concentration 20% v/v) was 
added to a small volume of ovemight culture to prior to storage at -80°C. Ahematively, 
cells were grown directly in LB media containing 10% glycerol prior to freezing. 
8.3.8 "Turbo" hybridisation screening of transformed bacterial 
colonies 
This rapid colony screening technique (adapted from Buluwela et al, 1989) was used to 
identify ligated constmcts of interest after bacterial transformation, and also as a method 
to fiher out undesirable colonies containing hedgehog sequences in the analysis of 
subtracted libraries. 
Colonies of interest were inoculated onto LB agar plates and grown at 37°C ovemight. 
Plates where either made in duplicate, with one being used for lifts and the other as an 
archive, or altematively a single plate was inoculated. For single replicate plates a short 
(~3 mm) streak was made with the agar surface broken at one end, so that some bacteria 
would remain after lifting. Dry uncharged nylon filters (Osmonics, Minnetonka, USA) 
were laid onto the warm (at least room temperature) agar plates and allowed to suck 
down onto the surface. A needle stab pattem was made to allow later alignment. After 
two minutes filters were carefully peeled from the plates, and placed colony side upon 
gel blotting paper (GB002; Schleicher & Schuell, Dassel, Germany) dampened with 
Turbo Juice (2x SSC, 5% SDS). Filters were microwaved for two to four minutes, until 
all liquid had evaporated and membranes were extremely dry and curled. Denatured 
DNA was now bound to the membrane and no further treatment was required. Purified 
plasmids were able to be investigated directly using a modification of the procedure 
whereby 1 ^1 of miniprep DNA was spotted directly onto dry membrane then tteated as 
above. 
Membranes were pre-hybridised for at least one hour in Church hybridisation buffer at 
65°C. The liquid was changed (to remove bacterial debris and salts) prior to addition of 
radioactive probe (labelled as for northem blotting), and hybridised for at least four 
hours (or ovemight). Membranes were washed five times for approximately 15 minutes 
with large volumes of O.lx SSC/0.1% SDS. Probe preparation and autoradiography was 
as for northem blots (see below). 
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8.3.9 DNA sequencing 
DNA sequencing was performed using ABI Prism dye terminator cycle sequencing 
(Perkin Elmer, Wellesley, USA) as per the manufacturers instmctions (based on the 
principle of Sanger et al, 1977). Completed reactions were electrophoresed and scanned 
by the Australian Genome Research Facility. 
8.3.10 Northern blotting and hybridisation 
Preparation and radioactive labelling of cDNA probes 
DNA sequences to use as probes were prepared either from purified PCR products or 
DNA isolated from agarose gel bands. Each labelling reaction used 25 ng of DNA as a 
template, which was radioactively labelled using Rediprime II (Amersham Pharmacia, 
Little Chalfont, UK), as per kit instmctions. 50 |j,Ci of [a-''^P]dCTP was used for each 
labelling reaction. 
After incubation, unincorporated nucleotides were removed using Sephadex-G50 
columns. These were formed just before use by adding 1 ml of Sephadex-G50/3x SSC 
slurry to a 1 ml disposable syringe, then spinning at 450 g for 5 minutes. 150 p.1 of 3x 
SSC was added to each labelling reaction to give a total volume of 200 |xl. This was 
added to the top of the compacted column and collected into a fresh tube by spinning 
again as above. 
Probe incorporation was checked by holding tube containing the purified probe exactly 
20 cm from a Geiger counter and comparing cps to that of the reaction prior to 
purification. (This method provides only a cmde estimate of incorporation, but is 
sufficient to detect occasional poorly labelling probes that have to be remade.) 
Elecfrophoretic separation and capillary transfer to membrane 
Total RNA was prepared using the RNeasy RNA isolation kit (Qiagen, Hilden, 
Germany), with poly(A)"^ isolated using "Message Maker" (GIBCO BRL, Life 
Technologies, Paisley, UK) when required. 10 jig total, or 2 pg poly(A)"^ RNA, was used 
per lane, and loaded in 50% formamide/6% formaldehyde/Ix MOPS buffer/lx "blue 
loading buffer" prior to elecfrophoresis on 1% agarose/3% formaldehyde/Ix MOPS gels. 
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Size estimates were made by including 0.24 to 9.5 kb RNA ladder (Gibco BRL, Life 
Technologies, Paisley, UK) in one lane to provide molecular weight standards (cut off 
and ethidium bromide stained prior to transfer step). RNA was moved to uncharged 
Magna nylon membrane (Osmonics, Minnetonka, USA) by capillary transfer in 20x SSC 
(ovemight). After transfer the membrane was washed in 2x SCC, then baked at 80°C for 
2 hours before being cross-linked with 120 mJ of light in a UV multilinker (Ultra-Lum 
Inc., Claremont, USA). 
Northem hvbridisation procedure 
Pre-hybridisation (4 hours) and hybridisation (ovemight) were performed in 5x SSPE, 
5x Denhardt's solution, 0.5% SDS in 50% formamide at 42°C, with 125 pg/ml heat 
denatured salmon sperm DNA added immediately prior to use. Extensive washing was 
performed at hybridisation temperature, using solutions in the range of 3x SSC/0.1% 
SDS (low stringency) to O.lx SSC/0.1% SDS (high stringency), with final washing 
concentration dependent on the probe of interest. 
Band detection, normalisation and densitometrv 
Bands were detected by autoradiography using Fuji "SuperRX" medical x-ray film and 
Kyokko High Plus intensifying screens (both from Fuji Photo Film Co., Tokyo, Japan). 
Autoradiographs were quantified using a GS-700 imaging densitometer (Bio-Rad, 
Hercules, USA) and Molecular Analyst 1.0.2 software (also from Bio-Rad). A 600 bp 
fragment of mouse GAPDH cDNA was used as a "loading control" probe for 
normalisation of differences in RNA amounts attached to the membrane between 
different samples on each blot. Such differences can occur because unequal amounts of 
RNA are initially elecfrophoresed (this was minimised in by spectrophotomeric 
quantification of all samples) or because capillary ttansfer efficiency is not uniform 
across the gel. The GAPDH conttol also addresses variations in the level of covalent 
bond formation to the membrane occurring post-transfer (such as those caused by 
shadows or gradients during UV cross-linking). GAPDH was chosen for northem blot 
normalisation as preliminary experiments (data not shown) indicated that GAPDH 
mRNA levels in the cell lines used were not significantly altered by Shh stimulation. 
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Probe stripping and blot storage 
After detection, radioactive blots were striped by placing them in near-boiling 0.1% SDS 
with gentle shaking, after which they were checked ovemight against x-ray film to test 
for residual radioactivity. Blots were always stored damp (in 0.1% SDS) at -20°C, prior 
to reuse. 
8.3.11 Culture and manipulation of mammalian cell lines 
General culture conditions 
lOTl/2, HaCaT, MC3T3-E1 and Cos7 cells were maintained in Dulbecco's modified 
Eagle's medium (DMEM; Gibco BRL, Life Technologies, Paisley, UK) supplemented 
with sfreptomycin (50 |ig/ml, Gibco BRL), penicillin (50 U/ml, Gibco BRL, Life 
Technologies, Paisley, UK), additional glutamine (2 mM, Gibco BRL, Life 
Technologies, Paisley, UK) and heat inactivated "Semm Supreme" (9.1%, 
BioWhittaker, Walkersville, USA). Cells were passaged after dissociation with 0.05% 
Trypsin/0.53 mM EDTA/lx PBS (Gibco BRL, Life Technologies, Paisley, UK) using 
standard techniques. In the case of HaCaT cells pre-treatment with 5 mM EDTA in PBS 
was required prior to trypsinisation. Cells were generally split at between 1 in 10 and 1 
in 20, with the exception of lOTl/2 cells for which stock cells were plated at 2000 
cells/cm^. To avoid the build up of differentiated cells and spontaneous non-contact 
inhibited transformants, lOTl/2 cells were never allowed to reach confluence and 
discarded at passage 20. All manipulations were performed in a class II biological safety 
cabinet. Cells were maintained at 37°C in a 5% CO2 atmosphere. For long term storage, 
cell lines were maintained above liquid nitrogen in culture medium containing 10% v/v 
DMSO (5% for lOTl/2), with additional serum added where necessary. 
Transfection of expression constmcts into mammalian cell lines 
For transient transfection, expression constmcts were introduced into cells by liposome 
mediated delivery. Liposomes were formed using Plus reagent and Lipofectamine 
(Gibco BRL, Life Technologies, Paisley, UK), as per the manufacturers protocol. 
Conditions for optimal transfection efficiency were determined by freating cell lines of 
interest with a constmct encoding a protein for which a plentiful antibody was available, 
using a range of DNA and Lipofectamine concenttations. Immuno-fluorescence 
detection and DAPI counterstaining were performed to determine the percentage of 
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successfully ttansfected cells in each case, in order to determine optimal transfection 
conditions. For lOTl/2 cells the maximum ttansfection efficiency under optimised 
conditions in preliminary experiments was around 30 percent, though this did show 
considerable variation from experiment to experiment. Cells were ttansfected in the 
absence of semm. The time of liposome addition was considered "time zero" in all 
experiments. After liposome treatment (3.5 hours) cells were washed with PBS and 
retumed to normal growth media (without antibiotics). For experiments involving RNA 
harvest cells were grown in 55 cm^ dishes, which were randomly assigned to treatment 
or conttol groups prior to ttansfection. For microarray and northem blot RNA harvests 
lOTl/2 cells were transfected with 4.6 fig of DNA per 55 cm^ dish, using 16.5 pi of Plus 
reagent and 27 pi of Lipofectamine. 
Transfection for stable cell line generation was performed as for ttansient ttansfection, 
except that 1/10 the amount of a G418 resistance plasmid (a gift of T. Evans) was 
transfected along with the constmct of interest. G418 (Gibco BRL, Life Technologies, 
Paisley, UK) selection was begun one day after ttansfection, using an appropriate 
concenttation determined previously from "kill-curve" investigations on sensitive cells. 
Direct stimulation of cells with Sonic hedgehog 
Recombinant protein experiments were performed using 100 nM Shh, an amount above 
Patched binding saturation levels from kinetic studies (Marigo et al, 1996a). Cells were 
kept in growth media appropriate to the cell line under investigation. When using Shh 
conditioned media this was diluted 1:1 with fresh growth media and incubated with 
cells. Negative conttols were always employed, which consisted of the appropriate 
protein resuspension/storage buffer in the case of recombinant protein, or pair-matched 
media collected after expression of a mutant control constmct in the case of Shh 
conditioned media. 
Isolation of primary murine neonatal keratinocvtes 
Primary cultures of mouse epidermal keratinocytes were established and maintained 
using a protocol based on the Rheinwald and Green technique (Rheinwald and Green, 
1975; Rheinwald, 1989; Leigh and Watt, 1994), with modifications as described in 
Jones, S. J. et al, (1997). Skin was dissected from euthanased 1 to 2 day old 
Quackenbush-Swiss mice, divided into 6 pieces, and incubated ovemight in Dispase 
solution containing 2.5% Bacillus polymyxa Dispase (equivalent to 22.5 U/ml final 
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concentration; Gibco BRL, Life Technologies, Paisley, UK), 0.02 mg/ml Gentamicin 
(Sigma, St Louis, USA), 100 U/ml Penicillin, 100 pg/ml Streptomycin, 8 pg/ml 
Fungizone (all from Gibco BRL, Life Technologies, Paisley, UK) and Ix PBS. This 
allowed separation of epidermis from dermis. 
Epidermal cell sheets were then passed repeatedly though a large bore plastic pipette for 
5 minutes, during which time the cells were dissociated with 0.05% Trypsin/0.53 mM 
EDTA/1 X PBS at room temperature. After neutralisation, cells were collected by 
centrifiigation (200 g for 8 minutes), and washed with PBS (a procedure that was 
repeated three times). Cells were resuspended in "3:1 keratinocyte selection media" (see 
below), counted, and plated at 4x10^ cells per 55 cm^ dish. Culture dishes were coated in 
rat tail collagen (Boehringer Mannheim, Mannheim, Germany) before use. Cells were 
cultured without a feeder layer and used for experiments without further passaging. 
Cultures were incubated at 37°C in 5% CO2, with the media changed after 24 hours to 
Keratinocyte semm free media without calcium, with the supplied epidermal growth 
factor and bovine pituitary extract supplements added as per the manufacturers 
instmctions (k-SFM; Gibco BRL, Life Technologies, Paisley, UK). Media was 
subsequently changed every two days and experiments initiated when the cells 
approached confluence. 
3:1 keratinocyte selection media: 
Major media components were DMEM and Ham's F12 media at a ratio of 3:1, with 
foetal calf semm added to a final concentration of 9.1% (all major components supplied 
by Gibco BRL, Life Technologies, Paisley, UK). The following supplements (all from 
Sigma, St Louis, USA) were added to the base media: 4.5 pg/ml Transferrin, 4.5 pg/ml 
Insulin, 7.6 ng/ml Cholera toxin, 0.2 pg/ml Hydrocortisone, 30 pg/ml adenine and 20 
pg/ml Gentamicin, 
8.3.12 Production of recombinant Sonic hedgehog protein 
Production of rShh protein in Cos7 
Constmct pShh-N-PMT21 (codons 1-198 of the mouse Shh cDNA encoding the 
N-terminal active region) was transfected into Cos7 (SV40 transformed African green 
monkey kidney cells) as described in Section 8.3.11. Both the pShh-N-PMT21 constmct 
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and protocol for rShh production in Cos7 cells were provided by the late Dr. T. Yamada. 
Briefly, media was changed 24 hours after transfection to semm free Optimem media 
(Gibco BRL, Life Technologies, Paisley, UK), without additives. Other altemate media 
were tried, such as kSFM or DMEM, but westem blotting indicated this was ineffective 
compared with the high yields obtained using Optimem. Cells were allowed to grow for 
a fiirther 48 hours prior to harvest of the collection media. Cell debris was removed by 
centtifugation (250 g for 5 minutes) and the media concenttated 50 fold using Centriprep 
columns (10 000 molecular weight cut-off "YM-10" from Millipore, Watford, UK) as 
per the manufacturers instmctions. Produced rShh was stored in small aliquots at -80°C 
until required. Quantification was performed by comparison to a series of BSA mass 
standards mn in parallel by acrylamide gel electrophoresis. 
Production of rShh protein in E. coli cells 
An expression vector for production of Shh in bacteria, pETmShhl98[6HisT-pETlld] 
(encoding amino acids 25-198 of the mouse protein and an attached hexa-histidine tag), 
was kindly provided by Dr. A. McMahon, and was derived from the parent plasmid 
pETlld from Novagen (Madison, USA). Recombinant Shh protein production and 
purification was performed as described in the manufactures instmctions for the pET 
system (Novagen, Madison, USA) with specific conditions as in Marti et al, (1995). 
Briefly, this involved transforming the above constmct into E. coli strain 
BL21(DE3)pLysS, and inducing Shh expression in 50 ml LB cultures using IPTG. 
Harvested cells were sonicated, filtered, and mn on "His-Bind" resin columns (Novagen, 
Madison, USA) where the hexa-histidine tag bound to divalent nickel cations in the 
matrix, allowing protein purification and concentration. After extensive washing, 
recombinant protein was eluted by addition of imidazole. Collected fractions containing 
rShh protein were pooled and dialysed using "Slide-A-Lyzer" cassettes (Pierce, 
Rockford, USA), prior to storage of small aliquots at -80°C. Quantification was 
performed as above. 
Production of conditioned media containing Shh in lOTl/2 cells 
For production of rShh conditioned media from lOTl/2 cells, transfections were 
performed as outlined in Section 8.3.11 (using the Shh expression and null-mutant 
plasmids described in detail in Section 3.4). Protein was secreted into standard growth 
media without added antibiotics (DMEM/9.1% heat inactivated semm supreme/2 mM 
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additional glutamine), that was added after liposome removal. Media was collected 3 to 
4 days post-transfection and centrifuged at 3000 g for 5 minutes to remove cell debris, 
prior to storage at 4°C. Media from a number of production plates was pooled to give a 
large volume stock to ensure stimulation with an equal concentration of Shh in all 
experiments. This was tested in lOTl/2 cells and shown to be potent in inducing AP 
activity. The activity of conditioned media produced by this method was found to be 
quite stable when stored at 4°C, and achieved consistently higher levels of AP induction 
than 1 pg/ml of commercial recombinant Shh protein (#461-SH, R&D systems Inc., 
Minneapolis, USA) when small scale 7-day quantitative assays were performed in 
parallel. 
8.3.13 Immuno-fluorescence studies in adherent cell lines 
Cells were grown on glass coverslips that were removed from culture dishes for analysis. 
Cells were fixed for 1.5 hours with 4% PFA, washed with Ix PBS/0.5 BSA, treated with 
PBS containing 0.1% Triton-X-100 for 5 minutes. After washing again in Ix PBS/0.5 
BSA, cells were incubated in the same solution with the primary antibody (ovemight at 
4°C). After washing, cells were incubated with an appropriate secondary antibody (1 
hour at room temperature), before staining nuclei with DAPI, washing again, then 
mounting in 0.1% N-propyl gallate/50% glycerol/lx PBS. Immuno-fluorescence was 
detected using an Olympus AX70 microscope and photographed on Kodak fihn. The 
antibody to Patched (a-Ptc chicken-23) was kindly provided by Dr. C. Wicking, while 
that to Smoothened (a-Smoothened rabbit-"Edith") was a gift of the late Dr. M. Gailani. 
8.3.14 Protein harvesting, electrophoresis and western blotting 
Total protein was obtained from cultured mammalian cells using standard methods 
(Sambrook et al, 1989). Briefly, cells were lysed in SDS gel-loading buffer, with 
sonication and boiling performed when necessary prior to electrophoresis. Purified or 
concentrated rShh protein was analysed by directly adding solutions containing it to 
Laemmli loading buffer. Size was estimated by comparison to molecular weight 
standards (Kaleidoscope pre-stained standards (Bio-Rad, Hercules, USA), or Benchmark 
pre-stained protein ladder (Gibco BRL, Life Technologies, Paisley, UK)). 
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Protein separation was performed on poly-acrylamide gels using standard dual layer 
vertical electtophoresis (refer Sambrook et al, 1989). Separating gels contained 375 mM 
Tris-HCl (pH 8.8), 0.1% SDS and typically used 12% bis-acrylamide that was 
pol)mierised in the presence of ammonium persulphate (APS) and N,N,N',N'-
tettamethylethylenediamine (TEMED). Stacking gel was polymerised similarly, except 
that 500 mM Tris-HCl (pH 6.8) was used and bis-acrylamide concentration was 3.5%. 
Gels were mn in Tris-Glycine mnning buffer (at 40 mA), prior to either Coomassie 
staining or westem blotting. 
Westem blotting was performed by ttansfering separated proteins onto "Hybond-C 
extta" supported nitrocellulose membrane (Amersham Pharmacia, Little Chalfont, UK) 
using a Sartoblot apparatus (Sartorius, Goettingen, Germany), as per the manufacturers 
instmctions. Membrane was blocked in PBS containing 5% skim milk powder and 0.1% 
Tween-20 (4°C ovemight), prior to primary antibody incubation in the same solution (1 
hour at room temperature). Membrane was then washed with PBS containing 1% heat 
inactivated normal goat semm and 0.1% Triton-X-100, then incubated with an 
appropriate peroxidase labelled secondary antibody. After washing, blots were incubated 
for 15 minutes in TBS containing 0.5% diaminobenzidine, prior to colour development 
by addition of 0.006% H2O2. 
8.3.15 Alkaline phosphatase enzyme activity assays 
Histochemical alkaline phosphatase assav 
AP activity was detected histochemically using a procedure modified from Katagiri et 
al, (1994), and was usually performed on cells grown on glass coverslips. Cells were 
fixed with 4% PFA for 10 minutes, washed with PBS, then incubated in darkness for 1 
hour with AP staining reagent (0.09 mg/ml Fast Blue BB sah, 0.5%) dimethylformamide, 
0.1 mg/ml Naphthol AS-MX phosphate, 2 mM MgCl2, 0.1 M Tris-HCl pH 8.5). After 
washing with Ix PBS, coverslips were mounted on glass slides in 0.1% N-propyl 
gallate/50% glycerol/lx PBS. Cells were photographed using Kodak film on an 
Olympus IMT-2 microscope using Nomarski interference conttast optics. 
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Quantitative alkaline phosphatase assav 
Quantitative AP measurement was performed using "ALP Procedure 104" (Sigma 
Diagnostics, St Louis, USA), which was scaled down to a microtiter plate format. Cells 
were harvested by dissociating with 0.05% Trypsin/0.53 mM EDTA, which was 
neutralised with growth media prior to cenfrifiigation (12 000 g for 30 seconds). Cells 
were washed in TBS prior to lysis in 0.9% NaCl with 0.2% Triton X-100, after which 
the manufacturers protocol was followed. Sample inputs were normalised to total protein 
concentration measured with Bradford reagent. Each reaction was read in triplicate at 
415 nm against p-Nitrophenol standards (Sigma Diagnostics, St Louis, USA), with a 
secondary read after acid addition to correct for background lysate absorbance. Since 
assays were performed at a different scale to the Sigma Diagnostics 104 procedure, and 
under modified conditions (the Sigma procedure is designed for blood testing, whereas 
lysed cultured cells in buffer are used here instead), the assay is no longer under Sigma 
"standard conditions". For this reason the amounts of p-Nitrophenol produced have not 
been expressed as units of enzyme activity. Instead the amounts of p-Nitrophenol 
produced provide a relative measure (with arbitrary units) of the level of AP activity 
between samples in any given experiment. 
8.3.16 Construction and analysis of normalised subtracted libraries 
All steps were carried out exactly as stated in the PCR-Select cDNA Subtraction Kit 
User Manual, using supplied enzymes, buffers and oligonucleotides (K1804-1, Clontech, 
Palo Alto, USA). PCR amplification was performed using "Advantage cDNA 
polymerase mix" (also from Clontech) and resulting normalised subtracted products 
were cloned into the plasmid vector pGEM-T-Easy (Promega corporation, Madison, 
USA). Libraries were fransformed into Epicurian Coli XLIO-Gold ulfra-competent cells 
(Stratagene, La Jolla, USA). Differential screening and assessment of subtraction 
success was carried out using the manufacturers recommended procedures. 
8.3.17 Microarray hybridisation and subsequent analysis 
Great care was taken to minimise the risk of introducing gene expression differences 
unrelated to the treatment of interest during cell culture experiments for microarray 
analysis. This included Shh stimulated and control cells being treated (either by 
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transfection or conditioned media addition) for a particular experiment coming from the 
same batch of seeded cells on the same day at the same time, with plates allocated 
randomly to the Shh or the confrol groups prior to treattnent. At the desired time after 
treatment cells were harvested in parallel using the same batch of lysis buffer. 
Every RNA preparation for microarray analysis was checked for quality by gel 
electtophoresis after processing, and again on the day of reverse transcription after 
concentration and aliquoting. All subsequent steps were performed in parallel for 
matched pairs of samples to be hybridised. 
Total RNA samples (40-65 pg) from treatment and pair-matched control samples were 
labelled with Cy-5 or Cy-3 dUTP, using oligo d(T) primer and Superscript II reverse 
transcriptase (Invitrogen, Carisbad, USA). RNA was removed by alkaline hydrolysis. 
Labelled cDNA was purified using YM-30 microcons (Millipore, Watford, UK). 
Hybridisation (in 0.25 mg/ml CotI DNA, 0.5 mg/ml Poly d(A), 4x SSC, 0.5% SDS, 50% 
formamide) was performed ovemight at 45°C, under coverslips in humidified chambers 
("Arraylt" brand from TeleChem Intemational, Sunnyvale, USA). Slides were washed 
for 3 minutes in 0.2x SSC/0.05x SDS, and 2x 3 minutes in 0.2x SSC, then spun dry prior 
to obtaining 16-bit greyscale fluorescence images for each channel with a GMS 418 
array scanner (Genetic MicroSystems, Wobum, USA). 
Images were imported into the image analysis software ImaGene (BioDiscovery; Marina 
del Rey, USA), which was used for the conversion of pixelated image data into an 
overall signal strength for each spot on each channel. ImaGene was able to fit a precise 
grid to each image, such that the perimeter of the spot at each position was accurately 
located. Every image was manually checked for poor quality spots, which were flagged 
accordingly. This procedure involved making sure spots that would have given 
artifactual results, such as those obscured by fluorescent fluff or dust, did not lead to 
erroneous results. The package was then used to ttansform the image files into an overall 
signal strength for each spot on each channel, and to provide an estimate of local area 
background signal for each data point. 
Normalisation and statistical analysis of local background adjusted signals was 
performed using Excel (Microsoft, Redmond, USA) and the GeneSpring package 
(Silicon Genetics, Redwood City, USA). In the former normalisation was performed by 
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applying a constant to all values such that the average intensity of spots on both channels 
was equivalent, in accordance with Hegde et al, (2000). GeneSpring analysis was 
performed with the data normalised using the median of signals on each channel as a 
synthetic positive confrol. Procedures for identification and prioritisation of putative 
differentially expressed clones were as outlined in Chapter 5. 
Clones corresponding to spots of interest were obtained from the 1MB microarray 
facility. Bacterial cultures were stteaked to ensure isolation of a single colony, and then 
re-grown in LB broth, after which aliquots were frozen as glycerols for storage and the 
remaining culture harvested for purification of plasmid DNA. Each of the plasmids 
(which corresponded to a spot of interest on the microarrays) was sequenced with Ml3 
forward and reverse primers as described by Hegde et al, (2000). Resulting sequences 
were used to search the GenBank (NCBI) database using the BLAST search algorithm. 
Genes were then assigned an identity. In any cases of ambiguity or low quality sequence 
the reactions were repeated. In most cases the clone sequence had a 100% match with a 
known mouse gene. In some cases the clones did not match known genes, but did match 
ESTs that represented the 3' UTR of known genes identified from tentative consensus 
sequences generated by The Institute for Genomic Research (TIGR) gene indices 
database. A small number of clones could not be matched to known genes, and may 
represent so called "unknown genes". Altematively such sequences may be from the 
UTRs of known genes for which sequence is not yet available on public databases. 
Plasmids were digested to liberate insert without poly(A)^ tail, separated by agarose gel 
electrophoresis, and purified with Geneclean (Biol 101) ready for use as northem 
hybridisation probes. 
8.4 Primers for PCR and DNA sequencing 
In general, primers have a nucleotide position from an appropriate GenBank mRNA 
reference sequence included in their name. This represents the nucleotide corresponding 
to the 5' most base of the oligo, such that the difference between the numbers can be 
used to calculate the length of the product amplified from cDNA. 
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General plasmid insert amplification and sequencing 
For routine screening and sequencing of clones the following primers were used: 
M13FNEB-20 (forward) 5' gta aaa cga egg cca gt 3 ' 
M13R-24 region (reverse) 5' gga aac age t a t gac ca t g 3 ' 
T7 Terminator (reverse) 5' get agt t a t tgc t e a geg g 3 ' 
T7 Promoter (forward) 5' t aa t a e gac t ea e ta t ag gg 3 ' 
Sp6 Promoter (forward) 5' a t t t ag gtg aca e t a t ag 3 ' 
PCR primers used for general amplification of cDNA microarray inserts, and in array chip 
manufacture, were the "Quackenbush" Ml3 primers (Hegde et al, 2000). These were also 
used for sequence verification of microarray clone inserts: 
Q-M13 (forward) 5' gtt tte eea gte acg aeg ttg 3' 
Q-M13 (reverse) 5' tga geg gat aae aat tte aea eag 3' 
General pEFBOS vector primers for insert amplification/sequencing: 
Efbos 3780FHdIII (for) 5 ' a t t aag e t t geg egg a t t c t t t a t eac 3 ' 
Efbos 4833R (reverse) 5' t t g t aa aae gae gge eag 3 ' 
Primers for RT-PCR and/or amplification of cDNA for northem blot probes 
Mouse Glil 
Mouse Glil primers were modified from those published by Walterhouse et al, (1993), 
in that the superfluous overhangs were removed and a miss-match between GenBank 
sequences and the published reverse primer was corrected. The resulting primers were: 
mGliF2 (forward) 5'eag gga aga gag eag aet ga 3' 
mGli R2 (reverse) 5'age tga tge age tga tee age eta 3' 
Human GLIl 
General amplification and genotyping: 
G2506F (forward) 5' gga eaa gtg eaa gte aag eea g 3' 
G3440R (reverse) 5' ett agg aaa tge gat etg tga tgg 3' 
Additional sequencing primers: 
G616F (forward) 5' aag tet gag etg gae atg etg g 3' 
G1090F (forward) 5' tge agt aaa gee tte age 3' 
G1647F (forward) 5' tea aae tge eea get tgt ee 3' 
G221 OF (forward) 5' aag age eag aag ttg gga e 3' 
G821R(reverse) 5' gag tea aat tee tgg etg c 3' 
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G1223R (reverse) 
G1979R (reverse) 
G2409R (reverse) 
G3100R (reverse) 
Mouse Patched 
General: 
Ptc6 73IF (forward) 
Ptc8 1146R (reverse) 
Sub-probe "A": 
mP 791F (forward) 
mP 1175R (reverse) 
Sub-probe "B": 
mP1175F (forward) 
mP 1465R (reverse) 
Sub-probe "C": 
mP 1462F (forward) 
mP 1794R (reverse) 
Sub-probe "D": 
mP 1797F (forward) 
mP2161R (reverse) 
Human Patched 
PTCH 3074F (forward) 
PTCH 3550R (reverse) 
Mouse Shh (sequencing primer) 
mShh 150 (reverse) 
5' tgt ttt ege age gag eta gg 3' 
5' eet gea ttg ggg ttg tat e 3' 
5' ttg ggt ggg gte agg ata tg 3' 
5' ttg tge ete eea ett tga gag 3' 
5' aet ttg aee eet tgg aat te 3' 
5' eag gat gge gge tge eet g 3' 
5' ggg agg aaa tge tga ata aag 3' 
5' aee tee aeg taa gte ete tg 3' 
5' tgg tte ate aaa gtg teg 3' 
5' aaa eet gag ttg teg eag 3' 
5' gtt ttg ceg ttt ett get e 3' 
5' gea gaa aat ate eaa tet tet gte e 3' 
5' ttt eac aag ecc etg tgt eag eag 3' 
5' aeg aag aga gtg tec aet tgg tge 3' 
5' tgc tgt tea geg tgg tg 3' 
5' tgg etg gag aea eet eag gat atg 3' 
5' ggg aat aaa etg ett gta gge 3' 
Human Shh 
Setl: 
SHH IF (forward) 5 ' geg a t t t aa gga ae t eac ecc c 3 ' 
SHH3R (reverse) 5 ' egg t t g a tg aga a tg g tg ec 3 ' 
Set 2 (as in Fan, H. et al, (1997)): 
SHH 139F (forward) 5' gte ate agt tec atg gge gag 3' 
SHH 557R (reverse) 5' etg agt ggt gge eat ett egt 3' 
Mouse Hip 
5' end of coding region: 
mHIP 759F (forward) 5 ' t t e tgc eac eaa eaa e t c 3 ' 
mHIP 1453R (reverse) 5 ' a t a e tg t g t a t t cca eaa ecc 3 ' 
3' end of coding and 3'UTR region: 
mHIP 1922F (forward) 5' t e a age ea t t e a g ta aeg 3 ' 
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mHIP266IR(reverse) 5' age aga agg aea gte tet e 3' 
Mouse Bmp2 
mBMP2 e2F (forward) 5' gtt tgg eet gaa gea gag ac 3' 
mBMP2 e3R (reverse) 5' atg gtt ggt gtg tee etg tg 3' 
Human Bmp2 
hBMP2 556F (forward) 5' aea tgc tag aee tgt ate gea gg 3' 
hBMP2 925R (reverse) 5' gea t t e tga tte aee aae etg g 3' 
Mouse Bmp4 
mBMP4 418F (forward) 5' ega gee atg eta gtt tga tae etg 3' 
mBMP4 800R (reverse) 5' gat get get gag gtt gaa gag g 3' 
Human Bmp4 (as in Fan, H. et al, 1997) 
BMP-2BF (forward) 5' eac cat gat tee tgg taa ec 3' 
BMP-2BR (reverse) 5' tet cca gat gtt ctt egt gg 3' 
Mouse Thgl (as in Fiorenza et al, 2001) 
mThg-1 1263F (forward) 5' gag age ett ate gte gag gt 3' 
mThg-1 1565R(reverse) 5' t e t cca eet tag eet tge c 3' 
Mouse TSC-22 
mTSC22 10IF (forward) 5' ttt gaa eea gge tge tgg ag 3' 
mTSC22 163OR (reverse) 5' geg eag aae gae tat aca ggt gag 3' 
8.5 Northern hybridisation probes 
DNA Probes were prepared either as isolates from digests of parent plasmids, or by 
RT-PCR amplification. Probes corresponding to microarray clones were prepared as 
described in Section 8.3.17. Additional probes were sourced as described in previous 
chapters. 
Shh 
Shh probe for both northem hybridisation and subtracted library screening was the 
0.6 kb N-terminal coding region from pShh-N-PMT21. 
Patched 
The probe for mouse Patched (mPtcl263) was the 1.3 kb intemal PVMII fragment 
isolated from a cDNA constmct kindly provided by Dr. M. Scott (plasmid 617-1). A 
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human probe was made from the corresponding Pvull fragment from the human cDNA 
(plasmid IB PTCH, provided by Dr. C. Wicking). Mouse Patched "sub-probes" were 
PCR amplified from plasmid 617-1 using primer sets A to D (described above). 
Patched2 
Patched2 expression was detected using a 0.3 kb probe from exon 13 of the mouse 
cDNA, corresponding to the intracellular loop region, as obtained from a constmct 
provided by Dr. C. Wicking. 
Glil 
Human and murine Glil transcripts were detected by hybridisation to the 1.6 kb mouse 
Glil coding region (plasmid provided by Dr. A. Joiner). 
Smoothened 
Mouse Smo mRNA was detected with a homologous 1.2 kb intemal Smal fragment from 
the human SMOH coding region (constmct provided by Dr. F. de Sauvage). 
Hip 
Murine probes (695 bp and 740 bp) were amplified by RT-PCR from mouse brain, using 
the primer sets described in the previous section. 
Bmp2 
Murine Bmp2 was detected with a 1.2 kb cDNA fragment containing 5' UTR and the 
majority of the coding region (ending at the E'coRI site at position 1406 of GenBank 
entry NM_007553). Source plasmid was kindly provided by Dr. P. Koopman. A 370 bp 
human Bmp2 probe was RT-PCR amplified from human keratinocyte RNA using the 
human Bmp2 primer set described in the previous section. 
Bmp4 
A 0.4 kb human Bmp4 probe was generated by RT-PCR from human keratinocytes using 
the primer set described in the previous section. Mouse Bmp4 mRNA was detected using 
a 1.0 kb cDNA fragment containing 5' UTR and coding sequence outside of the 
conserved Bmp2IBmp4 region (Jones, C. M. et al, 1991; constmct (pSP72-BMP4) 
kindly provided by Dr. A. McMahon). 
HNF-3P 
The murine HNF-3p probe (657 bp) contained coding sequence located between intemal 
Sacll restiction sites (positions 254 bp and 911 bp on GenBank entry X74937), and was 
digested from a parent plasmid obtained from Dr. S. Grimmond. 
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Angiopoietin2 
Angiopoietin2 probe consisted of the complete mouse cDNA (-2.5 kb), amplified by 
PCR from plasmid B(1575d2), which was provided by Dr. S. Grimmond. 
GAPDH 
A 600 bp sequence from the central coding region of the mouse GAPDH cDNA was 
used as a loading conttol probe on both mouse and human northem blots, detecting a 
single transcript of-1.3 kb in both cases (plasmid kindly provided by Dr. M. Little). 
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Appendix A: Use of the Geometric 
IVIean in IVIicroarray Analysis 
While biologists are familiar with measures of central tendency such as the arithmetic mean, 
median and mode another related statistic, the geometric mean, is less well known. This 
appendix is intended as a brief outline as to why it is appropriate in this thesis for the 
averaging of replicate microarray data points. 
Where R„ is a ratio and N is the number of replicates: 
Geometric Mean = i(l{R^x R^x R^x.. .R^) 
or alternatively it can be represented as: 
Geomettic Mean = anti log 
/^ 1 Af 
^ZM^J 
K^ti 
The geometric mean is used instead of an arithmetic mean as an estimator of central tendency 
when working with numbers that represent relative quantities. Although an arithmetic mean is 
often used in the literature for a range of work that generates fold change (e.g. microarrays, 
assays involving reporter constmct responses and relative densitometry) it is inappropriate in 
such cases. 
Attempts to calculate arithmetic means on data in the form of relative numbers leads to the 
formation of "harmonic" estimates of central tendency such that two different estimators are 
obtained depending on which number was the denominator when the original ratios were 
calculated. This means that different conclusions may be drawn depending on the arbitrary 
decision of which data is considered the "baseline" response. Clearly an appropriate estimator 
should allow unbiased comparison, such that the same net conclusion is reached no mater 
whether a hypothesis is constructed to consider a population A verses B or visa versa. The 
geomettic mean avoids this problem in that its reciprocal is the number that is obtained if the 
ratios themselves are expressed as fractions the opposite way up prior to calculation. 
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In Summary (where R„ represents a data point as a ratio): 
Arithmetic Mean(/?i, i?2,..., i?;^ ) ?^  
Arithmetic Mean 
but the following does hold true: 
Geometric Mean(i?] ,R2,...,Rff) = f 
Geometric Mean 1 1 
V ^ l ^ 2 ^N J 
and therefore in terms of microarray analysis: 
•-7 C 1 
Geometric Mean of -^— data points = 
y Geomettic Mean of - ^ data points 
Cy5 
The geomettic mean is frequently used in other fields, particularly economics and finance 
where it is used to analyse another form of "relative" data, that of the rates of returns on 
investments over time. Many other statistically valid methods also exist for dealing with 
replicates in microarray studies. Most microarray papers deal with this issue appropriately, 
but historically some authors have not. 
Appendix B: Supplementary Microarray 
Data 
B1. Raw lists of putatively regulated clones with 
associated microarray data 
The data presented in the following tables provides normalised microarray ratios for 
individual gridded clones at each timepoint, along with the results of validation tests where 
conducted. Extreme values caused by very low signal on one channel but a large signal on the 
other have not been removed, since the data in this form was used largely as a screening tool. 
All data has been filtered to remove spots with low signal strength on both channels, using a 
threshold calculated two standard deviations above the average background signal. 
In the case of the 48 hour transfection timepoint ratios were calculated from two replicates 
and therefore this data is of lower confidence as an estimate of the true ratio than other 
timepoints where four replicate data points were obtained. 
In all cases the chips represent Sonic hedgehog stimulation (either by transient transfection or 
conditioned media) compared with a pair-matched Shh null mutant treatment. 
Criteria for inclusion in "putative clone of interest" lists 
Clones showing putative differential expression have been categorised into the following 
categories for the purposes of display in the following tables: 
Set 1: Ratios of highest tmst. Normalised geometric mean ratio greater than 
1.5 or less than 1/1.5. Signal at least 2 standard deviations above 
average slide background signal on both channels for all replicates. 
Set 2: High tmst in direction but not in magnitude of ratio. Normalised 
geometric mean ratio greater than 1.5 or less than 1/1.5. Gene lowly 
expressed on one channel for one or more replicates, but other channel 
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has significant expression for all replicates (possibility of a number near 
zero on one chaimel which can lead to non-representative ratios). 
Set 3: Data of lower confidence. Normalised geometric mean ratio greater than 
2 or less than 1/2. Average calculated from reduced mmiber of 
replicates as some data points rejected (those which fall within 2 
standard deviations of average slide backgrotmd or have been manually 
flagged as "bad" spots and been removed from the analysis).* 
* Clones in this category tend either to represent lowly expressed genes or printed spots of 
lesser quality that do not hybridise well. Lowly expressed genes can fall below the noise 
threshold easily, especially if one of the replicate hybridisations has yielded lower quality 
signal or high noise (as occurred for several slides). 
Key to clone set abbreviations and formatting 
U = mouse UniGene 2k clone set 
N = NMEBA (normalized mouse embryonic branchial arch library) 
I = 1MB "in-house" clone set 
Ratio greater than 2 or less than 0.5, for spots meeting Set 1 or Set 2 
screening criteria (key clones of interest). 
Validated Sonic hedgehog responsive genes are indicated in the tables with coloured text: red 
indicates confirmed up-regulated genes, while confirmed down-regulated genes are shown in 
blue. 
CAl'TION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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Summary: clones of interest 4 day conditioned media timepoint 
4dCM Putative Up-regulation Set 1 
G
eo
m
et
ric
 
m
ea
n
 
ra
tio
 
3.1 
2.5 
1.8 
1.6 
3.7 
1.5 
1.5 
1.6 
1.6 
ID from 
supplied 
chip file 
AA050732 
W42107 
AA060795 
AI327133 
AA050733 
AA050002 
AA116287 
AA116711 
AA145018 
Description from manufacturers supplied chip file 
5' similar to SW;GALE RAT P18645 UDP-GLUC0SE4-
EPIMERASE 
5' similar to gb;X14432 Mouse mRNA for 
thrombomodulin(MOUSE) 
5' similar to WP:F42H10.4 CE00166 CRIP 
3" similar to SW;FBN1 BOVIN P98133 FIBRILLIN 
1 PRECURSOR 
5'similar to SW;TSC2 MOUSE Q00992 
PUTATIVEREGULATORY PROTEIN TSC-22. [1] 
5' similar to gb;M38337 Mouse milk fat globulemembrane protein 
E8 mRNA, complete (MOUSE) 
5'similarto gb;Z19054 BETA-CATENIN (HUMAN); gb;M90364 
Mouse(MOUSE) 
5'similar to gb;D37874 Mouse FcRn gene. (MOUSE) 
5' similar to gb;U09874 Mus musculus SKD3 mRNA.complete 
cds (MOUSE) 
Cl
on
e
 
Se
t 
U 
U 
U 
U 
u 
u 
u 
u 
u 
O
bt
ai
ne
d 
an
d 
Re
-
se
qu
en
ce
d 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Se
qu
en
ce
 
m
at
ch
es
 
ac
ce
ss
io
n
 
# 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
Updated True ID from GenBank BLAST Of 
applicable) 
XM_136069 Mus musculus glucocorticoid-
induced leucine zipper (Gilz) 
[as on left] 
NM 010688 Mus musculus LIM and SH3 protein 
1(Laspi) 
XM_136069 Mus musculus glucocorticoid-
induced leucine zipper (Gilz) 
[as on left] 
[as on left] 
Status post 
Verification (if 
applicable) 
Validated Shh 
Target Gene 
(Induced) 
Validated Shh 
Target Gene 
(Induced) 
Validated Shh 
Target Gene 
(Induced) 
Validated Shh 
Target Gene 
(Induced) 
False Positive (highly 
expressed gene) 
no evidence of 
differential expression 
4dCM Putative Up-regulation Set 2 
G
eo
m
et
ric
 
m
ea
n
 
ra
tio
 
1.6 
1.6 
2.0 
2.6 
3.5 
2.0 
1.5 
1.8 
2.3 
im 
1.6 
1.6 
1.9 
1.5 
1.8 
I 2.2 
1.7 
1.6 
ID from 
supplied 
chip file 
IMAGE; 
3168457 
BE334139 
BE333652 
AA003942 
W48569 
AA017847 
AA122755 
W34412 
W54549 
AA117096 
BE333945 
BE333957 
IMAGE; 
3168545 
BF147370 
BE333748 
BFi47369 
BF147372 
BE456175 
Description from manufacturers supplied chip file 
-
BE334139 
Similar to TR:Q13485 Q13485 DPC4. ;, mRNA 
5'similartogb;X56160 ma1 TENASCIN 
PRECURSOR(HUMAN); gb;X56304 Mouse mRNA fortenascin 
(MOUSE) 
human BDNF 
5' similar to gb;D13738 Mouse mRNA for receptortyrosine 
kinase, complete cds (MOUSE) 
5' similar to gb;M80360 Mouse Rep-3 protein mRNA, complete 
cds(MOUSE) 
5" similar to SW;YJAD ECOLI P32664 HYPOTHETICAL 29.8KD 
PROTEIN IN THIC-HEME INTERGENIC REGION. 
5' similar to gb;L38607 Mus musculus (MOUSE) 
5'similar to gb;X76850 M. musculus mRNA for MAP kinase-
activatedprotein kinase (MOUSE) 
BE333945 
similar to TR:Q15131 015131 PISSLRE MRNA.; BE333957 
0.00 
BF147370 
BE333748 
similar to SW:BF2_MOUSE Q61345 TRANSCRIPTtON 
similar to SW:AFAR_RAT P38918 AFLATOXIN B1 
BE456175 
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# 
? 
Yes 
Yes 
Yes 
Yes 
? 
Yes 
? 
? 
? 
? 
Updated True ID from GenBank BLAST (if 
applicable) 
BC025475 Mus musculus. Similar to hypothetical 
gene supported by U92995 
XM_124281.1| Mus musculus tenascin C (Tnc), 
HUMBDNFB Homo sapiens brain-derived 
neurotrophic factor precursor (BDNF) 
NM_008242 Mus musculus forkhead box Di 
(Foxdi)/Brain factor2 
[as on left] 
NM 008445 Mus musculus kinesin family member 
3c (Kif3c) 
[as on left] 
[no GenBank gene hits - "Unknown"] 
XM_134453 Mus musculus similar to EGLN1 
protein (Eglnl) 
NM_008242 Mus musculus forkhead box D1 
(Foxdi) / Brain factor2 
NM 025475 Mus musculus RIKEN cDNA 
2410007P03 gene (2410007P03Rik) 
Status post 
Verification (if 
applicable) 
Passed some but not 
all validation criteria 
Passed some but not 
all validation criteria 
Validated Shh 
Target Gene 
(Induced) 
False Positive (highly 
expressed gene) 
no evidence of 
differential expression 
Validated Shh 
Target Gene 
(Induced) 
4dCM Putative Up-regulation Set 3 
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tio
 
2.4 
ID from 
supplied 
chip file 
BF147397 
Description from manufacturers supplied chip file 
BF147397  
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# 
? 
Updated True ID from GenBank BLAST (if 
applicable) 
AF020308 Mus musculus HRS gene 
Status post 
Verification (if 
applicable) 
CAUTION: Clone "Gene ID's" and corresponding descriptions should be interpreted w i^th care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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(as on left. NM_01051.& Mus musculus insulin~ Validated Shh2.8 8E333469 similar to gb:M36332 Moule insulin-like growth N Ves Ves Target Genelike growth factor 2 Ilgf2)) (Induced)
2.1 BE333773 BE333773 N Ves Ves {no GenBank gene hits - "Unknownj no evidence ofdifferential expression
XM_136069 Mus musculus glucocorticoid- Validated ShhU 8E332067 8E332467 N No ? Target Geneinduced leucine zipper (Gilz) (Induced)
2.2 BF011713 BF011713 N No ? XM 124686 Mus musculus pleckstrin homology.Sea and coiled/coil domains 3 (Pscd3)
2.1 BF011922 BF011922 N No ? BC025496 Mus musculus. Similar to veside aminetransport protein 1
2.3 BE333715 similar to gb:L08115 Mus musculus antigen (MOUSE N
BC014706 Mus musculus, Similar to ATPase, H+
2.1 BF147798 BF147798 similar to TR:09VHG4 Q9VHG4 CG8444 PROTEIN. :. N No ? transporting, lysosomal (vacuolar proton pump)
membrane sector associated protein MB-9
2.3 W44060 5' similar to gb;L14677 Mus musculus Epoc-1 mRNA,compiete U
cds (MOUSE)
5'similar to gb;X62753 FOLATE RECEPTOR, ADULT
2.2 AA139715 PRECURSOR (HUMAN);gb;M64782 Mouse folate-binding U
orotein 1 (MOUSEl
2.1 AA003328 5' similar to gb;U22396 Mus musculuspolyomavirus late initiator Upromoter binding (MOUSE)
2.0 AA038306 5' similar to gb;X93037 M.musculus mRNA forWDNM1protein U(MOUSE)
2.1 AI385846 5'similar to TR;082887 062687 RENAL OSMOTIC STRESS- UINDUCED NA-CLORGANIC SOLUTE COTRANSPORTER.
2.1 A1385848 5'slmilar to TR;041172 041172 ENV. U
2.2 AA023770 ~~~~~~~~~:~:::;:tA48184 transcriptioninitiation factor lID U
2.1 AA060403 ~~~~i~~~~,~~~lf~6~s~tmusculusosteocalcin-rerated protein U
2.1 AA125379 5'similar to gb;D26532 Mouse gene for PEBP2aB2 (MOUSE) U
2.1 AAI66187 5' similar to gb;L06465 Musmusculus cytochrome oxidase U
subunit Vla (MOUSE)
2.2 AA013594 5' similarto SW;KC1A_BOVIN P35506 CASEIN KINASEI, UALPHA ISOFORM
2.1 AA023595 5' similar to PIR;A45054 A45054 probableintercellular signal Utransducer or transmitter Fz-1
4dCM Putative Down-regulation Set 1
~
""
0:: ~"'~E IDfrom ~ ],l~ Status post
.gg
supplied Description from manufadurers supplied chip file
"
" ~ ai~·2 Updated True 10 from GenBank BLAST {if Verification (IfGif!
.§ "c" &~ ~ applicable)chip file " ~ applicable)E ~~ " E2 u If) "
Cl 0
0.53 AA162879 5' similar to gb;L12029 Mus musculus cytokine (MOUSE) U Ves No NM 016752 Mus musculus UDP-galactose False Positive (highlytransloeator 2 (Uga~2) expressed gene)
0.58 AA139961 5' similar to gb;D26089 Mouse mRNA for c:dc21 Uhomolog(MOUSE)
0.57 AA145048 ~~:,a~~~~~~~~~U~~)2Mouse testis-specifice-abl protein U
0.66 AA114591 5' similar to gb;L21993 ADENVLATE CVCLASE. TYPEII U(HUMAN)
0.49 AA124045 5'similar to gb;D10523 2-0XOGLUTARATE DEHVDROGENASE UEl COMPONENT(HUMAN)
0.65 C (1343111) (C (1343111» Sean Grimmond I
0.62 BE335884 1~IE335884 similar to TR:060493 060493 SORTING NEXIN 3. U
0.56 BF011818 similar to TR:088584 088584 VERSICAN V3 ISOFORM NPRECURSOR.; BF011818
0.64 AA119599 5'similar to gb;M64429 Mouse B-raf oncogene mRNA, complete Ucds(MOUSE)
0.62 W09388 5' simirarto \\IP;F09E5.3 CE02610 DEOXYRIBOSE- UPHOSPHATEALDOLASE
0.61 AA028564 5' similar to PIR;S44774 844774 C30A5.1 protein- UCaenorhabditis elegans
0.65 1IV62914 5' similar to SW;ACCC_ANASP 008862 BIOTINCARBOXYlASE U
[clone obtained but poor growth, poor plasmid ? {uncooperative0.49 W91173 5' similar to SW;NIDO_HUMAN P14543 NIDOGENPRECURSOR U Got ? yield, PCR has numerous bands, problems making
orobOt clone]
0.63 AI892413 5' similar to gb;X70398 M.musculusP311 mRNA (MOUSE) U
(ty V.Iid8tod Shh0.21 Sftpl (Sftp1) se.n Grtmmond I V•• Sfrp.1 (typing error in manufacturers entry] Target Genepo) (R.p....sod)
Validated Shh
0.61 L (Sfrp-2) (L (Sfrp-211 se.n Grtmmond I V•• V.s Sfrp-2 Target Gene
(R.p....sod)
0.56 AA154597 5' similar to gb;X61399 Mouse F52mRNA for a novel protein U Ves Ves [as on left)(MOUSE)
0.62 AA051341 5' similar to PIR;A41735 A41735hyaluronate-binding protein U Ves Ves [as on left] no evidence ofTSG-6 precursor - human differential expression
0.64 AA106952 5' similar to gb;U00674 Musmusculus NMRI fibroglycan U(MOUSE)
0.47 AA049816 5' similar to gb;D32040 Mouse mRNA forproteoglycan, PG·M{V3) U(MOUSE)
0.41 Rpx3 (Rpx3) Sean Grimmond I Ves Ves las on left) no evidence ofdifferential expression
0.51 HTK (HTK) sean Grimmond I Ves No HTK Ugand
CAPTION: Clone "Gene !D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene settlones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (1MB) clones.
283 
4dCM Putative Down-regulation Set 2 
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0.61 
0.64 
0.33 
mm 
0.66 
0.62 
0.28 
0.44 
0.53 
0.67 
0.16 
0.47 
0.65 
1^ 
0.56 
0.64 
0.49 
0.27 
e.11 
0.47 
0.58 
0.53 
0.57 
0.58 
0.61 
0.63 
0.59 
0.04 \ 
0.66 
0.55 
0.51 
^Bi 
0.56 
0.64 
; 0.37 
0.57 
0.11 
0.55 
0.54 
0.64 
0.29 
0.53 
ID from 
supplied 
chip file 
AA153570 
AA000892 
Nkx2.5 
Fgf8 
BE335886 
BE456918 
BF012253 
BF147023 
AA061454 
AA153700 
AA154035 
W84068 
AA004018 
W91144 
AA060051 
AA066354 
AA137337 
LhxS 
Sfrp-2 
B(1575d2) 
r01486 
BE456989 
BE334020 
BF147350 
BE333462 
BE333686 
BF011644 
Sfrp-4 
HNF35 
BE332524 
L22473 
Sox9 mouse 
IMAGE; 
3169081 
BF147690 
BF147749 
BF147799 
BF147800 
BF011889 
W65601 
AA168789 
Amh 
Sfrp-3 
Description from manufacturers supplied chip file 
5* similarto TR;G468012 G468012 PKR INHIBITOR P58. 
5' similarto rii-(,654676 B54676 antiquitin - rat 
(Nkx 2.5) Sean Grimmond 
(Fgf8) Sean Grimmond 
similarto gb:X83536 M.musculus mRNA for 
similarto gb:X55885 ER LUMEN PROTEIN RETAINING 
RECEPTOR 1 (HUMAN); BE456918 similarto gb:X55885 ER 
LUMEN PROTEIN RETAINING RECEPTOR 1 (HUMAN); 
BE332646 
similarto SW:PTN_MOUSE P20935 PLEIOTROPHIN 
BF147023 
5' similarto SW;S61A CANFA P38377 PROTEIN 
TRANSPORTPROTEIN SEC61 ALPHA SUBUNIT. 
5'similar to gb;L08266 Mouse Face mRNA, complete cds 
(MOUSE) 
5' similarto gb;X58957 TYROSINE-PROTEIN KINASE ATK 
(HUMAN);gb;L08967 Mus musculus B cell cytoplasmic tyrosine 
kinase (MOUSE) 
5' similarto gb;X00734_cds1 TUBULIN BETA-5CHAIN 
(HUMAN); gb;X04663 Mouse mRNA for beta-tubulin (MOUSE) 
5' similarto gb;X08058_rna1 GLUTATHIONES-TRANSFERASE 
P (HUMAN); gb;U15654_ma1 Mus musculus glutathiones-
transferase pi class (MOUSE) 
5' similarto SW;ANGT MOUSE P11859ANGIOTENSINOGEN 
PRECURSOR. [1] 
5' similarto gb;S62138 GROWTH ARREST ANDDNA-DAMAGE-
INDUCIBLE PROTEIN GADD153 (HUMAN) 
5' similarto gb;M64174 TYROSINE-PROTEIN KINASE 
JAK1 (HUMAN) 
3'similartoTR;P97329 P97329 KINESIN-LIKE PROTEIN 174. 
(LhxS) Sean Grimmond 
(Sfrp-2) Sean Grimmond 
(B (1575d2)) Sean Grimmond 
human syndecan 1 
similar to gb:X51703 Mouse mRNA for ubiquitin (MOUSE); 
BE456989 similarto gb:X51703 Mouse mRNA for ubiquitin 
(MOUSE); BE333409 
similarto TR:O76058 076058 DJ1409.2 ;, mRNA 
BF147350 similarto gb:M60474 Mouse myristoylated 
similar to gb:D12907 Mouse gene for47-kDa heat 
BE333686 
similarto SW:RL6_MOUSE P47911 60S RIBOSOMAL 
(Sfrp-4) Sean Grimmond 
(HNF35) Sean Grimmond 
similarto TR:O65204 065204 ACTIN.;, mRNA 
HUMAN BAX ALPHA 
-
BF147690 similarto TR:O70341 070341 TAIPOXIN-
ASSOCIATED CALCIUM BINDING PROTEIN 49. ; BF012221 
BF147749 
similarto TR:088665 088665 BROMODOMAIN-CONTAINING 
PROTEIN BP75.; BF147799 similarto TR:088665 088665 
BROMODOMAIN-CONTAINING PROTEIN BP75. ; BF011673 
BF147800 similarto TR:035297 035297 SECRETED 
APOPTOSIS 
BF011889 
5' similarto gb;M76231 SEPIAPTERIN REDUCTASE(HUMAN) 
5' similarto gb;J03210 72 KD TYPE IV 
COLLAGENASEPRECURSOR (HUMAN); gb;M84324 Mus 
musculus type IV collagenase mRNA.complete cds (MOUSE) 
(Amh) Sean Grimmond 
(Sfrp-3) Sean Grimmond '*^' 
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# 
Yes 
? 
? 
? 
(typ 
0) 
Yes 
? 
Yes 
? 
No 
(typ 
0) 
Yes 
? 
? 
? 
Yes 
Yes 
Updated True ID from GenBank BLAST (if 
applicable) 
[as on left] 
[could not obtain clone and altemative from 
submitter failed] 
3' similarto gb:X83536 M.musculus mRNA for 
membrane-type matrix (MOUSE);, mRNA 
sequence 
NM_019766 Mus musculus telomerase binding 
protein, p23 (Tebp-pending) 
Lhx5 (typing error in manufacturers entry) 
[as on left] 
Angiopoietin2 
[as on left] 
NM_010336 Mus musculus endothelial 
differentiation, lysophosphatidic acid G-protein-
coupled receptor, 2 (Edg2) 
MUSALGL Mus musculus alpha-globin 
HNF3beta [typing error in manufacturers entry] 
[as on left] 
BC021403 Mus m., ADP-ribosylation factor 1 
NM_009144 Mus musculus secreted frizzled-
related sequence protein 2 (Sfrp2) 
XM 124528 Mus musculus WD repeat domain 1 
(Wdr1) 
[as on left] 
[as on left] 
Status post 
Verification (if 
applicable) 
no evidence of 
differential expression 
? [uncooperative 
clone] 
no evidence of 
differential expression 
Validated Shh 
Target Gene 
(Repressed) 
Validated Shh Target 
Gene (Induced) 
no evidence of 
differential expression 
no evidence of 
differential expression 
Validated Shh Target 
Gene (Induced) 
False Positive (highly 
expressed gene) 
Validated Shh 
Target Gene 
(Repressed) 
^ 
Validated Shh 
Target Gene 
(Repressed) 
no evidence of 
differenfial expression 
CAUTION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match dieir expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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0.55 P(Ms~ (P (Msf) Sean Glimmond I
similar to gb:XOS021 Murine mRNA with homology to yeast l29
0.62 BE332452 ribosomal protein (MOUSE); BE332452 similar to gb:XOS021 NMurine mRNA with homology to yeast L29 ribosomal protein
(MOUSE); BE332607
0.33 hl3471 human HSPG I Yes Yes HUMHSPGC Human heparan suttate proteoglycan no evidence of(HSPG) core protein differential expression
0.60 BF011570 BF011570 N
0.65 BF147807 similar to SW:TDXN_MOUSE 008807 THIOREOOXIN N
0.55 BF147061 similar to TR:Q07065 007065 P63 PROTEIN. ;, mRNA N
4dCM Putative Down-regulation Set 3
c ;,
.. a: 811l~~ 10 from ;; ~~ Status post~~ <J) ~~.~ Updated True ID from GenBank BLAST ~fsupplied Description from manufadurers supplied chip file ~ "c" Verification (Ifc ~ ~ applicable)
E chip file !2 ~~ :0"''' applicable)g 0 (l)E~
"
0
0.49 BF012164 BF012164 N
0.50 BE456965 BE456965 N
0.46 AA060537 S' similar to gb;M60456 Mouse cydophilin mRNA,compiete cds U(MOUSE)
0.50 BF147652 BF147652 similar to SW:143T_HUMAN P2734814-3-3 NPROTEIN TAU
0.48 AAl54189 5'similar to gb;X66114_mal MITOCHONDRIAL 2- UOXOGlUTARATE/MALATECARRIER PROTEIN (HUMAN)
CAtITlON: Clone "Gene \D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set"clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (IMB) clones.
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2.3 
1.6 
1.7 
2.7 
1.6 
2 J 
1.9 
1.6 
2.5 
1.8 
1.5 
1.8 
ID from 
supplied 
chip file 
AA0S0732 
AA059664 
AA163371 
W42107 
AI327133 
AA050733 
AA003942 
AA106138 
W48569 
W54549 
AA165813 
BE333957 
. c IMAGE; 
1 3168453 
Description from manufacturers supplied chip file 
S' similar to SW;GALE RAT PI 8645 U0P-GLUCOSE4-
EPIMERASE 
5'similarto SW;GPV HUMAN P40197 
PLATELETGLYCOPROTEIN V PRECURSOR 
5' similarto gb;U20532 Mus musculus p45 NF-E2 relatedfactor2 
(MOUSE) 
5' similarto gb;X14432 Mouse mRNA for 
thrombomodulin(MOUSE) 
3' similarto SW;FBN1 BOVIN P98133 FIBRILLIN 
1 PRECURSOR 
5' similar to SW;TSC2 MOUSE Q00992 
PUTATIVEREGULATORY PROTEIN TSC-22. [1] 
5' similarto gb;X56160_ma1 TENASCIN 
PRECURSOR(HUMAN); gb;X56304 Mouse mRNA fortenascin 
(MOUSE) 
5' similarto gb;M13699 CERULOPLASMIN 
PRECURSOR(HUMAN) 
human BDNF 
5' simiisr to gb;L38607 Mus musculus (MOUSE) 
5' similarto SW;RL34 HUMAN P4920760S RIBOSOMAL 
PROTEIN L34. 
similar to TR:Q15131 015131 PISSLRE MRNA. ; BE333957 
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No 
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No 
Yes 
Updated True ID from GenBank BLAST (if 
applicable) 
XM_136069 Mus musculus glucocorticoid-
induced leucine zipper (Gilz) 
[as on left] 
XM_136069 Mus musculus glucocorticoid-
induced leucine zipper (Gilz) 
XM_124281.1| Mus musculus tenascin C (Tnc), 
HUMBDNFB Homo sapiens brain-derived 
neurotrophic factor precursor (BDNF) 
NM_008242 Mus musculus forkhead box DI 
(Foxdi) / Brain ractor2 
Antithrombin. XM_123537 Mus musculus serine 
(or cysteine) proteinase inhibitor, clade C 
(antithrombin), member 1 (Serpinci) 
[as on left] 
Status post 
Verification (if 
applicable) 
Validated Shh 
Target Gene 
(Induced) 
Validated Shh 
Target Gene 
(Induced) 
Validated Shh 
Target Gene 
(Induced) 
Passed some but not 
all validation criteria 
Passed some but not 
all validation criteria 
Validated Shh 
Target Gene 
(Induced) 
no evidence of 
differential expression 
no evidence of 
differential expression 
3dCM Putative Up-regulation Set 2 
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1.9 
i 2^6 
1.6 
1.7 
1.7 
j^gg^^^^ 
2.5 
3.0 
1.9 
1.6 
1.8 
1.6 
ID from 
supplied 
chip file 
AA060966 
BE334007 
BE334026 
BF147332 
BE334150 
AA000432 
BE333773 
BE333959 
BE334236 
BF147370 
BF147387 
BF147371 
Description from manufacturers supplied chip file 
5' similarto gb;U17259 Mus musculus pi9 mRNA,complete cds 
(MOUSE) 
BE334007 
BE334026 
BF147332 
similar to TR:Q9Z2C8 Q9Z2C8 Y-BOX PROTEIN MSY2. ; 
BE334150 
5' similarto SW;CERL RAT P98087 CEREBELLIN-
LIKEGLYCOPROTEIN. [1] 
BE333773 
BE333959 
BE334236 
BF147370 
BF147387 
BF147371 similarto gb:X13664 Mouse mRNA for N-ras protein 
(MOUSE); BE334239 
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? 
? 
Updated True ID from GenBank BLAST (if 
applicable) 
[no GenBank gene hits - "Unknown"] 
[Similarity to various Thymopoietins] 
XM 124528 Mus musculus WD repeat domain 1 
(Wdrl) 
[as on left] 
[no GenBank gene hits - "Unknown"] 
[no GenBank gene hits - "Unknown"] 
AF177029 Mus musculus molossinus 
tetratricopeptide repeat domain 4 (Ttc4) 
[no GenBank gene hits - "Unknown"] 
[no GenBank gene hits - "Unknown"] 
Status post 
Verification (if 
applicable) 
Passed some but not 
all validation criteria 
no evidence of 
differential expression 
(basal not detectable) 
no evidence of 
differential expression 
no evidence of 
differential expression 
(basal not detectable) 
3dCM Putative Up-regulation Set 3 
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2.0 
ID from 
supplied 
chip file 
BE333960 
Description from manufacturers supplied chip file 
BE333960 
Cl
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Se
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No 
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# 
? 
Updated True ID from GenBank BLAST (if 
applicable) 
[no GenBank gene hits - "Unknown"] 
Status post 
Verification (if 
applicable) 
^^, 
CAUTION: Clone "Gene ID's" and corresponding descripfions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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Appendix B: Supplementary Microarray Data
~
ci!~ 8<1)~~ 10 from ;; ~B Status post~~ '" ~~ ~~-~ Updated True 10 from GenBank BLAST (ifsupplied Description from rnanufadurers supplied chip file ~ "C~ Verification (if~ applicable)
chip file 0 ~ ~ a~1l appncable)~ U .5 go ~E:i:5<1)
"
0
5' similar to gb;X52560_oos1 CeAATlENHANCERBrNOING [clone obtained but poor growth, poor plasmid ? [uncooperative0.64 AA023476 PROTEIN BETA (HUMAN); gb;M61007 Mouse alpha-l- I Got ?
acidglycoprotein (MOUllE.\ yield, problems making probe] clone)
0.56 Fgf8 (FgfB) Sean Glimmond '" I Los ? [could not obtain done and ahemative from ? (uncooperativet submitter failed] clone]
0.61 BF011818 similar to TR:088564 088564 VERSICAN V3 ISOFORMPRECURSOR.; BF011816
0.47, BF012253 similar to SW:PTN_MOUSE P2D93S PLEIOTROPHIN
0.64 AA061454 5' similar to SW;S61A_CANFA P38377 PROTEINTRANSPQRTPROTEIN SEC61 ALPHA llUBUNIT.
0.63 A1693879 5' similar to TR;005209 005209 VCP-ltKE ATPASE.
0.59 W44222 5' similar to gb;M68458 ER LUMEN PROTEINRETAININGRECEPTOR 2 (HUMAN)
0.66 AA125559 5' similar to gb;U21301 Mus musculus c--mertyrosine kinase
receptor mRNA, complete (MOUSE)
0.53 W65556 5' similar to SW;SARA_MOUSE P36536 GTp· U No ? False Positive (highlyBINDINGPROTEIN llARA. (1) expressed gene)
0.62 W83689 ~;~~~a~I~:~~~~_:;g~~1~3~~~cD:~1EPTIDETRANSPORT
0.61 W91144 5' similar to SW;ANGT_MOUSE P11859ANGIOTENSINOGENPRECURSOR. 11)
5' similar to gb;L19185 NATURAL KILLER CELL ENHANCING
0.63 AI893726 FACTOR B(HUMAN); gb;U20611 Mus musculus thioredoxin-
deoendent Oeroxidereductase MOUSE
0.48 LhxS (LhxS) Sean Grimmond I Ves (typ Lhx5 (typing error in manufacturers entry) no evidence of0) differential expression
0.64 11)1486 human syndecan 1 I Ves Ves [as on left] no evidence ofdifferential expression
0.56 AI692413 5' similar to gb;X70398 M.musculusP311 mRNA (MOUSE)
(ty Validated Shh0.42 Sl1pl (Sflp1) Sean Grimmond I Ve, Sfrp·1 [typing error in manufacturers entry) Target GenepoI (Repre,sed)
VllidotedShh
0.51 L (Sfrp-Z) (L (Sfrp-Z)) Slln Grimmond I Ve, Ve, Sfrp-Z Target Gene
(ReDresSldl
.- False Positive (highly0.60 Sox9 mouse I Ves Ves [as on left]
expressed gene)
0.65 AI893380 5' similar to gb;013003 Mus musculus reticulocalbinmRNA,
complete cds (MOUllE)
0.66 A1893384 5' similar to TR;070349 070349 HVPOTHETICAL 138.7KDPROTEIN.
0.56 AI322433 5' similar to SW;RS16_HAEIN P44382 30SRIBOllOMALPROTEIN ll16.
0.66 W34326 5' similar to llW;DCMC_ANMN P12617 MALONVL-COADECARBOXYLAllE PRECURWR
0.65 W41962 5' simitarto :>W;GOU_DROME 006003 GOLIATH PROTEIN
0.64 AAl06362 5' similar to gb;U09416 Mus musculus retinoid Xreceptorinterading protein (MOUSE)
0.49 W89849 5' similarto gb;L12721 Mus musculus adipocytedifferentiation- U Ves Ves (as on left, also known as Oelta·like (dlk)J
associated protein (MOUSE)
0.56 AA049616 5' similar to gb;032040 Mouse mRNA forproteogtycan, PG·M(V3)(MOUllE)
0.50 Rpx3 (Rpx3) Sean Grimmond I Ves Ves las on left] no evidence ofdifferential expression
3dCM Putative Down-regulation Set 2
~
"
~ 0:: 8Vl~~ 10 from ;; ~5 Status post
.gg
'"
~ ~ ii~·Q Updated True 10 from GenBank BLAST (Ifsupplied Description from manufadurers supplied chip file ~ ll'!l &~ fi Verification (If'i)e! ~ applicable)~ chip file " ~~ " E applicable)u '" ~~ 0
0.45< Nkx2.5 (Nkx 2.5) Sean Grimmond I Ves Ves {as on left] no evidence ofdifferential expression
0.66 NKx (NKx ) Graham Kay I Ves Ves Nkx2.5 no evidence ofdifferential expression
0.66 W64068 5' similar to gb;XOO734_cds1 TUBULIN BETA·5CHAIN(HUMAN); gb;X04663 Mouse mRNA for beta·tubulin (MOUSE)
0.61 W64946 5' similar to PIR;S51025 S51025 AMP·ae:tivatedprotein kinase-human
5' similar to gb;J03569_cds1 UBIQUITIN--L1KEPROTEIN GOX
0.4l! W65579 (HUMAN); gb;J04761_cds2 Mouse housekeeping
DXll253EIMOUllEl
0.59 W77148 5' similar to SW;GA6S_HUMAN P34059N--ACETYLGALACTOMMINE-6-SUUFATAllE PRECURllOR
5' similar to llW;PZP_HUMAN P20742 PREGNANCV
0.60 W83112 ZONEPROTEIN PRECURllOR. 141 PIR;ll13495 PIR;ll21637
PIR;ll09106
0.54 AA120487 5' similar to SW;YBN5_YEAST P38219 HYPOTHETICAL44.2 KDPROTEIN IN SC02-MRFl INTERGENIC REGION.
0.33 A1893724 5' similar to gb;X61100 NAOH·UBIQUINONEOXIDOREDUCTAllE 75 KDSUBUNIT PRECURWR (HUMAN)
Validated Shh
0.:14 Sfrp-Z (Sfrp-2) Sean Grimmond ~ I Ve, Ve, las on left] Target Gene(Repre,sed)
CAliTlON: Clone "Gene !D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (IMB) clones.
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NM 010336 Mus musculus endothelial
0.65 BE333686 BE333686 N No ? differentiation, tysophosphatidic acid G·protein-
coualed receOtor. i CEd02)
0.54 AAOO0813 5' similar to gb;M22488 BONE MORPHOGENETICPROTEIN 1PRECURSOR (HUMAN)
mouse Mlicrophage inftllmmatory protein 1 gamma (MIPI. V.lidtlted Shh0.66 U49613 gammll) I Ve. Ve. las on telt] J::~=
0.56 Sfrp-4 (Sfrp-4) Sean Grimmond I Ves No MUSALGL Mus musculus atpha-globin no evidence ofdifferential expression
BF147100 similar to TR:035297 035297 SECRETED NM_009144 Mu. musculus secreted frizzled- V.lidated Shh0.21 BF141100 N No ? Target GeneAPOPTOSIS related sequence protein 2 (Sfrp2) (Rep",...dl
0.57 Wl0465 5' similar to gb;K02587 Mouse gamma·A-crystallin(MOUSE) #Nt #Nt #Nt #NtA #NtAA A A
0.58 AA162284 S' similar to gb;MI9643 Mouse Krox·24 protein mRNA, U Ves Ves [also known as EGR-l) False Positive (DNAprep effect)
0.63 W85565 S' similar to SW;ACI2_HUMAN P35249 ACTIVATOR 137 KD #Nt #Nt #Nt #NtA #NtASUBUNIT A A A
0.54 W71599 5' similar to SW;PDI_CHICK P09102 PROTEINDISULFIDE #Nt #Nt #Nt #NJA #NJAISOMERASE A A A
0.61 AA051341 5' similar to PIR;A41735 A41735hyaluronate-binding protein U Ves Ves las on left) no evktence ofTSG-6 precursor - human differential expression
5' similar to SW;HTOA_HAEIN P45129
#Nt #Nt #NI0.61 AA013893 ~1~~BpA:i~~~~~~rICSERINE PROTEASE DOIHHOA- A A A #NtA #NtA
0.60 AAOO0449 5' similar to gb;X06323_c:ds1 MITOCHONDRIAL #Nt #Nt #Nt #NtA #NtA60SRIBOSOMAL PROTEIN L3 (HUMAN) A A A
0.64 AA145262 5' similar to SW;YJJ7_YEAST P40857 HYPOTHETICAL 24.5 KD #Nt #Nt #Nt #NlA #NtAPROTEIN INCHS6-BCKl INTERGENIC REGION. A A A
Validated Shh
0." Amh (Amh) sa." Grimmond I Ve. Ve. [e. on Iell) T.rget Gene
(Re.",...dl
0.57 BF012143 BF012143 N No ? XM_126064 Mus musculus similar to hypotheticalprotein FLJ11807 (LOC216636)
3dCM Putative Down-regulation Set 3
c
":.'l a: ~U)~E IDfrom 0; -g"§ Status post
.gg rn
" c &i£'~ Updated True 10 from GenBank BLAST (ifsupplied Description from manufaClurers supplied chip file
"
Verification (IfQ) !! c -0" 5- (ij :g applicable)" ~~ chip file .2 ~~ ~E~ applicable)"
"
0
0.44 Wl8451 5' similar to PIR;A40283 A402835'-cyclic-nucleotide
ohosohodiesterase
0.35 h29804 human NOV
0.50 W66665 5' similarto SW;SMS_SALTY P24517 SMS PROTEIN
0.47 W65601 5' similar 10 gb;M76231 SEPIAPTERIN REDUCTASE(HUMAN)
0.49 AA166187 5' similar to gb;L06465 Musmusculus cy1ochrome oxidasesubun~ Via (MOUSE)
0.49 AA139531 S' similar to SW;CC18_SCHPO P41411 CELL U Los [have attained alternative - yet to sequence]DIVISIONCONTROL PROTEIN 18. t
0.50 AAl201 00 S' similar to SW;YBN5_YEAST P38219 HYPOTHETICAL44.2 KDPROTEIN IN SC02-MRFl INTERGENIC REGION.
CAUTION: Clone "Gene !D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (1MB) clones.
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Summary: clones of interest 4 day post-transfection timepoint
4dT Putative Up-regulation Set 1
~
.i!~ ~ I/) ~~ 10 from 0; ~~ Status post
.g ~ "' ~ ~ ~ §.~ Updated True 10 from GenBank BLAST (ifsupplied Description from manufacturers supplied chip file ~ "" Verification (itQ:ie chip file " " £"q applicable) applicable)g
" ~~~ 0
1.7 AA051250 5' similar to gb;X76505 M.musculus (MOUSE) U No ? NM 022563 Mus musculus discoidin domainreceptor family. member 2 (Ddr2)
4dT Putative Up-regulation Set 2
~ ~
~ a: 8(/)~~ IDrrom 0; ~~ Status post
.gg "' ~ -5.2 Updated True tD from GenBank BLAST (ifsupplied Description from manufacturers supplied chip file
"
Verification OfQ:ie ~ al~ g.. ~ applicable)g chip file 52 ~$ applicable)" ",E~~
5' similar to SW;AGRI_CHICK P31696 AGRIN NM_01044W Mus musculus nuclear receptor Validated ShhU AA030357 U Ve. No Target GenePRECURSOR.[l) sUbfamily 4, group A, member 1 (Nr"') (Induced)
4dT Putative Up-regulation Set 3
~ ~
.. a: 811)~~ IDfrom jj i~ Status post.g~ ii~·g Updated True ID from GenBank BLAST flfsupplied Description trom manufadurers supplied chip file
" al~ g~ ~ Verification (da:;e ~ applicable)E chip file 52 .5g' applicable)
ill " :El
ln ",E~
"
0
2.4 W10979 5' similar to gb;Y00839_ma1 LYSOSOMALALPHA·GLUCOSIDASE PRECURSOR (HUMAN)
2.1 AI325865 5· similar to TR;015509 015509 ARP2I3 COMPLEX 20KDASUBUNIT
2.2 AI327133 3· similar to SW;FBN1_BOVIN P98133 FIBRILLIN1PRECURSOR
5' limil.r to SW;TSC2_MOUSE 000992 XM_136069 Mus mUlculus glucocorticoid- Validated Shh3.0 AA050733 U Ve. Ye. T,arget GenePUTAnVEREGULATORY PROTEIN TSC-22. (1) induced leucine zipper (Gilz) (Induced)
2.1 AA030895 5· similar to gb;l25081 TRANSFORMING PROTEINRHOC(HUMAN)
2.0 AA124047 5'simiiartogb;J05633INTEGRIN BETA-5 SUBUNITPRECURSOR (HUMAN)
2.1 AA138105 5'similar to TR;E236368 E236368 CELL SURFACEGLVCOPROTEIN CD53.
4dT Putative Down-regulation Set 1
c
"~ a: ~ In ~E IDfrom jj i~ Status post.g~ supplied Description trom manufadurers supplied chip file
" al~ ~ ~.~ Updated True ID from GenBank BLAST (jf Verification (tfQie ~ applicable)~ chip file 52 ~~ ~E ~ applicable)"
"
0
0.66 C (1343111) (C (1343111» Sean Gnmmond
5' similar to gb;J02683 ADP.ATP CARRIER
0.53 AA140461 PROTEIN,FIBROBLAST ISOFORM (HUMAN); gb;X70847
M.musculus mRNA for adeninenucleotide translocase (MOUSEl
5' similar to gb;X14420_cdsl PROCOLLAGEN ALPHA1 (111)
0.66 W83493 g~~i~;n~~o~~~r.~:-~:I~~~t~6M.musculus
(done obtained but poor growlh, poor plasmid ? [uncooperative0.59 W91173 5' similar to SW;NIOO_HUMAN P14543 NIDOGENPRECURSOR U Got ? yield, PCR has numerous bands, problems making
orobel done)
5' similar to gb;L34059 NEURAL-CADHERIN
0.62 AA038?53 PRECURSOR(HUMAN); gb;M31131 Mouse neural cadherin
(MOUSE)
0.56 HTK (HTK) Sean Grimmond I Ves No HTK Ugand
CAllTlON: Clone "Gene !D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene setclones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with' a small number of "in
house" (1MB) clones.
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0 61 
0.56 
012 
0 58 
0 64 
0.24 
0.45 
053 
0 66 
0.01 
0 61 
0 59 
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0.11 
0.01 
0.0« 
0.15 
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0 56 
0.24 
027 
ID from 
supplied 
chip file 
AA166385 
W33838 
AAl45048 
W64979 
AI325900 
AA117573 
BF012253 
AI323811 
AI325852 
W78552 
Sfrp-2 
AA16369S 
W66916 
W85672 
W90953 
S(lp1 
L (Sfrp-2) 
AA163181 
AA000648 
AA049ei6 
AAl 18600 
RPK3 
P (MsO 
Descnption from manufacturers supplied chip file 
5' similar to gb,M16465 Mouse calpactin 1 light chain(MOUSE) 
5' similarto SW;DE81_YEAST P38707 
PUTATIVEASPARAGINYL-TRNA SYNTHETASE DED81 
5' similar to gb:J02995_rna2 Mouse teslis-specificc-abi prolein 
mRNA. complele (MOUSE) 
5' similar to SW.COPB f ^ T P23514 COATOMER 
BETASUBUNIT 
5'similar to SW.IDHC RATP41562 
ISOCITRATEDEHYDROGENASE 
5' similarto gb,Y00281 RIBOPHORIN 1 PReCURSOR(HUMAN) 
similar to SW PTN_IJ10USE P20935 PLEIOTROPHIN 
5' similar to SW:STA1 MOUSE P42225 SIGNAL TRANSDUCER 
AND ACTIVATOROF TRANSCRIPTION 1 
5'similar to SW.IDHC MOUSE P70404 
ISOCITRATEDEHYDROGENASE 
5' similar to gb.M16827 ACYL-COA 
DEHYDROGENASEPRECURSOR. MEDIUM-CHAIN SPECIFIC 
(HUMAN): gb.U07159 Mus musculusmedium-chain acyl-CoA 
dehydrogenase mRNA. complete (MOUSE) 
(Sfrp-2) Sean Grimmond 
5' similarto gb.U20156 Mus musculus macrophagemigration 
inhibitory factor (MOUSE) 
5' similar to PIR.A54090 A54090 PxF protein -Chinese hamster 
5' similar to gb.X07414 Mouse mRNA for excisionrepair prolein 
ERCC-1 (MOUSE) 
5' similarto PIR.A54105 A54105 fibrillin-2precursof - human 
(Sfipl) Sean Grimmond 
(L (Sfrp-2)) Sean Grimmond 
5' similar 10 gb;L00681 Mus musculus unp gene,complete cds 
(MOUSE) 
5' similar to gb.S45630 ALPHA CRYSTALLIN B 
CHAIN(HUMAN). gb.M73741_rna2 Mouse alpha-B2-crystallin 
gene, completecds (MOUSE) 
5' similar to gb:D32040 Mouse mRNA forproteoglycan. PG-M(V3) 
(MOUSE) 
5' similar to gb,Z23064 cdsl HETEROGENEOUSNUCLEAR 
RIBONUCLEOPROTEIN G (HUMAN). gb,U36929 Mus musculus 
RbmmRNA. complete cds (MOUSE) 
(Rpx3) Sean Gnmmond 
(P (Msf)) Sean Gnmmond 
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Updated Tme ID from GenBank BLJVST (if 
applicable) 
[as on left] 
Sfrp-1 [typing error in manufacturers entry] 
Sfrp-2 
[as on left[ 
Status post 
Venfication (if 
applicatile) 
Validated Shtt 
Target Gene 
(Repressed) 
Validated Snh 
Target Gene 
(Repressed) 
Validated Shh 
Target Gene 
(Repressed) 
no evidence of 
differential expression 
4dT Putative Down-regulation Set 3 
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0 46 
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supplied 
chip file 
BE335884 
Description from manufacturers supplied chip file 
BE335884 similar to TR 060493 060493 SORTING NEXIN 3 
|1] 
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Updated Tme ID from GenBank BU^ST (if 
applicable) 
Status posl 
Verification (rf 
applicable) 
( \ l 1 ION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identitlcations have also been found with a small number of "in 
house" (1MB) clones. 
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~ummary: clones of interest 3 day post-transfection timepoint
3dT Putative Up-regulation Set 1
"~~ 0: B(/)~10 from " i~ Status post(/) ~§~ Updated True 10 from GenBank BLAST (~E c supplied Description from manufadurers supplied chip file
"
n" Verification (Ifo ~ c " , 2"~" applicable)
" "
chip file 51 ~~ applicable)ClE " (l)E~0
5' simila, to gb;X14432 Mouse mRNA for Validated Shh1.1 WU107 U Yes Yes [as on left] Target Genethrombomodulin(MOUSE) (Induced)
1.8 AA163204 5' similar to gb;X69064 M.musculus Ank·1 mRNA forerythroid
ankyrin (MOUSE)
2.1 W36063 5' similar to gb;M29960 STEROID RECEPTOR TR2(HUMAN);gb;U30482 Mus musculus TR2 (MOUSE)
1.5 AA145018 5' similar to gb;UQ9874 Mus musculus SKD3 mRNA,comptete U Yes Yes [as on left) no evidence of
cds (MOUSE) differential expression
1.6 AA152842 5' similar to gb;M65255 Mousehydrophilic protein (MOUSE)
3dT Putative Up-regulation Set 2
.g .g
10 from ~~ .. Status postQ:j~ al~ g~ ,§ Updaled True 10 from GenBank BLAST (ffE c supplied Description from manufacturers supplied chip file :il Verification Ofg ~ chip file .~ ~ ~ n ~ applicable) applicable)ClE 1? EG1 2";;; g51 00: (/)E~
"
-CHIMERIC CLONE 2 JOINED INSERTS- - False Positive (Atp5' similar to gb;U01317_cds1 HEMOGLOBIN EPSILONCHAIN contains NM_009573 Mus m. zinc finger protein of
1.8 AA004110 (HUMAN); gb;JOO417 Mouse earfy embryonic beta- U Yes No the cerebellum 1 (Zic1) AND NM_009729 Mus m. highly expressed, Zic
globin(MOUSE) ATPase, H+ transporting, lysosomal 16kD, VO lowly expressed no
subun~ C (Al06vOcl evidence diff reg)
1.8 AA118588 5' similar to gb;U01662 Mus musculus done M2·2transcriptionfactor USF2 mRNA, complete (MOUSE)
1.8 AA024123 5' similar to gb;U07634 Mus musculusreceptor-protein tyrosinekinase (MOUSE)
5'similar 10 gb;M84127_cds1 UDP-
1.5 AA137865 ~~~g~=~~~.~~~~~~~~~MAN) 1C
5'similar 10 gb;X62753 FOLATE RECEPTOR. ADULT
1.7 AA139715 PRECURSOR (HUMAN);gb;M64782 Mouse folate-binding
orolein 1 (MOUSEl
1.7 AA144743 5' similar to gb;X14004 Mouse protamine 2 mRNA(MOUSE)
5' similar 10 TR;G624634 G624634
1.7 AA138824 CYTOPLASMICPOLYADENYlATION ELEMENT BINDING
PROTEIN.
1.6 W08528 5' similar to gb;D45860 Mouse mRNA for magnesiumdependentprotein phosphatase (MOUSE)
1.8 W41325 5' similarto gb;S54005 THYMOSIN BETA-10 (HUMAN)
1.5 AA036340 5' similar 10 SW;LEU3_SOLTU P29696 3-ISOPROPYLMALATEDEHYDROGENASE PRECURSOR
1.5 AA106507 5' simUarlo TR;G4GG130 G4GG130 ES1 PROTEIN.
5' similar to SW;GALE_RAT PlI645 UOP-GLUCOSE4· XM_136069 Mus musculus glucocorticoid. Validated Shh1.5 AA050732 U Yes No Target GeneEPIMERASE induced leucine zipper IGilz) (Induced)
1.5 AA116866 5',mRNA sequence.
1.8 AA137894 5'similar to SW;YFHE_ECOll P36540 HYPOTHETICAL 20.1 KDPROTEIN INHSCA
2.2 AA125375 5'similar 10 SW;SARA_MOUSE P36536 GTP-BINDING U Yes Yes [as on left] False Positive (highlyPROTEIN SARA. expressed gene)
1.8 W1070Q 5' similar 10 gb;X02750_cds3 PROTEIN CPRECURSOR(HUMAN)
1.7 AA036072 5' similar to gb;M98339 Mouse GATA·bindingtranscription factor(MOUSE)
2.0 AA062136 5' similar 10 gb;U25114 Mus musculusprotoporphyfinogen
oxidase mRNA. complele (MOUSE)
1.5 AA144819 5' similar to gb;X79446 M.musculus Odf1 mRNA fomuter densefiber protein of sperm (MOUSE)
1.6 AA144415 5' similar 10 SW;PFTA_MOUSE 061239PROTEINFARNESYLTRANSFERASE ALPHA SUBUNIT
1.7 AA139854 5' similar 10 WP;T01B7.4 CE03588 PEPTIDYL-PROLYLCIS-TRANS ISOMERASE
5' similar to gb;J04634_ma3 Mouse cell surfaceantigen 114/A10 Antithrombin. BC019447 Mus musculus, Similar to no evidence of1.7 Wln84 U Yes No serine (or cysteine) proteinase inhibitor, dade CmRNA. complele (MOUSE) (antithrombi"nl, member 1 differential expression
2.0 W36940 5' similar to gb;D31943 Mouse mRNA for SH2 domaincontaininggene induced by (MOUSE)
1.5 W18451 5' similar 10 PIR;A40283 A402835'-cyclic-nucleotidephosphodiesterase
1.8 W18922 5' similar to gb;X81633 M.musculus mRNA for s17protein(MOUSE)
2.0 W29221 5' similar to gb;U27195 Mus musculus leukotriene C4synthase
mRNA. complele cds (MOUSE)
1.7 AA017847 5' similar to gb;D13738 Mouse mRNA for receptortyrosinekinase, complete cds (MOUSE)
1.9 W09235 5', mRNA sequence.
-,..
CAl;TION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (1MB) clones.
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1 6 
1 9 
1,9 
1 9 
2 2 
1.S 
1 6 
17 
1 6 
1 6 
1 9 
2 2 
2,3 
2,1 
2,4 
2 2 
2,0 
1 6 
18 
2,4 
1,8 
1,6 
1 7 
1,7 
1 7 
2.0 
2.3 
1,8 
1,7 
1,9 
18 
16 
1 6 
16 
2.2 
2,0 
AA038306 
AA060358 
AA060086 
AA059683 
AA059653 
WS4549 
AA105375 
AA041573 
AI893692 
AA165813 
AAl39618 
AA154314 
AI893722 
AI893735 
AAO67005 
BE333959 
BE333963 
IMAGE: 
3168453 
BE334233 
BF147387 
W30253 
AA017865 
W09285 
AA060700 
AA059779 
AA162373 
AA072841 
W41982 
AI323154 
W48157 
AAl55094 
AA073840 
W16201 
W33884 
AA139628 
BE333962 
5' similar Io gb,X93037 M musculus mRNA for WDNMIprotein 
(MOUSE) 
5' similar to gb;D12646 Mouse kif4 gene, cds (MOUSE) 
5' similar to gb,M74491 ADP-RIBOSYLATION FACTOR 
3(HUMAN) 
5' similar to gbU17297 Mus musculus integral 
membranephosphoprolein band 7 2b (MOUSE) 
5' similar to gb,X80903 M musculus mRNA for Della-likel protein 
(MOUSE) 
5 similar to gb;L38607 Mus muscutus (MOUSE) 
5' similar to gb,U12791 Mus musculus spf HMG CoAsynthase 
mRNA, partial cds (MOUSE) 
5' similarto PIR,S51739 S51739 AEBP1 prolein -mouse 
5'similar to gb;M11560 FRUCTOSE-BISPHOSPHATE 
ALDOLASE A (HUMAN),gb;Y00516 Mouse mRNA for aldolase A 
(MOUSE) 
5' similar to SW;RL34_HUMAN P4920760S RIBOSOMAL 
PROTEIN L34 
5'similar to TR,G1226242 G1226242 EF-HAND CA2-I- BINDING 
PROTEIN P22 
5' similar to gb,S66427 RETINOBLASTOMA BINDING PROTEIN 
1 (HUMAN) 
5' similar Io gb,M81695 LEUKOCYTE ADHESION 
GLYCOPROTEIN P150,95ALPHA CHAIN (HUMAN), gb,D13509 
Mouse mRNA for PAP homologousprotein (MOUSE) 
5' similar to TR:048839 048839 PUTATIVE UBIQUITIN 
SPECIFICPROTEASE 
5'similar to TR,G1041240G1041240GAMMA-ADDUCIN 
BE333969 
similar to gb X66032 M musculus mRNA for cyclin B2 (MOUSE) 
BE333963 
similar to gb L25080 TRANSFORMING PROTEIN RHOA 
(HUMAN), BE334233 
BF147387 
5' similarto PIR,S17145 S171456-phosphofructo-2.kinase 
5' similar to gb,M91442 Mouse connexin 31 l(MOUSE) 
5' similarto gb:M29874 CYTOCHROME P450 1186 (HUMAN) 
5' similar Io SW;RT61 RAT PI 7982 ALLOANTIGEN 
RT61 PRECURSOR 
5' similar to gb,J03202 LAMININ GAMMA-I 
CHAINPRECURSOR (HUMAN): gb:J02930 Mouse laminin B2 
Cham mRNA, completecds (MOUSE) 
5'similar to gb,X67688 TRANSKETOLASE (HUMAN), gb,U05809 
Mus musculusLAFI transketolase mRNA, c^omplete cds 
(MOUSE) 
5' similarto gb,U24173 Mus musculus p21(MOUSE) 
5' similar to SW:GOLI_DROME Q06003 GOLIATH PROTEIN 
5' similar to gb:X68805 M musculus MMCP-5 mRNA fonnast cell 
protease 5 (MOUSE) 
5' similar to TR,Q80717 Q60717 HYPOTHETICALPROTEIN 
5' similar to gb,L20315 Mus musculus MPS1 gene and mRNA, 
5' similar to TR:G1255116 G1255116 HEAT-
RESPONSIVEPROTEIN 
5' similar to gb,U39738 Mus musculus P21 activatedkinase-3 
(MOUSE) 
5' similar to gb:X05978 CYSTATIN A (HUMAN) 
5'similar to gb:L10678 PROFILIN II (HUMAN) 
similar to TR:Q13356 01 3356 CYCLOPHILIN-LIKE 
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Antithrombin XM_123537 Mus musculus senne 
(or cysteine) proteinase inhibitor, clade C 
(antithrombin) member 1 (Serpincl) 
[no GenBank gene hits - "Unknown"] 
[as on left] 
[no GenBank gene hits - "Unknown"] 
[as on leftl 
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no evidence of 
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no evidence of 
differential expression 
(basal not detectable) 
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diflerential expression 
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C M ' I I O N : Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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3dT Putative Down-regulation Set 1
Appendix B: Supplementary Microarray Data
c ~
m a: 8U)~~ 10 from ;; ~8 Status post
" 0 '" me ii5'~ Updated True 10 from GenBank BLAST (If~~ supplied Description from manufadurers supplied chip file ~ "C~ Verification (rtc ~ ~ ~10 ~ applicable)chip file 0 applicable)~ U "go ",Em.:5'"
"
0
0.60 AA162679 S' similar to gb;L12029 Mus musculus cytokine (MOUSE) U Yes No NM_016752 Mus musculus UDP-galactose False Positive (highlytranslocator 2 (Ugatt2) expressed gene)
0.66 AI325900 5' similarto SW;IDHC_RAT ::=-4."562ISOCITRATEDEHYDROGENASE
0.61 AAl16745 S' similar to gb;M36829 Mouse heat-shock proteinhsp84 mRNA(MOUSE)
0.62 AA051250 5' similar to gb;X76505 M.musculus (MOUSE) U No ? NM 022563 Mus musculus discoidin domainreceptor family, member 2 (Odr2)
0.66 C (1343111) (C (1343111» Sean Grimmond
0,47 BF012253 similar to SW:PTN_MOUSE P20935 PLEIOTROPHIN
[done obtained but poor growth, poor plasmid ? [uncooperative
0.56 W91173 5' similarto SW;NlOO_HUMAN P14543 NIDOGENPRECURSOR U Got ? yield, peR has numerous bands, problems making
"",bel clone)
0.59 AAl54597 5' similarto gb;X61399 Mouse FS2mRNA for a novel protein U Yes Yes (as on left](MOUSE)
0.64 AA049816 5' similar to gb;D32040 Mouse mRNA forproleoglycan, PG·M(V3)(MOUSE)
0.61 Rpx3 (Rpx3) Sean Grimmond I Yes Yes [as on left] no evidence ofdifferential expression
3dT Putative Down-regulation Set 2
c ~m a: ~ ..~ IDfrom ;; i?il ~ ~.~ Status post.g .g '" m g Updated True 10 from GenBank BLAST (ifsupplied Description from manufacturers supplied chip file ~ il~ Verification (rtiie c in; 8 applicable)E chip file
" ~~ applicable)g 0 (J)E~
"
0
0.61 AA124045 S'similar to gb;D10523 2-0XOGLUTARATE DEHYDROGENASEEl COMPONENT(HUMAN)
0.58 AA162940 S',mRNA sequence.
0.65 AA017738 5' similar 10 gb;L04733 KiNESIN LIGHT CHAIN(HUMAN)
0.29 lhxS (lhxS) Sean Grimmond I Yes (Iyp lhxS (typing error in manufacturers entry) no evidence of0) differential expression
(ty VelidotedShht.U Snpl (Snpl) Seen Grimmond I Ve. Sfrp·1 [typing error In manufacturers entry] Target Genepo) (ReDlftsed)
0.64 o (moesin) (0 (moesin» sean Grimmond I Yes No [no GenBank gene hits· ·Unknownj False Positive (highlyexpressed gene)
3dT Putative Down-regulation Set 3
c ~
:Il a: 8Ul~E IDfrom ~ ~~ Status post
.g .g '" 1ii~.2 Updated True ID from GenBank BLAST (ffsupplied Description from manufacturers supplied chip file ~ "C ~ i~ § Verification (ifii e c ~ ~ applicable)E chip file
" j~ applicable)g 0 ",Em
"
0
0.43 BFOl2253 similar to SW:PTN_MOUSE P2093S PlEIOTROPHIN
C.o\lITlON: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (IMB) clones.
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Summary: clones of interest 2 day post-transfection timepoint
Due to problems obtaining replicate hybridisation data of acceptable quality for this timepoint
clones are unable to be categorised with as much confidence as other shown timepoints. The
data shown below has not been put into sets as it represents only a single hybridisation and as
such should be interpreted with care.
2dT Putative Up-regulation
~ ~m 8Ul~E 10 from <;; ~8 Status post.g~ II) m~ ~ §.~ Updaled True ID from GenBank BLAST (ifsupplied Description from manufacturers supplied chip tite ~ Verification (ifQi~ § <l~ applicable)E chip file ~[ lifm~ applicable)lif 0 (/)E~
'"
0
2.4 AA024266 5' similar to SW;NU6M_RAT P03926 NADH- U Yes Yes las on left] no evidence ofUBIOUINONEOXIDOREDUCTASE CHAIN 6 differential expression
2.2 AA002476 5' similarta SW;COPZ_BOVIN P35604 COATOMER U Yes Yes (as on left]ZETASUBUNIT
2dT Putative Down-regulation
~ ~::l 811l~E 10 from <;; ~~ Status post<>0 II) ~§~ Updated True 10 from GenBank BLAST (if~~ supplied Descnption from manufacturers suppfied chip file ~ ,,~ Verification rtf
chip file § ~ ~ ~~~ applicable) applicable)E .5 ~lif 0 :5 Ul
'"
0
0.45 AA116883 5' similar to SW;HP1_HUMAN P45973HETEROCHROMATINPROTEIN 1 HOMOLOG
5' similar 10 9b;X66363 SERINElTHREONINE-PROTEINKINASE
0.48 A1325848 ~~~~;~~:~l~9:~~:'~~O~;~SCUIUS of PCTAIRE-3
3' similar to gb:X83536 M.musCulus mRNA for
0.47 BE335886 similar to gb:X83536 M.musculus mRNA for N No ? membrane-type matrix (MOUSE);, mRNA
seQuence
0.17 BF012023 BF012023 N No ? NM_033581 Mus musculus protocadherin gamma
subfamily C, 3 (Pc:dhgc3)
0.47 AA030885 5' similar to gb;M95586 TRANSCRIPTION FACTORE2-ALPHA(HUMAN)
0.48 AA021816 S' similarto SW;ADDl_RAT 005764 ADDUCIN-liKEPROTEIN
0.40 r{)1486 human syndecan 1 I Yes Yes [as on left] no evidence ofdifferential expression
0.33 IMAGE;3168878
0.47 AI893988 5' similar to gb;X60304 M.muscutus mRNA forprotein kinase C·della (MOUSE)
0.09 AI325886 5' similar to gb;D50263 Mouse DAN mRNA (MOUSE)
0.47 W41716 5' similar to gb;M95586 TRANSCRIPTION FACTORE2·ALPHA(HUMAN)
0.39.' IMAGE;3166986
CAUTIO~: Clone "Gene lO's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGerie set clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (1MB) clones,
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Summary: clones of interest 1 day post-transfection timepoint
1dT Putative Up-regulation Set 1
c
"~ a: 8 (/) ~10 from " ~8 Status post
.gg U> me [; ~.Q Updated True 10 from GenBank BLAST (If
supplied Description from manufadurers supplied chip file
"
n" &¥ ~ Verification (IfG:i~ c " " applicable)~ chip file 52 ~~ " E applicable)" U> m~ 0
1.5 M162951 5'similar to gb;X17500 Mouse mRNA for putative transcriptionfadoraf the insulin (MOUSE)
1.6 W67230 5' similar to gb;L25444 60S RIBOSOMAL PROTEINL35A(HUMAN)
1.7 M003123 5' similar to SW;RL39_RAT P02404 60S RIBOSOMALPROTEINL39. (2J PIR;R6RT39
1.5 M155541 5' similarto SW;GBG5_BOVIN P30670 GUANINENUCLEOTIOE-BINDING PROTEIN G(IYG(S)IG(O) GAMMA-5 SUBUNIT.
1.7 M059996 5' similar to gb;Z26676 60S RIBOSOMAL PROTEIN U Yes No XM_123629 Mus musculus Kruppel·like factor 7L36(HUMAN) (ubiquitous) (Klf7)
1.9 M002476 5' similar to SW;COPZ_BOVIN P35604 COATOMER U Yes Yes las on left]ZETASUBUNIT
1.5 BE456172 similar to SW:RS9...;.HUMAN P46781 40$ RIBOSOMAL
1.6 M166606 5' similar to gb;K02928 Mouseribosomal protein L30 gene, U Yes Yes las on leftJ
complele cds (MOUSE)
1dT Putative Up-regulation Set 2
c ~m
" "~ IDfrom ;; "g8 u '" c Status postu 0 U> me a5~.!2 Updated True 10 from GenBank BLAST (if~~ supplied Description from manufacturers supplied chip file " al~ g~ ~ Verification (if~ chip file § ~~ applicable) applicable)" U> mCI 0
1.6 M033401 5' similarto SW;SUI1_HUMAN P41567PROTEINTRANSLAnON FACTOR SUl1 HOMOLOG
1.5 M163512 5' simiiartogb;X12517 U1 SMAUNUCLEARRIBONUCLEOPROTEIN C (HUMAN)
?,9 W56963 5' similar to PIR;S40989 540989 hypotheticalprotein F55H2.6 -Caenorhabditis elegans
2,9 M162264 5' similar to gb;M19643 Mouse Krox-24 protein mRNA, U Yes Yes (also known as EGR-1] False Positive (DNAprepeffed)
3.6 AJ243425 human EGR-1 I Yes Yes [as on left] False Positive (DNAprep effect)
similar to SWCOXO MOUSE P17665 CYTOCHROME C
1.7 BF147661 OXIDASE POLYPEPTIDE VIIC PRECURSOR; BF147661
similar to SW:COXO MOUSE P17665 CYTOCHROME C
1dT Putative Up-regulation Set 3
c
,l!~ " "10 from ;jj 'gB u '" c Status post.g~ me ~ ~.~ Updated True 10 from GenBank BLAST (ifsupplied Description from manufacturers supplied chip file
" al~ Verification (ifa;r!! c applicable)
E chip file 0 ~:: £E ~ applicable)g U
CI 0
2.2 M123346 5' similar to SW;P120_MOUSE P30999 P120 PROTEIN.
2.6 W09926 5' similar to gb;J03544 GLYCOGEN PHOSPHORYLASE,BRAINFORM (HUMAN)
2.1 M026564 5' similarto PIR;S44774 544774 C30A5.1 protein -Caenorhabditis elegans
2.1 M145793 5'similar 10 gb;X57351 INTERFERON-INDUCIBLE PROTEIN 1-6D(HUMAN)
2.2 BF012276 similar to TR:092530 092530 PROTEASOME INHIBITOR
2.5 M163695 5' similar to gb;U20156 Mus musculus macrophagemigrationinhibitory factor (MOUSE)
2.0 M163916 5' similar to gb;U11027 Mus musculus C57BU6J Sec61 protein
complexgamma subunit (MOUSE)
2.2 W34432 5' similar to PIR;A45174 A45174 eyes absent U Fail ?
similar to gb:X05021 Murine mRNA with homology to yeast L29
2.4 BE332452 ribosomal protein (MOUSE); BE332452 similar to gb:X05021Murine mRNA with homology to yeast l29 ribosomal protein
(MOUSEl; BE332607
2.0 IMAGE;3169306
2.1 BF011912 BF011912
CAlITlON: Clone "Gene !D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene sef clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (1MB) clones,
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1dT Putative Down-regulation Set 1
~ m
m 0:: 8(1)~E 10 from m ~8 Status post.g~ rn m ~ ~ ~.~ Updated True ID from GenBank BLAST (~supplied Description from manufacturers supplied chip file m "C m Verification (ifa;:~ ~ m ' !e ~ applicable)~ chip file .2 ~~ applicable)0~ 0
0.65 AAOO2979 5' similar to SW;ATNe_CHICK P33879 sodium/potassium-transporting atpase beta-2 chain
0.48 X03672 mouse bAC:;"
0.64 AA116745 5' similar to gb;M36829 Mouse heat-shock proteinhsp84 mRNA(MOUSE)
0.64 AA139447 5'similarto SW;PAD1_SCHPO P41876 PADl PROTEIN. 111
0.39 BF147395 BF147395 similar to gb:X56468_ma114-3-3 PROTEIN THETA(HUMAN); BE334300
0,48 BF147652 BF141652 similar to SW:143T_HUMAN P2734814-3-3PROTEIN TAU
0.62 BF012160 similar to $W:CNBP_MOUSE P53996 CELLULAR NUCLEIC
5' similar to gb;Z19585 THROMBOSPONDIN 4
0.61 AA036274 ~~3~:)SOR(HUMAN);gb;M66620 Mouse thrombospondin 3
5' similar to gb;X12597 HIGH MOBILITY GROUPPROTEIN
0.65 AA123346 HMG1 (HUMAN); gb;UD0431 Mus musculus HMG-1 mRNA,
com leteCds (MOUSE)
0.65 AA162371 5'similar to TR:G55535 G55535100 KDA PROTEIN.
0.59 BE334329 similar to TR:095406 095406 CORNICHON. ; BE334329
0.67 BF147721 similar to SW:ANX2_MOUSE P07356 ANNEXIN II ;, mRNA
0.56 AA044542 5' similar to gb;J04046 CALMODULIN (HUMAN);gb;M19380Mouse calmodulin (MOUSE)
0.39 AA116762 5'similar to gb;S65738 OESTRIN (HUMAN); gb;D00472 Mouse
mRNA forcofilin, complete cds and flanks (MOUSE)
0,33 BE332606 similar to gb:M33212 Mouse nucleolar protein N038 mRNA,
complete cds (MOUSE); BE332606
0.58 IMAGE;3166549
0.58 BF147439 similar to SW:ROF_HUMAN P52597 HETEROGENEOUS
0.66 AAOO6793 5' similar to gb;l25080 TRANSFORMING PROTEINRHOA(HUMAN)
0.63 AA066708 5' similar to gb;D90151 Mouse mRNAforCArG-binding fador-A.
complete cds (MOUSE)
0.61 Al692436 5' similar to gb;J04181 Mouse A-X adin mRNA, completecds(MOUSE)
0.61 AA066481 5' similar to gb;X65488_cds1 HETEROGENOUSNUClEARRIBONUCLEOPROTEIN U (HUMAN)
0.60 AI692633 5'similarto gb;X63526 ELONGATION FACTOR 1-GAMMA(HUMAN)
similar to sw:nu4rn_mouse p03911 nadh-ubiquinone
0.49 BF147497 ~:dOreductasechain 4; bf147497 similar to sw:nu4m_mouse
3911 nadh-ubiauinone
1dT Putative Down-regulation Set 2
~ ~~ 10 from 3l "g~ BU)~ Status post<.> 0 m ~ ai2·9 Updated True 10 from GenBank BLAST (if~~ supplied Description from manufadurers supplied chip file m "co> 5-~ ~ Verification (if§ m' applicable)E chip file .5 g mE applicable)g 0 :5U) rn m
'"
0
0.64 AA123466 5'similar to gb;M21019 Mouse R-ras mRNA, complete cds(MOUSE)
0.4> aa083969 human ODC
0.52 IMAGE;3166664
0.48 BF147705 similar to TR:089113 0891131ER5.;, mRNA
0.48 IMAGE;3169515
0.61 AA014475 5' similar to gb;X58965 NUCLEOSIDE DIPHOSPHATEKINASE B(HUMAN)
5' similarto gb;X56160_ma1 TENASCIN Passed same but not0.63 AA003942 PRECURSOR(HUMAN); gb;X56304 Mouse mRNA fartenascin U Yes Yes XM_124281.11 Mus musculus tenascin C (Tne), all validation crtleria(MOUSEl
0.66 AAOO2277 5' similar to PIR;S49172 549172 translationinitiatianfador elF-4gamma - human
5' similar to SW;YB48_YEAST P38129 HYPOTHETICALTRP-
0.67 AA139665 ASP REPEATS CONTAINING PROTEIN IN PGll-KTR4
INTERGENIC REGION.
Validated Shh
0.53 Sfrp-2 (Sfrp-2) Sean Grimmond I Ye. Yes (as on teft) Target GeM
(Re....sed)
similar to SW:MAPR_MOUSE 055022 MEMBRANE
0:38 BF147535 ASSOCIATED PROGESTERONE RECEPTOR COMPONENT. ;
BF147535 similar to SW:MAPR MOUSE 055022 MEMBRANE
0.62 BF147025 BF147025
0.21 AA041626 5' similar to SW;IPP2_RABIT P11845 PROTEINPHOSPHATASEINHIBITOR 2
0.3'4 aa129991 human Elongation factor 1.a1
-
CAUTION: Clone "Gene !D's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGehe set clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (1MB) clones,
296 Appendix B: Supplementary Microarray Data
0.61 BE332524 similar to TR:065204 065204 ACTIN. ;, mRNA
0.63 BE456962 BE456962 similar to SW;N358_HUMAN P49792 NUCLEARPORE
l similar to SW:RB48_HUMAN a09028 CHROMATIN ASSEMBLY0.48 BF011932 FACTOR 1 P48 SUBUNIT; BF011932
BC014706 Mus musculus. Similar to ATPase, H+
0.57 BF147798 BF14n98 similar to TR:Q9VHG4 Q9VHG4 CG8444 PROTEIN.;, N No ? transporting, lysosomal (vacuofar proton pump)
membrane sector associated protein M8-9
0.47 BF147804 similar to SW:ARP3_HUMAN P32391 ACTIN·L1KE PROTEIN
5' similar to gb;M15990 PROTD-ONCOGENETYROSINE-
0.19 AA067001 PROTEIN KINASE YES (HUMAN); gb;X67677 M.musculus c;..
vesmRNA (MOUSEl
0.66 AA034560 5' similar to WP;ZK945.3 CEOl734 PUMILIO-REPEATLIKEDOMAIN
0.54 BF147388 BF147386 similarto SW:SE15_HUMAN 06061315 KD
0.65 BE331853 similar to SW:VBP1 HUMAN Q15765 VON HIPPEL-LiNDAUBINDING PROTEIN-I; BE331853
0.30 IMAGE;3168999
0.60 BF147561 similar 10 SW,NPLI_MOUSE P28856 NUCLEOSOME
1dT Putative Down-regulation Set 3
c
"
~ <r
" "E 10 from ;; -g~ ~ c Status post
.g .g (f) ~ c ai~·9 Updated True 10 from GenBank BLAST (if
supplied Description from manufacturers supplied chip file m
'C " 5-~ :a Verification (ifQ)~ c " ~ applicable)E chip file .Q .. :if ~E~ applicable)g u i$1Il
Cl 0
0.47 A1893069 S' similar to gb;J00314_ma2TUBULIN BETA-1 CHAIN (HUMAN);gb;X04663 Mouse mRNA for beta·tubulinlMOUSE)
0.47 BF147608 similar to TRQ9ROP3 Q9ROP3 SID478P.;, mRNA
0.48 WQ9926 5' similar to gb;J03544 GLYCOGEN PHOSPHORYLASE,BRAINFORM (HUMAN)
0.46 AA153522 5' similar to WP;T17E9.1 CE01405
5' similar 10 gb;YOO371_ma1 HEAT SHOCK COGNATE71 KO
0.42 AA117004 PROTEIN (HUMAN); gb;U27129 Mus musculus breast heal
-
-
shod< 73prolein (MOUSE)
0.48 BE457031 similar to TRQ9Z1Q2 Q9Z1Q2 NG26. ;, mRNA
5' similar 10 gb;Y00371_ma1 HEAT SHOCK COGNATE71 KD
0.45 AA163643 PROTEIN (HUMAN); gb;U27129 Mus musculus breast heat
shock 730mlein (MOUSel
CAlITlON: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set Clones DO NOT
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in
house" (IMB) clones.
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B2: Comparison matrix to identify genes of interest 
in multiple treatments or at multiple timepoints 
The following matrix contains summary data from microarray spots that appear as "clones of 
interest" in two or more timepoints or treatments for spots meeting the screening criteria in 
Appendix Bl. This was used as a tool to highlight genes with particularly compelling data 
through the principle of biological pseudo-replication (refer Chapter 5). Genes which show 
apparent differential expression at multiple timepoints or with both Shh stimulation methods 
are considered unlikely to have arisen by chance and probably represent true Shh target genes. 
It is important to note that not all genuine target genes appear on this list. In particular any 
genes which show transient responses may be absent. 
Ratios are only included where the criteria for magnitude and repeatability were met for the 
particular treatment/timepoint, otherwise the cell is shown as "-". Ratios shown here still 
include extreme values. Abbreviations are as in Appendix Al. Data for the 1 day and 2 day 
timepoints is of lower quality than that for other timepoints (aged chips hybridised poorly or 
less replicates able to be obtained) and should be interpreted with care. 
CAUTION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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Geometric mean ratio 
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-
-
-
-
-
-
0,6 
-
-
0,6 
-
-
-
-
-
-
-
0,6 
2 2 
-
-
-
3 0 
-
-
0 6 
-
0 6 
1 7 
-
3d
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2 7 
0 4 
-
1 8 
-
-
-
-
-
0,6 
-
-
0 5 
0,6 
-
0 6 
0,5 
0 7 
-
1 6 
1 9 
2,3 
2 8 
0 6 
15 
0 6 
-
-
0 6 
-
0 6 
4d
CM
 
2 5 
• 
2 0 
2 3 
2 0 
2,2 
0 5 
-
16 
-
0,6 
0 6 
2 1 
-
0 6 
0 5 
0 5 
0 5 
-
1 6 
-
2 6 
3 1 
3,7 
0,6 
-
0,0 
0 5 
0 5 
-
0 6 
0 5 
Gene ID 
W42107 
W18451 
AA038306 
W54549 
AA017847 
AA139715 
AA162879 
AAl63695 
AAl45018 
AAl 62284 
AAl 45048 
AAl 54597 
AA166187 
V\/41982 
AA028564 
AA061454 
W65601 
W84068 
AI325900 
AI327133 
AA002476 
AA003942 
AA050732 
AA050733 
AA051341 
AA165813 
W91144 
W91173 
AAl16745 
AA049816 
AA051250 
AI892413 
AAl24045 
Description from supplied chip 
file 
6' similar to gb;X14432 Mouse mRNA for 
thrombomodulml MOUSE) 
5' similar Io PIR;A40283 A402835'-cyclic-
nucleotide phosphodieslerase 
5' similar to gb;X93037 M musculus mRNA for 
WDNMIprotein (MOUSE) 
5' similar to gb;L38607 Mus musculus 
(MOUSE) 
5' similar to gb;D13738 Mouse mRNA for 
receptortyrosine kinase, complete cds (MOUSE) 
5'similar Io gb,X62753 FOLATE RECEPTOR, 
ADULT PRECURSOR (HUMAN):gb:M64782 
Mouse folate-binding protein 1 (MOUSE) 
5' similar to gb;L12029 Mus musculus cytokine 
(MOUSE) 
5' similar to gb,U20156 Mus musculus 
macrophagemigration inhibrtory factor (MOUSE) 
5' similar to gb;U09874 Mus musculus SKD3 
mRNA,complete cds (MOUSE) 
5' similar Io gb;M19643 Mouse Krox-24 protein 
mRNA, 
5' similar to gb;J02995_rna2 Mouse lestis-
specificc-abl protein mRNA, complete (MOUSE) 
5' similar to gb;X61399 Mouse F52mRNA for a 
novel prolein (MOUSE) 
5' similar to gb;L06465 Musmusculus 
cytochrome oxidase subunit Via (MOUSE) 
5'similar to SW;GOLI DROME Q06003 
GOLIATH PROTEIN 
5' similarto PIR;S44774 S44774 C30A5 1 
prolein -Caenortiabditis elegans 
5'similarto SW;S51A CANFA P38377 
PROTEIN TRANSPORTPROTEIN SEC61 
ALPHA SUBUNIT 
5' similarto gb;M76231 SEPIAPTERIN 
REDUCTASE(HUMAN) 
5' similar to gb;X00734_cdsl TUBULIN BETA-
5CHAIN (HUMAN): gb:X04663 Mouse mRNA 
for beta-tubulin (MOUSE) 
5'similar loSWJDHC RATP41562 
ISOCITRATEDEHYDROGENASE 
3'similar to SW;FBN1 BOVIN P98133 
FIBRILLIN IPRECURSOR 
5'similar to SW;COPZ BOVIN P35604 
COATOMER ZETASUBUNIT 
5'similar to gb,X56160 mal TENASCIN 
PRECURSOR(HUMAN); gb:X56304 Mouse 
mRNA lor tenascin (MOUSE) 
5'similar to SW;GALE RAT P18645 UDP-
GLUCOSE4-EPIMERASE 
5'similar to SW;TSC2 MOUSE Q00992 
PUTATIVEREGULATORY PROTEIN TSC-22, 
[ f ] 
5' similarto PIR:A41735 A41735hyaluronate-
binding protein TSG-6 precursor - human 
5' similar to SW;RL34 HUMAN P4920760S 
RIBOSOMAL PROTEIN L34 
5'similar to SW;ANGT MOUSE 
PI 1859ANGIOTENSINOGEN PRECURSOR-[l| 
5'similar to SW;NIDO HUMAN PI 4543 
NIDOGENPRECURSOR 
5' similar to gb:M36829 Mouse heat-shock 
proteinhsp84 mRNA (MOUSE) 
5' similar to gb:D32040 Mouse mRNA 
forproteoglycan, PG-M(V3) (MOUSE) 
5' similarto gb;X76505 M musculus (MOUSE) 
5' similarto gb:X70398 M,musculusP311 mRNA 
(MOUSE) 
5'similar Io gb;D10523 2-OXOGLUTARATE 
DEHYDROGENASE El 
COMPONENT(HUMAN) 
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7 
? 
Updated True ID from 
GenBank BLAST (if 
applicable) 
[as on left] 
[as on left] 
NM 006242 Mus musculus 
forkhead box DI (Foxd1)/ 
Bram factor2 
NM_016752 Mus musculus UDP-
galactose translocator 2 {Ugall2) 
[as on left] 
[also known as EGR-1] 
(as on left) 
[as on left] 
XM_124281 1| Mus musculus 
tenascin C (Tnc), 
XM 136069 Mus musculus 
glucoconicoid-induced leucine 
zipper (Gilz) 
XM_136069 Mus musculus 
glucocorticoid-induced leucine 
zipper (Gilz) 
[as on left] 
Antithrombin XM_123537 Mus 
musculus serine (or cysteine) 
proteinase inhibitor, cJade C 
(antithrombin), member 1 
(Serpincl) 
[clone obtained but poor growth, 
poor plasmid yield, PCR has 
numerous bands, problems 
making probe] 
NM_022563 Mus musculus 
discoidin domain receptor family, 
member 2 (Ddr2) 
Status post 
Verification (if 
applicable) 
Validated Shh Target 
Gene llnduced) 
Validated Shh Target 
Gene (Induced) 
False Positive (highly 
expressed gene) 
no evidence of 
differential expression 
False Positive (DNA 
prep effect) 
Passed some but not all 
validation crttena 
Validated Shh Target 
Gene (Induced) 
Validated Shh Target 
Gene (Induced) 
no evidence of 
differential expression 
no evidence of 
differential expression 
? ]uncooperative clone] 
CAI TION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 
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Geometric mean ratio 
(only shown where screening 
criteria meet) 
1d
T 
-
-
-
-
-
-
-
-
0 5 
-
-
-
0 6 
-
-
2 4 
-
-
-
• 
-
-
-
0 5 
0 6 
-
2d
T 
0 4 
0 4 
-
-
-
0 5 
-
-
• 
-
-
-
-
3d
T 
-
0 3 
-
-
-
04 
0 6 
-
0 7 
-
-
-
2,2 
1 6 
2 4 
-
-
0 5 
4d
T 
-
0 0 
0,2 
0 0 
0 7 
0 3 
0 0 
0 6 
-
0 5 
-
-
-
-
-
-
-
-
-
0 2 
3d
CM
 
0 6 
0 6 
2 5 
0 6 
0 5 
0 5 
0 6 
0 6 
04 
04 
0 5 
0 3 
0,5 
-
-
-
1 6 
2,5 
1 8 
3 0 
1 5 
1 8 
0 5 
0 6 
-
0 2 
0 5 
4d
C
M
 
0 6 
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35 
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0 3 
0 3 
0 1 
0 0 
0 3 
0 3 
0 4 
0 1 
0 7 
0 6 
0 5 
0 5 
0 6 
0 6 
0 7 
0 6 
1 5 
2 1 
1 6 
-
• 
-
0 6 
0 6 
0 5 
2 1 
0 1 
0 3 
Gene ID 
r01486 
Sox9 m o u s e 
W48569 
r01486 
LhxS 
Nkx 2 5 
FgfS 
Sf rp-4 
A m h 
S f i p l 
Rpx3 
Sfrp-2 
C (1343111) 
P (Msf) 
L (Sfrp-2) 
H T K 
B E 3 3 2 5 2 4 
B E 3 3 5 8 8 4 
B E 3 3 5 8 8 6 
B E 3 3 2 4 5 2 
B F 1 4 7 3 7 0 
B E 3 3 3 7 7 3 
B E 3 3 3 9 5 7 
B E 3 3 3 9 5 9 
IMAGE 
3 1 6 8 4 5 3 
B F 1 4 7 3 8 7 
B E 3 3 3 6 8 6 
B F 0 1 1 8 1 8 
B F 1 4 7 6 5 2 
B F 1 4 7 7 9 8 
B F 1 4 7 8 0 0 
B F 0 1 2 2 5 3 
Description from supplied chip 
file 
human syndecan 1 
human BDNF 
human syndecan 
(LhxS) Sean Gnmmond 
(Nkx 2 5) Sean Gnmmond 
(FgfS) Sean Gnmmond 
(Sfrp-4) Sean Gnmmond 
(Amh) Sean Gnmmond 
(Snp1) Sean Gnmmond 
(Rpx3) Sean Gnmmond 
{Strp-2) Sean Gnmmond 
(C (1343111)) Sean Grimmond 
(P (MsO) Sean Gnmmond 
(L (Sfrp-2)) Sean Gnmmond 
(HTK) Sean Gnmmond 
similar to TR 065204 065204 ACTIN ,, mRNA 
eE335884 similar Io TR 060493 060493 
SORTING NEXIN 3 [1| 
Similar to gb X83536 M musculus mRNA for 
similar to gb X05021 Munne mRNA wilh 
homology to yeast L29 nbosomal protein, 
BE332452. BE332607 
BF147370 
BE333773 
similar loTR 01 51 31 015131 PISSLRE 
MRNA , 66333957 
BE333959 
BF147387 
BE333686 
Similar Io TR 088564 088S64 VERSICAN V3 
ISOFORM PRECURSOR ,BF011818 
BF147652 similar to SW 143T_HUMAN 
P27348 14-3-3 PROTEIN TAU 
BF147798 similar to TR Q9VHG4 09VHG4 
008444 PROTEIN 
BF147800 similar to TR:036297 035297 
SECRETED APOPTOSIS 
similar to SW PTN_MOUSE P20935 
PLEIOTROPHIN 
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Updated True ID from 
GenBank BLAST (if 
applicable) 
|as on lefl] 
(as on left) 
HUMBDNFB Homo sapiens 
brain-derived neurotrophic factor 
precursor (BDNFj 
[as on left] 
LhxS (typing error in 
manufacturers entry) 
[as on left) 
[could not obtain clone and 
alternative from submitter failed] 
MUSALGL Mus musculus alpha-
globin 
[as on left] 
Sfrp-1 [typmg error m 
manufacturers entry] 
[as on left] 
[as on left) 
S(rp-2 
HTK Ligand 
3'similar to gbX83536 
M musculus mRNA for 
membrane-type matnx 
(MOUSE),, mRNA sequence 
[no GenBank gene hrts -
"Unknown-] 
[no GenBank gene hrts -
'Unknown"] 
[as on left] 
[no GenBank gene hrts -
"Unknown"] 
[no GenBank gene hits -
"Unknown-] 
NM_010336 Mus musculus 
endothelial differentiahon, 
lysophosphatidic aad G-protem-
coupled receptor. 2 (Edg2) 
BC014706 Mus musculus, Similar 
to ATPase, H+ transporting, 
lysosomal (vacuolar proton 
pump) membrane sector 
associated protein M8-9 
NM 009144 Mus musculus 
secreted frizzled-related 
sequence protein 2 (Sfrp2) 
Status post 
Verification (if 
applicable) 
no evidence of 
differential expression 
False Positive (highly 
expressed gene) 
Passed some but not all 
validation cntena 
no evidence of 
differential expression 
no evidence of 
differential expression 
no evidence of 
differenital expression 
? [uncooperative clone] 
no evidence of 
differential expression 
Validated Shh Target 
Gene (Repressed) 
Validated Shh Target 
Gene (Repressed) 
no evidence of 
differential expression 
Validated Shh Target 
Gene (Repressed) 
Validated Shh Target 
Gene (Repressed) 
no evidence of 
differential expression 
no evidence of 
differential expression 
no evidence of 
differential expression 
(basal not detectable) 
Validated Shh Target 
Gene (Repressed) 
(known to be highly 
expressed in 10T1/2 
cells) 
( M l ION: Clone "Gene ID's" and corresponding descriptions should be interpreted with care and only assumed correct if specifically 
indicated as sequence verified by the author in the right hand columns of the table. Approximately 16% of UniGene set clones DO NOT 
match their expected identity when sequenced or are contaminated. Miss-identifications have also been found with a small number of "in 
house" (1MB) clones. 

Appendix C: Detection of a Common 
Polymorphism in Human GLI1 
The 3.6 kb pcDNA3-hGlil clone insert was sequenced in its entirety to investigate whether a 
change may have arisen to explain the dramatic difference in potency between the pcDNAB-
hGlil and pRK7-N-Myc-hGli constructs (refer Section 3.3.5). The sequence was found to be 
100% identical to the GenBank sequence submitted for the clone (Kinzler et al, 1988, 
GenBank X07384). Intriguingly, when the sequence of this clone was compared to the 
sequence of the pRK7-N-Myc-hGli insert (supplied in its entirety by Dr. F. De Sauvage and 
verified for 3' and 5' regions) a base change was evident. The pRK7-N-Myc-hGli insert 
contained a G to A substitution at position 2876 (GenBank X07384) resulting in an amino 
acid change from Glycine to Aspartic acid in the corresponding codon. Serendipitously, this 
change introduces a new restriction enzyme cut site for Tfil, allowing design of a 
straightforward screening strategy to test for the occurrence of this variant in the normal 
population (Figure C.l). The reasoning behind this investigation was the fact that the insert 
from the pGli-K12 clone (and its derivative pcDNA3-hGlil) were initially derived from 
cancerous tissue, and there is a possibility the mechanism of GLU induced tumourigenesis 
may involve more than overexpression by amplification. In short, it was of interest to see 
which of the variant codons represented the wild-type GLH sequence. 
Buccal cell DNA was prepared from nine unrelated individuals, and further DNA samples 
available from six NBCCS patients were analysed. The region of interest was amplified by 
PCR using the GUI specific primers G2506F and G3440R (see JVIaterials and Methods). The 
PCR yielded the expected 935 base pair product, as well as a smaller band, which remained 
despite attempts at optimisation. To prevent this smaller band confounding analysis the PCR 
reactions were separated by agarose gel electrophoresis and the 935 base pair band isolated 
for each. The DNA in the isolated bands was used as the template for a secondary PCR with 
the same primers to yield large quantities of the pure 935 base pair sequence from each 
individual. The PCR products were then digested with Tfil, giving differing band pattems on 
agarose gels from which genotype could be determined. 
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Genotyping for a selection of the samples is illustrated in Figure C.l. Of the alleles analysed, 
64 percent contained the diagnostic Tfil recognition sequence not present in GenBank 
sequence X07384. Eight of the fourteen individuals investigated were homozygous for this 
change. Although the sample size is small there is sufficient evidence to suggest that the 
position 2876 A and T nucleotide variants represent common allelic polymorphisms of the 
GUI gene. This polymorphism has also been found by another group, where it was not 
thought to have any functional consequence (Dr. F. de Sauvage; personal comm.). Sequencing 
of a number of cloned PCR products suggested that the 2876 A variant is linked to another 
single nucleotide polymorphism, a G to C change, at position 3376 of the GenBank sequence 
(data not shown). 
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Figure C.l Genotyping human GLIl variants by agarose gel electrophoresis after Tfil 
digestion of a PCR product. 
A or G indicates the nucleotide present at cDNA position 2876 (GenBank sequence 
X07384). Digestion pattems of the 935 bp PCR product are shown on the right. Nl to 
N7 are unrelated normal individuals, N8 to N13 represent NBCCS patient DNA 
templates. The inferred genotype is shown below each lane. Controls are digested 
products from the pcDNA3-hGlil ("G") and pRK7-N-Myc-hGli ("A") plasmids. Ladder 
is "Ikb ladder" from Gibco BRL. 
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It seems unlikely that the sequence present in the pcDNA3-hGlil construct causes the severe 
decrease in potency compared with pRK7 N-Myc-hGli, since homozygotes of both allele 
types were found within normal individuals. Studies to estabUsh conclusively whether the 
position 2876 A variant had impaired function were considered beyond the scope of this 
thesis, and this issue was not investigated further. 
Appendix D: Publications Arising from 
Thesis 
Ingram W. J., Wicking C. A., Grimmond S. M., Forrest A. R. and Wainwright B. J. (2002). 
Novel Genes Regulated by Sonic Hedgehog in Pluripotent Mesenchymal Cells. 
Oncogene. 21(53): 8196-8205. 
Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells
Wendy J Ingram1,2,3, Carol A Wicking1,3, Sean M Grimmond1, Alistair R Forrest1 and
Brandon J Wainwright*,1,2,3
1Institute for Molecular Bioscience, The University of Queensland, Queensland 4072, Australia; 2Department of Biochemistry and
Molecular Biology, The University of Queensland, Queensland 4072, Australia; 3Cooperative Research Centre for Discovery of
Genes for Common Human Diseases, 576 Swan St, Richmond, Victoria 3121, Australia
Sonic Hedgehog is a secreted morphogen involved in
patterning a wide range of structures in the developing
embryo. Disruption of the Hedgehog signalling cascade
leads to a number of developmental disorders and plays a
key role in the formation of a range of human cancers.
The identification of genes regulated by Hedgehog is
crucial to understanding how disruption of this pathway
leads to neoplastic transformation. We have used a Sonic
Hedgehog (Shh) responsive mouse cell line, C3H/10T1/2,
to provide a model system for hedgehog target gene
discovery. Following activation of cell cultures with Shh,
RNA was used to interrogate microarrays to investigate
downstream transcriptional consequences of hedgehog
stimulation. As a result 11 target genes have been
identified, seven of which are induced (Thrombomodulin,
GILZ, BF-2, Nr4a1, IGF2, PMP22, LASP1) and four
of which are repressed (SFRP-1, SFRP-2, Mip1-g, Amh)
by Shh. These targets have a diverse range of putative
functions and include transcriptional regulators and
molecules known to be involved in regulating cell growth
or apoptosis. The corroboration of genes previously
implicated in hedgehog signalling, along with the finding
of novel targets, demonstrates both the validity and
power of the C3H/10T1/2 system for Shh target gene
discovery.
Oncogene (2002) 21, 8196 – 8205. doi:10.1038/sj.onc.
1205975
Keywords: Sonic Hedgehog; downstream target genes;
C3H/10T1/2; microarray
Introduction
Members of the hedgehog (Hh) protein family are potent
secreted morphogens, involved in regulating a diverse
range of developmental processes in the mammalian
embryo. From the formation of organs such as lung and
gut, to the development of bone and cartilage, control of
CNS cell specification, patterning of the limbs, develop-
ment of hair follicles and decisions of left-right
asymmetry, signals from hedgehog molecules are vital
(reviewed by Ingham andMcMahon, 2001). In mammals
the family is represented by three proteins, Desert (Dhh),
Indian (Ihh) and Sonic Hedgehog (Shh), the latter of
which appears to play the most widespread develop-
mental role. Shh undergoes auto-cleavage and post-
transcriptional modifications, including the addition of a
cholesterol moiety, before the N-terminal active form
(Shh-N) is released from secreting cells (Porter et al.,
1996). The Hh signal is received by the transmembrane
receptor Patched, and transmitted through a regulatory
cascade. Upon binding Hh, Patched releases its inhibi-
tion of Smoothened (Smo), a transmembrane protein
reminiscent of the frizzled family of Wnt receptors. Smo
is then free to transmit the signal downstream, a major
consequence being control of the Gli family of
transcription factors, through which many of the effects
of Hh are thought to be mediated.
Disruption of the Hh signalling pathway is a major
determinant of tumour formation, particularly for the
common skin cancer basal cell carcinoma (BCC). This
was established from the discovery that Patched is
mutated in the familial cancer predisposition disorder
nevoid basal cell carcinoma syndrome (NBCCS), as
well as in many sporadic BCCs (Hahn et al., 1996;
Johnson et al., 1996). In addition to the role of Patched
as a tumour suppressor, other members of the Hh
pathway, including Smo and Gli1, have been implicated
as oncogenes in a range of tumour types (reviewed by
Wicking et al., 1999). Consistent with its pivotal role in
embryonic development, aberrant hedgehog signalling
is also associated with a range of human developmental
anomalies (reviewed by Villavicencio et al., 2000).
The pluripotent mesenchymal mouse embryonic cell
line C3H/10T1/2 (hereafter abbreviated to 10T1/2) is
responsive to Shh stimulation, with pathway activation
leading to cellular differentiation. A large proportion of
Shh stimulated 10T1/2 cells enter the osteoblastic
lineage, leading to a dramatic increase in alkaline
phosphatase activity which can be readily assayed
(Kinto et al., 1997; Nakamura et al., 1997; Spinella-
Jaegle et al., 2001). Studies in 10T1/2 cells have lead to
a greater understanding of the functions of Shh
(Pepinsky et al., 1998, 2000; Williams et al., 1999;
Saeki et al., 2000), Smo (Murone et al., 1999) and Gli
family members (Ruiz i Altaba, 1999), as well as
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2002
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providing a means to investigate comparative effects of
vertebrate Hh proteins (Pathi et al., 2001). In this study
we have extended the use of 10T1/2 cells to provide a
useful model system for the discovery of novel
downstream target genes regulated by the Hh pathway.
Genes downstream of Shh are thought to provide
the messages that tell cells how to differentiate or when
to divide. Little is known about how dysregulation of
these target genes is involved in neoplastic transforma-
tion. In order to answer this question we need to
identify genes controlled through Hh signalling, and
determine how their expression is affected by pathway
activation. To date only a small number of target genes
have been described in vertebrate tissues. These include
HNF-3b (Roelink et al., 1995) and COUP-TFII
(Krishnan et al., 1997) in the developing neural tube,
SWiP-1 (Vasiliauskas et al., 1999) and SFRP-2 (Lee et
al., 2000) in somitic mesoderm, and angiopoietin2 in
developing vasculature (Pola et al., 2001). Other tissue-
specific targets include members of the BMP (Bitgood
and McMahon, 1995), PAX (Ericson et al., 1996),
SOX (Hargrave et al., 2000) and TBX (Gibson-Brown
et al., 1998; Garg et al., 2001) families. Hedgehog-
interacting protein (HIP) is a target in a number of cell
types adjacent to Hh expressing regions, and is thought
to act as an antagonist of Hh signalling (Chuang and
McMahon, 1999). In all systems studied to date the
Patched gene is a target of its own repression, and its
transcription is elevated upon stimulation with Hh.
This up-regulation may antagonise further Hh stimula-
tion, or may play a direct role in cell cycle control as
Patched is reported to interact with Cyclin B1 (Barnes
et al., 2001).
A model system ideally suited to screening for
expression changes in as yet unidentified downstream
genes has been established by activating the Hh
pathway in 10T1/2 cells and using known target genes
as markers of the response. This approach has proved
successful, with a number of novel Shh target genes
identified, and targets previously reported in other cell
types being corroborated, using cDNA microarrays.
The newly discovered Shh target genes encode
molecules involved in nerve formation, transcriptional
regulators, putative Wnt signalling antagonists, and
various genes with roles in growth or apoptosis. Our
finding of novel Shh regulated genes provides candi-
dates whose abnormal expression may be decisive in
initiating tumour formation in a range of human
cancer types.
Results
Cell-to-cell contact is required before 10T1/2 cells become
fully responsive to Shh
Initial experiments involving transient transfection of a
Shh-N expression construct (pShh-N-PMT21) and
analysis of the response of known target genes
suggested that 10T1/2 cells may not become fully
responsive to Shh until the cells reach confluence (2
days post-transfection). We have previously observed
that cells treated with Shh conditioned media show
more rapid response times with several markers if the
cells are already confluent at the time of Shh addition
(data not shown). Experiments were conducted to
investigate a possible relationship between cell density
and the ability of these cells to respond to Shh. Using
alkaline phosphatase (AP) activity as a marker of Shh
induced osteoblastic differentiation, cells were found to
respond more strongly as initial seeding density was
increased prior to stimulation with Shh conditioned
media (Figure 1). To show that this effect was due to
Figure 1 Effect of cell contact on Shh response in 10T1/2 cells.
Error bars represent +/71 standard deviation. (a) Alkaline phos-
phatase (AP) assays performed on cells at a range of initial den-
sities and stimulated for 7 days with Shh conditioned media show
a correlation between increasing starting cell density and AP ac-
tivity. Each data point represents four replicate wells. (b) AP as-
says performed on pools of cells with equal starting densities but
differing degrees of allowed density show cell contact is required
for a full response to Shh. Cell pools were trypsinized every 3
days. Cells permitted to reach confluence were allowed to re-ad-
here at current density, whilst cells for which contact was limited
were split over a number of dishes. Stimulation with Shh condi-
tioned media was maintained for 9 days prior to assay. Cells were
counted prior to assay to ensure equivalent numbers were har-
vested at end of growth period. Each data point represents three
replicate pools of cells
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cell density, and did not simply reflect a higher
percentage of cells being stimulated from the outset,
a second experiment was conducted where the level of
cell contact was limited. This was achieved by
continuously stimulating pools of cells, all with the
same initial seeding level, and trypsinising every third
day in order to control cell density. Cells which were
allowed to reach confluence displayed a strong AP
response, whilst cells in which cell contact was limited
throughout the 9 day stimulation period had no
detectable increase in AP activity (Figure 1).
Establishing timing of response to Shh using known
downstream target genes
In order to determine the most appropriate timepoints
to harvest cells for microarray analysis, responses of a
number of known Shh target genes were investigated
by Northern blotting following Shh transfection. 10T1/2
cultures were transiently transfected with either wild-
type Shh-N (pShh-N-PMT21) or a truncated function-
ally null (as shown by Figures 1 – 4 and 6, and other
data not shown) mutant construct (pD64-Shh-N-
PMT21). Cells were harvested at intervals from 3 h
to 5 days post-transfection, and RNA used for
Northern analysis. The first observed responses were
the up-regulation of Patched and Gli1, initially detected
2 days post-transfection, and continuing to increase
over following days (Figure 2). Up-regulation of
Hedgehog interacting protein (HIP) was observed later,
4 days post-transfection. Patched2 up-regulation was
also observed in this late timeframe (Figure 3).
Induction of Angiopoietin2 and HNF-3b transcription
was observed in an intermediate timeframe, as was an
increase in alkaline phosphatase enzyme activity (data
not shown). As a result of these investigations,
timepoints from 24 – 96 h were chosen for microarray
analysis. This range was chosen to maximize the
chance of finding both early target genes and genes
responding in a similar fashion to Patched2 and HIP.
Microarrays yield novel target genes regulated by Sonic
Hedgehog
Microarrays containing 3936 clones from a normalized
mouse embryonic branchial arch (NMEBA) library, the
mouse UniGene set, and a number of other known
genes were screened. Pair-matched experiments were
conducted with Shh-N and the null-mutant control to
obtain RNA for microarray analysis at 24, 48, 72 and
96 h timepoints for cells stimulated by transient Shh
transfection, and at 72 and 96 h for cells treated with
Shh conditioned media. Conditioned media experiments
complemented the transfection studies to maximize the
chances of target gene discovery and provide a further
level of confirmation for Shh responsive genes. Twelve
microarray experiments were performed, with two
duplicate RNA samples hybridized to slides at each
timepoint for both conditioned media and transfection
studies. Each slide contained two duplicate sets of the
spotted clones, positioned in separate blocks. The null-
mutant control construct was designed so that the cell
would produce a near full length Shh-N mRNA but a
highly truncated protein. This was used rather than an
empty vector control to ensure the general transcription
and translation mechanisms of the cells were stimulated
in both the reference and test RNA populations,
minimizing false positive results.
Microarray spots were considered for further
investigation if the geometric mean of normalized
ratios for induction or repression was above twofold
in any one time/treatment combination, or above 1.5-
fold in multiple time/treatment combinations. Putative
target genes were used to probe a set of blots
containing RNA from each investigated timepoint for
both conditioned media and transient transfection.
RNA for blots was isolated from transfections
independent of those used to perform microarray
analysis. Genes that showed obvious regulation by
Shh were used to probe a further set of RNA blots as a
second validation (where independent plasmid prepara-
Figure 2 Northern blots showing early responses of known tar-
get genes to Shh in 10T1/2 cells. RNA obtained from cells trans-
fected with pShh-N-PMT21 (Shh-N) or pD64-Shh-N-PMT21
(mutant) plasmids, or treated with conditioned media collected
from cells expressing the same constructs. (a) Up-regulation of
full length Patched mRNA (transcript 1) and alternate transcripts
(2 and 3) in response to Shh. Transcript 4 is not regulated by Shh.
(b) Up-regulation of Gli1 transcripts in response to Shh stimula-
tion by transfection and conditioned media treatment. GAPDH
probe provides loading control
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tions were used for transfection). Those which showed
altered expression in all stimulation experiments were
considered genuine Shh target genes and are presented
in Tables 1 and 2.
Validated targets were identified from within all
three sets of genes present on the microarrays, with
data for GILZ, BF-2, IGF2 and SFRP-2 obtained from
multiple independent clone spots. Clones for GILZ,
SFRP2 and BF-2 were present in the NMEBA and
UniGene sets. The Shh targets showed detectable
expression changes in the range of 3 to 4 days, with
the majority of the genes showing a detectable response
at 2 days. No validated target responses were identified
at 24 h. As with known targets investigated in pilot
studies, the earliest observed responses appear to
correlate with the time the cells form a confluent
monolayer.
The induced genes generally showed increased
changes in expression as the timecourse progressed.
The two Shh repressed SFRP genes behaved in a
similar fashion to each other. In the absence of Shh
these genes showed an increase in expression level with
increasing cell density or time in a monolayer
environment. Upon stimulation with Shh, this increase
in expression over time was inhibited (Figure 4). Fold
change data from the four day transient transfection
and conditioned media treatments has been included in
Tables 1 and 2, and generally represents the maximal
response for the timepoints investigated. Northern
blots of RNA from stimulated and control treated
cells for a selection of the novel target genes identified
in this work are shown in Figure 4.
IGF2, BF-2, Amh and SFRP-2 are regulated by Gli1
There is evidence to suggest that hedgehog signalling is
frequently mediated by the Gli genes, but that this is
not exclusively the case. We investigated a number of
the newly identified target genes in 10T1/2 cells to find
out whether they were regulated by an elevation in Gli1
transcription. Cells were transiently transfected with a
Gli1 expression construct, and RNA from these cells
and appropriate controls was collected at 12, 24, 48
Figure 3 Northern blots showing late responses of known target
genes to Shh. (a) Multiple transcripts of Hedgehog interacting pro-
tein (HIP) are up-regulated by pShh-N-PMT21 (Shh-N) or pN-
Myc-hGli-PRK7 (Glil) expression in 10T1/2 cells. GAPDH probe
provides loading control. (b) Poly(A)+ blot of pShh-N-PMT21
(Shh-N) or pD64-Shh-N-PMT21 (mutant) transfected RNA at 4
days post-transfection. The full length Patched2 mRNA (tran-
script 1) is significantly up-regulated by Shh when assessed by
GAPDH normalized densitometry Figure 4 Northern blots showing responses of a selection of Shh
target genes identified by microarray. RNA obtained from 10T1/2
cells transfected with pShh-N-PMT21 (Shh-N) or pD64-Shh-N-
PMT21 (mutant) plasmids, or treated with conditioned media col-
lected from cells expressing the same constructs. GAPDH probe
provides loading control. (a) Peripheral myelin protein 22
(PMP22) and Brain factor 2 (BF-2) show up-regulation, whilst Se-
creted frizzled related protein 2 (SFRP-2) shows an inhibition in
the increased expression level that is observed in control cells over
time. (b) Thrombomodulin (Thbd) is up-regulated by Shh. (c) Nu-
clear receptor subfamily 4, group A, member 1 (Nr4a1) is up-regu-
lated by Shh
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and 72 h timepoints. Two of the Shh induced genes,
IGF2 and BF-2, showed up-regulation in response to
Gli1, whilst Shh repressed genes Amh and SFRP-2
were down-regulated by Gli1 (Figure 5). Thrombomo-
dulin, LASP1 and Mip1-g did not show any detectable
response to Gli1 transfection.
GILZ appears to be the only TSC-22 family member
regulated by Shh in 10T1/2 cells
The TSC-22 family in mammals has three characteristic
members, Transforming growth factor b stimulated
Clone-22 (TSC-22), TSC-22 homologue 1 (Thg1; also
called Thg-1pit in mouse), and Glucocorticoid Induced
Leucine Zipper (GILZ), the latter of which was
identified in the present study as a target of Shh
signalling. In Drosophila the family is represented by a
single gene, bunched/shortsighted, which is implicated in
decapentaplegic (dpp) signalling in the developing eye
(Treisman et al., 1995; Dobens et al., 1997, 2000). The
fact that Hh is responsible for controlling dpp
expression in Drosophila, combined with the recent
discovery that TSC-22 is down-regulated by stable Gli1
expression in rat kidney cells (Yoon et al., 2002),
makes this family of particular interest in the Shh
pathway. All three members of this family were
investigated in the 10T1/2 system. Whilst the induction
of GILZ on microarrays and northerns was strong and
reproducible, no evidence was found of detectable
change to the basal expression level of TSC-22 or Thg1
on northerns upon Shh stimulation (Figure 6). The
absence of a response of TSC-22 to Shh in 10T1/2
cells, even though TSC-22 is a known target of Gli1,
highlights the fact that different response profiles are
present in different tissue systems.
Discussion
Microarrays containing 3936 cDNA elements were
screened to identify novel targets of Shh signalling in
the 10T1/2 embryonic mouse cell line, which has the
ability to differentiate into a variety of mesodermal cell
lineages. A range of strategically chosen timepoints,
based on responses of known Shh pathway targets in
10T1/2 cells, were used to maximize the chance of
Table 1 Downstream targets induced by Sonic Hedgehog in 10T1/2 cells identified by microarray approach and confirmed by Northern
blotting
4 day T 4 day CM
Gene induced by Sonic Hedgehog Function MA Nth MA Nth
Glucocorticoid induced leucine Putative transcriptional regulator; 1.9 3.8 3.3 7.4
zipper (GILZ) protein – protein interactions (1.2, 3.0) (2.1, 5.3)
Brain factor 2 (BF-2) Winged helix/forkhead transcription 1.9 4.3 2.2 6.6
factor (1.7, 2.1) (1.2, 3.9)
Thrombomodulin (Thbd) Membrane receptor; regulation of blood 2.2 3.3 2.6 6.7
coagulation; putative growth factor (1.3, 3.3) (1.8, 3.6)
Nuclear receptor subfamily 4, Orphan nuclear receptor; putative 3.8 1.7 1.5 1.4
group A, member 1 (Nr4a1) transcription factor (2.0, 8.3) (1.3, 1.7)
Insulin-like growth factor 2 (IGF2) Regulation of somatic growth and cellular N/A 2.5 3.1 7.8
proliferation (2.0, 3.6)
Peripheral myelin protein 22 (PMP22) Myelination in the peripheral nervous N/A 2.0 1.8 2.9
system; putative growth factor (1.5, 1.9)
Lim and SH3 protein 1 (LASP1) Binds actin; role in signalling pathways 1.6 1.1 1.9 2.0
organising cytoskeleton (0.4, 9.1) (1.7, 2.3)
T=transfection; CM=conditioned media. Fold changes shown are geometric mean of normalized microarray ratios (MA), or Northern blot
densitometry data after standardizing to a GAPDH loading control (Nth). N/A indicates signal strength below noise threshold at this timepoint.
Values in brackets indicate data range (min, max) from microarray analysis. A value of one represents no change
Table 2 Downstream targets repressed by Sonic Hedgehog in 10T1/2 cells identified by microarray approach and confirmed by
Northern blotting
4 day T 4 day CM
Gene repressed by Sonic Hedgehog Function MA Nth MA Nth
Secreted frizzled related protein 1 (SFRP-1) Wnt signalling antagonist/regulator 79.4 76.3 73.8 74.1
(76.1, 714) (73.2, 75.7)
Secreted frizzled related protein 2 (SFRP-2) Wnt signalling antagonist/regulator 76.8 76.7 74.6 719.0
(72.1, 715) (71.7, 714)
Anti-mullerian hormone (Amh) TGFb family glycoprotein; regression 75.9 76.1 73.5 76.1
of mullerian duct (75.5, 76.3) (72.3, 76.2)
Macrophage inflammatory protein-1 gamma Chemokine; pyrogen 75.8 72.2 72.5 73.8
(MIP1-g) (71.7, 73.0) (71.8, 74.3)
T=transfection; CM=conditioned media. Fold changes shown are obtained from the geometric mean of normalized microarray ratios (MA), or
Northern blot densitometry data after standardizing to a GAPDH loading control (Nth), ‘7’ indicates down-regulation. Values in brackets
indicate data range (min, max) from microarray analysis. A value of one represents no change
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identifying novel target genes upon activation by Shh
transfection. Stimulation with conditioned media was
used to complement the transfection studies. Validation
of microarray leads by Northern blotting allowed us to
establish 11 targets of Shh stimulation in 10T1/2 cells,
seven of which were induced (Thrombomodulin (Thbd),
Glucocorticoid induced leucine zipper (GILZ), Brain
factor 2 (BF-2), Nuclear receptor subfamily 4, group A,
member 1 (Nr4a1), Insulin-like growth factor 2 (IGF2),
Peripheral myelin protein 22 (PMP22), Lim and SH3
Protein 1 (LASP1)), and four of which were repressed
(Secreted frizzled related proteins 1 and 2 (SFRP-1 and
SFRP-2), Macrophage inflammatory protein-1 gamma
(MIP1-g), and Anti-mullerian hormone (Amh)). The
majority of these represent novel downstream genes
not previously reported as targets of Shh.
In this work cDNA microarrays have proved an
extremely powerful tool for the discovery of Shh target
genes, however it proved important to address
limitations of this approach. The spotted UniGene
clone set was found to have evidence of cross-
contamination, and 16% of clones did not match their
expected identity. Similar observations with arrayed
cDNA clone sets have been reported by other
researchers (Halgren et al., 2001). Thus it was crucial
to individually sequence and validate pure plasmid
species from each clone of interest to determine true
identities. Only genes showing consistent and repea-
table induction or repression, and confirmed
independently by Northern blotting, are presented as
Shh target genes in this work.
In preliminary experiments it became apparent that
there was an unexpected lag after Shh transfection
before downstream transcriptional responses were
observed. This was further supported by the micro-
array data, where targets were not detected prior to the
48 h timepoint. It was shown that this was due to a
requirement for 10T1/2 cells to reach high density
before a full response to Shh was initiated. A similar
effect has previously been described in the NIH3T3 cell
line (Taipale et al., 2000), and it will be interesting to
see if density-dependent cofactors of Shh activation are
identified in future studies.
Several target genes discovered by our microarray
approach have previously been described in other
systems. IGF2 is implicated as a Hh target due to its
elevation in rhabdomyosarcoma and normal tissue
from Patched knockout mice (Hahn et al., 2000). The
Figure 5 Northern blots of 10T1/2 cells transiently transfected
with a human Gli1 expression construct (pN-Myc-hGli-PRK7)
or empty vector control show newly identified Shh target genes
also regulated by Gli1. (a,b) Expression of Insulin-like growth fac-
tor 2 (IGF2) and Brain factor 2 (BF-2) is induced in response to
Gli1. (c,d) Expression of Secreted frizzled related protein 2
(SFRP-2) and Anti-mullerian hormone (Amh) is repressed by
Gli1. All genes shown gave greater than 1.5-fold changes in ex-
pression at two or more timepoints when quantified by GAPDH
normalized densitometry
Figure 6 Regulation of members of the TSC-22 family by Shh.
Northern blots of RNA from 10T1/2 cells transfected with
pShh-N-PMT21 (Shh-N) or pD64-Shh-N-PMT21 (mutant) plas-
mids, or treated with conditioned media collected from cells ex-
pressing the same constructs. GAPDH probe provides loading
control. Glucocorticoid induced leucine zipper (GILZ) was identi-
fied by microarray as a downstream target of Shh, and shows
up-regulation by Northern blot when stimulated by transfection
or conditioned media treatment. In contrast, two other known
members of this gene family, TGFb-stimulated clone 22 (TSC-
22) and TSC-22 homologue 1 (Thg1), do not show regulation by
Shh in 10T1/2 cells (using GAPDH normalized densitometry) at
the timepoints investigated
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corroboration of such findings further validates our
model system. SFRP-1 and 2 have previously been
reported as targets in presomitic mesoderm where both
genes are induced by Shh (Lee et al., 2000). In contrast
Shh inhibited the expression of both genes in 10T1/2
cells, showing that target genes may respond differently
in different tissue contexts, presumably under the
control of additional factors.
A number of the verified downstream targets of Shh
show altered expression in human cancer tissue, or are
known to be involved in tumourigenesis. For example
LASP1 is amplified frequently in breast carcinomas,
where it is thought to cause cytoskeletal changes during
neoplastic transformation (Bieche et al., 1996). Throm-
bomodulin also shows expression changes in a variety
of cancers, and has been hypothesized to play a role in
tumour invasion and metastasis (Wilhelm et al., 1998).
Putative roles in apoptosis control are features of a
number of the identified Shh target genes, including
Nr4a1, GILZ, SFRP-1 and SFRP-2 (D’Adamio et al.,
1997; Melkonyan et al., 1997; Li et al., 2000). The
aberrant expression of such genes when Hh pathway is
perturbed may be a factor in tumour formation.
SFRPs bind Wnt proteins and are thought to regulate
Wnt function (reviewed by Polakis, 2000). The Wnt
pathway, and the genes controlled by it, are strongly
implicated in cancer formation, particularly in color-
ectal cancer, where mutations in the tumour suppressor
APC activate a Wnt response through the stabilization
of b-catenin (reviewed by Taipale and Beachy, 2001).
The Hh pathway may provide a mechanism to
modulate Wnt signalling in vertebrates through the
regulation of SFRP-1 and SFRP-2, and predispose
cells to neoplasia when this control is disrupted.
Other newly identified Shh target genes have putative
roles in growth regulation. PMP22 encodes a protein
component of the myelin sheath of peripheral nerves
which is also implicated as a growth factor (Jetten and
Suter, 2000). Though this gene has not previously been
implicated in Hh signalling, Dhh is involved in the
development of the peripheral nerves and may regulate
PMP22 during this process. Another induced gene,
Thrombomodulin (Thbd), encodes a receptor that forms
a complex with thrombin to reduce the rate of blood
clotting. It is unclear what role this gene might play in
embryonic mesodermal cells, however Thbd knockout
mice display embryonic lethality before the cardiovas-
cular system develops, suggesting a function for Thbd
in development independent of its anticoagulant
activities (Healy et al., 1995; Weiler-Guettler et al.,
1996). Further studies have proposed mechanisms by
which Thbd and Thrombin may be involved in
controlling cell proliferation (reviewed by Freedman,
2001), though a link to the Hh pathway has not
previously been described.
Expression of Gli1 in 10T1/2 cells caused an
expression change for some Shh target genes but not
others, suggesting Gli1 is not an exclusive mediator of
Shh signalling in embryonic mesodermal cells. Strong
evidence already exists for bifurcation of the pathway,
with Shh regulating at least one target gene, COUP-
TFII, through a Gli independent mechanism (Krishnan
et al., 1997). Expression changes in IGF2, BF-2, Amh
and SFRP-2 in response to Gli1 transfection provide a
further level of evidence for these genes as bona fide
downstream targets of Shh signalling. DNA binding
studies have indicated that human Gli1 binds the nine
base pair consensus sequence GACCACCCA (Kinzler
and Vogelstein, 1990), with functional assays confirm-
ing a number of closely related sequences are also
bound by Gli proteins in a range of species (Alexandre
et al., 1996; Sasaki et al., 1997; Gustafsson et al., 2002;
Yoon et al., 2002). Analysis of available upstream
promoter sequence obtained from the Celera mouse
database showed a number of putative and known Gli
binding motifs to be present in each of the four Shh
target genes shown to be regulated by Gli1. This
suggests that the regulation of these genes by Gli1 is
via a direct mechanism, though this is speculative and
awaits detailed functional studies.
Two recent studies have also used microarrays to
investigate aspects of the Hh signalling pathway. Kato
et al. (2001) transfected a neuroepithelial cell line with
a Shh expression construct and identified two target
genes, whilst Yoon et al. (2002) used RNA derived
from transformed foci generated by stable Gli1
expression, revealing 30 Gli1 target genes in rat
epithelial kidney cells. The genes identified in these
studies are distinct from those reported in this work.
This may reflect tissue specific pathway responses,
differences in potency and timing of stimulation
methods, or a lack of overlap between cDNA sets
used in studies to date.
An investigation of one gene family of interest
showed that although the transcriptional regulator
GILZ is a strongly regulated target of Shh in 10T1/2
cells, the related gene TSC-22 does not show evidence
of regulation in this cell type, even though it has
previously been identified as a down-regulated target of
Gli1 in kidney cells (Yoon et al., 2002). This highlights
the fact that Hh proteins can induce quite different
responses in different cell types and tissue environ-
ments. Presumably Hh signalling is influenced
considerably by a variety of fine tuning mechanisms
and regulating factors, which vary spatially and
temporally, allowing Hh to display such a diverse
range of patterning functions in the developing
embryo.
Our finding of both previously known and novel
target genes in the 10T1/2 system shows the power of
this approach for Shh target gene discovery in
pluripotent mesoderm. The diverse functions of Shh
target genes identified in 10T1/2 cells are a reflection of
the plasticity of this cell type. Microarrays used in this
work contained a relatively small percentage of genes
from the mouse genome, and future studies will be
possible with substantially larger cDNA sets. Expres-
sion studies with the murine target genes and their
human homologues in normal tissues and NBCCS
related tumours will further elucidate their importance
in development and disease. It is hoped that the
discovery of such genes controlled by hedgehog
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signalling will provide vital clues to the aetiology of
various human neoplasms, and that understanding of
their roles may provide greater opportunities in the
future design of anti-tumour therapies.
Materials and methods
Cell culture, transient transfection and conditioned media
production
C3H/10T1/2 Clone 8 cells (Reznikoff et al., 1973) were
obtained from the American Type Culture Collection (at
passage 10), and maintained in Dulbecco’s Modified Eagle’s
Medium supplemented with streptomycin (50 mg/ml), peni-
cillin (50 units/ml) and Serum Supreme (9.1%, BioWhittaker).
Stock cells were plated at 2000 cells/cm2, never allowed to
reach confluence and discarded at passage 20. For pathway
activation a construct encoding the active N-terminal domain
(amino acids 1 – 198) of mouse Sonic Hedgehog in pMT21
(pShh-N-PMT21), or a null mutant version of this construct
containing a 64 bp deletion of the start ATG region (pD64-
Shh-N-PMT21), were transiently transfected into cells.
Transfection was performed with lipofectamine plus (Invitro-
gen) 3.5 days after seeding at 2000 cells/cm2, when the cells
approximately 80% confluent. Alternatively, conditioned
media (diluted 1 : 1) was used for Shh stimulation, with time
zero at same density as transfection initiation.
Conditioned media was produced by collecting 3 day post-
transfection growth media from pShh-N-PMT21 and pD64-
Shh-N-PMT21 treated cells, and centrifuging at 3000 g for
5 min to remove cell debris. Media from a number of
production plates was pooled to give a large volume stock to
ensure stimulation with an equal concentration of Shh in all
experiments. This was tested in 10T1/2 cells and shown to be
potent in inducing alkaline phosphatase (AP) activity. The
activity of conditioned media produced by this method was
found to be quite stable when stored at 48C, and achieved
consistently higher levels of AP induction than 1 mg/ml of
commercial recombinant Shh protein (#461-SH, R&D
systems Inc.) when small scale 7-day quantitative assays were
performed in parallel (data not shown).
Activation with Gli1 was by transient transfection of
human Gli1 cDNA in the vector pRK7 (pN-Myc-hGli-
PRK7; Murone et al., 1999), using empty pRK7 as a negative
control. In all activation experiments with Shh or Gli1, a
subset of cells grown on coverslips were removed prior to
RNA isolation and histochemically assayed for AP to ensure
transfection had been successful in initiating a strong
pathway response in a large percentage of cells.
Alkaline phosphatase assays
Alkaline phosphatase (AP) activity was detected using a
histochemical procedure, modified from Katagiri et al. (1994).
Cells were fixed with 4% PFA for 10 min, washed with PBS
and incubated with AP staining reagent (0.09 mg/ml Fast
Blue BB salt, 0.5% dimethylformamide, 0.1 mg/ml Naphthol
AS-MX phosphate, 2 mM MgCl2, 0.1 M Tris-HCl pH 8.5) for
1 h. Additionally, quantitative measurement was performed
using the ALP Procedure 104 kit (Sigma Diagnostics), using
0.9% NaCl with 0.2% Triton X-100 for cell lysis. Sample
inputs were normalised to total protein concentration
measured with Bradford reagent. Each reaction was read in
triplicate at 415 nm against p-Nitrophenol standards (Sigma
Diagnostics), with a secondary read after acid addition to
correct for background lysate absorbance.
Microarray hybridization and analysis
Microarray chips were manufactured by the IMB microarray
facility. These consisted of PCR products spotted onto poly-
L-lysine coated glass slides using standard protocols. Chips
contained 3936 spots which were duplicated in separate
blocks on each slide. Spots represented 1594 cDNA clones
from the mouse UniGene set (Research Genetics); 1920
cDNA clones from a normalised mouse embryonic branchial
arch library (NMEBA; constructed by B Soares, University
of Iowa, IA, USA); and a further 422 spots including control
spots and various mouse and human clones.
Total RNA samples (40 – 65 mg) from treatment and pair-
matched control samples were labelled with cy-5 or cy-3
dUTP, using oligo d(T) primer and Superscript II reverse
transcriptase (Invitrogen). RNA was removed by alkaline
hydrolysis. Labelled cDNA was purified using YM-30
microcons (Millipore). Hybridization (in 0.25 mg/ml CotI
DNA, 0.5 mg/ml Poly d(A), 46SSC, 0.5% SDS, 50%
formamide) was performed overnight at 458C, under cover-
slips in humidified chambers. Slides were washed for 3 min in
0.26SSC/0.056SDS, and 263 min in 0.26SSC, prior to
obtaining fluorescence images with a Genetic MicroSystems
G418 scanner. RNA from each treatment-timepoint combi-
nation was hybridized to two independent microarray chips,
giving a total of 12 hybridizations.
Spot intensities were quantified using ImaGene software
(BioDiscovery). Normalization and statistical analysis of
local background adjusted signals was performed with
spreadsheets, and also using the GeneSpring package (Silicon
Genetics). In the former normalization was performed by
applying a constant to all values such that the average
intensity of spots on both channels was equivalent, in
accordance with Hegde et al. (2000). Data was filtered so
that spots were only considered for analysis when one or
both channels had a significant signal. GeneSpring analysis
was performed with the data normalized using the median of
signals on each channel as a synthetic positive control.
Clones corresponding to spots of interest were obtained
from the IMB microarray facility. Plasmids from pure
cultures were sequenced with M13 primers (Hegde et al.,
2000). Identity was established using BLAST and the
GenBank database (NCBI). Plasmids were digested to
liberate insert without poly(A)+ tail were possible, separated
on agarose gel and purified with Geneclean (Biol 101), ready
for use as Northern probes.
RT–PCR generation of additional cDNA probes
Probes for mouse Thg-1pit and TSC-22 were generated by
RT–PCR using M-MLV reverse transcriptase for cDNA
synthesis (Invitrogen). Products were purified by Ultraclean
PCR cleanup (MoBio) prior to use as probes on Northern
blots. Primers for 1530 bp TSC-22 product 5’-tttgaac-
caggctgctggag-3’ (forward) with 5’-gcgcagaacgactatacaggt-
gag-3’ (reverse); and for Thg-1pit as in Fiorenza et al. (2001).
RNA isolation and Northern blotting
Total RNA was prepared using the RNeasy RNA isolation
kit (Qiagen), with poly(A)+ isolated using Message Maker
(Life Technologies, GIBCO–BRL) when required. Northern
analysis of 10 mg total (or 2 mg poly(A)+) RNA was
performed by electrophoresis on 1% agarose/formaldehyde
gels with transfer to Magna nylon membrane (Osmonics).
Pre-hybridization (4 h) and hybridization (overnight) were
performed in 56SSPE, 56Denhardts, 0.5% SDS in 50%
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formamide at 428C. Probes were labelled with 32P by random
priming (Rediprime II, Amersham Pharmacia), and purified
on G-50 sephadex. Bands were detected by autoradiography
using Kyokko High Plus intensifying screens (Fuji). Auto-
radiograms were quantified using a GS-700 imaging
densitometer (Bio-Rad). A 600 bp fragment of the mouse
GAPDH cDNA was used as a loading control probe.
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